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ABSTRACT 
Chronic conditions have an impact on the quality of life (QoL) of families as well as patients 
themselves, and the two are often linked; the greater the effect on the patient, the more the 
QoL of the family members is reduced. Research into family QoL exists in several medical 
specialties, but studies have usually been focused on carers or families of patients with one 
specific disease. Currently, there is no generic instrument that can be used to measure the 
impact of illnesses on the partner or family members of patients. This study describes the 
development of the Family Reported Outcome Measure (FROM-16)
©
. The aims of this study 
were to investigate the impact of disease on family members of patients over a wide range of 
specialties, identify key impact areas and develop a generic family quality of life measure. 
Semi-structured interviews were carried out with 133 family members of patients from 26 
medical specialties. Family members were invited to discuss all the areas of their lives that 
had been affected by having an unwell relative. Thematic analysis was carried out using 
NVivo9© software. A preliminary 31-item measure was developed from the content of the 
interviews with family members. Content validity was assessed using qualitative and 
quantitative data from expert panels involving clinicians and family members. A separate 
cohort of 240 family members was recruited for both Rasch analysis and factor analysis to 
reduce items. A further 120 family members completed the final version of the FROM-16 for 
full psychometric testing including construct validity and reliability.  
Most family members interviewed were female (61%), the partner or spouse of the patient 
(56%) or the parent (22%). The mean age was 56.1 years (range= 21-85) and the mean 
duration of the patient’s disease was 8.9 years (range= one month to 60 years). 10 key 
themes of family quality of life were identified from interviews. The median number of themes 
reported by family members was 6 (range= 1-10). The key themes included: emotional 
impact (mentioned by 92% of subjects), daily activities (91%), family relationships (69%), 
sleep and health (67%), holidays (62%), support and medical care (61%), work and study 
(52%), financial impact (51%), social life (37%), and time planning (14%). Relationships 
between the themes were identified.  
A 31-item generic family quality of life instrument, the Family Reported Outcome Measure 
(FROM)©, with a 5-point Likert response scale was developed. The content validity panel's 
ratings of each item on a 4-point scale for the four attributes showed either "strongly agreed" 
or "agreed" (88%), with an ICC value of 0.98 (CI=0.97-0.99) suggesting a high agreement 
between the panel members' responses.  
Collapsing response categories, removing misfitting items and combining items with residual 
correlations produced a good fit to the Rasch model (n=240, Total χ2 = 56.6, df = 48, p = 
III 
 
0.18). Factor analysis produced a 16-item measure with two factors. The FROM showed high 
internal consistency (n=120, Cronbach’s α= 0.91), high reproducibility (n=51, ICC=0.93) and 
a mean completion time of two minutes. Construct validity was proven through the correlation 
between the FROM and the WHOQOL-BREF total scores (n=119, r=-0.55, p<0.001), and the 
correlation between the FROM and the patient’s overall health score (n=120, r=-0.51, 
p<0.001).  
This large scale multi-specialty study has demonstrated the great, yet similar impact that 
illness can have on the quality of life of family members of patients. Family quality of life is a 
previously neglected area of healthcare which needs to be addressed in order to provide 
better support for the patient and for the family unit.  The FROM is both reliable and valid for 
use in family members of patients. It has a potential for wide use, including clinical (all 
medical specialties), industrial and social sciences. 
 
 
 
 
 
 
 
IV 
 
LIST OF ABBREVIATIONS 
ADHD Attention deficit hyperactivity disorder 
AMED Allied and complementary medicine 
ANOVA One way analysis of variance 
CAT Computer adaptive testing 
CFA Confirmatory factor analysis 
CVI Content validity index 
DFI Differential item functioning 
DIF Differential item functioning 
EFA Exploratory factor analysis 
EMA European Medicines Agency 
FDA Food and drug administration 
FDLQI Family dermatology life quality index 
FROM Family Reported Outcome Measure 
GH Global health 
GHS Global health score 
GP General practitioner 
HIV Human immunodeficiency virus 
HMIC Health management information consortium 
HRQoL Health-related quality of life 
ICC Intraclass correlation 
I-CVI Item content validity index 
KMO Kaiser-Meyer-Olkin 
NICE National Institute of Clinical Excellence 
PASW Predictive Analytics SoftWare Statistics 
PRO Patient reported outcomes 
PSI Person separation index 
QALY Quality adjusted life year 
QoL Quality of life 
S-CVI Scale content validity index 
UHW University Hospital of Wales 
WHO World Health Organisation 
  
V 
 
GLOSSARY OF TERMS 
PRO measure Any report of the status of a patient’s health condition that comes 
directly from the patient, without interpretation of the patient’s 
response by a clinician or anyone else. 
Construct validity Evidence that relationships among items, domains, and concepts 
conform to a priori hypotheses concerning logical relationships that 
should exist with other measures or characteristics of patients and 
patient groups 
Content validity Evidence from qualitative research demonstrating that the 
instrument measures the concept of interest including evidence 
that the items and domains of an instrument are appropriate and 
comprehensive relative to its intended measurement concept, 
population, and use.  
Face validity Whether, on the face of it, the instrument appears to be assessing 
the desired qualities. 
Factor analysis The process of summarising or reducing a large set of variables 
using a smaller set of factors or components. 
Rasch analysis A statistical technique used for investigating what should be 
expected in responses to items if measurement is to be achieved 
Reliability The ability of a PRO instrument to yield consistent, reproducible 
estimates. 
Practicality Describing the feasibility of using an instrument in its intended 
population and clinical setting. 
Sensitivity to change Evidence that a PRO instrument can identify differences in scores 
over time in individuals or groups who have changed with respect 
to the measurement concept. 
Likert scale A bi-polar response scale with descriptors ranging from none or 
little of an attribute at one end, to a lot or maximal at the other end. 
Regression analysis Exploring the predictive ability of a set of independent variables on 
one continuous dependent measure. 
Purposive sampling Sampling with a purpose in mind, or previous knowledge of the 
population. 
Saturation point When interviewing patients, the point when no new relevant or 
important information emerges and collecting additional data will 
not add to the understanding of how patients perceive the concept 
of interest and the items in a questionnaire. 
Thematic analysis A method for identifying, analysing, and reporting patterns 
(themes) within data. It minimally organises and describes a data 
set in rich detail. 
Recall period The period of time patients are asked to consider in responding to 
a PRO item or question. 
 
Adopted from: (Bhatti 2011; Braun and Clarke 2006; FDA 2009; Pallant 2005; Pallant and 
Tennant 2007; Streiner and Norman 2008) 
  
VI 
 
LIST OF TABLES 
Table 1.1 Definitions of Quality of Life 4 
Table 1.2 Results of key search terms 8 
Table 1.3 Summary of studies that included a control group 11 
Table 1.4 Further examples of less common themes identified from the 
literature 
12 
Table 1.5 The characteristics of four family quality of life measures 19 
Table 2.1 The specialties included in the study 25 
Table 3.1 Demographics of family members recruited for interview (n=133)  48 
Table 3.2 Identified themes and subthemes from 133 interviews representing 
26 medical specialties 
49 
Table 3.3 The mean and median number of themes mentioned by family 
members of patients in each medical specialty (in descending 
order) 
54 
Table 4.1 The background of the members of content validity panel A 88 
Table 4.2 The judges’ ratings (n=23) of the 30 items across four criteria 92 
Table 4.3 The I-CVI values for the 30 items of the preliminary version of the 
FROM 
94 
Table 4.4 Changes made to the preliminary version of the FROM as a result 
of content validation 
97 
Table 5.1 The 26 specialties included in the item reduction stage of the study 109 
Table 5.2 Demographics of the family members during the item reduction 
stage 
109 
Table 5.3 Comments regarding the developmental 31-item FROM from family 
members of patients during the item reduction phase 
110 
Table 5.4 The 31 items of the developmental version of the FROM 114 
Table 5.5 The category response percentages for the 31-item developmental 
FROM 
120 
Table 5.6 The rescore values for each response category of the 31-item 
developmental FROM 
121 
Table 5.7 The step by step removal of mis-fitting items in the FROM 124 
Table 5.8 The local dependency identified within the FROM and potential 
solutions 
126 
Table 5.9 Uniform and non-uniform DIF identified in the items of the 31-item 
developmental FROM 
128 
Table 5.10 The stepwise process of item removal during Rasch analysis 131 
Table 5.11 Uniform and non-uniform DIF identified in the items of the 16-item 
final FROM 
133 
Table 5.12 Loading of items onto the first component extracted during principal 
component analysis of the FROM 
134 
Table 5.13 The principal component analysis for the 16-item FROM 138 
Table 5.14 The structure matrix of the FROM showing the loading of each item 
onto the two factors extracted 
140 
Table 6.1 The 25 specialties included in the validation stage of the study 150 
Table 6.2 Demographics of the family members during the validation stage 151 
Table 6.3 The affirmation percentage for each FROM item (n=120)  152 
Table 6.4 Frequency of the total FROM scores (n=120) 152 
Table 6.5 Comparison of family members’ mean total and individual item 
scores for their own gender 
156 
Table 6.6 Family members’ mean total and individual item scores for patients’ 
gender. 
158 
Table 6.7 The FROM mean total scores for each category of family member’s 
age 
159 
Table 6.8 The mean total FROM scores for each patient age category 
 
161 
Table 6.9 The FROM mean total scores for each family member relationship 163 
VII 
 
category 
Table 6.10 The FROM mean total scores for family members of patients from 
each of the 24 specialties  
165 
Table 6.11 The top five and bottom five specialties with regard to mean total 
FROM score and total score for each domain 
167 
Table 6.12 The mean total FROM score for family members according to level 
of education 
168 
Table 6.13 The mean total FROM score for family members according to total 
household income per year 
169 
Table 6.14 The mean total FROM score for family members according to 
patient disease duration 
169 
Table 6.15 Internal consistency (Cronbach’s α) of the 16 items of the FROM 170 
Table 6.16 Item- total statistics of the FROM 171 
Table 6.17 Intraclass correlation coefficient values for individual items, total 
scores for domains and total FROM score 
172 
Table 6.18 Comments from family members regarding the face validity and 
practicality of the FROM and corresponding comments from the 
study investigator 
175 
Table 6.19 The attributes of the FROM and the WHOQOL-BREF 177 
Table 6.20 Descriptive statistics of the FROM and the WHOQOL-BREF 177 
Table 6.21 The correlations between the domains of the FROM and the 
WHOQOL-BREF 
178 
Table 6.22 Correlations between the individual items of the FROM and the 
global health score 
180 
Table 6.23 
(a and b) 
Results of the hierarchical multiple regression analysis for the total 
FROM scores 
181/182 
  
VIII 
 
LIST OF FIGURES 
Figure 2.1 The six main stages of the study 24 
Figure 3.1 The percentage of family members affected by each of the ten 
themes 
52 
Figure 3.2 A model of family quality of life informed by the identified themes, 
reflecting between themes the relationships from the family 
members’ perspective 
70 
Figure 3.3 The 30-item preliminary version of the FROM 79 
Figure 4.1 The 31-item developmental version of the FROM 100 
Figure 5.1 The 13 steps used for Rasch analysis 108 
Figure 5.2 Summary statistics for the 31-item developmental version of the 
FROM 
115 
Figure 5.3 The threshold map for the 31-item developmental version of the 
FROM 
117 
Figure 5.4 The ordered category probability curve for item 1 118 
Figure 5.5 The disordered category probability curve for item 4 118 
Figure 5.6 The threshold map for the 31-item developmental version of the 
FROM after collapsing response categories 
123 
Figure 5.7 The item characteristic curve for item 14 showing uniform DIF by 
family member age 
127 
Figure 5.8 The item characteristic curve for item 15 showing non-uniform DIF by 
family member gender 
127 
Figure 5.9 The person-item location distribution of the FROM 135 
Figure 5.10 The summary statistics for final 16-item version of the FROM 136 
Figure 5.11 Scree plot to show the variance in the components of the FROM 139 
Figure 5.12 The final 16-item version of the FROM (FROM-16) 143 
Figure 6.1 Histogram to illustrate total FROM score and frequency 153 
Figure 6.2 A box and whisker plot to illustrate distribution of the FROM total 
score (n=120) 
154 
Figure 6.3 The mean scores for individual items of the FROM (n=120) 155 
Figure 6.4 Mean FROM score for individual items for male and female 
participants 
157 
Figure 6.5 The FROM mean scores for each age category of family members 159 
Figure 6.6 The relationship between family members’ age and FROM total 
score 
160 
Figure 6.7 The FROM mean scores for each patient age category 162 
Figure 6.8 The relationship between patients’ age and total FROM score 163 
Figure 6.9 The FROM mean total score for family members of patients across 
24 different specialties 
166 
Figure 6.10 The relationship between the initial FROM score and the follow up 
FROM score 7-14 days later for family members of stable patients 
173 
Figure 6.11 Mean scores for the individual items of the FROM at initial 
recruitment and follow up after 7-14 days 
173 
Figure 6.12 The relationship between the FROM and the WHOQOL-BREF 
scores 
178 
Figure 6.13 The relationship between the total FROM score and the Global 
health score (family members’ assessment of patients’ health) 
179 
 
1 
 
 
 
 
CHAPTER 1 
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BACKGROUND 
In 1948, the World Health Organisation (WHO) defined health as “a state of complete 
physical, mental and social well-being and not merely the absence of disease” (The 
WHOQOL Group 1948). Since then, interest in the concepts of well-being and quality of life 
have grown, both in clinical and research environments. The definition of Quality of Life 
(QoL) varies between authors, with the most commonly used definition provided by the 
WHO: “an individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns” (The WHOQOL Group 1997). The definition of QoL often depends on the area of 
one’s life which is being assessed, with the term “Health-related quality of life” (HRQoL) 
being applied to the impact of illnesses or treatments on the lives of patients or those around 
them. The term QoL when applied in health studies often only includes those areas of 
patients’ lives which are relevant to their illness. Assessing the effect of health on a patient’s 
life using the term HRQoL helps to ensure that all areas of a patient’s life are included in the 
assessment, and not just the obvious physical effects of the illness. Quality of Life is a 
multidimensional concept, which can be difficult to define or measure, as it is often made up 
of a number of different components of a patient’s life, which can often vary in importance 
from patient to patient. Rather than just a measure of health, QoL takes into account social, 
physical and psychological factors, and is more than just a measure of well-being. For the 
purpose of this thesis the terms “Quality of Life” and “Health-related quality of life” will be 
used interchangeably.  
Table 1.1 shows the variation in definitions of QoL between authors. At the most basic level, 
the Oxford English Dictionary (2004) defines QoL as “The standard of living, or degree of 
happiness, comfort, etc., enjoyed by an individual or group in any period or place; an 
instance of this.” Although, like other definitions, this description relates the term “happiness” 
to QoL, it does not pick up on the particular areas of an individual’s life which are impacted. 
On the other hand, the definition given by Haas (Haas 1999), places the concept of QoL in 
context of the person’s own environment: “QOL is a multidimensional evaluation of an 
individual’s current life circumstances in the context of the culture and value systems in 
which they live and the values they hold. QOL is primarily a subjective sense of well-being 
encompassing physical, psychological, social, and spiritual dimensions. In some 
circumstances, objective indicators may supplement or, in the case of [people] unable to 
subjectively perceive, serve as a proxy assessment of QOL.” The differences in detail of 
each definition are clear, but the one thing they all have in common is that they all convey the 
idea of QoL being a subjective concept, using phrases such as “an individual’s perception” 
and “that individual’s present experiences”. QoL relates directly to an individual’s hopes and 
expectations; improving an individual’s QoL is an attempt to reduce the gap between  the 
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present and that individual’s expectations, which can vary greatly from person to person 
(Bhatti 2011). It is therefore important that quality of life is measured by patients themselves, 
as measurement by other individuals such as healthcare professionals can be inaccurate 
(Slevin et al. 1988). The subjective nature of QoL can manifest itself in several ways. The 
external factors which contribute to an individual’s environment or circumstances vary hugely 
from person to person, for example the makeup of the patient’s family, socioeconomic status, 
job or career, religion and relationships. These factors all have the potential to influence the 
patient in both a negative and positive way, and each factor will be seen as more or less 
important by individual patients. Often, the individual’s perspective on their QoL is influenced 
by past experiences relating to these factors. Another way in which QoL is subjective is 
defined by the individual’s personality, character and attitude to life. All three of these 
aspects have the potential to contribute to how a patient views their QoL, and is unique to 
each individual. This provides a further reason as to why QoL is best assessed by the 
individual concerned, as it may be difficult for a proxy measure to recreate the unique 
balance between environmental factors, personal factors and past experiences and future 
hopes and expectations. However, there are some circumstances where it may be necessary 
for another individual (e.g. a member of the healthcare team or family member) to act as a 
proxy to the patient when measuring QoL, such as when the patient is a very young child, or 
seriously unwell.  
The measurement of QoL falls under the umbrella term “patient reported outcomes” (PROs), 
which includes information provided by the patient, usually in relation to symptoms, disease, 
treatment, preferences, satisfaction or experiences (Doward et al. 2010). Quality of life 
assessment is often used alongside other forms of PROs, for example symptom 
assessment, or the measurement of health behaviour, to create a true picture of the disease. 
Alongside PROs, other forms of assessment where QoL can be measured include observer 
reported outcomes, where the quality of life measurement is made by someone other than 
the patient (usually a family member or clinician), as described above. The concepts used 
when measuring QoL can be derived from past literature (Farquhar 1995), or directly from 
patients (Basra and Finlay 2007), for example through interviews, questionnaires or focus 
groups. Both methods have their advantages; literature reviews can provide a broad 
overview of the important issues for patients with a particular disease, whereas interviews 
with patients can provide “real-life” information including quotes and examples from patients. 
However, the latter approach reflects the way patients describe themselves in relation to their 
functional behaviour, both physical and psychosocial. This helps ensure reliability and validity 
of the resultant QoL instrument. 
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Table 1.1: Definitions of Quality of Life 
Author  Definition 
(Calman 1984) Measures the difference, or the gap, at a particular period of time 
between the hopes and expectations of the individual and that 
individual’s present experiences.  
(Cella and Cherin 
1988) 
Refers to patients’ appraisal of and satisfaction with their current 
level of functioning compared to what they perceive to be possible 
or ideal. 
(Clinch and Schipper 
1993) 
The perception of the impact of the disease and is both subjective 
and culturally bound. 
(Cohen et al. 1996) “Subjective well-being” 
(Felce and Perry 
1995) 
Quality of life is defined as an overall general wellbeing that 
comprises objective descriptors and subjective evaluations of 
physical, material, social, and emotional wellbeing together with the 
extent of personal development and purposeful activity, all weighted 
by a personal set of values. 
(Ferrans 1990) A person’s sense of well-being that stems from satisfaction or 
dissatisfaction with the areas of life that are important to the 
individual. 
(Haas 1999) QOL is a multidimensional evaluation of an individual’s current life 
circumstances in the context of the culture and value systems in 
which they live and the values they hold. QOL is primarily a 
subjective sense of well-being encompassing physical, 
psychological, social, and spiritual dimensions. In some 
circumstances, objective indicators may supplement or, in the case 
of [people] unable to subjectively perceive, serve as a proxy 
assessment of QOL. 
(Oxford English 
Dictionary 2004) 
The standard of living, or degree of happiness, comfort, etc., 
enjoyed by an individual or group in any period or place; an instance 
of this. 
(WHOQOL 1993) An individual's perception of his/her position in life in the context of 
the culture and value systems in which he/she lives, and in relation 
to his/her goals, expectations, standards and concerns. It is a 
broad-ranging concept, incorporating in a complex way the person's 
physical health, psychological state, level of independence, social 
relationships, and their relationship to salient features of their 
environment. 
 
Due to the complex, multidimensional nature of QoL, it is a concept which can be difficult to 
quantify.  Quality of life can be assessed in a number of different ways depending on the type 
of study and intended outcomes. Using QoL instruments which have been validated and 
standardised can allow the comparison of results across disease states and groups of 
patients, whilst taking into account the different factors which influence the patient’s QoL, for 
example social, physical and psychological. In order to account for individual variation in the 
influence of each factor on different patient’s lives, QoL instruments often allow  the user to 
rate the level of the impact of each of the factors on their QoL (e.g. ‘not at all’ ranging to ‘a 
lot’).  
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Types of Quality of Life Instruments 
There are two main types of QoL instruments; generic and disease-specific measures. 
Generic measures can be used over a large group of patients, and give a measure of QoL 
which is not related to a specific disease, but can include the effects of a wide range of 
diseases or treatment. This is particularly useful when measuring the impact on QoL of a 
community or group of patients, rather than individuals (Huebner et al. 2004), as the scores 
can be used to directly compare individual patients, or identify population-wide trends. 
Generic measures tend to include broader items, designed to be applicable to a wide 
population. In contrast, disease-specific measures are designed to be used to assess QoL in 
a specified disease, and can detect changes in individuals’ QoL following clinical 
interventions. These measures, which can be used to determine the extent to which a patient 
has been affected by suffering from a disease, can help clinicians to decide on appropriate 
treatment, but cannot be used to compare across conditions or treatment programs (Revicki 
and Ehreth 1997). Disease-specific measures contain items which are particularly relevant to 
the disease in question, for example items measuring specific symptoms or the impact of the 
clinical features of the disease. On some occasions, generic measures are used in patient 
groups suffering from specific diseases, but give a much less detailed picture of the patient’s 
QoL, especially when measuring change in disease state (Revicki and Ehreth 1997). The 
information gathered by using these measures can be too generalised, especially when 
using the resulting QoL score to influence patient care or choose a specific drug treatment. 
Temple et al (2009) argue that a disease-specific instrument can provide better insight into 
the unique issues faced by patients. Some QoL studies may use both a generic and disease 
specific measure, in order to capture the different patient viewpoints or to compare the 
results of using each type of measure (Klassen et al. 2000). 
The term “quality of life” can also be used in relation to health utilities, often measured using 
preference based instruments, which allow the patient to express their preference for 
different health states in relation to cost or number of years of life.  Preference based 
instruments can are often used in cost-analysis studies, or decision-making, for example by 
pharmaceutical industry or healthcare providers (Tolley 2001). The most widely used 
preference based instrument is the EQ-5D (1990), which can be used to derive utility values 
for specific diseases or disease states. Quality adjusted life years (QALYs) can then be 
calculated to combine quality with quantity of life, and allow for comparison between the 
benefits of different treatments in terms of length of time living in a certain health state.  
Quality of life measurement can be undertaken in a variety of different settings and for 
different purposes. Quality of life measures have traditionally been used in research and 
clinical settings to provide information about the needs of the patient.  This includes 
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assessing the results of healthcare interventions, screening for psychosocial problems, 
monitoring patient progress, determining choice of treatment and prioritising funding  
(Fitzpatrick et al. 1992). The use of PRO data in clinical trials is becoming more common and 
quality of life assessments relating to new products can help support marketing campaigns, 
measure cost-effectiveness of new drugs, and provide information on the effectiveness of 
medical interventions (Marquis et al. 2006). Measuring improvement in quality of life using 
both psychometric and preference-based measures, as well as producing safety and efficacy 
data may distinguish a product from its competitors (Revicki and Ehreth 1997). Quality of life 
measurement is especially important when evaluating treatments for chronic diseases, where 
new drugs are used to reduce disease severity or limit disease progression (Revicki and 
Ehreth 1997), both of which can be proven by using PRO data alongside clinical data. Over 
the last four years, the Food and Drug Administration (FDA) have recognised the importance 
of the inclusion of PROs in clinical trials, and produced guidance in 2009 to attempt to 
standardise their use, and outline recommendations for instrument development (FDA 2009). 
The European Medicines Agency (EMA) have also produced guidance on the use of HRQoL 
measures in trials, but their guidance is more general and does not contain specific 
information regarding instrument development (EMA 2005). 
The FDA guidance contains information and recommendations as to the minimum standards 
required for development and validation of PRO measures. This helps to ensure that PRO 
measures are developed to the highest standards and are suitable for their purpose, 
especially when being used as part of the evidence for licensing of a new drug. These 
standards include reliability, sensitivity to change and validity. Reliability measures how able 
the instrument is to yield consistent, reproducible results (FDA 2009) with regards to stability 
of scores over time when no change is expected in the concept being measured. This could 
include test-retest reliability, which measures the stability of the instrument over a short 
period of time, or internal consistency, which measures the extent to which items measuring 
the same concept correlate. For interviewer-administered PRO measures, reliability testing 
could also include inter-interviewer reliability, or the inter-rater variability to test consistency 
(EMA 2005). Validity ensures that the instrument is measuring what it is intended to 
measure. Content validity tests whether the measure is composed of the elements collected 
during the initial data collection phase (those which are important to the patient, or concept 
being measured), and whether these elements are proportionally and clearly represented in 
the measure. Construct validity tests the outcome of the measure against a pre-formed 
hypothesis, based on existing literature (EMA 2005). The measure should also be able to 
identify differences in scores over time in individuals or groups who have changed with 
respect to the concept being measured (sensitivity to change). This is a particularly important 
attribute when the measure is used to demonstrate the impact of a new treatment or 
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intervention on the patient’s life. Designing a measure with these attributes in mind, and 
implementing them into the design process helps to ensure that the resulting measure is 
suitable and accurate for its intended use. 
Although the majority of QoL measures are designed for use with patients, there has been 
increasing interest in the impact of illness on those surrounding the patient, and how the 
patient’s illness impacts their lives (Poston et al. 2003). The following information provides a 
focused literature review investigating the impact of illness on the lives of family members of 
patients. This is the first step in understanding a topic where there is a lack of evidence in 
most medical specialties.  
REVIEW OF THE LITERATURE 
The aim of this focused literature review was to identify literature examining the impact of 
illness on family members of patients across a range of medical specialties. The main 
purpose of the review was to identify any relevant information relating to the generic impact 
of illness on families, for example including several specialties in one study, or drawing 
comparisons. Family quality of life studies in individual specialties or diseases were also 
identified, along with the key impact areas and common themes throughout studies. The 
literature review also aimed to obtain information about measuring the impact of illness on 
the family, and to identify any existing QoL measures.  
The first exploratory review of the literature revealed that many of the articles reviewed were 
written several decades ago, as there is not a large volume of modern literature specifically 
examining impact on the family. Therefore it was decided that carrying out a systematic 
review would have lead to a substantial reduction in the number of articles to be reviewed, 
therefore influencing the intended comprehensive nature of the review. Therefore, a focused 
literature review was carried out, with search terms chosen that were both broad, and more 
specific to elicit the required information.  
Search strategy and selection criteria 
The review was based around the PRISMA Statement; a 27-item checklist designed to 
ensure the transparent and complete reporting of reviews and meta-analysis (Moher et al. 
2009). Although the PRISMA Statement is designed to ensure transparent systematic 
reviews, many of the principles were also relevant to this literature review, for example 
“Describe the rationale for the review in the context of what is already known” and “Present 
full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated” (Moher et al. 2009). Following this guidance helped ensure that the 
review was comprehensive and replicable.  
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The main search term used was “family quality of life” and this was also substituted with 
“impact/effect on family”, and “secondary impact”, and these were combined with “disease” 
(Table 1.2). The term “partner” was also used. “Impact on family” was combined with several 
common medical specialties.  
Table 1.2: Results of key search terms 
Key search term(s) used Number of references retrieved 
Family quality of life 193 
Impact on family 2493 
Impact of disease on family 12 
Effect on family 1349 
Effect of disease on family 3 
Family + disease 388 
Family scale 491 
Family measurement 113 
Impact on family + surgery 0 
Impact on family + medicine 12 
Impact on family + dermatology 0 
Impact on family + psychiatry 0 
Impact on family + respiratory 0 
Impact on family + cardiology 0 
Impact on family + renal 0 
Impact on family + gynaecology 0 
Impact on family + paediatrics 0 
Impact on family + urology 0 
Impact on family + gastroenterology 0 
Impact on family + disability 0 
Greater patient 2946 
Secondary impact 165 
Impact on partner 113 
Chronic disease + family 38 
 
The OVIDSP Medline was selected as the primary search platform. This included the 
following resources:  Cardiff University Books and Journals, PsycArticles, AMED (Allied and 
Complementary Medicine), British Nursing Index 1985-present, Embase 1947-present, HMIC 
(Health Management Information Consortium), ICONDA 1976 to June 2011, Medline In 
Process, Medline 1947-present, and PsycINFO 1806 to July Week 1 2011. A Google Scholar 
search was also carried out using the same search terms. Searches were limited to sources 
published in English. A search of the Compendium of Quality of Life Instruments was also 
carried out (Salek 1998, 2007). This compendium lists over 150 questionnaires and profiles, 
and the search was carried out to identify any existing family quality of life measures. Two 
measures of possible relevance to the impact of disease on family members of patients were 
identified. The search was carried out in July 2011, and updated in January 2013 to include 
more recent relevant publications.  
9 
 
Each abstract identified was read to determine the type of study and its relevance. Where 
appropriate, the full paper was read in detail. To be included in this review, a source had to 
be an original paper, summary article or review, in English, concerned with the impact of any 
illness or disability on the family of patients.  A total of 1517 abstracts were screened, and 
158 were identified for review. No sources were identified when combining “impact on family” 
with several major medical specialties and only 13 sources were identified using the term 
“impact of disease on family”. In addition, using the term “greater patient” resulted in 2946 
articles but on review, these were not relevant to the “Greater Patient concept” pertaining to 
the secondary impact on the family and partner (Basra and Finlay 2007). The majority of 
sources reviewed were concerned with family members of patients of one medical specialty 
or one specific disease, and were often limited to the effect on one particular family member, 
for example partners. No information was found regarding the more general impact of 
disease on families of patients over more than one specialty. However, many of the studies 
revealed similar ways that family members of patients were impacted by disease. 
Definition of family 
The term “family” is difficult to define.  The mid 20th century concept of family, with 
heterosexual parents and offspring living under the same roof is seldom used, and many 
authors now consciously use a wider and more open definition of family. The dynamics 
between family members are constantly evolving, and there is evidence of many diverse 
family types in the modern western European society. Scott (2006) describes a decline in 
“family life”, with falling marriage rates but increasing  divorce and cohabitation, which she 
associates with the transformation of the role of women in society and increased 
secularisation. Poston et al (2003) define family as “people who think of themselves as part 
of the family, whether by blood or marriage or not, and who support and care for each other 
on a regular basis”, and this definition is thought to acknowledge the diverse social 
arrangements that may constitute a family (Jokinen 2006). In other studies, the terms 
“family”, “informal caregiver”, “carer”, and “caregiver” are used interchangeably (Pochard et 
al. 2001; Swanberg 2006). Many authors use their own definitions of family according to their 
own values and beliefs. The authors must also decide how to take into account the views of 
individual family members and the family as a whole (Jokinen 2006). Beutler et al. (1989) 
outline the concept of “family realm”, describing unique relationships which tend to be more 
permanent than friendships, the strong emotional attachments between family members, and 
the exclusive ethics and dynamics within the family structure. For this review, we have taken 
a broad view of the term family and accepted each author’s interpretation as valid.  Where 
studies refer to caregivers (or carers), it was ensured that this related to family caregivers. A 
wealth of literature was found relating to carers/caregivers, but this was excluded from the 
review as this study focuses on the impact of illness on family members, not always those 
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who identify themselves as carers, but may still be impacted. Rather than repeat previous 
work relating to carers, this review aims to uncover some of the hidden impacts on family 
members of patients, whether they care for the patient, or not . As it is not yet known whether 
the ways that family members are impacted are the same as the ways that carers are 
impacted, the two were kept separate, unless specified as “family caregivers”. This literature 
review does not aim to cover the extensive information available regarding patient carers, but 
focuses on other family members who are often overlooked in family-related studies, 
particularly when they are not parents of paediatric patients. 
The history of family research 
Historically, medicine has been largely physician-centred, with physicians withholding 
diagnostic information from patients, refraining from discussing treatment options with 
patients, and making clinical decisions without first consulting the patient, and often without 
patient consent. Since the 1960s, medicine has undergone a rapid “patient centered shift”, 
where patients perspectives are now taken into account, and the teaching of psychosocial 
aspects of medicine are now a requirement in medical schools (Laine and Davidoff 1996).  
During the late 1970s, high profile law cases, such as that of Cruzan (Lo and Steinbrook 
1991) encouraged physicians to share clinical decisions with both the patient and the family 
members, signifying the beginning of a new approach to medicine which included taking into 
account the secondary aspects surrounding the patients ’ lives such as family and social care. 
Changes in the 1960s and 1970s in education and health, as well as an increased 
awareness of patients with special needs, helped to emphasise the great importance of the 
role that the family plays in modern healthcare. Today, family-centred care is supported by 
several major studies (Kuhlthau et al. 2011; Radwin et al. 2011), and is a topic which is at the 
forefront of many clinicians’ minds. Family-centred care is an approach to healthcare which 
emerged as an important concept in the second half of the twentieth century and includes 
considering the role of families in promoting the health and well-being of their children 
(2003).  The American Academy of Pediatrics (2003) outline the main principles surrounding 
family-centred care: recognising the vital role that families play in ensuring the health of all 
family members, and acknowledging that emotional, social and developmental support are 
integral parts of healthcare.  It is thought that following these principals leads to better health 
outcomes, wiser allocation of resources and greater patient and family satisfaction.  
RESULTS 
Several major disease-specific studies have been carried out on the impact of disease on 
families of patients and these were first reviewed in order to understand what is already 
known about the area. A longitudinal study of the effects of chronic childhood illness on 
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families of paediatric patients resulted in the development of the Impact on Family Scale 
(Stein and Riessman 1980). This is a 24-item scale with four quality of life domains which 
has been revised to a 15- item scale (Williams et al. 2006). On the basis of interviews with 
187 family members of children with a disability, Poston et al.(Poston et al. 2003) proposed 
ten domains representing family quality of life. These formed the basis of the Beach Center 
Family Quality of Life Scale (Hoffman et al. 2006). 
Several key review articles were identified concerning the impact of illness on the quality of 
life of the partner (Rees et al. 2001),  the impact of cancer on the family (Lewis 1986), and 
the impact of chronic disease in the elderly on the patient’s family (Kriegsman et al. 1994). 
Several studies included control groups (Table 1.3). 
Key impact areas 
Most chronic diseases have similar effects on patients’ partners and other family members 
such as psychological and emotional functioning, disruption of leisure activities, effect on 
interpersonal relationships, and financial resources. However there may be some aspects 
which attain dominance in one particular disease as compared to other diseases. Several 
common themes were identified from the studies reviewed, providing an understanding of the 
extent of the impact of disease on family members of patients.  Further examples of less 
common themes mentioned are summarised in Table 1.4.  
Table 1.3: Summary of studies that included a control group 
Author Family member 
group 
Control Summary 
(Goldbeck 
2006) 
Parents of children 
diagnosed with 
cancer, diabetes or 
epilepsy. 
Parents of 
healthy children. 
Parents of children diagnosed with 
cancer, diabetes or epilepsy reported 
significantly lower quality of life 
compared with healthy controls. 
However they were also more satisfied 
with their family situation compared 
with healthy controls. 
(Lawson et 
al. 1998) 
Families of children 
with atopic dermatitis. 
Families of 
healthy children. 
Families of children with atopic 
dermatitis have a lower family function 
level than families of healthy controls. 
(Hagedoorn 
et al. 2000) 
Male and female 
partners of cancer 
patients. 
Healthy couples. Female cancer patients and female 
partners of patients perceived more 
psychological distress and a lower 
quality of life than women in healthy 
couples. Psychological distress and 
quality of life did not differ between 
male partners of patients and their 
healthy controls. 
(Coyne et 
al. 2010) 
Family members of 
overactive bladder 
(OAB) patients. 
Family members 
of healthy 
individuals. 
The OAB-FIM discriminated between 
OAB and control family members with 
OAB family members demonstrating 
significant impact on quality of life. 
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Table 1.4:  Further examples of less common themes identified from the literature 
Affecting sleep (Basra and Finlay 2007; Coyne et al. 2010; Davis et al. 2009; Eghlileb et al. 
2007; Elliott and Luker 1997; Ferrario et al. 2004; Kornblith et al. 1994; Lawson et al. 1998; 
Weitzenkamp et al. 1997)  
Concerns about medical treatment (Basra and Finlay 2007; Cappelleri et al. 2008; Eghlileb 
et al. 2007; Ferrario et al. 2004) 
Altered food choices (Basra and Finlay 2007; Elliott and Luker 1997; Komulainen 2010)  
Using religion, spiritual and cultural beliefs to cope (Basra and Finlay 2007; Brown et al. 
2003; Cohen et al. 2006; Koldjeski et al. 2007; McMillan and Mahon 1994; Palma et al. 
2012) 
Feeling obliged to give care (Boeije et al. 2003) 
Concerns about receiving information about the disease and understanding (Bowen et al. 
2011; Ferrario et al. 2004; Koldjeski et al. 2007; Weitzenkamp et al. 1997)  
Needing support from others (Brown et al. 2003; Majasaari et al. 2005; Mellon 2002) 
Limited freedom (Davis et al. 2009) 
Worrying about death of the patient (Ferrario et al. 2004; Osse et al. 2006; Weitzenkamp et 
al. 1997) 
Psychological impact 
Family members suffer greatly from the emotional effects of living with, and caring for, a 
relative with a disease, with the impact of some diseases being felt by every member of the 
family (Bowen et al. 2011). Emotional impact resulting from having an unwell relative was the 
most common topic discussed in the literature. The psychological distress felt by family 
members often results from their feelings of helplessness and lack of control (Basra and 
Finlay 2007; Sallfors and Hallberg 2003). Many different emotions are mentioned by family 
members: guilt, anger, worry, upset, frustration, embarrassment, despair, loss and relief. 
Each emotion affects family members in different ways and to different extents, often 
depending on the disease severity of the patient (Balkrishnan et al. 2003; Berge et al. 2006) 
and the period of time that has passed since the diagnosis (Koldjeski et al. 2007). The coping 
strategies of family members have also been reported (Kempainen, 2007; Wade, 2001; 
Bush, 1997; Barnett, 2012 ). In one study, Gauthier et al. (2007) found that the emotional 
burden of caregivers of patients with amyotrophic lateral sclerosis significantly increased 
over a period of nine months of the illness, whereas the patient’s psychological wellbeing 
remained relatively stable. In one paediatric study, it was found that children with a family 
member suffering from multiple sclerosis were three times more likely than the general 
community to develop a psychological illness (De Judicibus and McCabe 2004).  
Hagedoorn et al. (2000) found that female partners of cancer patients had higher 
psychological distress than male partners.  However, no significant difference was seen 
between genders when measuring overall quality of life of relatives. Several other studies 
have found gender differences in responses to caregiving (Boeije and Van Doorne-Huiskes 
2003; Bristol et al. 1988; Northouse et al. 2000; Pitceathly and Maguire 2003), although 
Walsh et al. (1999) found no difference in the well-being of the partners of rheumatoid 
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arthritis patients, based on the gender of the patient. As well as looking at differences in 
gender, authors have also used the relationship to the patient as a variable; it is not just the 
parents and partners who are affected emotionally by a relative’s disease (O'Brien et al. 
2009). For example, Fisman et al. (2000) reported that siblings of children with pervasive 
developmental disorder suffered from “significant adjustment problems” compared to a 
control group. In addition, Hardy et al. (Hardy et al. 2008) found no significant difference in 
the post-traumatic stress symptoms and psychological functioning of parents of adult cancer 
sufferers and parents of paediatric patients, and that parents of adult patients may remain 
“psychologically vulnerable” for many years after treatment ends. This is also reflected by 
Sabo et al. (2013) who found that spouses of patients undergoing haematopoietic stem cell 
transplantation were still at risk of depression one year after the transplant.  
Several studies have focused on the effect on the health of the family member. Family 
members of female HIV patients with poor health reported feeling a greater burden and 
family members who reported less family cohesion reported higher depressive mood and 
greater burden (Demi et al. 1997). Looking after an unwell patient can also cause increased 
feelings of anxiety for the family member regarding their own health (Osse et al. 2006), 
especially in cancer, where family members worry about the possibilities of cancer being 
genetic, or the possibility of recurrence (Mellon 2002). Kornblith et al. (1994) found that 
spouses of patients with prostate cancer experienced a greater psychological distress than 
the patients themselves, and this finding is echoed in several similar studies (Rees et al. 
2001; Weitzenkamp et al. 1997). Conversely, Huygen et al. (1992) found no difference 
between the morbidity of spouses of patients diagnosed with a serious disease and a group 
of matched controls. 
Pochard et al. (2001) questioned the ability of family members to make decisions about the 
care of relatives in intensive care, as they demonstrated that more than two thirds of family 
members visiting patients suffered from anxiety or depression. This study included “all 
individuals who visited the patient in the ICU, regardless of their relationship to the patient”, 
so the effects on the quality of life specifically of the family are unclear. Werner at al. (2009) 
investigated the effect of an out-of-home residential placement on the QoL of families of 
patients with intellectual disability, and found that many of the common negative emotions 
felt by families of patients were reduced or eliminated after the placement, including anger, 
frustration, and resentment.  
Financial impact 
One of the greatest burdens on family members of patients is the financial cost to the family 
(Clarke et al. 2009; Martinez-Martin et al. 2012). This can include treatment costs, transport 
to appointments, the cost of hiring a carer, and adapting their home environment to 
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accommodate their relative’s needs. In a Canadian study, Brown et al (2003) asked families 
how much they spent on average in a month on care, support, or equipment for their family 
member with an intellectual disability. On average, these families spent C$624 per month, 
and many described not having any money left at the end of the month. In a similar USA 
study, the financial impact on families caring for patients with dementia varied from US$3630 
to US$17700 depending on the severity of the patient’s dementia (Langa et al. 2001). 
The financial strains felt by family members of patients often lead to stress and worry, adding 
to the already great emotional impact they suffer from as a result of caring for their relative. 
Family members of dermatology patients increase their working hours in order to support 
their family financially, and many turn to state benefits to cover the extra costs to them and 
their family which can often lead to the family having to compromise on the needs of other 
family members, or alter their lifestyle significantly by opting for cheaper living choices (Basra 
and Finlay 2007). Davis et al. (2009) interviewed parents of children with cerebral palsy to 
determine how their quality of life has been affected by their child’s illness. The authors found 
that providing even the basic necessities when caring for a child with cerebral palsy put 
financial pressure on the parents, and that accessing funding was also challenging, which 
again increased stress and emotional effects. The difficulties involved in accessing funding 
are greater in low income families, who often receive minimal support and face greater 
problems with social functioning and relationships (Lapidus and Kerr 2001). Walton-Moss et 
al. (2005) interviewed family members with a variety of relationships to patients with mental 
illness and categorised the families as “hanging on”, “being stable”, or “doing well” as a result 
of the interviews. The families who were classed as “hanging on” in the study all shared 
common problems relating to limited financial resources and limited social support. 
Impact on family relationships 
Family members of patients experience a negative effect on their family relationships, 
whether between the relative and the patient, or between other members of the family as a 
result of the patient’s illness. Poor satisfaction with family relationships does not bode well for 
chronic disease management regardless of the disease and often family members find 
relationships difficult as they do not know how to emotionally support each other (Lewis 
1990). Bowen et al. (2011) interviewed 25 family members of patients with multiple sclerosis. 
Generally, the families reported negative effects on their relationships with each other 
resulting in arguments, tension, and a lack of understanding of each other’s feelings. In 
particular, relatives struggle to deal with patients who have altered significantly in terms of 
beliefs, outlook, and behaviour, as a consequence of their disease. There was little time for  
relationships between other members of the family, and family members often felt the strain 
of having to spend a lot of time with the patient, with many reporting this as a reason for their 
15 
 
relationship being strained (DesRosier et al. 1992). Many patient-related quality of life studies 
mention the negative effects on family relationships and if the unwell member is affected, it is 
likely that the other family members will feel the negative changes in the family relationships 
too. For example, Golics et al. (2009) found that 38% of adolescents with dermatological 
conditions felt that their family relationships had been affected as a result of their condition.  
Partners of patients often experience a negative effect on their sex lives as a result of the 
patient’s disease. One relative of a patient in a psoriasis study stated that “my wife feels 
embarrassed when she undresses with me in the bedroom” (Eghlileb et al. 2007). This can 
lead to friction between couples, and in some cases can lead to the breakdown of 
relationships, or partners seeking sexual encounters outside the relationship (Basra and 
Finlay 2007; Elliott and Luker 1997). In a study of parents of children with chronic health 
conditions, the decrease in the mothers’ marital satisfaction reported in the study was 
influenced by their perceptions of the impact of their child’s condition (Berge et al. 2006). 
Partners of stroke patients described having to “find a new marital path” after the stroke; 
describing how they had to rebuild and alter their relationship to account for the impact of the 
stroke and their new carer role in the relationship (Kitzmuller et al. 2012).  
However, in some families relationships can grow stronger (Kim et al. 2007), as the family 
members work together to help each other and become more closely knit. Brown et al. 
(2003) used their measure, The Family Quality of Life Survey, to assess the impact of having 
a child with an intellectual disability on parents. They found that the majority (21 out of 34 
interviewed) of families were taking the initiative to maintain good family relations, and 
engaging in family activities to encourage this. An increase in family closeness was also 
found by Mellon (2002). One husband of a cancer survivor said “I look at life differently after 
that. I feel much closer to her”. In one study looking at family members of patients with lung 
cancer, 40% of family members reported a closer relationship with the patient as a result of 
providing care to them (Mosher et al. 2013).  
Education and work 
Living with, or caring for, a relative with a disease can have a large impact on the education 
and careers of family members. This could include disruption of school work in siblings or 
children of the patients, or the employment of adults being affected by their relative’s 
disease, and the burden of care which is placed upon them. Some families studied by Brown 
et al. (2003) felt that some of their family members would not be able to attend work or 
school in the near future. One family member is quoted: “The unpredictable natures of our 
children’s health and lives does not often fit with a typical, progressive work profile”.  In eight 
of the 34 families studied, one or both parents had given up an education or career to care 
for their child with a disability. Basra and Finlay (2007) found that 40% of family members of 
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dermatology patients felt that their employment was affected by their relative’s skin condition. 
This was due to a variety of reasons including needing to look after the patient, taking time 
off work for hospital appointments, and emotional effects preventing individuals from going to 
work. Looking after a patient with cancer can also have a huge impact on a family member’s 
work on a day-to-day basis, as discussed in an interview-based study by Swanberg (2006) 
Twenty seven of the 30 caregivers interviewed were family members of patients, and the 
study found that they were reporting late for work, missing work, spending time at work 
talking on the telephone to their relative and, as in the previous studies, some left work due 
to their carer responsibilities. 
Leisure time 
An important part of family QoL is family members being able to participate in the hobbies 
they enjoy (Poston et al. 2003). The majority of families in a large, international Canadian 
study reported barriers that prevented them from taking advantage of leisure opportunities 
(Brown et al. 2003). The barriers reported linked into other domains of Family Quality of Life, 
including lack of time due to the responsibilities of care, limited finance, and lack of support 
available. However, encouragingly, it has been shown that when family members do take the 
initiative to plan leisure activities, they usually work out positively, despite the restrictions due 
to the relative’s illness, and families show high satisfaction with this achievement (Brown et 
al. 2003). 
Family members also find difficulty in taking family holidays for a variety of reasons, often 
depending on the disease state of their relative. Problems with finding suitable 
accommodation with wheelchair access can make holiday planning “awkward” (Davis et al. 
2009). Relatives of patients with skin diseases in one study described limitations of holiday 
planning, for example not wanting to swim together at the beach or their relative having to 
wear certain types of clothes (Eghlileb et al. 2007). Similarly, parents of children with food 
allergies described the restrictions on their holiday plans because of their child’s allergy 
(Komulainen 2010). These are burdens which could also affect family members of patients 
with other diseases. 
An increase in housework load has also been reported as a result of living with an unwell 
relative, particularly in those with skin disease where more frequent washing of bed linen and 
more cleaning is required (Basra and Finlay 2007). This impacts on the day-to-day activities 
of the relative, potentially leading to emotional problems including stress and worry, and 
takes up time which could be used to socialise or spend time with other members of the 
family.  
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Social impact 
A large number of the existing studies into the burden of disease on family members note the 
drastic effect that caring for a patient has on their social lives (Basra and Finlay 2007; Davis 
et al. 2009; Eghlileb et al. 2007; Poston et al. 2003). Notably, mothers caring for disabled 
children felt that their lives were so different from their friends and felt that they could only 
contribute to depressing conversations, and therefore lost friends as a result (Davis et al. 
2009). Other family members described friends “drifting away”, as they did not understand 
the family situation (Bowen et al. 2011). 
In one study, a large number of individuals with a relative suffering from a skin disease 
complained of social disruption (Eghlileb et al. 2007). Many of the problems they face could 
be applicable to a number of diseases, for example feeling embarrassed by their relative’s 
condition in public places, but some are more psoriasis specific, for example feeling 
embarrassed about their relative’s skin flakes. Conditions which result in visible signs of 
disease (for example basal cell carcinoma on the face or chronic obstructive pulmonary 
disease requiring oxygen therapy) may have a greater effect on the social lives of patients 
and their relatives, for fear of strangers’ reactions to their visible condition. This is explored in 
relation to dermatological conditions by Basra and Finlay (2007). Hunfeld et al. (2001) found 
that mothers of adolescent patients suffering from severe chronic pain reported more 
restrictions in their social life than mothers of children with less severe chronic pain and the 
authors suggest that this could be directly related to the illness. 
As well as concern about their own social lives, family members also worry about their unwell 
relative being socially accepted, especially in the case of a parent caring for a child, where 
many report that their child’s acceptance is a “high priority” for them (Poston et al. 2003). 
Parents also report feeling upset about their child being bullied at school due to their illness 
(Basra and Finlay 2007). 
Instruments to measure family quality of life 
Several studies have lead to the development of instruments designed to measure the 
impact of disease on families of patients. However, these instruments are mostly disease or 
specialty specific, and can therefore only be used to assess the quality of life of the family of 
a particular group of patients. 
The Family Dermatology Life Quality Index is a ten-item questionnaire designed to measure 
the quality of life of family members of dermatology patients (Basra et al. 2007). The 
questionnaire, which has undergone full psychometric evaluation (Basra et al. 2008), 
contains items such as “Over the last month how much emotional distress have you 
experienced due to your relative/partner’s skin disease (e.g. worry, depression, 
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embarrassment, frustration)?”.  The Impact of Pediatric Epilepsy Scale (Breau et al. 2008), is 
designed to  measure the impact of childhood epilepsy on the patient and their family. Using 
this measure, Breau et al. (2008) found that the severity of seizures correlated directly with 
the quality of life of the patient and their family. This correlation with disease severity is 
reflected in a study by Ben Gashir et al. (2002) who found that disease severity negatively 
influences the quality of life of families of children with atopic dermatitis using the Family 
Dermatitis Impact Questionnaire (Lawson et al. 1998). Further examples of disease-specific 
measures include the Psoriasis Family Index (Eghlileb et al. 2009), the Overactive Bladder 
Family Impact Measure (Coyne et al. 2010), and the Quality of Life in Life Threatening Illness 
- Family Carer Version (Cohen et al. 2006), which is designed to be used with carers of 
palliative oncology patients with the aim to develop and deliver the most effective services to 
these carers. In fact, many of the existing instruments to measure family quality of life have 
been designed for use in families of patients with cancer (McMillan and Mahon 1994; 
Weitzner and McMillan 1999) and mental health illness (Baronet 1999). 
The Impact-on-Family Scale, as mentioned above, measures the impact of childhood chronic 
illness on the family (Stein and Riessman 1980). Similarly, the extensively tested Beach 
Centre Family Quality of Life scale (Hoffman et al. 2006), was designed for and evaluated in 
families of children with disabilities. The questions in this measure fall under five main 
categories: family interaction, parenting, emotional well-being, physical/emotional well-being, 
and disability-related support. The Family Quality of Life Survey is another example of a 
measure designed for use in family members of patients with or without an intellectual 
disability (Issacs et al. 2007). This survey takes on average an hour to complete and is 
designed to assess the aspects of family quality of life which are important to a family and 
whether these aspects are being adhered to. 
The Caregiver Quality of Life Index (McMillan 1996), is a four-item visual analogue scale 
measure designed to assess the quality of life of primary caregivers of hospice patients 
receiving homecare, but not specifically family members.  The Family Strain Questionnaire 
(Ferrario et al. 2004) was also identified, but again the population group was defined as 
“principal caregivers” and not family members. Furthermore, the measure assesses the 
burdens or problems and needs of caregivers of patients and not the overall quality of life. 
These generic measures were examined for evidence of psychometric testing, and most 
were found to demonstrate good evidence of validity and reliability testing. The properties of 
these generic measures are summarised in Table 1.4, including the areas covered by each 
measure. No measure was found which can be used to assess and compare the impact of 
any disease on family members of patients.  
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CONCLUSION 
There is a wide range of information in the literature about the impact of disease on family 
members of patients. However, most studies are focused on a specific group of patients, or a 
specific family member of a patient.  It is unknown whether the results of disease-specific 
studies are applicable to a more general population, or whether family members are affected 
in similar ways across every medical specialty. For example, the family quality of life domains 
suggested by Poston et al. (2003) result from a study with family members of disabled 
children. Kazak (2002) discusses the lack of “reliable and valid family outcome measures” 
and the negative effects of family outcome studies of one disease or clinical area, including 
the lack of communication between medical specialties and obscuring commonalities across 
different disease areas. Although many studies conclude that a more family-centred 
approach to care (Bowen et al. 2011; Brown et al. 2007; Fisher 2006; Koldjeski et al. 2007), 
and further education of professionals is needed (Jokinen 2006), no generic measure exists 
to assess the impact of a variety of diseases on family members of patients.   
The impact of disease on families of patients is often unrecognised. Comparing and 
contrasting information from families of patients with a variety of diseases could uncover new 
domains of quality of life unique to family members, which, with appropriate support in place, 
could result in a higher standard of patient and family care. Taking into account the quality of 
life of families as well as patients can offer the clinician a unique insight into issues such as 
family relationships and the effect of treatment decisions on the patients’ close social group 
of partner and family, the “Greater Patient” (Basra and Finlay 2007). 
To understand the needs of family members of patients and be able to offer appropriate 
support, we first need to understand the ways in which their lives are affected. This review 
has highlighted the need for a multi-specialty study investigating the issues faced by families 
of patients, how these differ between diseases, and exploration of the common themes and 
ideas.  
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AIMS OF THE STUDY 
 To investigate the impact of a wide range of diseases on family members. 
 To develop and validate a quality of life measure for use by individual members of a 
patient’s family to assess the impact on the family member’s life of having a person in 
the family with a disease. 
 
OBJECTIVES 
 To identify and understand the research about family quality of life which already 
exists. 
 To identify key dimensions of quality of life for families of patients and design a model 
or diagram to represent family quality of life. 
 To compare and contrast the impact of disease on family members of patients across 
different clinical specialties. 
 To investigate whether the impact of illness on family members varies by age, 
disease duration or gender. 
 To investigate the psychometric properties of the new measure. 
 To outline possible uses for the new measure. 
 To record and evaluate feedback from family members of patients regarding the 
interviews, the study and the new measure. 
 To further understand the Greater Patient Concept (Basra and Finlay 2007) and the 
role of the family in the life of a patient with chronic disease. 
 To make recommendations as to the specific areas and possible ways in which family 
members of patients can be supported. 
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CHAPTER 2 
 
Study Rationale and 
Methodological Framework 
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STUDY RATIONALE 
The impact of illness on family members of patients has already been explored in many 
areas of medicine, with the majority of work focused around physical and mental disability, 
dermatology and oncology (Basra and Finlay 2007; Cohen et al. 2006; Poston et al. 2003). 
Illness has been shown to have a major impact on families of patients across all of these 
areas. In fact, the quality of life of family members correlates with that of the patient (Basra 
and Finlay 2007), and in some cases the quality of life of the family member can be worse 
than that of the patient themselves (das Chagas Medeiros et al. 2000; Rees et al. 2001; 
Weitzenkamp et al. 1997). Much of the previous research into family quality of life focuses on 
those members of the family who are primary caregivers, or use the terms “family” and 
“caregiver” interchangeably. There is still a lack of understanding of the impact of illness on 
those members of the family who are not necessarily the primary carer, but are still part of 
the family and may still be affected. 
Disease-specific and specialty-specific questionnaires have been designed to measure the 
impact of illness on family members of patients. As these measures have been designed to 
be used with family members of specific patient groups, they cannot be used in a general 
population, or to compare and contrast the impact of different illnesses.  
Generic health-related quality of life instruments exist for patients, such as the SF-36 and the 
WHOQOL (Brazier et al. 1992; Skevington et al. 2004). These measures are designed to be 
used to assess the impact of illness on patients, regardless of their illness, and are currently 
routinely used in clinical practice and policy making, highlighting the importance of 
considering the effect on the patient’s quality of life when making treatment decisions. From 
previous disease-specific studies, it can be clearly seen that the impact of illness on family 
members is also widespread and of high importance, but there is currently no way of 
measuring it in a generic way and being able to compare and contrast between illnesses and 
specialties. Furthermore, as the subject of family quality of life is a relatively new concept, it 
is an area which has not been explored in many disease areas, or been highlighted to 
clinicians.  
Exploring the ways in which disease impacts family members over a wide range of conditions 
will allow comparisons to be drawn between different disease areas. Areas of family 
members’ lives which are affected will be identified, and will give a more clear idea of areas 
where more support is required. The impact of illness on those members of the family who 
are not necessarily the primary caregiver will also be explored, where in previous studies 
they have often been overlooked. The extent of the impact will also be of interest, and the 
results of a qualitative exploration will form a solid basis for the production of a generic family 
quality of life measure. 
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A family quality of life measure will allow the generic impact of illness on family members of 
patients to be quantified for the first time. In the same way that generic patient QoL 
measures are used in clinical practice and health research, the impact of illness on families 
will be able to be used as an additional endpoint, or outcome measure. The impact of 
treatment decisions on family members of patients will be able to be measured, and the new 
measure will increase the awareness of the family impact of disease in a clinical setting. 
This thesis describes the qualitative investigation into the impact of illness on family 
members of patients, and the development of a generic family quality of life measure. 
STUDY DESIGN 
This is a mixed methods study, based around six stages. Figure 2.1 shows the main stages 
of the study and the processes involved: 
Figure 2.1: The six main stages of the study 
STUDY POPULATION 
The participants in this study were family members or partners of patients attending 
outpatient clinics and inpatients at hospitals in the Cardiff and Vale University Health Board 
(University Hospital of Llandough, University Hospital of Wales, Gabalfa Clinic), and Velindre 
NHS Trust over a range of medical specialties.  In order not to restrict the study to the 
selection biases inherent in studies entirely based in secondary care, family members  of 
patients in primary care were also recruited. 
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Selecting specialties 
As one aim of this study was to identify the impacts of illness on families from a generic point 
of view, a wide variety of specialties were selected to be included in the study. The aim of 
this selection process was to widen the recruitment of family members to maximise the 
number, type, severity and length of diseases considered. The study team obtained from the 
Health Board website a list of medical and surgical specialties based at the Cardiff and Vale 
University Health Board and selected 25 of these specialties (Table 2.1). These included 
medical and surgical specialties, dental surgery (including trauma), mental health (including a 
community outreach team) and several paediatric specialties.  It was felt that excluding 
family members of paediatric patients would leave the study incomplete, especially given the 
huge emphasis on the impact of illness on families of children in previous literature 
(Opperman and Alant 2003; Stein and Riessman 1980; Wennick et al. 2009).  General 
Practice was added as a 26th specialty, to cover the views of relatives of patients being 
treated in a primary care setting (Table 2.1).   
Table 2.1: The specialties included in the study 
Cardiology Infectious Diseases 
Care of the Elderly Mental Health 
Chronic Pain Neurology 
Colorectal Surgery Oncology 
Dental Surgery Ophthalmology 
Dermatology & Paediatric Dermatology Orthopaedics & Paediatric Orthopaedics 
Ear, Nose & Throat Paediatric Endocrinology  
Endocrinology & Diabetes Post-stroke 
Gastroenterology Renal & Renal transplant 
General Practice Respiratory 
Genetics Rheumatology 
Gynaecology Urology 
Haematology Wound Healing 
 
Contact was made with one consultant clinician from each of the 26 specialties identified and 
the subsequent recruitment process was discussed with each consultant. Each consultant 
was asked to identify at least five patients who best represented the conditions they saw 
under their specialty area.  At each stage of the study, the consultant first approached the 
patient and their family member(s) to gain permission for the investigator to then approach 
them and introduce them to the study. 
Inclusion and exclusion criteria 
Inclusion criteria for family members 
• Age 16 years and above 
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• Able to understand and read English 
• An immediate family member, or partner living with, or caring for, a patient diagnosed 
with one or more medical conditions under one of the selected specialties (Table 2.1) 
• Able to give written informed consent 
Inclusion criteria for patients  
• Able to understand and read English (if over 16 years old) 
• Diagnosed with one or more medical conditions under the selected specialties (Table 
2.1) 
• Able to give written informed consent (if over 16 years old) 
• Attending clinic with a family member, or currently a hospital inpatient. 
Exclusion criteria for family members 
• Age under 16 years 
• Unable to understand and read English 
• Not considered by the patient as a family member 
• Unable to give written informed consent 
• Having a severe handicap or disability which prevents them participating in an interview 
or completing a questionnaire. 
Exclusion criteria for patients  
• Unable to understand and read English (unless under 16 years old) 
• Unable to give written informed consent (unless under 16 years old)  
The definition of family 
As explored in Chapter 1, many authors interpret the definition of family in many different 
ways, and the definition of family is constantly evolving with society. Before this study began, 
it was important to have a clear definition of our interpretation of the term “family”. We agreed 
with the definition of family given by Poston et al.: “people who think of themselves as part of 
the family, whether by blood or marriage or not, and who support and care for each other on 
a regular basis” (Poston et al. 2003). This meant that we included unmarried partners of 
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patients, children and parents-in-law, and cousins. As long as the family member considered 
themselves as “family”, and offered support to the patient on a regular basis, they could be 
recruited in the study. This wide definition reflects a modern society, where families are not 
always made up of two heterosexual parents and their offspring. It also allows different 
relationships within the family to be explored, and does not restrict those more distant family 
members who play an active role in the patient’s life. This definition of family also reflects the 
complexity of family life in Britain today. Furthermore, unlike many of the existing studies 
which refer to family carers or caregivers, the family members recruited in this study are not 
necessarily those who provide care to the patient, but their lives may still be impacted by the 
patient’s illness. 
ETHICAL CONSIDERATIONS 
During the design of the study, particular attention was paid to the ethical considerations 
surrounding all stages of the study.  These issues of ethical concern are addressed below. 
Ethical approval was sought from the South East Wales Research Ethics Committee, and 
was granted on 21st May 2010 (Appendix A).  Local approval was also granted from Cardiff 
and Vale University Health Board Research and Development Department (Appendix B) and 
Velindre NHS Trust Research and Development Department (Appendix C).  The study was 
also registered with the Data Protection Officer for Cardiff and Vale University Health Board. 
An expert in the area of quality of life research was asked to review the project and gave a 
favourable opinion (Appendix D). 
Written informed consent was taken from both the patient and the family member prior to 
data collection. The consent taken from the patient allowed the family member to talk about, 
or give information about, the impact of the patient’s medical condition on their life. Separate 
information leaflets and consent forms were designed for family members and patients, and 
also for those patients under 16 years of age (Appendix F-I). The study was fully explained to 
both the patient and the family member and they were given a chance to ask any questions 
they may have had before taking consent.   
Confidentiality was of paramount importance during this study, as many sensitive issues 
were discussed during the interviews. Patients and family members were given a code 
number to identify them during the study. Only the study team had access to the codes and 
data arising from the study, and these have been kept securely within the university building. 
Interviews and questionnaire completion were carried out in private rooms and participants 
were assured about the privacy and confidentiality of any information they provided. This was 
also emphasised in the information leaflets, along with examples of how the information 
taken from interviews would be quoted anonymously in publications.  
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The interviewer undertook formal interview training and has previous interviewing 
experience. Care was taken to use language comprehensible to all study participants. The 
interviewer was aware that sensitive questions were being asked, and if the family member 
was too uncomfortable or emotional during the interview or completion of the questionnaire 
(as determined by asking the participant), the interview would be terminated and information 
discarded if the family member or patient wished. In that unlikely circumstance, the family 
member would be offered a further opportunity to be given advice concerning the issues 
raised. 
For the convenience of the patient and the family member, the venue and time of the 
interview or questionnaire completion was decided by them. The family member had the 
option to request the interview or questionnaire completion whilst the patient was being seen 
by the clinician in the clinic.  
The ethics of recruitment were also considered during the study design. Patients and family 
members were approached in clinics or inpatient settings. They were then introduced to the 
study by the clinician, given the information leaflet to read and given the opportunity to ask 
questions. They were then given 48 hours (or longer if they wished) to decide whether to 
take part in the study. If they did decide to take part, the investigator was then available to 
conduct the interview or administration of the questionnaire in the clinic or on the ward.  
PROCEDURE 
The study was conducted between August 2010 and August 2012, in six main stages (Figure 
2.1).  
Stage 1: Conceptualisation of Family Quality of Life 
Prior to the design of the study, the concept of family quality of life was examined in depth. 
This involved the study of available literature on the subject, in particular identifying the gaps 
in the current knowledge of the area, in order to ensure that this study was not repeating 
previous work and that the work focused on previously unexplored areas. The related 
literature was collated into a literature review, the results of which are given in Chapter 1. For 
each original report, the design and methods were examined, so that the most appropriate 
and effective methods were written into the protocol for this study. The limitations of each 
reviewed study were also noted and considered during the design of this study. The available 
literature on family quality of life also provided information about the themes which had 
arisen from these studies, which might therefore be of importance in this study. Themes and 
ideas which arose from previous related studies were used to form the basis for an interview 
structure, and provided ideas of possible questions to ask family members of patients. 
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Exploring the concept of family quality of life allowed an advance understanding of the 
possible themes which may have arisen from the interviews with family members, and how 
these themes compare to previous studies. A full understanding of the background of the 
study area was therefore of great importance during the study design.  
Stage 2: Qualitative Interviews 
It was important to select the most appropriate method for collecting the qualitative data 
regarding how family members are affected by illness. Several different methods were 
considered for the qualitative data collection: 
Focus groups  
This is a type of group interview which can be a quick and efficient way to collect qualitat ive 
data. The advantages of focus groups include the benefits of the interactions between 
members, commenting on each other’s ideas and points of view (Kitzinger 1994), with the 
discussion reminding participants of additional issues. Other advantages include not 
discriminating against those who cannot read and write and encouraging those who are 
reluctant to be interviewed on their own (Kitzinger 1995). However, focus groups were 
considered inappropriate for this study as it was felt that the information being discussed 
could potentially be very personal to the participants and many may not want to talk about it 
in front of others, especially if they are not used to talking to anyone about how the patient’s 
illness has affected them. This view was informed by previous recent experience of the 
research team in gathering qualitative information concerning Major Life Changing Decisions 
(Bhatti et al. 2011), where there was great difficulty in recruitment for focus groups.  It is also 
important that the views of family members from a variety of specialties are collected, and 
although it is the role of the moderator to ensure contribution from all members during a 
focus group meeting, the discussion could be dominated by those family members who have 
experienced the greatest impact. It is considered extremely important that the participants 
feel comfortable enough to open up and discuss sensitive issues and it was felt that this may 
not be achieved during a focus group. 
Questionnaires  
Questionnaires with spaces for family members to write their answers were also considered 
as a method of data collection. This method needs relatively few resources and requires little 
effort to recruit a large number of participants. However, there is the high possibility of a low 
response rate if the questionnaires are posted (Zelnio 1980), and there is often a lack of 
sensitivity as the respondent cannot elaborate on answers as easily as in an interview or 
focus group. As family quality of life over a number of specialties is a new concept which has 
not been explored for the purpose of development of a measurement method before, 
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questionnaires were not chosen as the method for data collection, as a rigid, structured set of 
questions would be required which would be difficult to predict at this stage of the research. 
Using questionnaires would potentially limit the richness of the data and not allow the 
investigator to invite the subject to expand upon answers given.  
Individual interviews  
Interviews with family members were the third potential method of data collection considered. 
Interviews have the advantage of being able to follow up the information the interviewee 
gives with further probing, or clarify anything ambiguous (Kvale and Brinkmann 2009). 
Although individual interviews can be time consuming and potentially induce bias into the 
data, they allow for in-depth data collection. Individual interviews were chosen as the method 
of data collection for this study as the method allows flexibility and the topics covered with 
family members have the potential to be personal or sensitive, therefore a one on one 
method of data collection is preferable. Steps were taken to reduce interviewer bias and the 
use of individual interviews worked well within the time constraints of the project. 
Qualitative interviews were carried out with family members of patients suffering from a 
variety of diseases over 26 specialties. Family members were asked about the ways their 
lives had been affected by having an unwell relative. Interviews were semi-structured, and 
participants were encouraged to give examples where possible. Effort was made to recruit a 
spread of family members (e.g. siblings, parents, spouses), in collaboration with the clinician 
from each specialty. The interviews were audio recorded and transcribed verbatim. 
Throughout the interviews, and as new themes emerged, potential uses of the new measure 
were considered and ideas of how family members of patients can be supported were 
explored. 
Stage 3: Item Generation 
The interview transcripts were analysed using the qualitative data analysis software NVivo
©
. 
This coding software allows the highlighting and sorting of the transcripts into common 
themes, or codes. Hierarchy of themes can also be established in the NVivo software, and 
relationships between the different themes can be identified. Examples from transcripts 
containing similar themes are grouped and easily retrieved in order to calculate the 
prevalence of each theme and identify specific examples to illustrate each theme. As well as 
using the NVivo© software, the interview transcripts were also re-coded by hand using a 
numbering system to ensure reliability between the paper and electronic methods. The 
process of coding the data followed that outlined by Braun and Clarke (2006), and included 
familiarising oneself with the data, generating initial codes, searching for themes, reviewing  
themes, and then defining and naming themes. A flexible approach to coding was used, and 
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both the coding process and themes were discussed in detail with the study team at regular 
stages. During coding, the transcripts are often examined for saturation, the point at which no 
new themes emerge from subsequent interviews, which can be used to determine adequate 
sample size in qualitative research (Guest et al. 2006). As it is important that this study 
covers family members of patients with a variety of illnesses, all 26 specialties must be 
included at interview stage. Therefore, sample size was not calculated as the interviews were 
carried out, but was calculated once the desired number of interviews from each specialty 
had been competed (>5), to ensure that saturation point had been reached. If saturation 
point had not been reached at this stage, further interviews would be carried out. This is 
explained further in Chapter 3. 
The themes generated were then used to form the items of the preliminary version of a 
generic family quality of life questionnaire. The questions were worded in a simple and 
comprehensive way, and each question was designed to measure a different concept. The 
questionnaire was designed so that the answer to each question would be scored to allow 
quantification of the overall effect their relative’s illness has on their quality of life. The 
questionnaire was developed so that it could be applicable to, and understood by, all 
members of a patient’s family over 16 years of age. The design of the questionnaire was 
such that the investigator, and after the questionnaire is launched the clinician, would be able 
to determine the area(s) of the participant’s life which are most greatly affected.  
Stage 4: Content validity  
Content validity ensures that the instrument measures the intended concept and that it is 
understood and relevant to the intended population (FDA 2009). It is often the first, and 
arguably the most important step in the validation of an instrument, as it underpins the theory 
of tests such as reliability and construct validity (Rubio et al. 2003). Members of the intended 
instrument population are asked to provide feedback regarding the measure, both in terms of 
individual items, and the content covered in the measure as a whole. This includes the 
instructions, layout and response options. This feedback is then used to justify that the 
measure covers the intended concept, and identifies areas where changes could be made. 
Additionally, clinicians are asked to give their feedback on the measure, and the relevance of 
items to the family members of the patients they treat, who are often involved in their care. 
The preliminary version of the instrument was evaluated by both an expert panel and by a 
family member panel who were recruited to test the content validity of the questionnaire 
items, which is considered important during instrument development (Streiner and Norman 
2008). The expert panel consisted of academic experts, consultant clinic ians and nurses 
from a variety of specialties, and they rated each item in the scale for its language clarity, 
completeness, scaling and relevance. They also reviewed the planned layout of the measure 
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and the instructions given. Agreement amongst the panel members was measured using 
interclass correlation and the panels suggested several changes to the measure which were 
then implemented to form the developmental version of the instrument.  
Stage 5: Item Reduction 
As in Stage 2, patients and family members were recruited over the 26 specialties with 
guidance from a consultant clinician. The aim of this stage of the study was to begin to 
validate the newly developed family quality of life instrument using a combination of item 
response theory and factor analysis. Item response theory was used to identify mis-fitting 
items, items which showed differential item functioning by age and gender, and items which 
were clustering and potentially measuring the same concept. Items with low item-total 
correlation (<0.2) were dropped (Streiner and Norman 2008). Factor analysis was then 
applied to allocate domains to the instrument, and also to confirm any mis-fitting items. The 
traditional method of using factor analysis alone has been criticised for assuming that each 
item contributes equally to the final score, assuming a standard error of measurement across 
the scale and posing problems with equating tests (Streiner and Norman 2008). Rasch 
analysis is now the preferred technique for item reduction, and it has been said that “only 
Rasch analysis constructs the kind of objective linear variables that social scientists need to 
quantify their constructs, map their fields of study, test their hypotheses, and measure the 
values of their social programs” (Wright 1996). Comparing both factor analysis and the 
cutting edge technique of item response theory gives increased confidence that the items, 
and the questionnaire as a whole, are functioning to a high standard. Comments and 
feedback from family members was taken into account when removing the items and 
amending the measure.  
Item response theory is a modern psychometric method usually carried out using the Rasch 
measurement model (Rasch 1960). Although the model has been widely used in education 
for the last 40 years, it has only recently been applied in the health sciences (Tennant and 
Conaghan 2007). The Rasch model shows “what should be expected in responses to items if 
measurement is to be achieved” (Pallant and Tennant 2007), and both polytomous (Andrich 
1978) and dichotomous (Rasch 1960) versions of the Rasch model are available. The Rasch 
model is based around the probabilistic Guttman pattern (Andrich 1985), meaning that if an 
item of higher difficulty is affirmed by the subject, the probability of an easier item also being 
affirmed is high (Tennant and Conaghan 2007). This also allows the scores for individual 
items to be summed to give a total score for a measure, as the Rasch model is based around 
a unidimensional model. An important part of the process of Rasch analysis is confirming 
whether a unidimensional scoring system is appropriate for the data set, and this can then be 
confirmed using classical test theory and factor analysis. Tennant and Conaghan (2007) 
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explains how the Rasch model transforms individual items scores to interval data, providing a 
linear relationship, using the example of a pain score: “The model assumes that the 
probability of a given respondent affirming an item is a logistic function of the relative 
distance between the item location and the respondent location on a linear scale. In other 
words, the probability that a person will affirm an item is a logistic function of the difference 
between the person’s level of, for example, pain and the level of pain expressed by the item, 
and only a function of that difference”. Rasch analysis can be used when designing a new 
scale and selecting items to include which contribute to a total score (Court et al. 2007), or 
when evaluating the properties of an existing measure (Liang et al. 2009). It can also be 
used in computer adaptive testing when creating an item bank (Lai et al. 2003). The process 
of Rasch analysis in this study was carried out using the software RUMM2030, which is 
designed to be able to perform the multiple tests required for exploring the data-model 
relationship, and produce the formal statistics required to test this relationship (Hagquist et 
al. 2009). This latest version of the RUMM software has several additional features 
compared to the earlier RUMM2020: the software can be used to assess dimensionality of 
the measure, data sets can be created with complete values only, the cumulative person 
distribution can be referenced to the normal counterpart in terms of the mean and standard 
deviation, and the clarity of presentation of results and graphs has been improved.  
Stage 6: Further Validation 
The aim of this stage was to assess the psychometric properties of the newly developed 
instrument and establish its validity, reliability and sensitivity to change. This would allow the 
new measure to be used effectively in future studies, and ensure that it is fit for its intended 
purpose. A new cohort of family members were recruited for this purpose. The following 
instruments were used during the further validation phase: 
The WHOQOL-BREF 
The WHOQOL-BREF is a generic quality of life instrument, commonly used across many 
different countries to assess the quality of life of adults with and without illness (Appendix S). 
The WHOQOL-BREF was developed from a longer and more detailed instrument, the 
WHOQOL-100, which has also been validated and used internationally (The WHOQOL 
Group 1998b). The WHOQOL-BREF was developed for use where time is restricted, where 
the investigator wants to reduce the burden on the subject, and where less detail is needed 
in the responses (Skevington et al. 2004). The items selected from the WHOQOL-100 for 
inclusion in the WHOQOL-BREF were identified using the data from multinational studies of 
the WHOQOL-100, and were selected by their relationship with the overall WHOQOL model, 
the discriminant validity and their proportion of variance within their domain (The WHOQOL 
Group 1998a). The WHOQOL-BREF is a self-administered questionnaire which consists of 
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26 items and 4 domains: physical, psychological, social and environmental (Skevington et al. 
2004). The instrument is scored on a 5-point Likert scale: Very poor, Poor, Neither poor nor 
good, Good and Very good and individual item scores are added to give a total score (two 
items are reverse-scored). Higher scores mean a higher quality of life. Scores from the 
WHOQOL-BREF can be transformed on a scale of 0-100 in order to be compared to the 
scores from the WHOQOL-100 (Skevington et al. 2004).  The WHOQOL-BREF has been 
extensively tested in a multinational and wide population for validity and reliability 
(Skevington et al. 2004; 1998a). The instrument has also been developed and validated in 
many different countries (Izutsu et al. 2005; Leung et al. 2005; Min et al. 2002; Yao et al. 
2002).  In this study, the WHOQOL-BREF was completed by family members, and was used 
to assess the construct validity of the convergent type. It was selected for use as it has a 
short completion time, has been widely validated in a range of populations, is straight forward 
to score and has been extensively tested in terms of reliability and validity; this increases the 
confidence in the measure to produce reliable results and put a minimal burden on the family 
members in the study. Before the measure was selected and this stage of the study was 
completed, the investigator thoroughly reviewed the content of the WHOQOL-BREF. 
The global health (GH) score 
The global health (GH) score was used in several stages of the val idation. The GH score 
asked family members about their subjective assessment of the patient’s health at the 
moment on a 0-10 visual analogue scale. 0 indicated worst possible health, and 10 indicated 
perfect health (Figure 2.1). 
The GH score was correlated to the total score of the family quality of life instrument during 
the construct validity stage and was used to assess whether the patient’s health status had 
changed during both test-retest reliability and sensitivity to change studies. 
Follow up recruitment procedure 
Subjects were followed up during both the test-retest reliability (after 7-14 days) and the 
sensitivity to change test (after 2 months). With the aim of maximising response rate, family 
members were given the option of being followed up via post or email, and provided postal or 
email addresses accordingly. Those who were followed up via post were sent a covering 
letter explaining the importance of returning the questionnaires on time (Appendix U), and a 
prepaid envelope to return them in. Each of the questionnaires was numbered by the 
investigators before they were sent out, so that they could be matched up with the correct 
subject when returned. Those subjects who chose to be followed up via email were sent a 
covering email with the same wording as the covering letter, with a link to an online version 
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of the instrument, together with an introductory page and an electronic version of the global 
health (GH) score. 
 
Figure 2.1: The global health (GH) score completed by family members of patients 
 
Once the subject had submitted their responses they were accessed online, via a password 
protected system, for analysis. Subjects were asked to enter their age, initials and 
relationship to the patient as unique identifiers, so that they could be matched up with the 
correct subject. During both forms of recruitment, no personal details relating to the family 
member or patient were released. Subjects were provided with contact details for the 
investigators in case they had any questions or trouble completing the questionnaires. Any 
subjects who had not completed their questionnaires after a week were followed up in order 
to increase the response rate. 
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Reliability 
Reliability has been described by Nunnally (1967) as “the extent to which [measurements] 
are repeatable and that any random influence which tends to make measurements different 
from occasion to occasion is a source of measurement error”. Reliability was tested using 
internal consistency and the test-retest method.  
Internal consistency  
This examines the variance between a subject’s true score, and the total score for a measure 
(Charter 2003), and the most widely used measure of internal consistency (Streiner 2003) is 
Cronbach’s alpha (α) coefficient (Cronbach 1951) which measures the degree of consistency 
of the scale. The α coefficient has a value of between 0-1 and authors differ in their opinions 
of the acceptable value of α. Most suggest that α should have a minimum value of 0.7 
(Heppner et al. 1992; Kaplan and Saccuzzo 1997), which was used as the determinate level 
for internal consistency during this study. Others suggest that the α value should be above 
0.8 (Clark and Watson 1995; Nunnally 1978). Some authors also suggest that if the 
instrument is to be used clinically, the α value should be above 0.9 (Ponterotto and 
Ruckdeschel 2007), although this contradicts Streiner and Norman (2008) who argue that if α 
is above 0.9 then there could be a high level of item redundancy and the scale may be too 
narrow in scope. Ponterotto and Ruckdeschel (2007) argue that an internal consistency 
greater than 0.7 should be met in instruments which have more than 11 items. 
Test-retest reliability  
The purpose of this type of reliability is to examine the reproducibility of results, and therefore 
the stability of the scale when repeated used under the same conditions. In the same way 
that it is important for an instrument to be able to detect a change in disease state, it is just 
as crucial for the instrument to demonstrate stability (Guyatt et al. 1987). The choice of time 
interval for follow up in a test-retest analysis is an important consideration. If the interval is 
too long, the disease state may have changed, or other external factors may influence the 
QoL. Conversely, if the interval selected is too short, the subject may remember their original 
responses and answer the questions from memory (Streiner and Norman 2008), often 
overestimating the reliability (Hunt et al. 1981). The test-retest reliability can vary depending 
on the nature of the disease (Meltzer and Hochstim 1970), and a retest interval of between 2 
and 14 days is usually considered acceptable (Streiner and Norman 2008).  In this study, 
family members were sent another copy of the instrument via email or post (depending upon 
their choice) 7-14 days after the initial recruitment, and asked to complete it again. The 
interval of 7-14 days falls within the acceptable time period outlined by Streiner and Norman 
(2008). It was felt that leaving a period of a week would help to prevent subjects answering 
the questions from memory, but by capping the time period at 14 days it would also help to 
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reduce the chance of change in the patient’s disease state. During this round of recruitment, 
family members were also asked to complete a global health (GH) score, rating the patient’s 
disease from 0-10 depending on how bad they felt the patient’s condition was. Subsequently, 
7-14 days later, the global health score was sent to the family member, along with the newly 
developed family quality of life instrument.  The questionnaire results were analysed for 
family members who had indicated no change, or very little change (no more than one point 
on the 0-10 scale) on the global health score. Correlation between the results from the initial 
recruitment and the results from the 7-14 day follow up were analysed using the Intraclass 
Correlation Coefficient (ICC), which is generally recommended over the Kappa coefficient 
when testing polytomous data for a number of reasons, including the fact that it can handle 
missing data (Streiner and Norman 2008).  
Validity 
 Face validity and practicality  
Face validity and practicality of the instrument was assessed for a second time after item 
reduction using feedback questions which were given to the family members during this 
stage of recruitment. Face validity is important, as if the item appears irrelevant on the 
surface, the subject may omit it (Streiner and Norman 2008), and an instrument with face 
validity is known to increase motivation amongst subjects and reduce dissatisfaction (Nevo 
1985). Family members were asked to complete four questions about the face validity and 
practicality using “yes” or “no” tick boxes. They were also asked to report any comments or 
reasons why they may have disagreed with the statements in the questions. As a further 
measure of practicality, family members were timed when completing the questionnaire. It is 
important that the instrument does not put a large time burden on the family member, and it 
was felt that the mean time taken to complete the instrument should be less than five 
minutes, so that during future use, it minimises burden on both the family member and the 
investigators or clinicians. The time taken to complete the instrument was correlated with the 
family member’s age using Pearson’s product moment correlation coefficient. Pearson’s 
product correlation was chosen as both values are made up of continuous data. The 
readability score and item lengths of the new instrument were also assessed. The standard 
Flesch test for readability was used (Flesch 1948), with the aim to score between 60 and 70, 
giving it a “standard” readability. The desired item length was “as short as possible, although 
not so short that comprehensibility is lost”(Streiner and Norman 2008). Holden et al (1985) 
also found that shorter items have higher validity coefficients.  
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Construct validity 
This was assessed to show that the newly developed instrument is measuring what it is 
intended to measure. Construct validity examines the relationships between behaviours and 
attitudes (Streiner and Norman 2008) and is often measured by comparing the scores of the 
new measure with a similar instrument with established validity.  However, new measures 
are often defining new concepts, and by definition, no similar measure exists. Therefore, 
construct validity is often assessed by developing a hypothesis which relates the attribute we 
are measuring to other known attributes (Streiner and Norman 2008). This hypothesis can be 
accepted as a measure of construct when there is a strong, positive fit between the 
prediction and the subsequent data (Cronbach and Meehl 1955). 
As no similar measure to the newly developed family quality of life instrument exists, two a 
priori hypotheses were devised to attempt to establish a relationship between the instrument 
and another measure. The first hypothesis devised was that the impact of illness on family 
member’s QoL is correlated to the family member’s overall QoL. During this stage of 
recruitment, family members were asked to complete both the WHOQOL-BREF, a generic 
quality of life measure, and the newly developed measure. The scores from the newly 
developed measure and the WHOQOL-BREF were then compared using Spearman’s 
correlation coefficient, as the newly developed measure has ordinal scaling and the 
WHOQOL-BREF has interval scaling. The hypothesis would be accepted if the correlation 
were to be negative (as the two measures are scored in different directions). Correlations 
would also be expected to be seen between the separate domains of the two questionnaires. 
Secondly, it was hypothesised that the impact of illness on family member’s QoL is 
correlated to the health of the patient, in this case, the global health (GH) score. The 
relationship between disease severity and impact on the family has already been proven in 
several individual specialties (Balkrishnan et al. 2003; Reiter-Purtill et al. 2008; Zashikhina 
and Hagglof 2009). The instrument score and the GH score were correlated using 
Spearman’s correlation coefficient, as both data sets are ordinal (Pallant 2005). 
Sensitivity to change 
It is important for any quality of life measure to be able to demonstrate change over time, or 
sensitivity to change (Lohr 2002). For the instrument, this means demonstrating a difference 
in family quality of life as a response to an improvement or decline in a patient’s health. In 
this study, a preliminary investigation of sensitivity to change was carried out with five family 
members of patients from five of the core medical specialties. After a period of 2-3 months, 
the 25 family members were sent another copy of the instrument and the global health score. 
This time period was chosen as it was felt that it was long enough for the patient’s health to 
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have changed in many of the wide range of conditions sampled, and was decided upon with 
the help and advice of experts. Those family members who indicated that their relative’s 
condition had changed in severity by two or more points on the global health score were 
included in the analysis, which compared their original scores during the third round of 
recruitment to their scores after 2-3 months. The participants were divided into two groups- 
“improved” (where the QoL score had decreased) or “worsened” (where the QoL score had 
increased). The two groups were compared using the Wilcoxon Signed rank test to assess 
the within-group difference, the Mann-Whitney U test to interpret the difference in the scores 
between the two groups and the Spearman’s rank correlation coefficient to determine the 
correlation between the changes in the QoL score and change in global health score. The 
sensitivity to change study was only a preliminary investigation with small numbers due to 
the time constraints of the project. This will be explored further in future work. 
Regression analysis 
A multiple regression analysis was carried out to identify some of the possible factors 
influencing family QoL. The choice of regression (standard, hierarchical, stepwise) was 
influenced by the results of the correlation tests carried out during the validation. The total 
QoL score was set as the dependent variable, and nine other demographic factors were set 
as the independent variables. These included health of the patient (GH score), family 
member age, family member gender, patient age, patient gender, relationship between family 
member and patient, patient’s disease duration, family member’s education level and family 
member’s total annual household income.  
DATA ANALYSIS 
Data was analysed during the study using a variety of software packages and statistical 
techniques. Qualitative analysis was completed using NVivo (version 9), which quantified the 
common themes identified and calculated the number of themes mentioned by each 
participant. The Predictive Analytics SoftWare Statistics (PASW version 18, formerly known 
as SPSS) was used for the statistical analysis of all of the data, including calculating the 
frequency and percentage of each category of each variable, the mean, median, standard 
deviation and minimum and maximum. PASW was also used to carry out parametric tests on 
the quantitative data. The use of parametric and non-parametric tests has been widely 
debated in the area of quality of life instrument development. Parametric tests (for example 
factor analysis, ANOVA and structural equation modeling), which assume normality of data 
are commonly used in instrument design, and have been used successfully for many years 
(Norman 2010). Furthermore, Norman (2010) describes these methods as “versatile, 
powerful and comprehensive”. Due to the large sample size, the fact that ANOVA has been 
shown to be robust for data with non-normal distributions (Pearson 1931) and the fact that 
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the results of parametric and non-parametric tests are often similar (Norman 2010), 
parametric tests were chosen to compare individual groups (gender, age groups, specialty 
etc.) and the family quality of life data. Spearman’s rank correlation coefficient was chosen 
as it is the recommended test to examine the relationship between sets of ordinal data 
(Pallant 2005). Throughout, a probability of p<0.05 was considered to be significant. PASW 
was also used for the factor analysis of the questionnaire, where an orthogonal Varimax 
rotation was selected as it is the most widely used rotation method, thought to produce the 
clearest results (Fabrigar et al. 1999). PASW was also used to plot a Scree plot, and produce 
structure and component correlation matrices. The software RUMM2030 was used to 
perform the Rasch analysis, including producing all tables (item and person fit, principal 
components, residual correlations), graphs (category probability curves, equating item 
subsets, item characteristic curves, person-item distribution, threshold map) and statistical 
analysis (paired t-tests, ANOVA, mean, median, maximum and minimum). Microsoft Office 
Excel 2007 was also used alongside RUMM2030 to carry out a binomial test, and was also 
used to build many of the graphs presented in the Results chapters. 
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INTRODUCTION 
In order to develop a quality of life measure for use in family members of patients, it was 
important to gather in-depth and high quality data about the ways that illness affects family 
members of patients. The aim of this part of the study was to collect in-depth information 
about the impact of illness on family members, which would serve as both the basis for a 
new measure, and as a valuable piece of qualitative work in its own right. Several methods 
for collecting this data were considered and this qualitative phase of the study was designed 
to underpin the constructs for further development of the measure, and to ensure that all 
aspects of this impact across medicine were captured. This information was then used to 
develop the items to be included in the new quality of life measure. Although this is a subject 
which has been covered in previous literature in individual disease areas, no other studies or 
bodies of work exist looking at the family impact of illness over a range of different diseases. 
Therefore, it was decided that original data from family members should be the source of the 
questionnaire items. This is especially important in the area of quality of life outcome 
research where the information gathered on which to base measurement tools should be 
subjective, and not measured or dictated by a clinician or observer (Streiner and Norman 
2008). 
METHODS 
Individual interviews 
Individual semi-structured interviews with family members of patients were chosen as the 
method of qualitative data collection. The aim of these interviews was to collect high quality 
and in-depth data about how illness affects family members of patients. To reduce 
interviewer bias, all interviews were carried out with the same interviewer. The interviews 
were semi-structured, with broad opening questions, subsequent follow on questions and 
then closed questions to encourage family members to give examples and expand on 
answers where possible. The opening question in each interview was “Can you tell me about 
any ways your life has been affected by having an unwell relative?”.  At the end of each 
interview this question was repeated again to give the family member a chance to talk about 
any areas that had not been already covered. Each topic that the family member brought up 
was covered in detail in the first part of the interview and then an interview guide, based on 
the previous literature looking at the impact of illness on families (Ferrario et al. 2004; Poston 
et al. 2003; Turnbull et al. 2004), was used to discuss any topics which had not already been 
covered. The interview guide contained some themes and questions relating to how illness 
affects family members. The interview guide was used as a prompt but was not heavily relied 
upon as the interviewer wanted to keep an open mind about potential themes and topics in 
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this new area of research. Using a semi-structured interview helps the participants to feel 
more relaxed and more conversational, encouraging them to open up and talk in more depth 
about sensitive issues.  
Inclusion and exclusion criteria 
The inclusion and exclusion criteria for family members and patients for qualitative data 
collection were as follows: 
Inclusion criteria for family members 
• Age 16 years and above 
• Able to understand and read English 
• Be an immediate family member, or partner living with, or caring for, a patient 
diagnosed with one or more medical conditions under one of the selected specialities 
(see chapter 2) 
• Able to give written informed consent 
Inclusion criteria for patients 
• Able to understand and read English (if over 16 years old) 
• Diagnosed with one or more medical conditions under the selected specialities (see 
chapter 2) 
• Able to give written informed consent (if over 16 years old; if patient is under 16 years 
old, parent/guardian must be able to give written, informed consent) 
• Attending clinic with a family member, or being a hospital inpatient. 
Exclusion criteria for family members 
• Age under 16 years 
• Unable to understand and read English 
• Not considered by the patient as a family member 
• Unable to give written informed consent 
• Having a severe handicap or disability which prevents them participating in an interview 
or filling out a questionnaire. 
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Exclusion criteria for patients 
• Unable to understand and read English (unless under 16 years old)  
• Unable to give written informed consent (unless under 16 years old)  
Sampling and recruitment procedure 
Patients were recruited for the study in conjunction with clinicians from 26 specialties at the 
University Hospital of Wales, Cardiff, University Hospital Llandough, Gabalfa Clinic, Velindre 
Cancer Centre, in General Practice or at the participant’s home. The selection of specialties 
and the clinicians’ involvement is explained fully under in Chapter 2.  
Purposive sampling (Barbour 2001) was used, where the clinicians selected at least five 
patients who were suffering from different conditions and were representative of typical 
patients in their specialty. It was considered important by the investigators to consider how 
the convenience sample in the study would differ from a randomly selected sample, so the 
interviewer met with each of the clinicians prior to recruitment to explain the importance of 
recruiting a representative sample from each specialty. Although this mostly included chronic 
patients, patients who were awaiting surgery or had undergone surgery were also included. 
Patients suffering from more than one medical condition were not excluded from the study as 
it was felt that including patients with co-morbidities would more closely reflect reality. 
Instead, the interviewer used the interview guide to focus the family member on the effects of 
the principal diagnosis: any extra information added to the richness and variety of the data.  
One family member of each of the patients identified was then approached and asked to take 
part in the study. A variety of family members were approached. Written informed consent 
was taken from both the patient and family member before the interview began. Each 
interview took place in a private room without the patient present, unless the patient was 
under 10 years of age and the parent was being interviewed. Each interview was audio 
recorded and transcribed verbatim.  
In order to obtain the highest quality data and reduce the chance of interviewer bias, the 
interviewer was trained for the task by attending a social research interviewing course and 
studied the art of interviewing, including the use of language, the set up of the interview 
room, and methods of analysis (Kvale and Brinkmann 2009).  
Demographics 
As well as collecting in depth information about the ways that illness can affect family 
members of patients, demographic details were also collected from family members and 
patients before the interviews. This was in order to allow the population interviewed to be 
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described, and at later stages in the study, comparisons were able to be made between 
different demographic categories. The data could also be used to assess the spread of 
patients and family members, and investigate the extent of the variety of conditions that were 
sampled. Demographics collected from the patient included: age, gender, ethnicity, primary 
diagnosis, other diagnoses, disease duration and occupation. Demographics collected from 
the family member included: age, gender, ethnicity, relationship to patient, and 
socioeconomic data including occupation, highest level of education and annual household 
income.  
Pilot interviews 
Three trial interviews were carried out with family members of patients prior to the beginning 
of the study. The results from these interviews were not included in the analysis, patients and 
family members were fully informed of the nature of the interviews and written informed 
consent was taken. The trial interviews gave the interviewer a chance to practise using the 
interview guide and make any necessary changes, as well as practicing using the audio 
equipment. The trial interviews also allowed the interviewer to rehearse the introduction to 
the study and practice using the consent and demographic forms. This allowed the 
interviewer to feel more relaxed and comfortable going into the first interview.  
Sample size consideration  
The sample size calculation for the interviews in this study was based around two 
considerations. The first was ensuring that the interviews contained data from family 
members across all 26 specialties, and as family members from some specialties were 
recruited before others, this meant that interviews had to be continued until a roughly equal 
number of family members had been sampled from all specialties. Given the time frame and 
the practicalities of the study, the interviewer aimed to recruit a minimum of five family 
members from each specialty, giving a total predicted sample size of 130 interviews. 
Secondly, the saturation point of the data was taken into consideration; a common way of 
determining sample size in qualitative research (Guest et al. 2006). The saturation point is 
the point at which no new themes arise, meaning that the participants are talking about 
common themes and a high level of confidence can be achieved that themes which are 
important and relevant to family members have been identified.  In this study, interviews 
were continued well past this point to ensure confidence in the data, and to be sure that 
relevant themes from all specialties had been covered. This is discussed further in the 
“Discussion” section of this chapter. 
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RESULTS 
Sociodemographic characteristics of the study participants 
140 family members of patients were approached and asked to take part in the study. Seven 
family members declined to take part due to time constraints. This gave a total of 133 family 
members of patients recruited for interviews across the 26 specialties. Most family members 
were White British (93%), female (61%), the partner or spouse of the patient (56%) or the 
parent (22%). The mean patient disease duration was 8.9 years (range 1 month to 60 years), 
and the mean patient age was 54.7 years (range 3- 97 years). The demographics of the 
family members interviewed can be found in Table 3.1. As the sample covered a large range 
of specialties and illnesses and was designed as an exploratory qualitative study with a 
restricted time frame, the sample was stratified by medical specialty but not by 
sociodemographic variables. A large-scale study in individual patient and family member 
groups has been suggested as a piece of further work.  Patients suffered from one or more 
of 144 diseases or types of surgery (Appendix E). The shortest interview lasted just 2 
minutes and 25 seconds and the longest lasted for 60 minutes. The total length of the digital 
recordings of the 133 interviews was 23 hours, 6 minutes and 52 seconds. The mean 
interview length was 12 minutes. There was no missing data in this part of the study as the 
demographic questionnaires were completed by the interviewer.  
Saturation point 
The saturation point was reached at interview number 40, after which no new themes 
emerged, and family members were reporting very similar issues. Interviews were continued 
past this point to include data from all specialties, in case new or unexpected themes 
emerged. As there were many specialties, the interview number was continued to 133, giving 
confidence that all themes had been identified. At least 5 participants were sampled from 
each specialty apart from infectious diseases, general practice and urology where 6 were 
selected. Between interview numbers 40 and 133, the participants gave different examples, 
adding to the richness of the data. 
Thematic analysis 
The content of the 133 interviews was transcribed and then coded using NVivo 9 software. 
The process of coding the data followed that outlined by Braun and Clarke (2006), and 
included familiarising oneself with the data, generating initial codes, searching for themes, 
reviewing themes, and then defining and naming themes. In many quality of life studies, 
coding frames are developed based on the content of the interviews before coding begins  
(Gabriel and Bowling 2004). It was felt that as this area of research had not been explored 
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previously, a rigid coding frame would be too restrictive. Instead, before coding began, the 
interviewer identified ten main themes from the content of the transcripts and these themes 
were used as a starting point for coding. A flexible approach was used for the coding (Braun 
and Clarke 2006), and subthemes/codes were coded under the ten main theme headings.  
Many of the subthemes identified from the coding related to one another, but each was 
placed under the most suitable theme heading and given appropriate labels to identify them. 
Quotes and examples from family members to represent each theme and subtheme were 
also identified from the text. Several steps were taken to verify the results of the coding and 
ensure reliable and high quality data (Singer et al. 1999): 
a. The coding process was repeated twice using the NVivo software. 
b. The coding process was also repeated manually by the interviewer, who wrote coding 
notes in the margins of the transcripts. 
c. The coding and themes identified were discussed in detail with the other investigators 
(AYF, SS and MKB) and a consensus was reached. 
The prevalence of each theme and subtheme was recorded to identify the most common 
areas of family members lives affected by illness. 
Themes identified 
Ten themes and 196 subthemes/codes were identified from the interviews with 133 family 
members. These themes represent the areas of family members’ lives which are affected by 
patients’ illness. The themes and subthemes are represented in Table 3.2 along with the 
percentage of family members who were affected by each theme. The main themes 
included: emotional impact (mentioned by 92% of subjects), daily activities (91%), family 
relationships (69%), sleep and health (67%), holidays (62%), support and medical care 
(61%), work and study (52%), financial impact (51%), social life (37%), and time planning 
(14%), as represented in Figure 3.1. 
The mean number of themes mentioned by participants was 6 (median= 6, S.D= 2.03, range 
0-10 [max=10]). The mean number of themes mentioned by family members from each of 
the 26 specialties was also calculated. Family members of haematology and genetics 
patients were affected by the most number of themes, and family members of gynaecology 
and diabetes patients were least affected (Table 3.3). 
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Table 3.1: Demographics of family members recruited for interview (n=133) 
Total number of family members (n) 133 
Gender  
     Males 39% 
     Females 61% 
Age (years)  
     Mean  56.1 
     Median 56 
     Range  21-85 
Relationship to patient  
     Spouse/partner 56% 
     Parent 22% 
     Child 15% 
     Niece/nephew 1% 
     Grandparent 2% 
     Sibling 2% 
     Grandchild 1% 
     Cousin 1% 
Educational level  
     Less than secondary school 11% 
     Secondary school 34% 
     A levels/college course 27% 
     University degree 17% 
     Masters/doctoral degree 6% 
     Prefer not to say 5% 
Ethnicity  
     White British 93% 
     Mixed 2% 
     Asian or Asian British 3% 
     Black or Black British 2% 
Combined annual household income  
     Less than £10,000 13% 
     £11,000-£20,000 26% 
     £21,000-£30,000 23% 
     £31,000-£40,000 8% 
     £41,000-£50,000 6% 
     £51,000-£60,000 5% 
     £61,000-£70,000 4% 
     £71,000-£80,000 1% 
     £81,000-£90,000 2% 
     £91,000-£100,000 0% 
     Over £100,000 1% 
     Prefer not to say 11% 
Age of patients (years)  
     Mean  54.7 
     Median 61 
     Range  3-97 
Patients’ disease duration (years)  
     Mean  8.9 
     Median 5.5 
     Range  1 month - 60 years 
 
49 
 
Table 3.2: Identified themes and subthemes from 133 interviews representing 26 
medical specialties 
Theme (percentage of family 
members affected) 
Subthemes/codes (percentage of family members 
affected) 
Emotional impact (92%) Accepting what has happened (6.0%) 
Affected behaviour or personality (9.8%) 
Aggression (0.8%) 
Angry (15.0%) 
Annoyed (6.8%) 
Anxious (5.3%) 
Can't cope (3.0%) 
Changing emotions (0.8%) 
Concern (6.0%) 
Confusion (2.3%) 
Crying (8.3%) 
Depressed (5.3%) 
Devastated (3.0%) 
Developed a tougher attitude (0.8%) 
Disappointed (1.5%) 
Disbelief (0.8%) 
Distress (3.0%) 
Fear (3.0%) 
Fed up (0.8%) 
Feeling down (1.5%) 
Feeling more emotional (6.8%) 
Feeling sorry for self (0.8%) 
Feeling tense (0.8%) 
Feels sorry for patient (5.3%) 
Frustration (27.1%) 
Grief (1.5%) 
Guilt (14.3%) 
Have to think about patient more (4.5%) 
Have to think ahead more (0.8%) 
Helpless (5.3%) 
Impatient (0.8%) 
In back of mind (10.5%) 
Increased responsibility (4.5%) 
Irritable (1.5%) 
Isolated (0.8%) 
Jealous (0.8%) 
Life on hold (1.5%) 
Life turned upside down (0.8%) 
Lonely (4.5%) 
Lost own life (3.0%) 
Missing patient when in hospital (1.5%) 
No one to talk to about feelings (20.3%) 
Panic (3.8%) 
Pretending everything is ok (6.0%) 
Psychological effects (1.5%) 
Relying on others and lack of control (1.5%) 
Rollercoaster (3.0%) 
Sadness (6.8%) 
Scared (1.5%) 
Shock (9.8%) 
Sick and tired (0.8%) 
Stressed (18.8%) 
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Torturous (0.8%) 
Try to laugh about it (3.0%) 
Upset (22.6%) 
Why us (4.5%) 
Wishing patient was well (2.3%) 
Won't get life back (0.8%) 
Worry (35.3%) 
Daily activities (91%) Avoid situations where alcohol is present (1.5%) 
Can't ask patient to help around house (1.5%) 
Can't physically deal with patient (2.3%) 
Caring for patient (37.6%) 
Change of lifestyle (6.8%) 
Child care issues (3.8%) 
Coping around the house (6.0%) 
Difficult to do shopping (1.5%) 
Difficulty with patient’s schooling (1.5%)  
Don't go out late at night (1.5%) 
Eating different diet (8.3%) 
Eating out (7.5%) 
Family activities (8.3%) 
Has to be a translator for patient (0.8%) 
Have to learn how to live differently (2.3%) 
Have to limit activities (3.0%) 
Have to move house (1.5%) 
Have to prioritise activities more (0.8%) 
Hobbies (34.6%) 
Increased housework (47.4%) 
Loss of freedom (4.5%) 
Making excuses not to visit patient (0.8%) 
No alone time (6.0%) 
No time for housework (2.3%) 
Not eating (1.5%) 
Patient moved into their house (0.8%) 
Plan mealtimes differently (0.8%) 
Retirement plans affected daily (4.5%) 
Stopped going out (8.3%) 
Takes up time (6.8%) 
Taking one day at a time (1.5%) 
Telephoning patient to check on them (0.8%) 
Thinks patient is lazy (0.8%) 
Thinks patient tries to do too much (3.0%) 
Travel (18.0%) 
Visiting patient in hospital (10.5%) 
Family relationships (69%) Argue more (24.1%) 
Become more of a carer (18.8%) 
Can't have children (0.8%) 
Difficult being single parent (2.3%) 
Doesn't like being away from patient (25.6%) 
Doesn't understand how patient feels (0.8%) 
Family torn apart (0.8%) 
Feels like patient has no one else to help them (5.3%) 
Feels that patient won’t listen to them (1.5%)  
Hard to communicate with patient (1.5%) 
Has to look after patient's children (3.0%) 
Hates the patient (0.8%) 
Having to explain to children (2.3%) 
Made relationship uncomfortable (0.8%) 
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Not spending enough time with family (4.5%) 
Other family members affected (14.3%) 
Other family members don't understand (2.3%) 
Patient thinks relative doesn't want to help them (0.8%) 
Playing more than one role (2.3%) 
Pressure from patient (3.8%) 
Relationship problems (3.8%) 
Sexual relationship (21.0%) 
Spend too much time together (4.5%) 
Stuck in the middle (0.8%) 
Supposed to care for each other (4.5%) 
Trying to get patient to go to school (0.8%) 
Want to spend as much time with patient as possible 
(1.5%) 
Wants patient to be normal (0.8%) 
Wants patient to be sectioned (0.8%) 
Wants to leave home because of patient (2.3%) 
Wishes patient was dead (0.8%) 
Wishes patient would talk more (0.8%) 
Worrying about how other family members are feeling 
(2.3%) 
Sleep and health (67%) Sleep affected (66.2%) 
Health affected (6.0%) 
Holidays (62%) Anticipating problems (6.0%) 
Arranging holidays (2.3%) 
Avoiding sun (3.0%) 
Cancelled holiday (9.0%) 
Change type of accommodation (3.8%) 
Changing holiday activities (10.5%) 
Didn't enjoy holiday (2.3%) 
Family problems caused by going on holiday (0.8%) 
Not going on holiday (30.8%) 
Problems with insurance (0.8%) 
Problems with medication on holiday (2.3%) 
Problems with patient when away (9.8%) 
Shorter holiday (3.0%) 
Travel (13.5%) 
Support and medical care (61%) Difficult to talk about disease (6.0%) 
Don't like asking for support (3.0%) 
Family support (20.3%) 
Knowledge of disease (15%) 
Medical care (39.1%) 
People don’t understand (8.3%) 
Support decreased in general (2.3%) 
Support from friends (16.5%) 
Support groups (6.0%) 
Welfare support (4.5%) 
Work and study (52%) Affects studying (3.8%) 
Can’t work (1.5%) 
Exams affected (0.8%) 
Good to forget about problems (3.8%) 
Had to change hours (6.8%) 
Had to give up job (9.0%) 
Having to juggle work (3.8%) 
Leaving work early (4.5%) 
Make up hours missed at work (0.8%) 
Not taking all holidays (1.5%) 
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Theme 
Taking time off for appointments (16.5%) 
Taking time off to look after patient (11.3%) 
Work not understanding (25.6%) 
Worrying about future work (3.0%) 
Financial impact (51%) Buying more (26.3%) 
Cancelling holiday (2.3%) 
Can’t afford house modification (1.5%)  
Desperation for money (0.8%) 
Having to give up work (3.8%) 
Having to think more carefully about finances (2.3%) 
Hospital parking (5.3%) 
Medication (1.5%) 
More expensive holidays (2.3%) 
More washing (1.5%) 
Petrol (9.8%) 
Private healthcare (2.3%) 
Started gambling (0.8%) 
Supporting patient (2.3%) 
Travel to hospital (6.8%) 
Unable to spend money (0.8%) 
Social life (37%) Can't afford social life now (1.5%) 
Changing friends (0.8%) 
Come home early from social activities (2.3%) 
Decreased (12.0%) 
Friends’ reactions (3.8%) 
Given up alcohol so don’t socialise (0.8%) 
Have to cancel social activities (4.5%) 
Have to think more carefully about social life (4.5%) 
Only go out locally (3.0%) 
Seeing family less (3.8%) 
Seeing friends less (9.0%) 
Strangers’ reactions (8.3%) 
Time planning (14%) No subthemes 
Figure 3.1: The percentage of family members affected by each of the ten themes 
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Description and discussion of the 10 themes 
Emotional impact 
One hundred and twenty two (92%) of the family members interviewed were affected 
emotionally by the patient’s illness. The most commonly mentioned emotions included worry 
(35%), frustration (27%), anger (15%) and guilt (14%).  
Worry was often reported when the family members were thinking about the future, or the 
death of the patient. One family member whose wife had been diagnosed with lymphoma 
explained how his emotional state had changed completely with the worry of the disease 
reoccurring: “you go through sort of like fear, anger, the whole... everything...the life that you 
had, you’ll never have back because in the back of your mind there’s always that worry of “Is 
it going to come back?”” 
Frustration was a common emotion felt by family members of patients in the study. The 
husband of a patient with leukaemia described “I do get very frustrated with it, because I look 
at her and think “I wish I could do something”, but there’s nothing I can do, I’m so reliant on 
other people...it’s a man thing isn’t it? We like to have a degree of control...and feel we are 
doing the right thing by our family”. Others described the changes they had to make to their 
lives as a result of having an unwell relative as being frustrating: “We’ve been married a long 
time and we’ve done things together and all of a sudden life changes completely, you can no 
longer do many things...it’s been quite frustrating.” 
One man described his mix of frustration and jealousy towards the family guide dog as a 
result of his partner’s Leber Optic Neuropathy: “sometimes I get frustrated cos you think, 
before she had the dog she was stuck in the house and she got the dog to get some 
independence. The dog means more to her than me because the dog will go out in the rain 
with her and I won’t”.  
Most of the anger felt by family members was directed at the situation they have found 
themselves in, with many expressing a “why us?” attitude. Others felt anger directed at 
others, for example the patient’s medical team: “I get angry sometimes, especially when I 
see her coming home and they’re [the doctors] saying they won’t give her another treatment 
and she’s sitting there in floods of tears”.  
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Table 3.3: The mean and median number of themes mentioned by family members of 
patients in each medical specialty (in descending order) 
Specialty 
Mean number of themes 
mentioned by family 
members 
Median number of themes 
mentioned by family 
members 
Haematology 8 9 
Neurology 8 8 
Genetics 7 9 
General practice 7 8 
Oncology 7 7 
Cardiology 7 7 
Mental health 7 6 
Colorectal surgery 6 6 
Paediatric endocrinology 6 7 
Elderly 6 7 
Orthopaedics 6 6 
Rheumatology 6 6 
Gastroenterology 6 7 
Renal 6 6 
Urology 6 6 
Chronic pain 6 6 
ENT 6 6 
Respiratory 6 6 
Infectious diseases 5 5 
Dental surgery 5 5 
Dermatology 5 6 
Post stroke 5 6 
Wound healing 5 5 
Gynaecology 5 4 
Ophthalmology 4 3 
Diabetes 4 4 
 
Feelings of guilt were reported by family members for a number of different reasons. Some 
family members felt guilty for not doing enough for the patient, for example not having time to 
take over the household chores, or help the patient with washing or dressing. Most reports of 
guilt came from family members who felt guilty for enjoying themselves when the patient is 
unwell, or for getting on with their daily lives when the patient is unable to. The 67 year old 
wife of a patient with uncontrolled hypertension explained how she loved her part time job in 
a charity shop, but felt guilty about working: “It makes me feel guilty that I’m still working 
because I keep thinking, especially [the patient] collapsed, we should make the most of the 
time we’ve got, but then if I’m stuck in the house with him then we just get on each others 
nerves”. One family member whose husband has bipolar disorder described feelings of guilt 
as she feels embarrassed by his condition and lies to friends and work colleagues, in case 
they think her husband is “crazy”. Two family members, both mothers of patients, explained 
that they felt they could have done more to prevent the patient from becoming unwell, and 
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this lead to feelings of guilt. One mother, whose child suffers from the rare genetic condition 
DiGeorge syndrome, felt guilty for not taking folic acid during her pregnancy, despite the fact 
that she had been told it would not have made a difference.  
Less commonly reported psychological effects included feeling upset, annoyed, helpless, 
stressed and lonely. Twenty seven (20%) of the family members found it difficult to find 
someone to talk to about these feelings, often keeping their feelings to themselves. One 
family member described her difficulty in finding someone to talk to about her feelings: “It’s 
nice to have somebody to talk to, you know, if they just pop in...and stay for a cup of 
tea...when you first get the diagnosis everybody comes around and everybody phones but 
then it peters off and no one bothers”. Another, whose son has diabetes, said “You just work 
your feelings out in your head, you don’t want to show the kids that you’re stressed because 
it just makes them worse.” Some participants reported that the stress of having to hide their 
emotions in order to provide support for the patient caused a change in their personality or 
behaviour, giving examples of becoming more withdrawn, more angry and more anxious. 
Others described feeling “helpless”, as they feel there is nothing they can do to help the 
patient. The husband of a patient with Crohn’s disease said: “It was quite difficult not being 
able to help her and obviously she was in pain quite a lot. It makes you feel useless because 
you can’t do anything apart from pass some encouraging words or sympathise but you can’t 
change it”. 
Feeling sympathy towards the patient, often described as “feeling sorry for” the patient was 
frequently described when family members talked about providing support. Others talked 
about finding it difficult to accept that their relative was unwell, particularly when the patient’s 
symptoms were debilitating or severe. One mother of a four year old child with 
developmental delay and learning difficulties explained; “From an emotional point of 
view...it’s obviously a very difficult thing to get used to. The fact you have a child you think 
will be OK and you have hopes for him, and to find that completely turned on its head, and 
the fact he’s probably going to need care 24/7 for the rest of his life...that impacts the whole 
family”.  
As well as talking in depth about these emotional effects, family members also talked about 
some of the physical effects these emotions had, most commonly crying. The grandmother of 
a patient with muscular dystrophy explained how she had cried every day for six months after 
the diagnosis was made, and just thinking about the diagnosis still made her cry 17 years 
later. Other family members said they felt more emotional in general, and would react to 
everyday situations differently to before. Some family members also reported feeling lonely, 
saying “I feel lonely because he [the patient] sleeps all the time”, and “He [the patient] lies in 
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bed and is looked after and no one cares about me”. Stress was another subject brought up 
frequently by family members. 
For some family members, the emotional effects of having an unwell relative are so severe 
that they compare their feelings to that of bereavement. One family member said “It’s 
almost...like a bereavement. You have aspirations for them...expect them to get married, 
have their own children, careers...and suddenly someone tells you actually your child is really 
disabled...it’s almost like having a child die”. 
Daily activities 
The negative effect on day-to-day living as a result of having an unwell relative was reported 
by 121 (91%) of the family members interviewed. For 51 (38%) of the family members this 
involved aspects of caring for the unwell relative, including helping with dressing, personal 
hygiene needs, assisting with mobility and providing food. Many family members reported 
feeling a burden from caring for the patient, which often left them feeling like they had no 
freedom and no time to enjoy their own interests. The wife of a patient with prostate cancer 
said “I wait on him, he just sits in his chair...I have to do his night bag [catheter bag] and 
everything and just have to be there really. If you go down the road or anything, you’re 
thinking “oh, I’ve got to get back and make his tea” because he doesn’t even make a cup of 
tea now, he can’t”. Another family member discussed the difficult issues with caring for her 
daughter and assisting with her personal hygiene during psychotic episodes: “When an 
episode would start she would wet herself, she would wee on the floor. When she was 
menstruating...I would have to help her. Otherwise she would just come downstairs covered 
in blood...So literally...it was a case of twenty four, seven”.  
Forty seven (35%) of family members reported their hobbies or pastimes being affected and 
described a complete change in lifestyle as a result. Some described hobbies or activities 
they enjoyed with the patient, which they could no longer do together: “We used to like 
climbing hills and mountains and she [the patient] can’t. It’s a bit distressing that she can’t 
share in all of my enjoyments”. Most family members who reported their hobbies being 
affected had to give them up, or spend less time on their own interests. The husband of a 
patient with vulvar neoplasia said: “I ride a motorcycle and obviously that’s had to go in the 
garage whilst she’s been ill because I can’t leave her”. Another family member described: “I 
was doing my keep fit and going to different classes and stuff but all that came to a stop 
because I couldn’t enjoy it any more. When I’m out on the bike I’m thinking about other stuff 
and when I’m walking I’m thinking “No, I should be doing something else”. The hobbies and 
activities family members described as being affected included sports (swimming, shooting, 
rugby, fishing, going to the gym), activities (walking the dog, going to the theatre, going 
bowling), going to church and attending language classes. 
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Eleven (8%) of the participants described having to drastically change their diet as a result of 
the patient’s illness, either to encourage the patient to eat a particular diet, or because they 
did not have the time to cook food or eat out. The wife of a patient with diabetes said “We 
now have to have regular meals. There are a number of things we choose not to attend 
because we know the food is either slow in coming or doesn’t come...it’s vital to know what 
you’re eating and you know it’s there before you have your injections”. One husband 
described the impact of his wife’s diet restrictions: “She’s got coeliac disease which 
means...she has to have everything bought in; pizzas, bread, everything. She can’t eat 
anything we would normally eat so I’ve got to make everything fresh for her which is a big 
expense as well”. Other family member described the impact of the patient’s medical 
condition on eating out at restaurants, for example the husband of a patient with Crohn’s 
disease not knowing exactly what ingredients are in the food, so being afraid to eat out in 
case the patient’s condition was aggravated.  
Sixty three (47%) of the family members described an increase in the amount of housework 
they had to do as a result of having an unwell family member. This was often a direct result 
of symptoms of an illness, for example having to do more washing when dermatology 
patients are applying creams, or the husband of a patient with leukaemia having to do more 
housework due to the side effects of the patient’s treatment making her too tired to  
contribute. One family member described having to do her unwell mother’s housework as 
well as her own: “It’s a case of hoovering, washing the dishes, going to the post office, 
sorting the paperwork. It’s an awful lot and they [parents] don’t realise...I’m  sure they don’t...it 
just takes up an awful lot to time...it’s just time we could be spending doing other things”. The 
wife of a patient with a pituitary adenoma and sciatia said “Cleaning and things like that...I 
mean, I do that because he’s not well enough...even as far as cutting the grass and things 
which he used to do before and he can’t do any more. Cooking, I do all things like that, 
whereas years ago he would do that...it’s much easier then. Now I guess it’s difficult for him 
to do and he doesn’t feel like doing it...his mood can sometimes be quite low”. Common 
examples of increased housework included washing, cooking, cleaning, making beds and 
gardening. Some family members had to pay for a cleaner as they felt they could not cope 
with the housework on their own, and many described how they were struggling with the 
amount of work they had to do.  
Twenty four (18%) found that their everyday travel was affected, most commonly because 
the patient was no longer able to use their usual form of transport. The daughter of a patient 
with chronic kidney disease described the family’s difficulty in getting the patient to hospital 
appointments: “My brother brings us in but then he has to get a day off work to come 
because she can’t travel by bus because she can’t stand at bus stops, she can’t physically 
wait the twenty minutes or so on a bus stop, and we’d have to catch two buses out here and 
58 
 
two back”. Others described how they could no longer travel to places or go on days out: “My 
wife could not possibly travel. I mean, I can’t get her down the drive...it takes two men to get 
her down the steps. In fact, we don’t go out now.” Some family members reported that the 
patient could no longer drive as a result of their medical conditions, and so it made it a lot 
harder for them to get around, especially if the family member was unable to drive. Many 
family members travelling with patients found it difficult, and often impossible, to use public 
transport.  
The family members’ time was often taken up visiting the patient in hospital or attending 
medical appointments. One mother said “It was busy because I was in [hospital] with her 
daily after finishing work, trying to find someone else to pick up the little one after school 
because she was too bad for me to take the little one into hospital to see her”. This impact 
was also seen with family members of surgical patients, making long journeys every day to 
see the patient for weeks after major surgery.  One family member described how her son 
was transferred to another hospital in Manchester, when she was living in Cardiff at the time, 
and she visited him at least once a week for the five months he was there. The impact of 
having to come to hospital for treatment was also felt by family members, particularly in 
dialysis patients where family members accompanied patients to their appointments three 
times a week. 
Other daily issues included problems with child care, often relating to family members having 
to look after children as well as take on additional responsibilities. Others had to employ child 
minders or ask friends or family to look after their children as they were too busy to do so. 
The daughter of an elderly patient with osteoporosis described how she felt she had lost her 
freedom: “I have reverted back to how it was when I was bringing up my children. Part of you 
feels to a certain extent that you are housebound...Sometimes I get frustrated that I can’t just 
go out like I once did and leave post-it notes to say where I am for the rest of the family” 
Family relationships 
Relationships amongst the family members were affected in 92 (69%) cases, with increased 
levels of stress and tension in households.  
The most common explanation for a change in family relationships was as a result of the 
family member feeling that they could not leave the patient, and had to be there to care for 
them as much as they could (26% of family members). Naturally, this led to family members 
feeling they spent too much time with the patient, often at the expense of spending time with 
other members of the family. This was especially true with mothers of patients who had other 
well children. One mother described the impact of caring for her unwell child on the rest of 
her children: “You get wound up and wound up and then the slightest thing...it ’s hard for 
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those two [other children] sometimes because they think that we’re sort of favouring her in 
some ways, helping her more, doing more for her and that kind of stuff. You try to explain but 
sometimes there are times when there’s just no patience left and everybody’s shouting”. 
Other family members described not being able to spend time with their children, for example 
helping them with their homework. Some family members in this study also spent a lot of 
time worrying about how their other relatives were feeling and whether they were affected by 
the patient’s illness, particularly worrying about the effect on children.  
Not surprisingly, 32 (24%) of the family members interviewed reported more arguments in 
the family as a result of the patient’s illness. Family members reported that arguments often 
arose from disagreements about responsibilities. A mother of two sons with Attention Deficit 
Hyperactivity Disorder (ADHD) said: “My other half couldn’t cope with what was happening 
so I was left to deal with everything. I dealt with all the claims for the boys, I had to deal with 
the doctors and all the appointments and his excuse was “I’m working, I’m working””. Many 
family members described strained relationships within the household, sometimes as a result 
of the patient’s changing mood affecting others in the family: “Mood swings, tempers, arguing 
all the time, screaming, yelling. It affects us all you know. One minute she can be really 
pleasant to us and the next minute she’s screaming down at us and we’re shouting saying 
really horrible nasty things”.  In some cases, the arguments stemmed from family members 
feeling pressure from the patient to look after them, and sometimes feeling unappreciated for 
what they do.  
The partners and spouses of patients acting as a carer found the change of role in the 
relationship challenging, and many reported a negative effect on their sex life as a result. 
Others reported a decline in their sexual relationship due to the patient’s physical condition, 
for example a lack of mobility. The wife of one patient described “Well, we have no sexual 
activity at all. There’s been nothing for the last five years and that has affected me because I 
was always a very touchy-feely person...now he’s totally switched off from it...I’m looking at 
the man I love and I want to be cuddled. I want affection and he can’t show any affection”.  
For some family members the side effects of the patient’s treatment affected their sex life, for 
example tiredness or low testosterone levels. One family member described how she no 
longer found her husband attractive as he had put on weight due to his condition. Although 
many family members described feeling frustrated at the way their sex life was affected, they 
also understood what the patient was going through, and described how their lack of sex life 
did not bother them as much as some of the other issues they were facing at the time. 
In one case, a mother described a feeling of hate towards her diabetic teenage daughter 
because of the way her illness has affected the family, saying that she sometimes wishes her 
daughter was dead: “I want to walk out and not come home again, give her up, pass her onto 
60 
 
someone else, and there have been times when I feel I can’t deal with her, I can’t and she 
won’t listen to me. She hates me, I hate her, I can’t talk to her. You know, if somebody said 
to me “yeah but she’ll be gone one day” and I know it’s terrible to say, but I think “yeah, I’ll 
get a rest then”.  Three family members interviewed said they had thought about leaving 
home, one family member described her family as being “torn apart”, and another described 
his mother’s illness as the reason for his marriage breakdown: “ I’ve also had some personal 
difficulty in my marriage...stemmed from the fact that we are a close family in many ways and 
my sister and I were trying to support my mum and dad to the highest degree and I got the 
balance wrong, and as a result my wife didn’t feel wanted, then someone else came along”.  
Sleep and Health 
Eighty seven of the family members (67%) reported a negative impact on their sleep and 
health as a result of having an ill relative. The two main reasons for loss of sleep were worry 
(32%) and having to wake in the night to help the patient (38%). Many family members were 
unable to sleep well as they would lie awake thinking about the patient, or what would 
happen in the future. One family member said “I’m on antidepressants, I can’t sleep without 
them...other than that I’m awake hours worrying. I’m so wound up”. Others worried that the 
patient would become unwell, or even die in their sleep, and so would wake up to check on 
them, with several family members describing how they would listen out for the patient 
breathing to make sure that they were alive. Other family members lost sleep as they had to 
physically get up in the night to help the patient, for example with personal hygiene needs, or 
to administer medication. The father of a patient with epilepsy described how he would wake 
up early to check on his son: “I don’t sleep too good at night because of his epilepsy...if 
[patient name] is in the shower, I know it sounds daft because he’s nineteen years old, but if 
he’s in the shower or the bath I make a point of being upstairs because I’ve got this thing that 
he could be in the bath and have a fit”. The wife of a patient with bipolar disorder described 
the pattern of her sleep loss: “As soon as he wakes up, my room is next door to him and I 
always listen...if he does not sleep he falls ill and that's one big sign...so when he does not 
sleep, I don’t sleep myself”. Other less commonly mentioned reasons for sleep loss included 
staying up late to research about the illness on the internet or being unable to sleep in their 
usual bed, for example having to sleep on the settee whilst the patient is unwell. Many family 
members also described the effect of sleep loss on their lives the following day, often 
affecting them at work, or putting strain on their relationships. One family member even 
described feeling guilty for sleeping, in case that patient needed her in the night. 
Some family members described a decline in their own health, and several had been 
diagnosed with depression. The mother of a 19 year old patient with schizo-affective disorder 
described how trying to look after her other daughter was affecting her sleep: “I was living off 
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an hour, or a maximum of two or three hours sleep a night and this was prolonged for 
eighteen months and in the end sleeping tablets weren’t even working...even 
antidepressants don’t help...just total anxiety all the time, the panic attacks I was having 
because I had to juggle everything”. Some felt that the stress of the patient’s illness 
worsened their own medical conditions, and brought on symptoms. Often, the family member 
would ignore their own medical condition or the symptoms they were suffering to concentrate 
on the patient. Others expressed concern about what would happen to the patient if they 
became unwell and could no longer look after the patient. Some family members even 
described feeling close to breaking down. 
Holidays 
A variety of problems associated with going on holiday were reported by eighty two (62%) of 
the family members in this study. The most common problem was not being able to go on 
holiday at all (31%), mainly because the patient was too unwell, but also because of the 
timing of regular hospital appointments and worrying about food abroad. The wife of a patient 
suffering from a number of medical problems including urinary retention, neuropathy and 
diabetes, described their reasons for not taking holidays: “We used to go but we don’t go 
anywhere now...because my husband has a back problem and had an operation so he finds 
it difficult to go very far with regards to driving and he prefers to sleep in his own bed now”. 
Another family member described having to split her family into two and take two separate 
holidays; one which was suitable for the patient and one which was fun for the rest of the 
family. Another reason given for not going on holiday was the family members themselves 
being too tired to go as a result of looking after the patient. Some family members described 
how they could no longer afford to go on holiday, often because of the patient or family 
member being unable to work. Family members also talked about being unable to go  on 
holiday on their own, or with friends, because they felt they could not leave the patient at 
home. One family member described the impact her husband’s illness has on the holidays 
she used to enjoy with friends: “The last holiday we went on was in 2005...I’ve not left him at 
all to go on holiday myself...maybe now in the next few months now that he’s getting better 
maybe I can think of that but I can’t see myself going on holiday because...this condition is 
very unpredictable, so it affected my holidays as I just don’t go on holiday”. 
Nineteen (14%) of the family members experienced problems with travel, which affected 
planning holidays or sometimes prevented them going on future holidays. Most of the 
problems with travelling related to the patient finding the travel difficult, for example having a 
lack of mobility, or the need to be near a toilet.  Most of the problems arose from travelling 
long distances on aeroplanes, often restricting the types of holiday the family decided to take 
in the future.  The mother of a child with a duplex kidney system described her problems with 
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travelling on holiday:  “Getting on a plane where you know your child will disturb other 
passengers and where she needs the toilet lots and she’s up and down the alleyway...it’s 
that embarrassment and fear”. Other family members described problems with disabled 
traveller services, for example the wife of an elderly patient with co-morbidities including 
Raynaud’s and osteoarthritis who booked a mobility buggy at the airport: “It was bucketing 
down and I was trying to get [patient name] into a wheelchair, two cases and two hand 
luggages. He fell in the car park and the driver didn't seem bothered at all. We didn't 
understand why he didn't come up and look for us. Instead of that we had to walk around 
looking for him”. One family member described the expense of buying different suitcases 
each time they went on holiday, trying to find one which was comfortable for the patient to 
use. The impact of travel restrictions on other members of the family was also felt: “Flying is 
not an option for us, certainly at the minute because [patient name] requires so much 
equipment. It would be impossible but not being able to access certain types of 
places...impacts on [sibling name], our eldest son because we’re not able to do all the big 
theme parks”. 
Twelve (9%) family members interviewed reported having to cancel holidays they had 
already booked, often losing money, and many had problems obtaining medical insurance for 
the patient to be able to travel. The husband of a patient who had recent surgery for 
talonavicular arthritis described how they had to cancel a holiday at the last minute: “She was 
on a stand by thing and they called her in to have the operation and I got in touch with the 
insurance company and there was no chance. So we lost all the money”.  The mother of a 29 
year old patient with colitis explained how her daughter’s condition affected her planned 
holiday on two occasions: “Well we were going to Austria, me and my husband, and then 
[patient name] was admitted so we cancelled it and then we thought we could go later on in 
the year so we rescheduled but then [patient name] took a turn for the worse so we cancelled 
it completely then, so we never went”.  
Many family members described having to change the type of holiday they take because of 
the patient’s condition.  For some, they had to change the type of accommodation they 
stayed in, for example staying in a ground floor room in a hotel. Others stopped going to 
sunny holiday destinations because of the patient’s condition. The mother of a patient with 
eczema said “I’ve often thought about going on holiday abroad but because of his skin 
condition we can’t. He can’t go out in the sun cos it flairs up worse in the sun, so we can’t go 
on holidays abroad”.  Some family members felt that they had to choose holiday destinations 
closer to home, to avoid long distance travel, and many changed the type of holiday they go 
on, because of the patient. The wife of an elderly patient with sarcoidosis explained their 
altered holiday plans: “When we say change our type of holidays, we used to go abroad a lot, 
now to go abroad the insurance is so astronomical that its ridiculous and we won’t be able to 
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get there unless we pay more for the insurance than the holiday. So we’re sticking to 
caravanning and staying in this country”. Many family members worried about problems with 
future holidays because of the unstable symptoms associated with some medical conditions. 
The family member of a patient with Crohn’s disease said: “We’re going to America so 
there’s no way I should have chosen that. We booked this back in May, was before this 
flared up again so there’s no way I would have gone that far away had I known that this was 
brewing up. Well we probably wouldn’t have gone away to be honest, I mean we might have 
gone locally somewhere but we wouldn’t have made a big commitment to go abroad”. Other 
holiday problems included family members reporting not enjoying their holidays because of 
worry about the patient, or describing problems relating to the patient’s medical condition 
whilst they were abroad. 
Support and medical care 
Eighty one (61%) of the family members of patients described the effects of lack of support 
from friends and other family members. They often felt that other people didn't understand 
what they were going through and many found it difficult to talk about the patient’s illness, 
often through embarrassment or a lack of knowledge about the condition. One family 
member, whose mother suffered from angina, described her frustration at the lack of support 
she received from the rest of her family: “Half the time people don’t want to know...I’ve got a 
shed load of brothers and sisters and none of them visit. You feel that they are selfish and 
they load it all on you”.  The husband of a haematology patient described how he could no 
longer rely on support from his friends: “I suppose it’s a man thing really but all my mates 
disappeared, you turn your back and all your friends are gone. The nurses offered me a 
support structure but I said “no, my friends [will help]”. I named some people, but 
unfortunately they all just vanished for six months, so I dealt with everything 
myself...basically they vanished”. 
Another family member described how she didn't like talking about the patient’s condition: 
“Talking about it is difficult, very, very difficult because when you talk about it you’ve got to 
confront the reality of it, but you don’t talk about it and sort of go into...it’s not denial, but it’s  
like...when people know about it, that's difficult”. The family members who were embarrassed 
to talk about the patient’s condition were often when the condition had a stigma attached, for 
example mental health conditions, or infectious diseases such as HIV.  The family member of 
a patient with HIV described the effect of keeping the illness a secret from the rest of the 
family: “Nobody apart from medical people know...we made a decision that we weren’t going 
to tell anybody, it’s the safest way. But that has had a bit of an effect on the children as they 
have to keep the secret”. One family member described how he told the pastor of his church 
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in confidence about his daughter’s diagnosis of HIV, but that the pastor told other members 
of the church and this affected people’s attitude towards the family. 
Often, the family members needed to remind patients to take medication and several 
described being affected by issues relating to the patient’s medical care including the timing 
of hospital appointments and not being given enough information about the patient’s 
condition. The mother of a 17 year old patient with acne explained: “He’s had to have a 
routine with his skin and being the age that he is, a teenager, you want to think they’re grown 
up and adult, but actually they’re still very childlike and you have to remind him to take the 
tablets and cream his skin...every day. It adds a little bit extra to your day having those extra 
things on your mind- it can be quite stressful. Also you feel you have to remind him because 
you're the mum and you know he will forget, but then he resents you reminding him”. Family 
members also described feeling nervous about hospital appointments, feeling like they do 
not know what is happening to the patient and finding it difficult to deal with the symptoms of 
the disease, particularly when the disease was unpredictable or when symptoms were 
severe. The mother of an adult patient with epilepsy described how she had to accompany 
the patient at all times when she left the house, in case she had a fit.  
Many family members said that they did not like asking for support from family, friends or 
welfare agencies. One mother described how she felt uncomfortable with asking for benefits 
she was entitled to: “The shame of having to realise we are entitled to certain benefits like 
free school meals...but we don’t take up that option because there’s still that shame thing 
around it for us”. Others who did ask for support from welfare agencies often found it difficult 
to get hold of. The partner of a patient suffering from sleep apnoea described their struggles 
with obtaining benefits: “Because the Social for him, have turned around and told him 
basically to naff off and that there’s nothing wrong with him. They’re not giving him the 
money that other people who have similar diagnosis and they’ve had every single penny 
given to them”. 
Work and study 
Sixty nine (52%) of the family members described how their own work or study was affected 
as a result of having an unwell relative. Commonly, family members had to take time off work 
to look after the patient or attend medical appointments with them. One family member 
described the effect of his wife’s illness on his work: “Well the number of hospital 
appointments we’ve got to go to...I’m lucky the way I work, I’ve got flexi time but I know it 
does cause issues...I suppose my staff see me supposedly swanning off early, I think they 
understand but I still feel, you know, another form of guilt for that as well”. Many family 
members described using up their annual holiday entitlement for hospital appointments and 
to look after the patient, leaving them with no holiday left for relaxation. Several family 
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members talked about saving up their holiday entitlement in case the patient became unwell 
and they needed to take time off to look after them. In some of these cases, the family 
members ended up losing out on taking holidays. Others talked about the difficulties they had 
with colleagues and bosses understanding their situation and allowing them to take time off 
work, particularly when they worked as part of a team. As well as taking time off work, some 
family members talked about having to change the hours they work or even change their job 
or career. One family member said: “Our expectations were that we would continue in our 
careers and I would do some further study...now my husband doesn’t work at all and I gave 
up the career I was in and started working part time in a job...I gave up a job with a very good 
salary and my husband gave up full time work”.  Another described how her son’s bipolar 
disorder affected her future career: “Since I got my doctorate, my PhD, I was thinking about 
going abroad to get an international job or at least to volunteer...but I cannot take him behind 
me all the time. I am concerned about him, you know being stable. I will always not be 
happy, always thinking “what is happening, what is happening”, so that has limited me”. 
In 12 (9%) cases the family member gave up their job completely. This had a huge financial 
impact on the families. The husband of a patient with severe depression said: “I just didn't 
have the time [to work]. There are so many appointments to go to and obviously my wife 
needed care, it got very difficult to carry on [with work] really. Work were ok at the start, they 
tried to help although they weren’t really that helpful in terms of having time off...we had to 
get a bit fussy and it was difficult as my wife needed me at home”. Often the decision to give 
up work came from feelings of guilt by the family member that their relative was at home by 
themselves with no one to look after them. Most family members accepted the fact they had 
to give up work, but others regretted it. One family member said “I would say [I gave up work] 
because she needed me more at home but I enjoyed my work far better than being at home”. 
As well as giving up work, some family members decided to take an early retirement to be 
able to care for the patient. Often in the situations when family members gave up work this 
was compounded by the patient being unable to work as well, causing huge financial 
problems for some.  
For those family members who were able to continue with work as normal, many described 
having to juggle their work with their family life, and having to return home from work in the 
evenings to look after children and do all of the housework. Others felt they could not do their 
jobs properly as they were constantly thinking about the patient, worrying or feeling tired. For 
some family members, the source of future work was a constant worry. One family member 
talked about her plans for work in the future: “Hopefully a job placement would be 
understanding that if you had to go...you can go. I don’t know how a work placement would 
be...I haven’t really crossed that path yet, but when it comes to it, that's something I will have 
to investigate more”.  
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As well as work being affected, family members who were studying also reported their 
studies being affected.  One family member described how she lost interest in her studies 
after her son became ill and so gave it up. Others had to postpone their studies to look after 
the patient, or due to emotional stress. One family member described exams being affected 
as he could not study effectively for them. Another said: “There were other things...after my 
husband had his diagnosis...there were some studies I was thinking of pursuing but after that 
I sort of put it aside and said “let’s see how this goes”, but in the middle of all that, trying to 
cope with all the pressures, I’ve just put it aside”.  
Financial impact 
The financial impact of illness on the family (reported by 68 family members; 51%) was great, 
with 35 (26%) participants reporting having to spend money on items relating to the patient’s 
illness, for example mobility aids or clothing. The mother of a teenage daughter with diabetes 
described her financial problems: “I can honestly say that it’s so much harder to buy healthier 
than it is to buy junk food...and being unemployed and not working...you basically take the 
cheaper choice...for her to eat a full healthy diet is impossible...I couldn’t afford to do it”. 
Other extra expenses reported by family members included buying an extra refrigerator to 
store medication, buying expensive skincare products for the patient, and making alterations 
to the family house, for example installing a stair-lift. Some family members reported that 
they required these extra items but could not afford them, so had to live without. The wife of 
a patient with multiple sclerosis explained: “You live to your means and there are things that 
we need to have done in the house, for instance the en suite bathroom has got quite a deep 
shower tray so on bad days [patient name] finds it difficult to step up into the shower without 
catching his foot, and so the bathroom needs work”.  
Some family members reported extra expenses relating to the patient’s condition, for 
example the cost of having to do more washing. The mother of a child with urinary problems 
said: “the washing machine would break down every six months because we were using it so 
much because of her health needs...it’s the costs associated with her needs”. Others 
reported the costs of travel to the hospital with the patient for appointments, or to visit them in 
hospital. These extra costs often arose from patients being unable to use their usual forms of 
transport, so had to pay for a taxi, for example. One family member described the impact of 
her mother’s illness on her finances: “Mum’s got a mobility car but I drive the car. I’m the only 
driver and the responsibility is down to me to pay for all the fuel. I can’t afford to do it...she 
says “I’ll give you something towards the petrol” and she’ll give me five pounds when I’ve 
already spent twenty pounds so it leaves me short of money”. Those family members who 
talked about the costs of hospital visits also commonly talked about the cost of hospital 
parking, and one family member described how she bought a new car which was more 
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efficient to try to save money when travelling to hospital three times a week for her husband’s 
dialysis. The husband of a patient with psoriasis talked about the costs of her treatment: 
“Travelling to and from here every day...[patient name] goes through a tank of petrol, 
especially coming here every day for the sun bed treatment. Then there’s clothes especially 
when she was using that tar stuff. I mean that stained her clothes so I mean virtually every 
year she had to have a new wardrobe when she was using that stuff”. Those family members 
who lived in England also reported the high cost of prescriptions. This was not applicable to 
those in Wales where prescriptions are free. In some cases, the extra costs associated with 
the patient’s illness were unexpected and often hidden. The elderly mother of a female 
patient with colitis explained how she often looked after her daughter’s children whilst she 
was unwell, but didn't want to put any burden on the patient by asking for money, so bought 
new sets of clothes for the children herself, including their school uniform.  
Often, as mentioned under the theme “Holidays”, family members were affected financially 
when planning holidays. This included the high cost of travel insurance for the patient, having 
to cancel holidays and losing money, and going on more expensive holidays. One family 
member described: “Obviously we can’t get decent insurance and on several occasions 
we’ve had to cancel holidays...for example we arranged to go to Rome for the [rugby] 
international...she was taken ill again and had to come in here [the hospital] and I lost the 
money from that”. Another theme already discussed which relates to financial impact is 
“Work and Study”. Both family members and patients having to reduce their working hours, 
or give up work completely had a huge financial impact on the family. The husband of a 
patient with chronic pain described the impact of his wife having to give up work: “The ability 
for her to work, the financial implications, having to think constantly about what you’re going 
to do and how you’re going to do things, be it shopping, decorating or even the most 
mundane things”. As a result of the financial impact reported by the family members in the 
study, many felt that they had to think more carefully about the way they spent their money. 
For one family member, he felt frustrated as, because of his wife’s illness, he no longer got 
the opportunity to spend his money as he would like, for example on holidays or days out. In 
contrast, the partner of a patient who had been recently diagnosed with HIV described how 
he had developed a “live for the day” attitude since the diagnosis, and had lost between 
£40,000 and £50,000 gambling over the previous two months. 
Social life 
Lack of money and feeling the need to leave social events early to look after the patient were 
amongst the many reasons for the impact on social life reported by the family members (49 
family members; 37% affected).  The mother of a child described how her child’s ADHD had 
an impact on her social life: “We have to pay babysitters seven pounds an hour to get 
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anyone to babysit and we don’t have any friends  and family who do it on a regular basis. I 
suppose we don’t like to ask because we know what a handful she is, so it’s financially 
difficult to have a social life because we’re paying a lot of money...but by about ten o’clock 
we’re just too tired to do much anyway”.  Others described feeling that they had to come 
home from social events early to look after the patient, for example to put them to bed. Many 
family members described a general decrease in their social life, and gave a variety of 
reasons for this. The main reason given was that family members did not feel comfortable 
being away from the patient for a long time, or that the patient was too unwell to join in with 
social activities. One family member said: “Because he doesn’t feel like it, because he’s tired, 
and because sometimes it’s just easier to stay in...I mean we do try and make an effort now 
and then... but it’s not regular, not even once a month now. Another said “My social life has 
been curtailed...It’s not so much that my wife wants me to be near her at all times, a lot more 
I don’t like being away from her for any length of time in case anything crops up”. Often, 
family members described variations in their levels of social activity depending on the health 
of the patient. Some family members reported cancelling planned social activities as the 
patient was too unwell to go, or the family member felt they could not leave them. Others 
only socialised locally so that they were not far away if the patient became unwell. 
Eleven (8%) were concerned about how strangers would react to their relative’s medical 
condition, especially when the condition was visible, for example relatives of dermatology 
and wound healing patients.  The wife of a patient with multiple myeloma described her 
concerns: “we used to go out, once or twice a week, or have a meal or something but now 
we can’t do it because with the treatment he doesn’t eat properly so we think why go out and 
pay all that money if he’s not going to eat it, so he won’t go, and he’s lost a lot of weight so 
we don’t want people to see him”. Family members reported feeling uncomfortable and angry 
about strangers staring at the patients and sometimes making negative comments. They 
often felt this was because of ignorance about the patient’s condition, for example thinking 
eczema was contagious. Some family members also felt embarrassed to go out of the house 
with the patient, or felt that the patient was too embarrassed to go out. As well as the 
reaction from strangers, some family members reported a negative reaction from their family 
and friends. One family member reported how her friends found it very difficult to understand 
her husband’s diabetes, and despite telling them that he would need to eat regularly and at 
set times, many would ignore her requests when hosting meals or planning days out. 
Another family member described how other parents reacted to her daughter’s diagnosis of 
epilepsy: “She used to go out for tea to different children’s houses during the week...then 
they found out about her epilepsy and she was dropped like a hot potato by the parents. She 
was no longer invited out for tea or anything. I found that hurtful because she was well...one 
mother said to me that she had a healthy daughter and didn't want her to pick it up, or catch 
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it from [patient name]”. Family members also reported having to plan their social activities 
more carefully, often planning their social lives around the patient.  
Time planning 
Nineteen (14%) of the participants talked about difficulty in being able to plan their time 
effectively because of the patient’s illness. Reasons included having to attend medical 
appointments at short notice and the unpredictability and worsening of patient’s symptoms. 
One family member said: “I get really frustrated and a bit angry, it’s very unfair of me but I 
don’t seem to be able to plan anything anymore. You know, if someone says “Would you like 
to come?” and I say “I’ll let you know”, because I know damn well that I’ll probably have to let 
them down if I say I’m going”. Other family members said that they no longer plan things 
months or years in advance, such as holidays, and many reported that they had lost any 
spontaneity in their lives as everything had to be planned to precision. Many family members 
described how a lot of time and effort had to go into planning days out, and as a result some 
did not feel they could be bothered to make plans. One family member said “We never plan 
anything anymore because if you plan something, something will always go wrong. If he [the 
patient] is alright then we just get up and go”. Examples of activities which family members 
found difficult to plan included holidays, days out, social life, transport to hospital 
appointments, family activities, shopping and daily activities, and visiting other members of 
the family. Several family members commented that they felt they had lost their freedom. 
Relationships between themes 
Although each of the themes and subthemes in the study measure individual concepts, 
relationships were identified by family members between many of the themes. In particular, 
the theme “emotional impact” was related to all of the other nine themes, apart from “time 
planning”. In turn, the theme “time planning” was related to “daily activities” and “social life”. 
Figure 3.2 shows the relationships between the ten themes identified. This shows that an 
impact on one area of a family member’s life may be related to an impact on another. For 
example, family members reported that a lack of sleep (sleep and health) as a result of 
feeling worried (emotional impact) during the night affected their work the next day (work and 
study). A lack of support from other family members (support and medical care) caused 
tensions in the household (family relationships) and stress (emotional impact) for the family 
member caring for the patient. These relationships reflect the multidimensional concept of 
quality of life, and demonstrate the widespread and varied knock on effects of illness on 
family members. 
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Figure 3.2: A model of family quality of life informed by the identified themes, 
reflecting between themes the relationships from the family members’ perspective 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive effects 
As well as the negative effects on family members’ quality of life reported above, a small 
number of positive effects were also identified by family members during the interviews.  
Seventeen (12.8%) of the family members’ interviews managed to identify one positive effect 
of the patient’s illness on their life, and these positive effects were only identified under the 
“emotional impact” and “family relationships” themes. In these positive examples, family 
members described relationships within the family improving as a result of the patient’s 
illness, and often they described becoming closer as a family or pulling together to support 
the patient through their illness. One family member said: “Whilst some would say “I’m not 
putting up with this anymore” and walk out, you think you can’t, can you? Have to battle 
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through, sort of thing. So I suppose it’s making our relationship stronger cos it’s making us 
work through things. But there are times when it does affect us”. Other family members 
described overcoming the “challenge” of the patient’s illness and making them realise how 
precious their life is. The majority of these positive comments were found in the “family 
relationships” theme, and eight of the ten themes contained no positive comments from 
family members at all. This shows an overwhelming negative impact of illness over the 
majority of areas of family members’ lives.  
One of the purposes of developing a generic family instrument is to identify the areas of 
family members’ lives that are impacted in a negative way so that support can be put into 
place to improve their lives. Including positive items in the instrument would have not 
represented a true picture of the impact of illness on families, as the positive effects were so 
limited and rarely reported. To be able to use the instrument in disease assessment, all of 
the items must be measuring the same, negative, trait and be scored in the same direction 
(Ware et al. 1995). Adding positive items into the instrument has the potential to cancel out, 
or dilute the negative effects reported by family members. The inclusion of positively worded 
items in a quality of life instrument may also compromise patient confidence in the 
instrument, as the majority of family members interviewed would struggle to identify any 
positive effects of the disease. Therefore, no positively worded items were included in the 
instrument. 
Informal feedback 
As well as talking in great detail about the ways their lives have been affected by having an 
unwell relative, many of the family members also commented on the study, and how they felt 
about being asked about the impact of the patient’s illness. Many of the family members 
explained that they had never been asked about how the patient’s illness affects them 
before, and others had not ever stopped to think about it. Several of the family members 
became emotional during the interviews and were often surprised about how emotional they 
felt. Many of the family members expressed how much they benefited from having talked 
about these issues, and had not discussed them with anyone else before. There were no 
negative comments from the family members regarding this study, and many of them 
commented about how they thought the study was a good idea, and how it might benefit 
them. Some of the family members said that they would now talk to others more, particularly 
other members of their family as a result of being interviewed. 
Instrument development 
The interview transcripts and themes identified were used to develop a quality of life 
measure for use in family members of patients. The study team gave detailed consideration 
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to the type of measure, the length, design, structure, layout and scale (Streiner and Norman 
2008). Throughout the instrument development process, thought was given by the study 
team as to the intended use(s) of the new measure and development decisions were made 
accordingly. For example, the completion time of the measure and ease of use for 
completion in a clinical setting, and the comprehensive yet simple language used in the 
measure, which would be understood by all, for example for use in a disease education 
setting. 
The type of measure was considered by the study team, and it was decided that a simple, 
self-administered questionnaire would be developed. Using a self-administered instrument 
could potentially help to eliminate interviewer bias, and places less burden on the 
administrator. The measure would be generic, as the themes identified cover family 
members of patients from 26 different specialties. In order for the measure to be user-
friendly, it was decided that the questionnaire should be short in length, and should take no 
more than five minutes to complete (tested at a later stage in the study). The instrument 
should have more than ten items to allow a minimum of one item from each theme identified, 
but should not have more than 50 items as this could put an increased burden on the 
participant and professional time especially if it is to be used in clinical settings. It was 
decided that the items would be constructed as statements rather than questions, as most of 
the data gathered from family members is made up of statements and examples. Using 
personal statements, for example using the term “I”, would help the family members to 
identify with the items more easily. It was also decided that the instrument would have a 
polytomous response scale, so that family members would be able to express their level of 
agreement with each item, or in this case, the extent to which each item affects their life. The 
study team decided that each item should be short and concise in length and simple 
language should be used to make the instrument user friendly and quick to complete. Using 
short sentences and simple language also reduces the reading ability of the measure, so that 
it is able to be understood by the majority of the population. A maximum of around twelve 
words for each item was therefore decided by the study team.  
Item generation 
The interview transcripts and coding were consulted during the item generation. The study 
team decided that all ten of the themes, and any of the 196 sub-themes mentioned by 
greater than 5% of family members interviewed, would be considered for inclusion as items 
in the new instrument. The aim of this cut off point was to exclude any “outliers” or unusual 
subthemes which would not be applicable to the generic population, but ensure that the most 
commonly mentioned subthemes were retained. However, any age, gender and specialty 
specific sub-themes were retained. or each of the subthemes mentioned by over 5% of 
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participants, a statement was developed to reflect the content of the theme. The original 
wording used by the family members was carefully considered, and any commonly used 
words were inserted into the items. Each item was phrased in a clear and concise way, and 
the universality of each item was also considered during this development phase; items were 
designed to be applicable to all ages, relationships to the patient and both genders, and 
specialty-specific wording was not chosen.  
It was decided that the theme “emotional impact” would be represented by statements 
relating to each of the sub-themes. Those mentioned by over 5% of family members were 
developed into items and then many were combined or eliminated as they overlapped with 
others. For example the sub-theme “feeling more emotional” was eliminated as it was 
included within all of the other sub-themes, which each expressed a different emotion. Most 
family members who mentioned this theme also gave examples of these emotions. The sub-
themes “angry” and “annoyed” were combined to form one item “I feel angry”. In the same 
way, the item “I feel sad” was developed to include subthemes “sad”, “depressed”, “crying” 
and “upset”. “Worry” formed its own item “I feel worried”, as it was the most prevalent 
emotion and linked with many of the other themes. The sub-theme “pretending everything is 
ok” was not included as it was unclear as to whether this was a positive or a negative aspect.  
Under the theme “daily activities”, two of the subthemes relating to eating were combined to 
form one item “my eating habits are changed”.  This item covered both “eating out” and 
“eating a different diet”. The sub-theme “caring for patient” formed one item, and the word 
“burden” was included, as it was a key word used by family members during the interviews. 
The sub-theme “travel” became one item, and after studying the interview transcripts, the 
word “every day” was added to the item, as it would distinguish the item from the holiday 
theme.  The sub-themes “takes up time” and “visiting patient in hospital” were combined to 
form one item. “No alone time” was used to form its own item, with the wording taken from 
the family member interviews; “it is hard to find time for myself”. The sub-theme “stopped 
going out” was combined with several of the similar sub-themes under “social life” and 
formed the item “I need to stay at home”, which covers both the social and day-to-day 
aspects of the theme. The item “my leisure activities are affected” was added to represent 
the examples the family members gave of activities they chose to do in their spare time. 
For the theme “family relationships”, the subtheme “become more of a carer” was eliminated 
as it is already covered by the “caring for patient” item. It was decided that the subthemes 
“argue” and “other family members affected” would be kept as two separate items, and 
original transcripts were referred back to for wording of these items. The sub-theme “sexual 
relationship” was retained and developed into the item “my sex life is affected”. The original 
interview transcripts were consulted during the development of this item, as there was 
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concern amongst the study team that the item could be only applicable to partners or 
spouses of patients. However, the interviews showed that, whilst this was often the case, 
there were also examples of parents of child patients whose sex lives were affected, or 
sexual relationships with family members’ partners where the family member and the patient 
are siblings, for example. Therefore, the item was retained. 
Under the theme “sleep and health”, three items were developed. The first item was 
developed from the sub-theme “sleep affected”, and the second from the subtheme “health 
affected”. The word “well-being” was also included, as it was one of the key words mentioned 
by family members under this theme. Thirdly, the item “I feel tired” was developed, as it was 
reported by many of the family members under the sub-theme “sleep affected”, but also in 
relation to “work and study” and “emotional impact” themes.  
As there were so many individual examples mentioned by family members under the theme 
“holidays”, the subthemes were combined to form one item. This is because many of the 
examples given by family members were considered by the study team to be disease-
specific. The one item “I experience problems with holidays” includes all of the relevant 
examples and sub-themes. Also, the study team identified that not all families would take 
holidays, and so it was felt that including more than one question under this theme would 
affect the universality of the items. 
Several of the sub-themes were removed from the theme “support and medical care” as 
when they were converted to items, it was unclear as to whether they should be positively or 
negatively worded. The sub-theme “support from friends” was felt not to be universal by the 
study team, and was eliminated. The sub-theme “people don’t understand” was combined 
with “Difficult to talk about disease”, and after consulting the interview transcripts, two 
separate items were formed, which also represented people’s reactions to the patient’s 
illness; “I worry about strangers’ reactions to my family member’s condition” and “I find it 
difficult to talk about my family member’s condition”. 
The theme “work and study” was made up of several quite specific sub-themes. Therefore, 
they were combined to form one item, “my work or study is affected”. The study team 
considered that it was appropriate to form only one item, as not all of the family members 
were employed, so having a single item improved universality and reduced the number of 
specific items. This was also the case for the theme “financial impact”, where one universal 
item; “my family expenses have increased” was developed to represent the individual, and 
often specific sub-themes. By far the most commonly mentioned sub-theme under “financial 
impact” was “buying more”, which is well represented by this single item.  
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Under the theme “social life”, the sub-themes “social life decreased” and “seeing friends less” 
were considered similar and combined to form a single item. The sub-theme “strangers’ 
reactions” was already covered by the item “I worry about strangers’ reactions to my family 
member’s condition”, designed to combine this sub-theme with the sub-theme “People don’t 
understand”. The theme “time planning” was represented by one item, as many of the 
examples given by family members were similar and were all encompassed by the item “I 
find it hard to plan my time and activities”. The word “activities” was added as during the 
interviews family members gave many specific examples of the activities they now found 
difficult to plan. 
The lengths of the 30 items generated were analysed. Only two of the items were over 
twelve words in length, containing 13 and 15 words. These items were retained as the 
wording of both of the items was still considered clear and concise. The items were scanned 
for ambiguity or complex language by the study team, and none was found. 
Addition of utility questions – the rationale  
During the interviews, it was noted that many of the family members gave examples of the 
time they spent looking after the patient, or put numbers to the amount of sleep they lost per 
night. Being able to measure this information could potentially be a surrogate indicator of the 
extent of the effect of illness on the family members. It would also add a semi-objective 
element to the measure and the change could be assessed over time. The interview 
transcripts were consulted, and three different areas which could be measured by time were 
identified; hours of sleep lost per night, hours spent caring for the patient and hours spent 
doing housework. These three themes had already been proven to be relevant to the impact 
of illness on the family, but adding a utility element to the instrument could increase its 
potential for use in economic evaluations (Torrance 1987). Each of the three areas were 
developed into a utility question, asking the family member to specify the number of hours 
per day they spent caring for the patient, doing housework and how many hours of sleep 
they lost per night. These three questions were included as a separate part of the 
developmental instrument.  
Instructions and layout 
The instrument was laid out over three A4 pages. The first page contained the three utility 
questions and a set of simple instructions for the user. These instructions were also repeated 
briefly at the top of the second page, and the 30 items were spread over pages two and 
three. The instructions reminded family members that this instrument is relating to them and 
how they feel, not how the patient feels, and asked them to tick a box for each statement. At 
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the end of the instrument, the words “Thank you. Please check that you have answered 
every question” were added to help reduce missing data.  
Scaling 
After considering the possible options for the instrument response scale, a Likert scale was 
selected as the most suitable for this instrument. This was because the family members in 
the interviews reported different levels of impact relating to each theme. For example, some 
reported that their social life was greatly affected across all areas, and others reported that 
their social life was affected, but just slightly, and gave one example. Therefore, the study 
team thought it important for the family members to be able to differentiate between these 
levels of impact, or intensity, when using the instrument. Likert scales allow logical, ordinal 
progression along the response options, and would allow the family members to subjectively 
express the extent of the impact of each theme. As some family members during the 
interviews had reported no impact for some of the themes, and others had reported a high 
impact, a bi-polar Likert scale (two ends with extreme values) was selected to give the family 
members a wide selection of response options, with the option of a “not at all” category. 
Using the guidelines set out by Streiner and Norman (2008) for designing measurement 
scales, a 5-point Likert scale, labelled as Extremely, A lot, Moderately, A little and Not at all, 
was developed. The number of response options (“steps”) was carefully considered. An odd 
number gave the user the option of choosing a middle, or neutral option, and therefore a 5 or 
7 step scale was considered. When an instrument is being designed to sum the individual 
scores to form a total score (as this instrument may have in the future), having a 5-point 
scale does not result in a significant loss of information (Streiner and Norman 2008), and so 
for ease of use, and to be user-friendly, a 5-point scale was initially selected. Having a 5-
point scale allows for a large range of total scores and therefore can increase the potential 
for demonstrating responsiveness and sensitivity of the scale. All five points on the scale 
were labelled to reduce bias towards labelled or unlabelled boxes when a mixture are used 
(Streiner and Norman 2008). As the aim of the instrument is to measure the user’s 
perception of frequency/ agreement, it does not matter that vague quantifiers are used to 
label the response options (e.g. “A lot”)(Streiner and Norman 2008). Although every effort 
was made by the study team to select adjectives for labels which represent equal intervals, 
the scale cannot be assumed to be interval (Streiner and Norman 2008) until further tests, 
such as Rasch analysis, are carried out. In addition to the five response options, the option 
“Not relevant” was also added to help identify any items which family members do not feel 
are relevant to them, and to aid with the later analysis of the questionnaire, for example when 
selecting items to remove. 
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Recall period 
The choice of recall period for any quality of life measure is very important. The abilit y of 
users to recall events is vastly overestimated by instrument developers (Norquist et al.), and 
as this new instrument will be used in family members of patients with a wide variety of 
illnesses, the disease symptoms cannot be used as a guide for recall period. As the 
response to questions is likely to be influenced by the patient’s health status at the time, and 
longer recall periods can increase patient burden, a shorter recall period is preferred (U.S. 
Department of Health and Human Services Food and Drug Administration 2009). As this 
instrument will also be used to demonstrate sensitivity to change over time later in the 
development, a short recall period will improve the accuracy of the data, as there will be less 
change of overlap of recall periods. Therefore, an immediate recall period was chosen for 
this generic family quality of life instrument. The phrase “at the moment” was chosen as it 
was used commonly by family members during the interviews. The inclusion of an immediate 
recall period will allow the measure to be used in family members of patients whose illnesses 
fluctuate on a day to day basis, as well as those whose symptoms occur less frequently, 
improving the generic properties of the measure. The information and literature used to 
decide the recall period was based around patient reported measures (Acaster et al. 2012; 
Norquist et al. 2012) and there is no similar guidance available for family measures. 
Therefore, the recall period will be assessed as part of the content validity by family 
members at a later stage of the study. 
Naming of the new generic family quality of life instrument 
After much deliberation between the study team, the new generic family quality of life 
instrument was named the Family Reported Outcome Measure (FROM).  This name 
complements the commonly used term Patient Reported Outcome (PRO) Measures, which 
refers to a group of instruments, including quality of life instruments, which give a subjective 
insight into patient’s opinions about their own health (Dawson et al. 2010). As the new 
instrument is offering the first insight into measuring family quality of life from the family 
member’s point of view on a generic level, the study team felt that this wide and all-
encompassing name reflected the wide use potential of the new measure. The name is 
distinctive, forms a simple acronym, and is easily identified as being a subjective reported 
outcome measure. Copyright of the measure and its name was established under the 
copyright law of England and Wales and also recorded at the United States Copyright Office 
at the Library of Congress, thereby establishing copyright worldwide through the US 
copyright agreements with many other countries. 
Thirty items with a 5-point Likert scale have been developed for inclusion in the preliminary 
version of the FROM (Figure 3.3). Before this preliminary version is finalised, and developed 
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into the “developmental version”, the items will be subjected to a content validity study where 
family members and experts will be asked their opinions on the proposed preliminary 
questionnaire as a whole. The original working title of the preliminary version, the Family 
Quality of Life Profile was preserved for the next stage of the study.  
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Figure 3.3: The 30-item preliminary version of the FROM 
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DISCUSSION 
The impact of a patients’ illness on families is widespread and profound and family members 
are affected in multiple ways across all medical specialties. This stage of the study has 
identified the major ways in which family lives can be affected by disease and the 
commonality of issues across all diseases. The impact on the family member is largely 
independent of the condition the patient suffers from. This is the first study to identify the 
similar experiences of family members of patients across the whole of medicine, and the 
unique findings are relevant to all healthcare professionals. Even in those specialties where 
family members are least affected, they still reported being affected by three of the ten 
themes, proving that the family impact of disease needs to be considered and addressed in 
all areas of medicine. Many family members also said how grateful they were to talk about 
the subject, that they had never been asked about it before and voiced the lack of support 
they had received in dealing with the effects of the patient’s illness. 
The percentage of prevalence have been reported for each theme but it is important to note 
that these percentages should be viewed as guides to each of themes, and not an attempt to 
formally quantify them. This extension of the theme descriptors is helpful in terms of 
communicating the importance of these issues. Reporting the percentages of family 
members affected by each theme adds to the depth and interest of the data, especially as 
this is a new subject which has not been investigated in this way before, and as there were a 
large number of interviews. As the interview guide used was semi-structured, and reviewed 
after the pilot interviews, all family members were given the chance to report on the key 
themes. The in-depth interviews with family members of patients from a wide range of 
specialities provides a solid platform for the development of a new generic family quality of 
life measure, whilst serving as a valuable piece of qualitative research on its own. 
Whilst the saturation point was identified as interview number 40, interviews continued well 
past saturation, as a decision was made to include a minimum of five family members from 
each specialty. In this situation, there is a disjunction between imposing a saturation point 
and the decision to include family members from all disease areas. Extending the interview 
number so far beyond saturation resulted in a large volume of data. Although no new themes 
emerged between interview number 40 and 133, new examples of each theme were given by 
family members, adding to the richness of the data. The main implication of continuing so far 
beyond the saturation point was the time required to transcribe and analyse such a large 
volume of data, where much of the data could be considered redundant. However, as the 
qualitative part of the study is an important piece of work in itself, and the new measure was 
designed to be used in a wide variety of illnesses, it was felt that it was more important to 
ensure that all specialties were covered in the qualitative work.  
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One of the difficulties faced when developing the preliminary instrument was deciding upon 
the recall period for the measure. This was particularly difficult given the number of 
specialties and disease areas covered and the difference in symptom frequency and type 
between the different diseases. Using the term “at the moment” was decided as the most 
suitable option, but it is important to note the impact of using an immediate recall period on 
the interpretation of results. It is likely that the current mood of the family member could have 
an impact on the way that they answer the questions and therefore the overall score of the 
measure. For example, a pre-existing negative mood could intensify the emotions felt by the 
family member, particularly in a clinical environment. In turn, a pre-existing positive mood, for 
example if the patient is given good news during the medical consultation could influence the 
way the family member responds to items in the measure in a positive way; playing down or 
minimising the negative impact of the illness on their life. Therefore, when interpreting scores 
from the measure it is important to bear in mind the influence of the current mood of the 
family member and possible influences on the score. Administering the measure on a 
number of separate occasions in different environments could help determine the extent of 
the influence of mood. 
 
SUMMARY 
 This chapter provides information on the ways that family members are affected by 
illness. 
 
 For the qualitative data collection, semi structured interviews with family members of 
patients were chosen as the method of data collection. 
 
 Sample size in the study was determined by the inclusion of at least five family 
members from each of the 26 specialties in the study. 
 
 Saturation point was calculated after the interviews were complete. 
 
 Three trial interviews were conducted prior to the start of the study.  
 
 133 family members of patients from 26 specialties were recruited and interviewed. 
 
 The content of the 133 interviews was transcribed verbatim and coded using NVivo9 
qualitative software. 
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 Ten themes and 196 sub-themes/codes were identified from the interview transcripts. 
 
 The ten main themes included: emotional impact (mentioned by 92% of subjects), 
daily activities (91%), family relationships (69%), sleep and health (67%), holidays 
(62%), support and medical care (61%), work and study (52%), financial impact 
(51%), social life (37%), and time planning (14%). 
 
 The mean number of themes mentioned by participants was six (median= 6, S.D.= 
2.03, range 0-10 [max=10]).  
 
 Family members of haematology and genetics patients were affected by the most 
number of themes, and family members of gynaecology and diabetes patients were 
affected by the least number of themes. 
 
 Quotes and examples from family members were used to illustrate each theme. 
 
 Relationships between themes were identified and a diagram model of family quality 
of life was produced. 
 
 Sub-themes mentioned by >5% of family members were developed into questionnaire 
items. Some items were merged or eliminated. 
 
 Three utility questions were also created. 
 
 The items were formed into a proposed preliminary instrument with a 5-point bi-polar 
Likert scale. 
 
 The instrument was named the Family Reported Outcome Measure (FROM). 
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CHAPTER 4 
 
Evaluation of the Content Validity 
of the Family Reported Outcome 
Measure (FROM) 
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INTRODUCTION  
Content validity checking helps to ensure that a scale has enough items and covers each of 
the domains measured (Streiner and Norman 2008). It is important that the items of an 
instrument are both relevant to, and representative of, the target population or construct, and 
obtaining good content validity can increase the probability of obtaining high construct validity 
in later stage validation tests (Haynes et al. 1995). 
Content validity involves both qualitative and quantitative methods. The most common 
method used is gaining the opinion of multiple “expert” judges using formalised scales to 
assess relevance, representativeness, specificity, and clarity. Using such scales can help to 
identify any items which need refining or omitting during questionnaire development (Haynes 
et al. 1995). After potential items were developed from the themes that emerged from 
interview transcripts and formed into a questionnaire (the preliminary version), the content 
validity of the items was assessed using a panel of judges (Appendix N). The content validity 
panel was an important step in the development of the developmental version of the Family 
Reported Outcome Measure (FROM) and gave the investigators a clear idea of whether the 
items that had been developed were relevant, phrased clearly and were complete in their 
wording. The questionnaire instructions, layout and scaling were also critically considered by 
the panel.  
Throughout this chapter, the terms “content validity panel”, “panel of experts” and “panel of 
judges” are used interchangeably, and all refer to the individuals who make up the panel 
carrying out the content validation.  The first version of the FROM made up from the themes 
from the qualitative phase is referred to as the “preliminary version”, the second version of 
the FROM made up from the results of this content validation is referred to as the 
“developmental version” and the third version, after item reduction is the “final” version, or the 
“FROM-16”. 
METHODS 
The content validity of FROM was carried out in two parts; qualitative and quantitative 
assessments. In the qualitative part of the process, members of a content validity panel were 
asked to comment on the preliminary version of the FROM as part of a semi-structured focus 
group set up. In the quantitative part, the panel members, and other experts, were asked to 
complete a formalised scale to assess each item, and the instrument as a whole. The results 
from the qualitative and quantitative parts of the process were then used to make changes to 
the items to ensure that they were relevant to, and representative of, family members of 
patients. The procedures for both parts of the process are described separately below, 
followed by the combined results. 
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PART 1: QUALITATIVE ASSESSMENT 
Selection of the content validity panels 
The 30 items developed for inclusion in the preliminary version of the FROM were subjected 
to content validation by a panel of judges. When selecting this panel, it is important to 
consider the instrument’s purpose (Cook and Beckman 2006), and therefore family members 
were invited to assess the content validity, as well as clinical and academic experts. It was 
decided by the investigators that a separate panel meeting would be held for family 
members, to encourage a more intimate and relaxed environment where they would feel 
more comfortable talking about personal issues. The recommended number of members of a 
content validity panel varies between 3 and 20 (Grant and Davis 1997).  
The first content validity panel (Panel A) was made up of consultants, specialist nurses and 
academic experts in the field of quality of life assessment. All consultants involved in the 
study across the 26 specialties were invited to attend the lunchtime meeting, and were asked 
to identify a clinical nurse specialist from their area who would be also willing to attend. Three 
academic experts in the field of quality of life were also invited to take part (the co-
supervisors of this research study). The Panel A discussion, which lasted one hour, took 
place in a board room within the University Hospital of Wales and was digitally recorded.  
Ten of the 26 invited consultants attended the meeting, along with one clinical research 
fellow, six specialist nurses, one genetics counsellor and three academic experts .  Table 4.1 
shows the background of the members of Panel A. 
The second content validity panel (Panel B) was made up of family members of patients. 
During the interview stage of the study, family members were asked whether they would be 
interested in attending the panel meeting, and six agreed. These family members were 
contacted via telephone and then by post inviting them to the panel meeting, which took 
place immediately after Panel A meeting in a board room within the hospital, and was also 
digitally recorded. Three of the six invited family members were able to attend: they were 
related to patients from general practice, mental health and genetics specialties. Although 
the numbers for panel B were low, further content validation was carried out with family 
members during the validation stage of the study. 
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Table 4.1: The background of the members of content validity panel A 
Specialty Number of panel members Profession 
Ophthalmology 1 Consultant 
Neurology 1 Consultant 
Infectious Diseases 1 Consultant 
Dermatology 4 Consultant 
Academic expert 
Academic expert 
Specialist nurse 
Paediatric Endocrinology 1 Consultant 
Chronic Pain 2 Consultant 
Specialist nurse 
Wound Healing 1 Research fellow 
Cardiology 2 Consultant 
Specialist nurse 
ENT 1 Consultant 
Gynaecology 1 Consultant 
Urology 1 Consultant 
Colorectal Surgery 1 Consultant 
Genetics 1 Genetics counsellor 
Dental surgery 1 Specialist nurse 
Gastroenterology 1 Specialist nurse 
Pharmacoepidemiology 1 Academic expert 
Procedure 
The two content validity panels were held in a private room around a large table to facilitate 
discussion between panel members. The meeting was chaired by CJG, whose role was to 
remind panel members about the purpose of the meeting, to present discussion topics, 
encourage discussion between panel members, and control the group dynamics so that each 
panel member had the chance to talk and discussion of irrelevant topics was kept to a 
minimum. In both panels, members were asked to discuss the preliminary questionnaire 
layout and design, discuss each item in turn, and discuss six potential problems identified by 
the investigators during the development of the preliminary version of the FROM. Panel A 
were asked to give their expert clinical opinions, having worked closely with both patients 
and families, and were asked to consider the details of the preliminary FROM in relation to 
the illnesses covered by their specialty. Clinical expertise is considered an important attribute 
for panel members when developing a clinically relevant measure (Grant and Davis 1997). In 
turn, Panel B were asked to give their personal opinions about how the preliminary FROM 
related to their experiences as family members of patients with chronic conditions. The 
results of both panels were then combined and changes were made to the items of the 
preliminary version of the FROM accordingly. If there was any disagreement between panels 
over decisions, the investigators would refer back to the qualitative interview transcripts to 
assist with final decisions.  
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Each of the 30 items was discussed in turn by both panels. Topics for discussion for each 
item were influenced by those outlined by Haynes et al. (1995): item relevance, 
representativeness, specificity and clarity. After each item was discussed in turn, the panel 
members were asked their opinions on six issues identified by the investigators during item 
development: 
1. Should the FROM contain frequent reminders throughout the questionnaire, 
reminding the family member that the questionnaire relates to them and not the 
patient? Several family members talked during the interviews about how the patient’s 
life was affected instead of theirs and had to be reminded regularly to talk about 
themselves. 
2. Should the items containing “leisure activities” and “hobbies” be split to form two 
separate items? This was debated by the investigators who could not come to a 
consensus during item development. 
3. Should the term “condition”, “disease” or “illness” be used in the FROM?  
4. Should the term “relative” or “family member” be used in the FROM?  
5. Should the order of response categories go from “not at all” to “extremely”, or the 
other way around? 
6. Are there any obvious potential translation problems? The FROM has the potential to 
be translated into different languages after publication and the panel were asked to 
consider whether they could see any obvious potential language or cultural problems. 
PART 2: QUANTITATIVE ASSESSMENT 
As a multi-method approach is recommended during content validation (Haynes et al. 1995), 
quantitative assessment was also carried out. Content validation is often supported by 
agreement statistics between the panel members (Futrell 1995) and this gives a statistical 
basis for item removal or rewording.  
Procedure 
The consultants, nurses, academic experts, family members and other healthcare 
professionals who were invited to attend the content validity panels meetings were also sent 
a copy of the preliminary version of the FROM and a questionnaire feedback form (Appendix 
M). Those who were attending the content validity panels were asked to bring along their 
completed forms, and those who were unable to take part in the panels were asked to 
complete their forms and return them to the investigators before the panel meetings. The 
comments on these completed forms were then used to form some of the discussion items 
during the panels.  
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Participants were asked to rate each of the 30 items from the preliminary FROM on a four 
point Likert scale (1= strongly disagree, 2= disagree, 3= agree, 4= strongly agree) for each of 
the following criteria: 
Language clarity: the sentences and wording should be clear, understandable, 
straightforward and simple. Phrases and wording should be unambiguous and jargon free 
and should be understood by someone with a reading ability of 12 years. 
Completeness:  the sentences should be complete, not broken and should end appropriately.  
Relevance: each item should be relevant to the subject area and target population.  
Scaling: the scoring system of the FROM is a 5-point adjectival scale. Panel members should 
rate the scaling system as to whether the response options fit the question, or not.  
The four criteria were developed on the basis of recommendations for structural elements in 
content validity (Ferketich 1991; Grant and Davis 1997; Lynn 1986). Under each rating scale, 
space was provided for comments or suggestions for change.  
RESULTS 
The results of the content validity are presented in two parts: quantitative and qualitative. The 
quantitative results are those from the questionnaire feedback forms rating scales. The 
qualitative results are the comments made on the questionnaire feedback forms (“written 
feedback”) and the discussions between the members of both panels (“expert panel” and 
“family member panel”). The changes made to the items of the preliminary FROM to form the 
developmental version of the questionnaire are then discussed, where both the qualitative 
and quantitative results are taken into account. 
Part I - Quantitative Assessment 
The results for the quantitative assessment were based on the returned questionnaire 
feedback forms (n=23). The results for each of the four rating criteria; language clarity, 
relevance, completeness and scaling were analysed (Table 4.2). Each of the 23 judges rated 
all 30 items, so this gave a total number of ratings of 690.  Items which had performed poorly 
under each of the criteria were identified. These were items where ≥ 4 of the 23 judges had 
selected “disagree” or “strongly disagree” for the criterion listed. The disagreement with these 
items was considered when deciding which items to amend or retain as a result of content 
validity assessment. 
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There was also a small amount of missing data (less than 10% for each question) present in 
the sample, which is reported at each stage below. Studying the layout of the questions 
given and the areas where missing data arose, it became apparent that a few of the 
respondents had not noticed the final page of questions as it was printed on double-sided 
paper, so had not answered them. With the way this part of the study was conducted, this did 
not cause a problem as the questions and responses were discussed during the panel 
meetings, and areas where missing data were present were discussed further and in more 
detail to identify whether the missing data was random or selective.  
Language clarity 
When the judges were asked whether the items showed good language clarity, there were 
511 ratings (74%) for strongly agreed, 90 (13%) for agreed, 41 (6%) for disagreed and only 6 
(1%) for strongly disagreed. Six percent of ratings were missing and therefore were not 
included in the analysis. The judges’ median rating for language clarity was 4 (“Strongly 
agree”). For language clarity, five items were identified as poorly performing items, with 
judges disagreeing or strongly disagreeing with the language clarity; item 9 “I feel a burden of 
caring for my family member” (n=7), item 12 “my family activities are affected” (n=5), item 16 
“I need to stay at home” (n=5), item 7 “My behaviour or personality is affected”  (n=4), and 
item 20 “I argue with my family member” (n=4).  
Completeness 
When the judges were asked whether the items were complete in their wording,  there were 
531 ratings (77%) for strongly agreed, 90 (13%) for agreed, 21 (3%) for disagreed and only 6 
(1%) for strongly disagreed. Six percent of answers were missing and so were not included 
in the analysis. The judges’ median rating for language clarity was 4 (“Strongly agree”). For 
completeness, only one item was identified as having disagreement, item 16 “I need to stay 
at home”, with 4 of the judges disagreeing that the item wording was complete. 
Relevance 
When the judges were asked whether the items were relevant to family members of patients, 
there were 559 ratings (81%) for strongly agreed, 69 (10%) for agreed, 14 (2%) for disagreed 
and no judges strongly disagreed. Seven percent of answers were missing and therefore 
were not included in the analysis. The median judges’ rating for language clarity was 4 
(“Strongly agree”). For relevance, only item 17 “my everyday travel is difficult” was identified 
as a problem item, with 5 of the judges disagreeing with the relevance of the item. 
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Scaling 
When the judges were asked whether the items fitted well with the response options, there 
were 497 ratings (72%) for strongly agreed, 90 (13%) for agreed, 48 (7%) for disagreed and 
only 6 (1%) for strongly disagreed. Seven percent of answers were missing and therefore 
were not included in the analysis. The median judges’ rating for language clarity was 4 
(“Strongly agree”). For scaling, two problem items were identified, where judges disagreed 
that the items matched well with the response options. These were items 8 “I feel I have no 
one to talk to about my thoughts” (n=5) and 16 “I need to stay at home” (n=4). 
The overall level of disagreement with the four criteria was 5%, with 1% of judges showing 
strong disagreement (Table 4.2), meaning that 95% of the judges thought that the items were 
written clearly, were complete, relevant to family members and fitted well with the response 
options. The item that judges most strongly disagreed with the criteria was item 16 “I need to 
stay at home”, which showed disagreement with regards to language clarity, completeness 
and scaling. 
Table 4.2: The judges’ ratings (n=23) of the 30 items across four criteria 
Judges’ 
response option 
Judges’ ratings of the 30 items against the four criteria (%) 
Language 
clarity 
Completeness Relevance Scaling 
Strongly agree 511(74) 531(77) 559(81) 497(72) 
Agree 90(13) 90(13) 69(10) 90(13) 
Disagree 41(6) 21(3) 14(2) 48(7) 
Strongly disagree 6(1) 6(1) 0(0) 6(1) 
Missing 42(6) 42(6) 48(7) 49(7) 
Content validity index  
As an additional test of content validity, the content validity index (CVI) was applied to the 
quantitative data (Lynn 1986).  The CVI has mainly been used in nursing research, for 
determination of content validity in the development of multi-item scales rated by multiple 
judges, and has been recommended over traditional methods, such as kappa, due to its 
ease of calculation and understandability (Polit et al. 2007). The CVI, which requires a 
minimum of three expert raters, can be calculated on an item level (I-CVI) and scale level (S-
CVI). The item content validity index (I-CVI) is calculated as a level of agreement between 
judges for each individual item. It is calculated by the number of experts giving a positive 
rating (“agree” or “strongly agree” in the case of the FROM) divided by the number of experts 
(n=23 for the preliminary FROM), therefore calculating the “proportion of judges in agreement 
about relevance” (Polit and Beck 2006; Polit et al. 2007).  The minimum acceptable I-CVI 
value for items varies depending upon the number of judges involved. Lynn (1986) gives a 
minimum acceptable value of 0.80 for ten judges but does not give values for a higher 
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number of judges. However, the author states that the minimum acceptable value decreases 
as the number of judges increases (Lynn 1986). For this study, a minimum value of 0.80 was 
used. Table 4.3 shows the I-CVI values for the 30 items. It can be seen that three of the 
items fall below the minimum acceptable value of 0.8; item 9 (0.78), item 16 (0.76) and item 
17 (0.79). This reflects the earlier results of the four rating criteria, where items 9, 16 and 17 
also showed problems with one or more of the criteria. These results will be considered when 
changes are made to the items of the preliminary FROM to form the developmental version 
of the questionnaire. 
The scale content validity index (S-CVI) is defined as “the proportion of total items judged 
content valid” (Lynn 1986). In the case of the preliminary FROM items, this would be those 
scored “agree” or “strongly agree” and is calculated by the average of the I-CVIs (Polit et al. 
2007). The minimum acceptable value varies depending upon the number of judges 
involved, but for more than three judges the minimum acceptable S-CVI value is 0.8 (Lynn 
1986). The S-CVI for the FROM items was calculated as 0.88, which is an acceptable value 
to suggest that the scale is content valid. 
Test of agreement 
The 30 items of the preliminary version of the FROM were rated on a 4-point ordinal scale for 
four different criteria by 23 judges. It is important to establish the reliability (or the interrater 
reliability) between the ratings given. This will determine whether the ratings given are 
consistent between judges, and whether the data produced by the judges’ ratings can be 
relied upon. The most commonly used measures of agreement are kappa coefficient and 
intraclass correlation coefficient (ICC).  Kappa coefficient is more appropriate when the data 
collected are nominal, whereas interval/ordinal data are best assessed using ICC, therefore 
ICC was chosen for the quantitative data (Elwyn et al. 2003; Futrell 1995). The intraclass 
correlation coefficient (ICC) analysis of absolute agreement between all 23 judges showed 
an ICC of 0.97 (p≤ 0.001, CI= 0.94 to 0.99), indicating a high level of agreement between the 
23 judges and supporting the content validity of the items chosen for the developmental 
version of the FROM. 
Part II - Qualitative Assessment 
The results from the questionnaire feedback forms (“written feedback”) and the discussions 
between the members of both panels (“expert panel” and “family member panel”) were 
reviewed and are presented in Appendix N. The members of both panels discussed each 
item in detail, along with the proposed questionnaire layout and the six potential problems 
identified by the investigators during the development of the preliminary version of the 
FROM.  
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Table 4.3: The I-CVI values for the 30 items of the preliminary version of the FROM 
Item number I-CVI value Item number I-CVI value 
1 0.96 16 0.76 
2 0.94 17 0.79 
3 0.88 18 0.89 
4 0.90 19 0.90 
5 0.89 20 0.82 
6 0.86 21 0.86 
7 0.88 22 0.83 
8 0.93 23 0.88 
9 0.78 24 0.90 
10 0.93 25 0.90 
11 0.93 26 0.89 
12 0.83 27 0.93 
13 0.90 28 0.93 
14 0.87 29 0.91 
15 0.94 30 0.89 
 
The FROM Items 
As well as voicing their opinions, the panel members made suggestions for changes to the 
items. In summary, both panels (referred to hereafter as “the panels”) suggested that the 
grey shading was misleading and should be shaded in the same way for each item. They 
also suggested that item 7 (My behaviour or personality is affected) measures two different 
concepts and should be split into two items. The panels disliked the wording of items 8 (I feel 
I have no one to talk to about my thoughts), 9 (I feel a burden of caring for my family 
member) and 11 (My eating habits are changed), and they did not think that the wording of 
these items fitted well with the response categories. The expert panel thought that there was 
an overlap between items 13 (My leisure activities are affected) and 14 (My hobbies are 
affected), but the family member panel felt that they could distinguish between the two easily. 
The panels also disliked the wording of item 16 (I need to stay at home) and the expert panel 
also disliked the wording of item 17 (My every day travel is difficult).  Both panels thought the 
wording of item 22 (I experience problems with holidays) could be improved, and made 
suggestions for alternative wording. For item 28 (I worry about strangers’ reactions to my 
family member’s condition), the expert panel felt the word “strangers” was not appropriate 
and should be changed. The expert panel also commented on the layout of the 
questionnaire, suggesting changes to the instructions and making general comments about 
the project and the development of the questionnaire. 
The FROM Potential Problems 
The two panels also discussed the six potential problems identified by the investigators 
during the development of the FROM: 
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1. Should the FROM contain frequent reminders throughout the questionnaire, 
reminding the family member that the questionnaire relates to them and not the 
patient? Several family members talked during the interviews about how the patient’s 
life was affected instead of theirs and had to be reminded regularly to talk about 
themselves. 
The written and verbal feedback from both panels concluded that it was not necessary to 
have reminders for every item, and that a reminder should be placed at the top of each page.  
2. Should the items containing “leisure activities” and “hobbies” be split to be two 
separate items? This was debated by the investigators who could not come to a 
consensus during item development. 
The results of the written feedback and the expert panels felt that there was a large overlap 
between the two items (13 and 14), and that one should be dropped. However, one member 
of the expert panel pointed out that it depended upon the individual’s interpretation of the two 
terms. Therefore, the family member panel were asked about their views on the two items, 
and felt that they should remain separate as they thought of leisure activities and hobbies as 
two different things. 
3. Should the term “condition”, “disease” or “illness” be used in the FROM? 
Both panels and the written feedback agreed that the term “condition” was the best wording 
to use in the FROM. 
4. Should the term “relative” or “family member” be used in the FROM? 
The expert panels and the written feedback had mixed opinions about this and did not come 
to a consensus, however the family member panel felt that the term “relative” was too distant 
and that “family member” should be used instead.  
5. Should the order of response categories go from “not at all” to “extremely”, or would 
the opposite be more appropriate? 
Several members of the expert panel felt that the order of the response categories should be 
reversed, starting with “not at all” and ending with “extremely”, with “not relevant” being the 
final category. One family member from Panel B felt that the ordering of the categories was 
acceptable, but the others did not have an opinion on this subject. Some members of the 
expert panel also suggested having three response options instead of five, but they were 
informed that this will be decided as a result of item reduction in the subsequent stages of 
development of the FROM. 
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6. Are there any obvious translational problems? The FROM has the potential to be 
translated into different languages after publication and the panel were asked to 
consider whether they could see any obvious potential language or cultural problems. 
Both panels commented that the language used in the items was pitched at the correct level, 
and the expert panel identified several potential translational issues. These included the fact 
that some cultures may feel that caring for an unwell family member is a duty, and that the 
family member is not entitled to feel any negative emotion. Potential problems with 
translating the response option labels were also identified.  
Changes to the Preliminary version of the FROM Resulting from the Content Validation 
The changes to the preliminary version of the FROM as a result of the content validity panels 
are summarised in Table 4.4. 
The panel’s views were that using grey shading on alternate items emphasised these items 
more than others. Consequently the grey shading was altered so the space in between each 
item was shaded. This meant that the same emphasis was placed on each item. The font 
type and size remained unchanged, as the panels felt that they were acceptable.  There 
were mixed responses from the panel members about the use of examples in the items, and 
so no examples were added as the investigators felt that examples in items may include 
response restriction and leading the family member to respond in a certain way. Item 6 (I feel 
tired) remained unchanged; the expert panel asked whether the question meant physically or 
emotionally tired, but the investigators came to the conclusion that it did not matter which, 
and that both were applicable to the item. Item 7 (My behaviour or personality is affected) 
was split into two separate items as both the family members and experts felt that two 
separate concepts were being measured. This item also scored lowly in the written feedback 
for language clarity, and therefore an improvement was made by splitting the item. Item 8 (I 
feel I have no one to talk to about my thoughts) scored poorly during the written feedback for 
scaling, and this was reflected by both panels. Therefore, the wording of the item was 
changed to “It is difficult to find someone to talk to about my thoughts”, as it was considered 
that this version of the item would be a better fit with the response options. Item 9 (I feel a 
burden of caring for my family member) had a low I-CVI and scored poorly on both language 
clarity and scaling during quantitative feedback. The two panels also debated about the item 
and some of the expert panel disliked the term “burden”. The family member panel were split 
in their opinion of the word “burden”, however as it originated from the original  interviews with 
family members, “burden” was retained but the item was rephrased to read “I feel that caring 
for my family member is a burden” to improve the language clarity. 
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Table 4.4: Changes made to the preliminary version of the FROM as a result of content 
validation 
Preliminary FROM Developmental FROM after content validity 
panel meetings 
Grey shading used for alternate items Grey shading used between every item  
No examples were used in the items  Unchanged 
Item 1: I feel worried Unchanged 
Item 2: I feel angry Unchanged 
Item 3: I feel guilty Unchanged 
Item 4: I feel sad Unchanged 
Item 5: I feel frustrated Unchanged 
Item 6: I feel tired Unchanged 
Item 7: My behaviour or personality is affected  Split into two items: 1. My behaviour is affected 
and 2. My personality is affected 
Item 8: I feel I have no one to talk to about my 
thoughts 
It is difficult to find someone to talk to about my 
thoughts 
Item 9: I feel a burden of caring for my family 
member 
I feel that caring for my family member is a burden 
Item 10: My housework has increased My housework is increased 
Item 11: My eating habits are changed My eating habits are affected 
Item 12: My family activities are affected Unchanged 
Item 13: My leisure activities are affected Unchanged 
Item 14: My hobbies are affected Unchanged 
Item 15: It is hard to find time for myself Unchanged 
Item 16: I need to stay at home I feel the need to stay at home 
Item 17: My every day travel is difficult  My every day travel is affected 
Item 18: My time is taken up visiting my family 
member in hospital or attending medical 
appointments 
Unchanged 
Item 19: My sex life is affected Unchanged 
Item 20: I argue with my family member Unchanged 
Item 21: My family expenses have increased My family expenses are increased 
Item 22: I experience problems with holidays I experience problems with going on holiday  
Item 23: I find it hard to plan my time and 
activities  
Unchanged 
Item 24: My own health or well -being is affected 
because of my family member’s condition  
Unchanged 
Item 25: My sleep is affected Unchanged 
Item 26: My social life is affected Unchanged 
Item 27: I worry about strangers’ reactions to my 
family member’s condition  
I worry about peoples’ reactions to my family 
member’s condition  
Item 28: I find it difficult to talk about my family 
member’s condition. 
Unchanged 
Item 29: My work or study is affected Unchanged 
Item 30: My relationships with other family 
members are affected 
Unchanged 
Opening statements containing the phrase “has 
been” 
Opening statements replaced with the word “is” 
Opening statements containing the word “tick” Opening statements containing the word “mark”  
Use of the term “family member”  Unchanged 
Use of the term “condition”  Unchanged 
No reminder at the top of each page of the 
questionnaire 
A statement at the top of each page of the 
questionnaire reminding respondents that the 
questions relate to them and not to the patient. 
Response categories ordered “extremely” to “not 
at all” 
Response categories ordered “not at all” to 
“extremely” 
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The tense of item 10 (My housework has increased) was altered to match the other items, 
instructions and response options which are written in the present tense. Item 11 (My eating 
habits are changed) was changed from “changed” to “affected”, as the expert panel and 
written feedback were unsure as to whether this item was relating to positive or negative 
changes, and they felt that the wording did not fit well with the response options.  
Although there was much debate between the expert panel regarding the wording of items 
12 (My family activities are affected), 13 (My leisure activities are affected) and 14 (My 
hobbies are affected), and whether there was a difference between the item concepts, the 
family member panel felt that they could distinguish between them and that they were 
valuable, and so all three items were retained and unchanged in their wording. Item 16 (I 
need to stay at home) was changed to “I feel the need to stay at home”, as quantitative and 
panel feedback suggested that the item was incomplete and showed poor language clarity. 
Item 17 (My every day travel is difficult) was changed to “My every day travel is affected”, to 
improve the language clarity. Although some of the members of the expert panel felt that this 
item was not relevant to family members of patients in their individual specialty (reflected by 
a low quantitative feedback score for “relevance”), the family member panel disagreed and 
felt that the item was relevant to many respondents and understood its meaning. Therefore, 
the item was retained. Although the investigators were concerned that the wording of item 19 
(My sex life is affected) could be too blunt or explicit, the panels both disagreed and so the 
wording was left unchanged.  
The wording of item 20 (I argue with my family member) was also unchanged, as although it 
was rated poorly with regard to language clarity during the quantitative feedback, a 
consensus for change could not be reached between the two panels. The tense of item 21 
(My family expenses have increased) was changed to match the other items, instructions 
and response options which are written in the present tense. Item 22 (I experience problems 
with holidays) was debated by both panels, as the expert panel did not know what type of 
holiday the item was referring to, and thought it was too vague. However, looking back to the 
interview transcripts and the origin of this item, it encompasses a huge variety of problems 
and many different types of holiday, so it was felt to be acceptable as the respondent would 
interpret the item in their own way. Furthermore, the family member panel endorsed the item 
as being relevant, and suggested changing the wording to “I experience problems with going 
on holiday” to improve the clarity. Written feedback for item 27 (I worry about strangers’ 
reactions to my family member’s condition) suggested changing the word “strangers” to 
“peoples”, as it could relate to people the respondent knows. The tense of the instructions at 
the beginning of the questionnaire was also changed to better reflect the immediate recall 
period and the tense of the item wording. As a response to comments from the expert panel, 
the instructions were changed from “tick a box” to “mark a box” to allow respondents to 
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indicate their answers with a cross if they desired. The statement “Remember, all of these 
statements relate to how your life is being affected by your family member’s condition at the 
moment” was added to the top of each page of the questionnaire as a result of feedback 
from both panels. The order of the response categories was reversed after feedback from the 
expert panel, and the use of the category “not relevant” was retained as the investigators felt 
it would be helpful to identify any mis-fitting or irrelevant items at a later stage. The use of 
“not relevant” will be readdressed later in the further development of the FROM. Although the 
utility questions received mixed feedback from both panels, they were retained as they had 
not yet been trialled in a population of family members, and the issue was readdressed later 
in the FROM development. 
The final changes identified during the qualitative and quantitative content validity were 
implemented to form the developmental version of the FROM (Figure 4.1). The 30 items 
were increased to 31 items, and the response categories remained the same. The 
developmental version of the FROM was then taken forward to the validation stage for item 
reduction. 
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Figure 4.1: The 31-item developmental version of the FROM 
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DISCUSSION 
The content validation of the preliminary version of the FROM was both an essential and 
enriching process. The design of the content validation process met the recommended 
criteria reported in the literature. For example, both qualitative and quantitative techniques 
were used (Haynes et al. 1995), and the minimum recommended number of 3 panel judges 
was exceeded (Grant and Davis 1997). Recommended structural elements for content 
validity were covered by assessing the scale for its language clarity, completeness, 
relevance and scaling. Both the qualitative and quantitative feedback was drawn from a large 
number of judges from mixed backgrounds (family members, clinicians, nurses, research 
fellow, genetics counsellor, academic experts), helping to increase confidence that the 
changes made to the questionnaire and the items were representative of the general 
population of family members, and were clinically relevant across a range of specialties. 
The inclusion of nurses as members of Panel A proved vital as they were able to offer a 
unique insight into the lives of their patients and their families and provide examples from 
their experiences of working closely with family units. In turn, the academic experts on the 
panel played a vital role in answering questions from panel members about both quality of 
life and questionnaire development. The discussion between the members of panel A was 
both lively and detailed, and although many of the panel members discussed the issues 
raised in relation to their own speciality, they could also appreciate the generic nature of the 
FROM, and seemed to bear this is mind when recommending changes. If consensus was not 
reached between panel members on decisions taken, the investigators referred back to the 
earlier interview transcripts with family members and used these to make final decisions. In 
turn, with some issues where disagreement was seen between panel A and panel B, the 
recommendation from panel B was often taken, as they were representative of the target  
population. In contrast to panel A, panel B had a more friendly and relaxed atmosphere. This 
informality was created by the investigators during the introduction speech, and continued 
throughout the panel meeting.  This allowed the family members on the panel to talk more 
openly about personal issues, and all the panel members felt comfortable enough to explain 
to the rest of the panel about how the items related to their own personal experiences, and 
gave examples. The relaxed panel environment was extended to the refreshment break, 
where the family members offered support to each other in relation to the issues raised in the 
panel meetings. Discussion of the item wording was of particular importance in panel B, as 
the language level of the FROM had to be targeted towards the intended audience, including 
using words that the family members understood and felt comfortable with. Both of the panel 
discussions were vital steps in the content validation of the FROM and enriched the quality of 
the questionnaire. 
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The use of quantitative feedback data to identify content problems amongst the proposed 
items was also successful. The percentage of judges who agreed and disagreed with each of  
the four criteria were identified, and the I-CVI was used to identify poorly rated items. These 
items were then improved following the recommendations from the panels. The majority of 
judges agreed that the preliminary FROM items were relevant, complete, contained clear 
language and fitted well with the response options. The agreement between panel members 
was tested and found to be high, giving confidence that the developmental version of the 
FROM shows high content validity. The panel discussions, statistics and changes made to 
form the developmental FROM provide a solid basis for the FROM to proceed to the item 
reduction stage. 
SUMMARY 
• Qualitative and quantitative methods were used for content validation of the preliminary 
FROM. 
• Two panels formed the qualitative part of the content validation process. The panels 
consisted of experts (n=21) and family members (n=3).  The written feedback from 
questionnaire feedback forms (n=23) was also used for qualitative data analysis. 
• For quantitative analysis, the panel members, and other invited family members and 
experts were asked to rate the preliminary FROM items using a 4-point Likert scale on 
four criteria: language clarity, completeness, relevance and scaling.  
• 95% of the judges thought that the items were written clearly, were complete, relevant 
to family members and fitted well with the response options. 
• The scale content validity index was 0.88 suggesting that the content validity for the 
scale was high. 
• The test of agreement between the written feedback from judges was measured using 
ICC and the result was 0.97 (p≤ 0.001, CI= 0.94 to 0.99), indicating a high level of 
agreement between the 23 judges. 
• The two panels discussed the individual items, the questionnaire layout and wording 
and some of the specific issues raised by the investigators. 
• The results from the two panel discussions and the written feedback were recorded in a 
structured way in order to be compared and contrasted. 
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• Changes to the measure were made as a result of qualitative and quantitative 
feedback; one item was split to form two items, and changes were made to item and 
instruction wording. These changes formed the developmental FROM. 
• The developmental version of the FROM was created ready for item reduction. 
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CHAPTER 5 
 
Item reduction of the Family 
Reported Outcome Measure 
(FROM) using Rasch and factor 
analysis 
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INTRODUCTION 
The developmental version of the FROM, with changes suggested by the content validity 
panel, was tested in a second field study of family members for item reduction. The results 
from the 31-item developmental questionnaire were then analysed using both item response 
theory and factor analysis. The three utility questions were also analysed and the results 
reported in this chapter. 
METHODS 
Study Population 
The study population for the validation of the FROM was made up of family members of 
patients across 26 medical and surgical specialties at the University Hospital of Wales, 
University Hospital Llandough, Velindre Hospital and General Practice.  During recruitment 
for this stage of the study, it was aimed to recruit equal numbers from each of the 26 
specialties, and decided that a minimum of five family members from each specialty would 
be approached for recruitment.  
Rasch analysis 
In this chapter, the process of Rasch analysis and the subsequent changes made to the 
FROM are explained as a stepwise process, explained in Figure 5.1 (see Chapter 2 for 
details of Item Response Theory and Rasch model). 
RESULTS 
Demographic Characteristics of the Study Participants 
245 family members were approached to take part in the study and four declined to 
participate due to time pressures. One subject was eliminated due to incomplete answers on 
the questionnaires. The final validation was carried out using data from 240 family members 
of patients, from 26 specialties shown in Table 5.1.  All 240 family members were asked to 
complete the developmental version of the FROM. The demographic characteristics of the 
family members are shown in Table 5.2. Most participants were female (67%), Caucasian 
(96%), the spouse or partner of the patient (50%), the child (21%) or the parent (18%). The 
remaining 11% were made up of a variety of other relatives including siblings and 
grandparents.  The mean age of family members was 53 years (range 16-90) and the mean 
age of patients was 53 years (range 1-91). The mean patient disease duration was 103 
months (8 years and 7 months). Disease duration ranged from one month to 63 years. 
108 
 
1. Choice of the 
Rasch model 
2. Overall summary 
statistics and fit to 
the model 
3. Check ordering of 
categories and 
rescore if necessary 
4. Check fit of items 
to the model and 
amend the item set 
to find fitting solution 
5. Check fit of 
individual persons to 
the model 
6. Check item 
endorsement  
7. Check items for 
local response 
dependency  
8. Check items for 
differential item 
functioning 
9. Amend item set as 
a result of steps 6-8 
to find a fitting 
solution  
10. Test the scale 
unidimensionality 
11. Report the 
targeting of the scale 
12. Report the person 
separation index  
13. Re-check 
summary statistics 
and fit to the model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: The 13 steps used for Rasch analysis 
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Table 5.1: The 26 specialties included in the item reduction stage of the study 
Cardiology Infectious Diseases 
Care of the Elderly Mental Health 
Chronic Pain Neurology 
Colorectal Surgery Oncology 
Dental Surgery Ophthalmology 
Dermatology & Paediatric Dermatology Orthopaedics & Paediatric Orthopaedics 
Ear, Nose and Throat Paediatric Endocrinology 
Endocrinology Post-stroke 
Gastroenterology Renal & Renal transplant 
General Practice Respiratory 
Genetics Rheumatology 
Gynaecology Urology 
Haematology Wound Healing 
 
Table 5.2: Demographics of the family members during the item reduction stage 
Total number of family members 
       Male 
       Female 
240 
80 
160 
Mean age of family members (range) 53 (16-90) years 
Relationship to patient 
       Spouse/partner 
       Parent 
       Child 
       Othera 
 
50% 
18% 
21% 
11% 
Ethnic origin 
       Caucasian 
       Asian/Asian British 
       Afro-Caribbean 
 
96% 
2% 
2% 
Total number of patients 
       Male 
       Female 
240 
114 
126 
Mean age of patients (range) 
Mean patient disease duration (range) 
53 (1-91) years 
103 (1-756) months 
a Other includes nephew, grandparent, sibling and grandchild.  
Applicability and Practicality of FROM 
During this stage of the study, family members were invited to comment on the 31-item 
developmental version of the FROM, in particular on the item wording, any items which were 
not relevant, the three utility questions, and the construct of the questionnaire as a whole. 
These comments also informed some of the decisions which were made during the item 
reduction. Table 5.3 shows the comments from family members, both positive and negative, 
at this stage of the study. The comments were informal remarks made by the family 
members rather than responses to structured questions. 
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Table 5.3: Comments regarding the developmental 31-item FROM from family 
members of patients during the item reduction phase 
 I find it difficult to fill in the box with patient’s diagnosis. 
 It’s hard to fill in the hours per day questions. Do I put a “0” if I don’t do it?  
 I’m stuck on the question about holidays. I can’t actually go on holiday at all, so I put 
“a little”? 
 Do I fill it out as me or as the patient? 
 I would prefer time frame responses, such as sometimes, a lot, all of the time. 
 I’m stuck on the utility questions. I can’t distinguish the time I spend waking up due to 
my own medical problems and my wife’s. 
 The questions are well worded and not too long. 
 It needs to be made more clear where the end is, as you turn over the page 
expecting it to finish. 
 What do I do if I don’t have any hobbies? 
 For the utility questions, if I don’t spend any time doing these things then what do I 
write? 
 I didn't notice “not relevant” as I didn't read the response options properly before I 
answered. 
 I don’t talk to anyone about my feelings so how do I answer that question? I didn't 
notice the “not relevant” box. 
 I can’t quantify the hours on the questions on the front page. 
 Most of the questions are not relevant to me. 
 The expenses question is really good and relevant as I now have to drive my wife to 
appointments every week. 
 “It is difficult to talk to someone about my thoughts”. I don’t know how to answer this 
one with the response options given as the questions don’t fit them. 
 I can’t answer the utility questions- it’s impossible to quantify this. 
 A lot of the questions overlap and its like asking the same questions over again.  
 I do the accounts for my relative, does that count for the “caring” utility question?  
 “I feel tired”. Well I feel tired anyway, but if this is relating to my wife then it needs a 
“because of...” after it. 
 “My every day travel is affected” is a very odd question- what does it mean? 
 I found some of the questions difficult to answer because I hadn’t really thought 
about them before. 
 “My personality is affected”. I think someone else should comment on this, I can’t 
really say. 
 What do I do after the first page? 
 The most relevant utility question is the sleep one. 
 I would like to see a “general comments” box so I can add more of my thoughts. 
 I find it hard to write the patient’s diagnosis. 
 Do I put my details on the front page? 
 The “every day travel” question is odd.  
 Does travel insurance count for the holiday question? 
 How would I know if my behaviour or personality has changed? You should be 
asking her this, not me. 
 The questions cover everything well. 
 I don’t feel like “burden” is the right word. 
 The question about sex life isn’t relevant to me.  
 The questionnaire is quick and easy to fill in. 
 I missed out the first question as there wasn’t much space between the top and the 
first question. 
 Does question 10 mean the work I do normally do around the house has doubled? 
 I think there’s a question missing. There should be a question about worrying about 
other members of the family being affected. I worry about my mother having to look 
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after my father. 
 I think for question 19 the two parts of the question should be swapped around so 
that medical appointments comes first as its more relevant. 
 I don’t understand the question about burden. What does it mean? Does it mean that 
it affects other areas of my life or that I find it difficult? 
 I think the questions reflect my thoughts really well and you seem to have covered 
everything. I couldn’t have written them better myself.  
 The questions you are asking are spot on. 
 Does “stay at home” mean my home or theirs? 
 “My personality is affected”. I've not got a clue, you'd have to ask someone else. 
 What do you mean by family activities? 
 That questionnaire will do well, the questions are really good. 
 Those questions are really spot on. 
 Whoever constructed that questionnaire did a really good job. 
 The main thing that distressed me was not finding out what was wrong with my wife 
for a long time, and no question covers that. 
Utility questions 
The developmental version of the FROM included three utility questions, designed to quantify 
the effects of the patient’s illness on three different areas of the family member’s life. The 
three utility questions were: 
How many hours on average per day (out of 24) do you spend doing the following:  
1. Caring for your family member (e.g. helping with dressing, showering, toileting, 
mobility) 
2. Housework (e.g. cleaning, cooking, shopping, washing)   
3. How many hours sleep do you lose per night due to worry or getting up in the night to 
help your family member? 
For each of the three questions, there was missing data, as many of the family members 
reported that the utility questions were very difficult to complete. The number of valid 
responses (n) and the response rate (r) is given for each question. The mean number of 
hours per day spent caring for the patient (n=207, r=86%) was 4.5 (range 0-24). The mean 
number of hours spent doing housework (n=214, r=89%) was 4.9 (range 0-24). The mean 
number of hours sleep lost per night (n=206, r=86%) was 1.5 (range 0-8).  
Family members found these three concepts very difficult to quantify, as seen in the patient 
feedback in Table 5.3. For each of these questions there was also a large amount of missing 
data. In order to produce a simple, easy to use measure, the burden on subjects needs to be 
low, and it was felt that these utility questions increased the burden on subjects. 
Furthermore, as the answers are given in numbers, it is difficult to compare them to the 
Likert-style items, and they would not be able to be incorporated in a total score. It was 
therefore decided that these three questions should be dropped from the FROM altogether.  
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However they provide interesting information, particularly the amount of time family members 
lose from their day providing care to the patient. 
Missing data 
Missing data for the utility questions has been discussed above, but there was also missing 
data seen in the questionnaire item responses. The amount of missing data varied between 
items, with the lowest missing data percentage of 0.4% and the highest of 17%. The amount 
of missing data can be used to analyse the acceptability of items, and can suggest that some 
items need to be re-worded or clarified if a large volume of missing data is identified. In this 
case, the high missing data percentages for some items suggests that re-wording should 
take place. In this stage of the study, missing data was analysed alongside the percentage of 
responses for each response category (Table 5.5) when selecting items to remove or re-
word. It is also important to consider how the missing data is handled. RUMM2030 gives the 
option to create data sets with complete data records only, or includes all cases but removes 
missing values case-wise. Both options were selected during the Rasch analysis, depending 
upon the test being used. 
Sample size 
The consideration of sample size during Rasch analysis is extremely important, as item fit 
statistics can be highly sensitive to sample size when using polytomous data (Smith et al. 
2008).  In general, to be able make discriminations between people, as large a sample size 
as possible is ideal (Streiner and Norman 2008). In order to be confident (99% sure) that an 
item calibration is within 1 stable logit, a sample size of 50 is required and in order to be 
within ½ a stable logit, the sample size requirement rises to 150 (Linacre 1999). The ideal 
sample size to produce a statistically stable measure given by Linacre (1999) is up to 250 
subjects. In this study, the sample size was 240, meaning that it is high enough to be 
confident that a statistically stable measure will be produced. 
Scoring of the developmental version of the FROM 
The developmental version of the FROM has 31 items, each scored on a 5-point Likert scale, 
with a 6th response option of “not relevant” (scored 0). Each item in the developmental 
version of the FROM was scored: “Not at all”= 0, “A little”= 1, “Moderately”= 2, “A lot”=3, 
“Extremely” =4. This gave a possible score range of 0-124.  
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Rasch analysis 
Rasch analysis was carried out on the developmental 31-item version of the FROM. Table 
5.4 shows the 31 items along with their item numbers for reference. The process of Rasch 
analysis followed that shown in Figure 5.1. 
Step 1. Choice of the Rasch model 
As the FROM has more than two response categories, the polytomous Rasch model was 
chosen, as opposed to the dichotomous model. There are two versions of the polytomous 
model; the Andrich Rating Scale Model (Andrich 1978) and the Masters Partial Credit Model 
(sometimes called the Unrestricted model) (Masters 1982). The Partial Credit Model places 
no restrictions on the threshold parameters, whereas the Rating Scale Model, which 
produces a higher degree of specificity, dictates that all thresholds must be equally spaced 
across the trait for all of the items. In other words, the Rating Scale Model expects the 
distance between the thresholds separating each response category (for example, between 
“Moderately” and “A lot”) to be the same across all of the items (Tennant and Conaghan 
2007). 
RUMM2030 uses a Likelihood-Ratio Test to determine which model should be used on a set 
of data. In the case of the FROM data, the Partial Credit Model was chosen, as the result of 
the Likelihood-Ratio Test showed that the data did not fit the Rating Scale Model (p<0.05). 
Step 2. Overall summary statistics and fit to the model 
The next stage in the Rasch analysis process was checking the overall summary statistics of 
the FROM and how well it fits to the model without any adjustment (Figure 5.2). The person 
and item fit statistics are transformed by RUMM2030 to an approximate Z-score representing 
standardised normal distribution. The fit residual mean value for all 31 items is -0.22 with a 
standard deviation of 1.97. The fit residual mean would be expected to be closer to 0, and 
the standard deviation would be expected to be much closer to 1 to give adequate fit to the 
model.  The misfit is supported by a significant chi squared interaction of 271 (degrees of 
freedom= 93) and p≤ 0.01, showing a lack of invariance of item difficulty across the scale, 
meaning that the scale cannot differentiate between the different groups; from those whose 
quality of life is affected greatly to those who are not affected at all. A chi squared probability 
value of above 0.05 would suggest that there is no significant deviation between the 
observed data and what is expected from the model (Bland and Altman 1995; Tennant 
2011). This could be caused by misfit to model expectations of respondents or items (as 
explained by the summary statistics), or both. 
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Table 5.4: The 31 items of the developmental version of the FROM 
Item number Item 
1 I feel worried 
2 I feel angry 
3 I feel guilty 
4 I feel sad 
5 I feel frustrated 
6 I feel tired 
7 My behaviour is affected 
8 It is difficult to find someone to talk to about my thoughts 
9 I feel that caring for my family member is a burden 
10 My housework is increased 
11 My eating habits are affected 
12 My family activities are affected 
13 My leisure activities are affected 
14 My hobbies are affected 
15 My personality is affected 
16 It is hard to find time for myself 
17 I feel the need to stay at home 
18 My every day travel is affected 
19 My time is taken up visiting my family member in hospital or attending 
medical appointments 
20 My sex life is affected 
21 I argue with my family member 
22 My family expenses are increased 
23 I experience problems with going on holiday 
24 I find it hard to plan my time and activities 
25 My own health or well-being is affected because of my family member’s 
condition 
26 My sleep is affected 
27 My social life is affected 
28 I worry about people’s reactions to my family member’s condition 
29 I find it difficult to talk about my family member’s condition 
30 My work or study is affected 
31 My relationships with other family members are affected 
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The residual mean value (0= perfect fit to model) for persons was -0.19 with a standard 
deviation of 1.34 (1= perfect fit to model), indicating no serious misfit amongst the 
respondents in the sample. It is also worth noting that at this stage the mean person location 
value was -0.99 (0= perfect fit to model), meaning that in general the family members were of 
a slightly lower “ability” than the FROM (their quality of life was affected at the lower end of 
what the items and responses allowed for), and that family members scored lowly on the 
scale. The 31-item developmental version therefore failed to fit the Rasch model, and 
improvements to the scale construct are required. 
Step 3. Check order of categories and rescore if necessary 
In a polytomous data model, checking the threshold ordering is very important when 
considering fit to the model. As a person ability increases (in the case of the FROM, as the 
quality of life of the family member is affected more greatly), then they should be more likely 
to obtain a higher score. This progression should be logical, so as the QoL is affected more, 
the family member is more likely to score a 20, than a 19, for example. The term “threshold” 
means “the point between two response categories where either response is equally 
probable...for example the probability of scoring a 0 on the item or scoring a 1 is 50/50” 
(Pallant and Tennant 2007). 
 
Figure 5.2: Summary statistics for the 31-item developmental version of the FROM 
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In RUMM2030, threshold ordering is checked using threshold maps, which identify 
graphically whether each item is progressing in a logical order. Disordered thresholds can 
indicate that subjects find it difficult to discriminate between response options, often when 
there are too many response options or when the labelling of the response options is 
confusing (Pallant and Tennant 2007). The common response to disordered threshold is to 
collapse the number of response categories, which often improves fit to the model (Pallant 
and Tennant 2007; Pesudovs and Noble 2005; Streiner and Norman 2008; Zhu et al. 1997). 
The threshold map in RUM2030 was checked for the FROM, to identify any disordered 
items. Figure 5.3 shows that 24 of the 31 items were disordered, as marked by “**” on the 
map. Next, the category probability curves for each item were looked at. Figure 5.4 shows an 
example of an ordered category probability curve for Item 1, where it can be seen that 
responses to this item fall in a logical, progressive order. On the other hand, Figure 5.5 
shows an example of a disordered probability curve for item 4, where it can be seen that 
even at the point where the probability of scoring a 2 is highest (at person location -1), it is 
still more likely that a 1 will be scored instead.  
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Figure 5.3: The threshold map for the 31-item developmental version of the FROM 
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Figure 5.4: The ordered category probability curve for item 1 
 
 
Figure 5.5: The disordered category probability curve for item 4 
 
It was decided that the response categories of the FROM would be collapsed in order to 
obtain threshold ordering across all items and improve fit to the Rasch model. Previously, 
two main approaches to collapsing the categories have been taken. Firstly, collapsing the 
categories individually for each item in turn, and therefore having a different scoring system 
for each item (Chien and Bond 2009; Lamoureux et al. 2006). Secondly, categories can be 
collapsed for the questionnaire as a whole, giving the same scoring system for each item 
(Lamoureux et al. 2008; Penta et al. 1998). In the case of the FROM, it was decided that the 
categories would be collapsed for the questionnaire as a whole, giving a uniform scoring 
119 
 
system. There were several reasons for this. Firstly, the majority of items were disordered 
and would need categories collapsing. Collapsing categories in the same way for all of the 
items would make the FROM easier for investigators and clinicians to score, as they would 
not be required to use a score sheet. It was felt that this would enable the FROM to be more 
widely used in a clinical setting, as it would also reduce the t ime burden on the clinician. 
Furthermore, having the same scale scoring for each item would avoid putting a greater 
emphasis on certain items where the subject can potentially score more highly if different 
scoring is used (Uhlig et al. 2007). This was felt to be especially important in the area of 
quality of life measurement, where the concept is subjective to the family member, and not a 
physical attribute, for example in a disability index.  
In order to decide which categories to collapse, the category response proportions were 
examined for each item, along with the category probability curves. Table 5.5 shows the 
proportions of responses in each scoring category, and it can be seen clearly that categories 
3 and 4 have few responses across most items. In particular, these categories contain less 
than 10% of responses for many items, and were therefore identified as low-scoring 
categories, suggesting that individually, they are not relevant for many family members.  For 
all but three of the items, combining categories 3 and 4 would result in a new category with 
percentage scores of over 10%.This was also reflected in the category probability curves for 
disordered items. Categories 3 and 4 (“A lot” and “Extremely”) were collapsed to form one 
category, and the categories were rescored, as shown in the “Rescore 1” column in Table 
5.6. Collapsing these two categories also made sense from a conceptual point of view, as it 
can be seen how subjects could find it difficult to distinguish between the wording of the two 
categories. 
Collapsing categories 3 and 4 did not improve the overall model fit. The chi squared 
probability value remained at 0, and mean item fit residual worsened to -0.35 (standard 
deviation 1.95).  Only one of the disordered items benefitted from the rescore, meaning that 
24 of the 31 items were still disordered. Therefore, the category probability curves were 
examined again, and it was decided that categories 1 and 2 (“A little” and “Moderately”) 
would also be collapsed to form one category. From a conceptual point of view, this would 
enable the subjects to more clearly distinguish between whether an event occurs “Not at all”, 
“A little/Moderately” or “A lot/Extremely”.  The column “Rescore 2” in Table 5.6 shows how 
the categories were rescored, giving a scoring system of 01122.  
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Table 5.5: The category response percentages for the 31-item developmental FROM 
 
Percentage response for each category 
Statement 0 1 2 3 4 
Item 1 3 20 27 27 23 
Item 2 47 25 12 6 9 
Item 3 53 24 9 6 8 
Item 4 17 26 15 20 22 
Item 5 21 28 15 16 20 
Item 6 25 23 16 17 19 
Item 7 39 33 15 10 4 
Item 8 51 18 12 9 10 
Item 9 76 13 8 3 0 
Item 10 47 18 16 13 6 
Item 11 52 28 10 5 5 
Item 12 25 26 20 15 14 
Item 13 32 24 20 13 11 
Item 14 47 22 12 11 9 
Item 15 47 31 10 8 4 
Item 16 41 28 10 14 7 
Item 17 36 25 14 18 6 
Item 18 55 24 8 8 4 
Item 19 27 39 19 9 6 
Item 20 58 14 9 7 12 
Item 21 51 29 12 6 2 
Item 22 37 26 19 8 10 
Item 23 37 18 13 16 17 
Item 24 41 27 11 15 7 
Item 25 47 3 11 7 5 
Item 26 34 3 12 13 11 
Item 27 39 27 13 11 9 
Item 28 63 19 9 6 3 
Item 29 69 20 4 4 3 
Item 30 60 22 10 4 4 
Item 31 64 19 9 4 4 
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Collapsing the five response categories into three meant that all 31 items were now ordered 
(Figure 5.6).  The summary statistics showed that the chi squared probability value remained 
at 0, and mean item fit residual worsened to -0.4 (standard deviation 1.88). Collapsing 
response categories did not improve the fit to the model, but as the thresholds are now 
ordered and the response categories are working correctly, further tests to improve fit to the 
Rasch model can now be carried out. It is important to note that creating fewer categories 
can impact the future responsiveness and sensitivity of the measure, as there is a narrower 
range of possible scores. 
Table 5.6: The rescore values for each response category of the 31-item 
developmental FROM 
Category (response 
option) 
Original score Rescore 1 Rescore 2 
Not at all/not relevant 0 0 0 
A little 1 1 1 
Moderately 2 2 1 
A lot 3 3 2 
Extremely 4 3 2 
Step 4. Check fit of items to the model and amend the item set to find fitting solution 
As well as looking at the overall fit, it is important to look at the fit statistics for individual 
items in order to identify those items which are misfitting and therefore not performing well. 
The fit residuals (the divergence of each person from the model) for each item were 
examined. As the data approximate a normal distribution, a mean of 0 and a standard 
deviation of 1 would be expected. Any items with a fit residual of greater than +/- 2.5 
(Mavranezouli et al.; Pallant and Tennant 2007) are a cause for concern as they represent a 
misfit to the Rasch model. High negative residuals suggest that items are not adding 
anything new to the scale (Mills et al. 2009; Tennant 2011) and can be considered for 
removal. In the case of the FROM, the misfitting items were identified as item 27 (fit residual 
-3.57), item 24 (-3.51), item 13 (-3.01), item 28 (3.25), item 3 (3.06) and item 10 (2.57). 
These items were removed from the FROM one at a time, starting with the most mis -fitting 
item (item 27). After each item removal, the overall fit statistics of the measure were 
evaluated (Table 5.7). Consequently, removing all six of the mis-fitting items improved the fit 
to the Rasch model (Table 5.7), bringing the standard deviations closer to one (analysis 
number 6). However, the chi squared probability value remained at 0, suggesting that there 
is still further work to be carried out to finalise the FROM. 
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Step 5. Check fit of individual persons to the model  
As well as checking the fit of individual items, it is important to check the fit of the individual 
subjects to the Rasch model. This can identify mis-fitting respondents who may be skewing 
the analysis. Similar to item mis-fit, individual persons are expected to fall within a fit residual 
of +/- 2.5. Those with a high negative fit residual could be answering too perfectly, and trying 
to answer the items as they think they should be (Tennant 2011), and low negative fit 
residual could mean that mis-fitting persons could be showing a bizarre response pattern 
(Tennant and Conaghan 2007). Removing mis-fitting persons from the analysis can often 
have a significant impact on the fit of the measure, however removing these persons could 
raise questions about the construct validity of health-related scales, especially those which 
are being newly developed, as the mis-fitting persons may represent an important aspect of 
health, for example an unreported co-morbidity (Pallant and Tennant 2007). In the case of 
the FROM, 11 respondents were identified as having fit residuals greater than +/- 2. 
Removing these respondents from the analysis improved the overall fit to the model slightly, 
bringing the mean item and person fit residuals down by 0.02 and 0.04 respectively. 
However, as the fit to the model was not greatly improved, and the removal of the mis-fitting 
respondents could have a negative effect on the construct of the FROM, it was decided that 
these respondents would be included in the further analysis. 
Step 6. Check item endorsement  
The endorsement for each item was examined using the category response frequencies in 
RUMM2030. Items which had a low endorsement level (a high percentage of respondents 
scoring 0) were considered for removal as they were not seen as important or relevant for a 
large number of family members. Conversely, items with a high endorsement level (a high 
percentage of respondents scoring 2) were viewed as being important and re levant to a large 
percentage of family members, and contribute greatly towards the impact on their quality of 
life. The two items which showed a lower level of endorsement compared to the others were 
items 9 and 29. The scores for item 9 were: 0=169, 1=46, 2=6. This item was a very 
important concept during the interview stage, but the wording of the statement was criticised 
by family members during their feedback. Therefore, it was decided that the concept behind 
this item should be retained in the FROM, but the wording of the item should be 
reconsidered. Item 29 was also lowly endorsed: 0=156, 1=55, 2=15. This item measures a 
similar concept to item 8, which shows higher endorsement, and therefore should be 
considered for removal. The endorsement level of individual items was considered during the 
later stages of Rasch analysis, when deciding on item retention and removal.  
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Figure 5.6: The threshold map for the 31-item developmental version of the FROM after 
collapsing response categories 
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Table 5.7: The step by step removal of mis-fitting items in the FROM 
Analysis 
number  
Description # items 
in scale 
Chi2 p 
value 
Item fit 
residual 
mean (S.D) 
Person fit 
residual mean 
(S.D) 
1 Developmental 
version of FROM with 
categories collapsed 
31 0 -0.4 (1.88) -0.2 (1.35) 
2 Remove items 27 and 
24 
29 0 -0.33 (1.68) -0.2 (1.29) 
3 Remove items 27, 24 
and 13 
28 0 -0.3 (1.59) -0.19 (1.26) 
4 Remove items 27, 24, 
13 and 28 
27 0 -0.33 (1.52) -0.2 (1.23) 
5 Remove items 27, 24, 
13, 28 and 3 
26 0 -0.35 (1.39) -0.22 (1.20) 
6 Remove items 
27,24,13,28,3 and 10 
25 0 -0.37 (1.37) -0.22 (1.19) 
Step 7. Check items for local response dependency 
One source of possible misfit within a scale is local response dependency. The Rasch model 
assumes local independence; once the main factor (in this case the Rasch factor) is 
removed, there is no correlation between items (Streiner and Norman 2008). This means that 
a person’s response to one item will have no bearing on their response to another item in the 
scale. Removing local dependence can help to improve fit to the Rasch model, often by 
eliminating or combining items which appear to measure the same attribute and show high 
correlation. In RUMM2030, local response dependency is assessed by looking at the 
residual correlations between items (Kahler and Strong 2006). Potentially problematic 
dependency between items can be identified between items if the residual correlation is 
between 0.2 and 0.3 above the average of all of the item residual correlations (Hansen et al. 
2012). There are other ways of carrying out checks for local response dependency, including 
directly correlating the item responses (Streiner and Norman 2008), but RUMM2030 
produces a correlation matrix of the fit residuals for each item. The average residual 
correlations of the FROM items was -0.039, therefore correlations between items of above 
0.16 were identified. Table 5.8 shows the items which were identified as having high residual 
correlations and the solution decided by the investigators for each. To decide on a potential 
solution, the wording of the items was considered, along with the level of endorsement and 
the feedback from family members regarding the items. The prevalence of each item concept 
during the interview stage was also considered. 
Step 8. Check items for differential item functioning  
Differential item functioning (DIF) is another important potential source of misfit in the data. 
Items are classed as showing DIF when different groups of respondents (for example male 
and female) within the same sample respond differently to an individual item (Pallant and 
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Tennant 2007). This can mean that an item is biased towards one particular group of people. 
Although there is no consensus regarding the best way to measure DIF, running an analysis 
of variance is the most common way (Streiner and Norman 2008), and also the method used 
by RUMM2030. Two types of DIF exist; uniform and non uniform DIF. Uniform DIF is seen 
when each group of respondents shows a consistent systematic difference in their responses 
to an item, across the whole range of the attribute being measured (Teresi et al. 2000), 
identified by a significant analysis of variance test. Non uniform DIF is seen when differences 
in groups vary across levels of an attribute, and there is non-uniformity in the differences 
between groups (Tennant and Conaghan 2007). Uniform DIF can cancel out in a measure, 
for example if there is one item biased more towards females and one towards males in the 
same measure (Tennant and Pallant 2006a). If the uniform DIF does not cancel out, the 
problem item(s) can be split, for example by gender, and scored separately(Lundgren-
Nilsson et al. 2005). Non-uniform DIF is more difficult to deal with, and items sometimes 
have to be rewritten or removed from the scale (Pallant and Tennant 2007). However, as 
emphasised by Streiner and Norman (2008), the impact and significance of the DIF must 
also be considered in relation to the concept being measured; it is important to consider 
whether the presence of DIF in the measure is problematic, and it is important to look further 
than the statistics.  
The presence of DIF in the FROM was identified using one way analysis of variance 
(ANOVA) carried out in RUMM2030. The respondents are split into roughly equal class 
intervals depending upon their FROM score. RUMM2030 produces tables for the ANOVA 
tests for each item, and these are examined for significant differences (p<0.05). Item 
characteristic curves were also produced for each item using RUMM2030, to show the 
effects of DIF graphically. The different groups analysed for the FROM were age and gender. 
Relationship to patient and medical specialty were also considered, but the numbers in these 
groups were so small that no reliable conclusion could be made. It was also decided that the 
presence of DIF by specialty was not problematic, and could be expected; family members of 
patients from different specialties would be expected to answer differently and be biased 
towards certain questions. For example, family members of patients from gynaecology or 
urology may score more highly on an item regarding their sex life due to the nature of the 
patient’s symptoms. DIF by relationship to patient was also not seen as problematic; closer 
relations to patients (e.g. spouses) may score more highly on some items than more distant 
relatives. DIF becomes more of a problem when using Rasch analysis for measurement in 
education or in validating disability scores where bias would be problematic.  
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Table 5.8: The local dependency identified within the FROM and potential solutions 
Items involved Potential solution 
Items 1, 2, 4 
and 5 
These four items are all measuring a similar attribute (emotions), so some 
local dependency could be expected. However, all of these items show 
good fit to the model. The endorsement level for all of the items was high, 
so all should be retained. 
Items 7 and 15 The two items are measuring similar attributes, and this was noted by the 
family members during this stage of recruitment. The two items were given 
poor feedback by family members, and so will have to be reworded if one 
is retained.  Item 7 is more highly endorsed so should be kept over item 
15. 
Items 12 and 
14 
These two items have similar wording, and only one should be retained. 
Item 12 is worded more clearly, as several family members felt that, as 
adults, they no longer have “hobbies”. The wording of item 14 fits well with 
the theme of the FROM. 
Items 14 and 
16 
Removed item 14 
Items 14 and 
18 
Removed item 14 
Items 16 and 
18 
It is difficult to see from a conceptual point of view why these two items are 
showing correlation as they measure two very different things. Therefore 
retain both. 
Items 12 and 
23 
Although it can be seen from a conceptual point of view why there is a 
correlation between these two items (both involve doing things together as 
a family), the theme of holidays was highly prevalent during the interview 
stage, and is clearly very important to family members so both items 
should be retained. 
Items 14 and 
30 
Removed item 14 
Items 20 and 
23 
Both items emerged as important concepts during the interview stage of 
the study and are measuring different things, so both should be retained.  
Items 6, 25 and 
26 
These three items are all measuring similar concepts so do not need to all 
be retained. Item 26 is the most highly endorsed, and items 5 and 26 
measure two overlapping concepts. These items need to be investigated 
further. 
 
DIF was identified in twelve of the FROM items (Table 5.9). The item characteristic curves 
were then examined to identify which group the item was biased towards when uniform DIF 
was shown. Figure 5.7 shows an example of uniform DIF by age seen in item 14, and Figure 
5.8 shows an example of non-uniform DIF by gender in item 15, where the lines on the graph 
can clearly be seen to be crossing, demonstrating non-uniformity. 
Step 9. Amend item set as a result of steps 6-8 to find a fitting solution  
Six of the mis-fitting items from the developmental 31-item version of the FROM were 
removed during step 4 of the Rasch analysis. The results of the tests for item endorsement, 
local response dependency and DIF showed that further item reduction is required for the 
FROM to fit the Rasch model. Removal of the items was carried out in a stepwise process 
with one problem item being removed at a time, and the effect on the summary statistics was 
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stated after each stage of item removal (Table 5.10). The reasons behind each stage of 
removal are stated below. 
 
Figure 5.7: The item characteristic curve for item 14 showing uniform DIF by family 
member age 
 
 
Figure 5.8: The item characteristic curve for item 15 showing non-uniform DIF by 
family member gender 
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Table 5.9: Uniform and non-uniform DIF identified in the items of the 31-item 
developmental FROM 
Item Uniform DIF by 
family member 
age 
Non-uniform DIF 
by family member 
age 
Uniform DIF by 
family member 
gender 
Non-uniform DIF 
by family member 
gender 
1 No No No No 
2 No No No No 
4 No No Yes (p=0.034) 
Female higher 
No 
5 No No No No 
6 No No Yes (p=0.011) 
Female higher 
No 
7 No No No No 
8 No No No No 
9 No No No No 
11 No No No No 
12 No No Yes (p=0.028) 
Male higher 
No 
14 Yes (p=0.015) 
Younger higher 
No No No 
15 No No No Yes (p=0.03) 
Female higher 
16 No No Yes (p=0.040) 
Female higher 
No 
17 No No No No 
18 No No No No 
19 No No No No 
20 No No Yes (p=0.009) 
Male higher 
Yes (p=0.003) 
 
21 No No No No 
22 No No Yes (p=0.001) 
Male higher 
No 
23 Yes (p=0.0009) 
Older higher 
No Yes (p=0.0098) 
Male higher 
No 
25 No Yes (p=0.044) No No 
26 No No Yes (p=0.017) 
Female higher 
No 
29 No No No No 
30 Yes (p=0.008) 
Younger higher 
No No No 
31 No No No No 
ANALYSIS 5  
Analysis 5 included the removal of the six mis-fitting items during step 4 of Rasch analysis, 
and lists the statistics that need to be improved to improve fit to the Rasch model. The chi2 
value should be above 0.05 for the measure to fit the Rasch model (Tennant and Conaghan 
2007). The fit residual means for items and persons were already close to 0, but a reduction 
in these values would be an improvement, and the standard deviations should be closer to 1.  
ANALYSIS 6 
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For the next step of item removal, five further items were removed. Items 6 and 25 were 
removed as they showed local dependency with item 26, which was retained as it was 
thought to be the most clearly worded item, and the most favoured by family members. Item 
14 was removed as a result of local dependency with several other items. Family members 
expressed that it was a badly worded item. Items 7 and 15 showed local dependency, and 
both were given poor ratings by family members. At this stage, both were removed. The 
removal of these five items improved the fit statistics, reducing the fit residual means and 
bringing the standard deviations closer to 1.  
ANALYSIS 7 
Items 8 and 29 showed local dependency, so they either needed to be combined into one 
item or one item removed. As each item should measure one concept, item 29 was deleted 
and item 8 was retained. The two items are describing a similar concept and have similar 
wording. Removal of item 29 worsened the fit statistics slightly, but not significantly enough 
to cause concern. The chi2 p value was also brought into an acceptable range (p=0.15).  
ANALYSIS 8 
Analysis 8 mirrored analysis 7, and item 8 was deleted whilst item 29 was retained. This 
worsened the fit statistics further, and worsened the chi2 p value once again (p=0.02). 
ANALYSIS 9 
During analysis 9, both items 8 and 29 were deleted. This was carried out to ensure that 
keeping either item 8 or item 29 was beneficial to the FROM from a Rasch point of view. 
Removal of both items worsened the fit statistics and the chi2 p value remained below 0.05 
(p=0.03). Therefore, as a result of analyses 7-9, and from a conceptual point of view, it was 
decided that item 8 should be retained and item 29 deleted.  
ANALYSIS 10 
During analysis 6, both items 7 and 15 were deleted. These items showed local dependency, 
low endorsement and were rated poorly by family members. To ensure that deleting both 
items was the correct decision, item 7 was added back into the FROM, as it was the more 
highly endorsed item of the two. This addition worsened the fit statistics slightly, and the chi2 
p value fell (p=0.01). Therefore, the removal of both items 7 and 15 was deemed to be the 
correct decision. 
ANALYSIS 11 
During analyses 11-15, three items which had been retained in the FROM up until this point, 
but which had potential problems were removed one by one to look at the effect they had on 
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the fit statistics. In analysis 11, item 19 was deleted as it was an item which received poor 
rating from family members and had a low endorsement. It was also felt that the concept of 
time was covered by item 16, which was retained. Deleting item 19 did not make a large 
difference to the fit residual mean values, but it improved the standard deviations and 
increased the chi2 p value (p=0.17), in comparison to analysis 7 which was the most recent 
analysis deemed to have the best combination of items.  
ANALYSIS 12 
In analysis 12, item 21 was deleted as it was lowly endorsed and the concept of relationships 
with other family members was covered by item 31 which was retained. Removal of item 21 
whilst retaining item 19 did not have a great effect on the fit statistics; the fit residual values 
for item fit worsened slightly, but improved slightly for person fit. Therefore, item 21 was 
tested further during analysis 14. 
ANALYSIS 13 
Item 17 was deleted during analysis 13 as it was the most mis-fitting item left in the FROM 
(fit residual value of -1.81). The chi2 p value was still not significant, so item 17 was deleted 
the concept of having to stay at home was also covered by other items, such as the 
emotional-based items. Item 17 was also largely mis-fitting in comparison to the other items, 
so it may have been skewing the analysis. The removal of item 17 further improved the fit 
statistics and increased the chi2 p value to 0.04. Therefore, it was decided that item 17 
should be removed from the FROM. 
ANALYSIS 14 
In analysis 14, items 17, 19 and 21 were deleted. Items 17 and 19 had already been 
identified for deletion, and removing item 21, which was identified as an ambiguous item 
improved the fit statistics and brought the chi2 p value up to 0.18. Therefore, analysis 14 was 
decided as the basis of the final set of 16 items for the FROM as the combination of items 
produced excellent fit statistics whilst reflecting the earlier qualitative themes. 
Dealing with DIF 
Eight of the 16 items retained during the item removal were identified during step 8 as having 
differential item functioning (DIF). As mentioned in step 8, items with uniform DIF can either 
be split into each of the groups in question (for example having different scoring systems for 
males and females for an item) or DIF can cancel out in a measure at test level (Tennant and 
Pallant 2006a) and the person estimates would not be affected. In RUMM2030, items with 
DIF are grouped into a subtest to see if the DIF cancels out. Table 5.11 shows that the items 
showing uniform DIF have the potential to cancel out, as there are roughly equal numbers of 
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items biased towards males and females. A subtest in RUMM2030 was carried out which 
showed that both DIF by gender and DIF by age cancelled out in the measure as a whole 
(p=0.6 and p=0.8 respectively). Only one item (item 20) showed non-uniform DIF. The 
wording of this item had already been discussed in detail during the content validity panel 
and by the family members during their feedback, and all family members felt that the direct 
wording of the question, using the term “sex life”, as opposed to “intimate relationships” was 
much clearer to them. Therefore, the item was retained in the FROM as the concept was 
very important to family members during the interview stage, especially for partners and 
spouses, and the preferred wording was used. To encourage family members to answer 
personal questions such as this item, it was made clear to participants that privacy and 
confidentiality was maintained during all parts of the study.  
Table 5.10: The stepwise process of item removal during Rasch analysis 
Analysis 
number  
Description # 
items 
in 
scale 
Chi
2
 p 
value 
Item fit 
residual 
mean (S.D.) 
Person fit 
residual 
mean (S.D.) 
5 Remove items 27,24,13,28,3 and 10 25 0 -0.37 (1.37) -0.22 (1.19) 
6 Remove items 
27,24,13,28,3,10,6,7,14,15 and 25 
20 0.0099 -0.27 (1.16) -0.2 (1.10) 
7 Remove items 
27,24,13,28,3,10,6,7,14,15,25 and 
29 
19 0.146 -0.28 (1.18) -0.22 (1.07) 
8 Remove items 
27,24,13,28,3,10,6,7,14,15,25 and 8 
19 0.017 -0.32 (1.2) -0.2 (1.1) 
9 Remove items 
27,24,13,28,3,10,6,7,14,15,25,8 and 
29 
18 0.025 -0.34 (1.15) -0.21 (1.03) 
10 Remove items 
27,24,13,28,3,10,6,14,15,25 and 29 
20 0.006 -0.30 (1.2) -0.2 (1.08) 
11 Remove items 
27,24,13,28,3,10,6,7,14,15,25,8,29 
and 19 
18 0.17 -0.33 (1.14) -0.21 (1.04) 
12  Remove items 
27,24,13,28,3,10,6,7,14,15,25,8,29 
and 21 
18 0.076 -0.31 (1.19) -0.2 (1.05) 
13  Remove items 
27,24,13,28,3,10,6,7,14,15,25,8,29 
and 17 
18 0.036 -0.28 (1.1) -0.2 (1.04) 
14 Remove items 
27,24,13,28,3,10,6,7,14,15,25,8,29, 
19,17 and 21 
16 0.18 -0.36 (1.07) -0.22 (1.01) 
Step 10. Test the scale unidimensionality 
One of the assumptions of Rasch analysis is unidimensionality, and this can be tested using 
RUMM2030. If the scale is unidimensional, the scores for each item can be summed to 
produce a total score. The unidimensionality of the scale and factor identification will be 
tested further using factor analysis, but carrying out this test in RUMM2030 gives an idea as 
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to whether the scale is unidimensional, using an independent t-test comparison of person 
locations estimated using two different subsets of items taken from the scale (Smith 2002).  
In a similar method to local dependency, the residuals (which remain when the Rasch factor 
is removed) are examined. The items are correlated with the first remaining factor (the first 
component). The items which correlate positively are grouped into one subtest, and those 
which correlate negatively are grouped into another (Table 5.12). Separate person estimates 
are then derived for the two subtests, and an independent t-test is carried out on the two 
subtests. For unidimensionality to be accepted, less than 5% of the t-tests should be 
significant at the p=0.05  level (Smith 2000). In the case of the FROM, 25 (9.66%) of the 236 
t-tests were significant, suggesting that the scale is not unidimensional. The deviating results 
from the t-tests were found to be significant when 95% confidence intervals from a binomial 
distribution were applied and the lower bound confidence interval did not overlap the 5% 
value (confidence intervals: 8% to 13%), which confirms that the unidimensionality of the 
FROM is not acceptable (Tennant and Pallant 2006b). This will be investigated further during 
factor analysis. 
Step 11. Report the targeting of the scale 
Figure 5.9 shows the targeting of the FROM. The top section of the graph represents the 
family members and their ability levels (how much their QoL has been affected) and the 
bottom part represents the item locations and distribution. The outliers can be seen at either 
end of the scale. The mean location score for items is set at 0, meaning that the targeting of 
family members can be assessed using the mean person location value, which in the case of 
the FROM was -0.622. For a well-located measure, the mean person location value should 
be around zero, and the small negative value seen in the case of the FROM suggests that 
the sample as a whole was located at a lower level than the items (Tennant and Conaghan 
2007). However, the deviation from 0 was not large and the sample consisted of patients with 
a diverse range of illnesses ranging by disease type, duration and severity, so was not 
directed towards those patients who are extremely unwell, or who have particularly affected 
relatives. There was no statistical difference (evaluated using one way analysis of variance in 
RUMM2030) between the location, or ability, of family members of different genders (p=0.97) 
and age groups (p=0.22). 
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Table 5.11: Uniform and non-uniform DIF identified in the items of the 16-item final 
FROM 
Item Uniform DIF by 
family member 
age 
Non-uniform DIF 
by family member 
age 
Uniform DIF by 
family member 
gender 
Non-uniform DIF 
by family member 
gender 
1 No No No No 
2 No No No No 
4 No No Yes (p=0.008) 
Female higher 
No 
5 No No No No 
8 No No No No 
9 No No No No 
11 No No No No 
12 No No Yes (p=0.043) 
Male higher 
No 
16 No No Yes(p=0.018) 
Female higher 
No 
18 No No No No 
20 No No Yes (p=0.011) 
Male higher 
Yes (p=0.003) 
22 No No Yes (p=0.002) 
Male higher 
No 
23 Yes (p=0.0008) 
Older higher 
No Yes (p=0.03) 
Male higher 
No 
26 No No Yes (p=0.005) 
Female higher 
No 
30 Yes (p=0.01) 
Younger higher 
No No No 
31 No No No No 
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Table 5.12: Loading of items onto the first component extracted during principal 
component analysis of the FROM 
Item Loading onto first principal component 
4 0.736 
5 0.558 
2 0.540 
1 0.473 
8 0.146 
31 0.021 
9 0.011 
26 -0.073 
12 -0.118 
20 -0.179 
11 -0.225 
22 -0.394 
23 -0.323 
30 -0.347 
16 -0.475 
18 -0.543 
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Figure 5.9: The person-item location distribution of the FROM 
Step 12. Report the person separation index  
The person separation index (PSI) is reported as a measure of reliability of the scale 
equivalent to Cronbach’s alpha (Cronbach 1951). The PSI indicates whether the measure 
can discriminate between different groups of respondents. The minimum acceptable level of 
the PSI is 0.7, meaning that the measure can significantly distinguish between 2 different 
groups of respondents. The PSI of the FROM was calculated at  0.88 (rounded to 0.9), 
meaning that the measure can significantly distinguish between 4 different groups of 
respondents (Fisher 1992). A high PSI is also an indicator that the fit statistics can be relied 
upon, as there is less error surrounding them (Tennant 2011). 
Step 13. Re-check summary statistics and fit to the model 
The summary statistics for the final version of the 16-item FROM demonstrated that it has a 
good fit to the Rasch model (Figure 5.10). The fit residual mean value for items was -0.36 
with a standard deviation of 1.07. The chi squared interaction value is 56.6 (degrees of 
freedom= 48) and p= 0.18. The residual mean value for persons was -0.22 with a standard 
deviation of 1.01.  
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Figure 5.10: The summary statistics for final 16-item version of the FROM 
 
FACTOR ANALYSIS 
The Rasch analysis of the FROM suggested that the measure is made up more than one 
dimension, or factor.  Therefore factor analysis, a component of classical test theory was 
used to identify these factors and assign items to each. Factor analysis can also be used to 
reduce items (Floyd and Widaman 1995) in a scale. The statistical methods of factor analysis 
are used to identify relationships between groups of items with similar themes. In the case of 
the FROM, Rasch analysis was used as the primary method of item reduction as it has many 
advantages over factor analysis (Streiner and Norman 2008). The suitability of the remaining 
16 items of the FROM were also assessed using factor analysis to strengthen the argument 
for the reduction of 31 items to 16. Factor analysis was used to help finalise the scoring of 
the final version of the FROM, and to decide whether the items in the FROM are uni or multi 
dimensional. 
There are two types of factor analysis; exploratory factor analysis (EFA) and confirmatory 
factor analysis (CFA). EFA is used when little is known about the correlation between a set of 
items, often when developing new measures as a way to identify the factor structure of the 
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new measure, or to reduce items (Fayers and Hand 1997). On the other hand, CFA is used 
to test a hypothesis or theory, usually when the factor structure of a measure is known 
(Pallant 2005). In addition, CFA has been recognised as having little potential value in quality 
of life research (Fayers and Hand 1997). Therefore, EFA was selected as the method for 
factor analysis of the FROM. 
Reliability of the FROM 
The reliability of the 16-item FROM was measured before the factor analysis was carried out. 
This can help identify items which are considered weak, and should be removed from the 
scale. If all of the items perform strongly, it can be taken as a sign that the Rasch analysis 
produced a reliable and strong version of the FROM. The internal consistency, measured 
using Cronbach’s alpha (Cronbach 1951) was 0.91, indicating good reliability of the scale 
(Pallant 2005).  Weak items which should be removed from a scale are those with a low 
item-total correlation. The definition of a low correlation varies between 0.2 (Kline 1986) and 
0.4 (Juniper et al. 1997), and all of the 16 FROM items were shown to have an item-total 
correlation of above 0.4 (range 0.4-0.7), which indicates that they are all strong discriminative 
items and should be retained. As a secondary measure, each item was then deleted from the 
scale in turn, and the Cronbach’s alpha remained high (0.90-0.91) each time. The further 
removal of items did not improve the reliability of the FROM, and in most cases the reliability 
was reduced. This gives further confidence that the FROM contains a strong and appropriate 
set of items.  
Tests for sample adequacy 
Gorsuch (1983) suggested guidelines for the sample size of subjects for factor analysis, and 
these were consulted in relation to the FROM. A minimum of five to ten cases for each item 
should be used as a sample size for factor analysis, and for the FROM, 240 subjects were 
used for a 16-item measure. Bartlett’s test of sphericity (Bartlett 1954) was applied to prove 
that the variables in the correlation matrix are correlated. It should be significant at p<0.05 to 
reject the hypothesis that the variables are uncorrelated (Pallant 2005). For the FROM, 
Bartlett’s test of sphericity was significant (p<0.001). A second test of sample adequacy was 
also applied, the Kaiser-Meyer-Olkin (KMO) (Kaiser 1974), where a value of >0.6 should be 
observed for the sample to be considered adequate for factor analysis (Kaiser 1974). The 
FROM showed a KMO of 0.91, which is considered “marvellous” (KMO >0.9) by Kasier 
(1974). 
Exploratory factor analysis 
Exploratory factor analysis was carried out using PASW statistical software. Factors were 
identified using a combination of several methods. Those factors with Eigenvalues ≥1 were 
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retained for further analysis, following Kaiser’s criterion rule (Pallant 2005). The principle 
component analysis for the 16-item FROM (Table 5.13) revealed three factors with 
Eigenvalues ≥1, which together explained 61% of the variance, higher than the minimum 
recommended 50% value for a stable factor solution (Streiner 1994). One of these factors 
was very close to the Kaiser’s criterion cut off point with an Eigenvalue of 1.008.  
Cattell’s scree plot (Cattell 1966) was drawn for the FROM (Figure 5.11). The scree plot 
shows a sharp drop after the first and second factors, and then the line becomes flat, 
suggesting the first two factors account for most of the variance. It is recommended that any 
factors above the “elbow” of the graph (factors 1 and 2 in the case of the FROM) are retained 
or considered for further analysis (Cattell 1966). This supports the results of the principal 
component analysis, as the third factor was on a borderline value for retention. Therefore, 
two factors of the FROM are taken forward for factor rotation. 
Table 5.13: The principal component analysis for the 16-item FROM 
Component 
Initial Eigenvalues 
Extraction Sums of 
Squared Loadings 
Total 
% of 
Variance 
Cumulative 
% Total 
% of 
Variance 
Cumulative 
% 
  
1 7.881 46.361 46.361 7.881 46.361 46.361 
2 1.486 8.741 55.102 1.486 8.741 55.102 
3 1.008 5.928 61.030 
   
4 .889 5.228 66.258 
   
5 .747 4.397 70.655 
   
6 .692 4.068 74.723 
   
7 .631 3.714 78.437 
   
8 .562 3.304 81.741 
   
9 .496 2.916 84.656 
   
10 .492 2.894 87.550 
   
11 .409 2.408 89.958 
   
12 .378 2.223 92.181 
   
13 .327 1.925 94.106 
   
14 .308 1.811 95.916 
   
15 .284 1.671 97.587 
   
16 .232 1.364 98.951 
   
17 .178 1.049 100.000 
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Factor rotation 
Factor rotation was carried out to identify the patterns of item loading onto each of the two 
factors. Varimax rotation was chosen, which is often regarded as the most conceptually clear 
and the most commonly used orthogonal rotation method and does not require the factors to 
be correlated to one another (Fabrigar et al. 1999).  After the Varimax rotation technique was 
applied, the structure matrix (Table 5.14) showed the loading of items onto two clear factors.  
All items loaded above the minimum threshold value of 0.4 (Finch 2006). Items were 
assigned the factor to which they had the highest loading. It was decided that as the loading 
values on both factors for item 9 were very similar (0.40 and 0.36), this item would be placed 
on the factor which best fits with the concept of the item.  
 
 
 
Figure 5.11: Scree plot to show the variance in the components of the FROM 
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Table 5.14: The structure matrix of the FROM showing the loading of each item onto 
the two factors extracted* 
 
 
Component 
1 2 
Q1  .676 
Q2 .316 .706 
Q4  .849 
Q5  .770 
Q8 .364 .534 
Q9 .406 .364 
Q11 .631 .307 
Q12 .641 .417 
Q16 .715 .446 
Q18 .763  
Q20 .686  
Q22 .594 .383 
Q23 .728  
Q26 .641 .357 
Q30 .745  
Q31 .534 .410 
*Extraction Method: Principal Component Analysis.  Rotation Method: Varimax with Kaiser 
Normalization. 
Final version of the FROM 
The final version of the FROM was developed as a result of the family member feedback, 
Rasch and factor analysis, the final version of the FROM (Figure 5.12) was developed. Each 
of the changes made to develop the final version is outlined below. 
Layout and design of the FROM 
The developmental version of the FROM was three A4 pages long. Now that the number of 
items and response categories have been reduced, the FROM was redesigned to fit onto 
one side of one sheet of A4 paper. This is more practical for use in a clinical situation, as it 
reduces responder burden and reduces the chance of pages getting mislaid during 
photocopying or printing. The font size of the instructions and items was reduced by one font 
size, but this made very little visual difference to the measure. The grey lines separating 
items were narrowed in order for the items to fit onto one page. Feedback from family 
members also showed that they found having to turn the page over to answer more 
questions confusing and unclear, so reducing the FROM to one page helped eliminate this 
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problem. The use of large individual tick boxes for each response category was maintained 
as it was felt to be clear and had not caused confusion when completed by the family 
members. 
Statements and instructions 
The statements and instructions on the FROM were condensed and made clearer for the 
final version. The investigators felt that there was no need to have the instructions repeated 
twice on the questionnaire, and so they were included just once, at the top of the page. The 
bold type face was retained, to emphasise the recall period chosen, and the fact that the 
FROM is relating to the family member’s life and not the patient’s. Rather than keeping the 
extra statement during the introduction, “please remember, this questionnaire is about your 
life, not your family member’s life”, the phrase “Because of my family member’s condition...” 
was added before each set of items, to draw the subject’s attention back to the fact that the 
FROM is about their life, as several family members reported being confused about this. The 
demographic questions were retained; age, gender, relationship to patient and patient’s 
diagnosis, although several family members found it difficult to complete the patient’s 
diagnosis section. This is a question which could potentially be completed by the investigator 
or clinician. The final instruction, “Please check you have answered every question. Thank 
you” was retained as it clearly worded and may help to prevent missing data. 
Utility questions 
As discussed earlier in this chapter, the three utility questions from the developmental 
version of the FROM were deleted as they caused too much responder burden and were not 
comparable to the other 16 items. 
Items 
As a result of Rasch analysis, 16 items were retained for the final version of the FROM. 15 of 
the 16 items had not caused any problems to family members when completing the 
developmental version, so the wording remained the same. However, the wording of item 9 
was given negative feedback by family members, particularly the use of the word “burden”. 
Family members were reluctant to answer this item as, although they regarded caring for 
their family member as being “difficult” at times, they did not feel it was a “burden”. This was 
reflected in the low endorsement statistics for this item. It was felt that item 9 measures an 
important concept, and one that was very prevalent during the interview stage, so the item 
was retained but the wording was changed. When family members gave feedback about this 
item, and during the interview transcripts, they often used the word “difficult”, so this was 
included in the item and “burden” was removed. The item was re-worded to read “Caring for 
my family member is difficult”.  
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Domains 
Factor analysis of the 16-item FROM revealed two factors. All of the 16 items loaded clearly 
and strongly onto one factor, apart from item 9 which loaded strongly onto both. The items 
loaded onto the two factors in a logical way according to their theme or construct; all of the 
similar items loaded onto one factor. The first factor, which was labelled “Emotional” loaded 
five items: Worried, angry, sad, frustrated, and difficult to talk to someone. The second factor, 
“Personal and Social Life” loaded 10 items: Hard to find time for self, travel, eating habits, 
family activities, holidays, sex life, work or study, relationships with other family members, 
family expenses and sleep. The emotional or psychological based items loaded clearly onto 
one factor, whilst the more social and daily aspects loaded onto the other. The naming of 
these factors is discussed further in the General Discussion chapter. Item 9 loaded strongly 
onto both factors and it was decided that it should be placed on the factor where it best fits 
the concept. Looking back to the interviews where the theme first emerged, family members 
described not just the physical impact of caring for the patient, but put a greater emphasis on 
the emotional effect this had on them and their relationship with the patient.  Many family 
members associated emotions such as sadness and frustration with the caring aspects. This 
is reflected in the new wording of the item “Caring for my family member is difficult”, as it 
encompasses both the physical side (the caring) and the emotional side (the difficulty).  The 
investigators felt that this item fitted better in the “Emotional” factor, which brought the item 
total for this factor to six items. 
Scoring 
The scoring for the final version of the FROM was amended, as the response categories 
were collapsed from five to three. The new categories were renamed as “not at all” (scoring 
0), “A little” (scoring 1) and “a lot” (scoring 2). The naming of the new categories was felt to 
be balanced, and the names of the categories were easily distinguishable from one another, 
for example a clear difference can be seen between “A little” and “A lot”. The new scoring 
system gives the final version of the FROM a total score of 32, and total domain scores of 12 
(six items in domain 1) and 20 (10 items in domain 2) respectively. An updated scoring box 
was added to the bottom of the FROM with space for the scores for each domain and the 
total score.  
The 31-item developmental version of the FROM was successfully reduced to a 16-item final 
version (FROM-16), which fits well to the Rasch model and displays two clear factors (Figure 
5.12). The final version of the FROM then underwent further validation, which will be 
described in Chapter 6. 
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Figure 5.12: The final 16-item version of the FROM (FROM-16) 
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DISCUSSION 
Item reduction of the 16-item FROM was carried out using a combination of traditional and 
modern approaches. The use of item response theory (Rasch analysis) indicated which 
items did not fit the statistical model desired for a Likert-scale instrument. Rather than relying 
solely on the statistical approach and removing “mis-fitting” items, the content validity data 
was referred back to in order to identify whether the poorly performing items were the same 
according to both statistics and family member feedback. These two forms of information 
were combined when deciding upon changes to be made to the developmental version of the 
FROM. Combining the two types of information helped to ensure that the resulting FROM 
measure was both statistically valid for use in the intended population and reflected the views 
and opinions of family members, as determined by the qualitative interview content and the 
content validity feedback. The types of changes made to the developmental FROM included 
collapsing response categories, re-wording items and removing items. The “problem” items 
identified by the Rasch analysis were also those which had been rated poorly by family 
members and experts during the content validity panels, and there were very few situations 
where conflicts arose between the Rasch analysis and family member feedback. To ensure 
that the final version of the FROM contained the most representative and statistically-sound 
combination of items, each problem item was removed in a stepwise process and the 
summary statistics of the measure were referred back to each time. At each stage, the 
investigator was aware of the influence of her judgment and opinion of each item, and a 
conservative approach was taken when deciding to remove items. At all stages, the results of 
the Rasch analysis was discussed with the study team, who provided their opinions on the 
decisions taken.  
Factor analysis was used to confirm the results of the Rasch analysis and to identify the two 
factors in the FROM. All items strongly loaded onto one factor (item 9 loaded strongly onto 
both), supporting the fact that the most relevant items had been retained during Rasch 
analysis. Furthermore, items were grouped into two factors which reflected the themes 
identified during the earlier qualitative phase. The careful combination of Rasch and factor 
analysis, along with the information from the content validity panels and qualitative interviews 
helped to ensure that the final version of the FROM contains the items which are most 
relevant to family members, and that they are able to express their own experiences and 
opinions accurately and fully using the FROM-16. 
SUMMARY 
 The developmental version of the FROM was given to 140 family members to 
complete. 
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 The family members provided informal comments as to the content of the 
developmental FROM which assisted in the item reduction process. 
 
 The three utility questions were dropped from the FROM due to poor feedback and 
low response rate. 
 
 Rasch analysis was performed using a 13-step process. 
 
 The Partial Credit Rasch model was selected. 
 
 The overall summary statistics for the developmental version of the FROM showed a 
poor fit to the Rasch model (fit residual mean for items (S.D)= -0.22 (1.97), persons 
(S.D)= -0.19(1.34), χ2 p=0). 
 
 The categories were collapsed for the questionnaire as a whole, giving a uniform 
scoring system and making the FROM score much easier for investigators and 
clinicians to calculate. 
 
 Six items were found to be mis-fitting with fit residuals greater than +/- 2.5, and these 
were removed one at a time. 
 
 Two items showed a low level of endorsement: items 9 (I feel the burden of caring for 
my family member) and 29 (My work or study is affected) and both were considered 
for removal. 
 
 Items were removed or combined in a stepwise process, with the overall fit statistics 
consulted at each stage. 
 
 16 items were retained and tested for differential item functioning (DIF) by age and 
gender. Eight of the 16 items showed uniform DIF by either gender or age, or both. 
Both DIF by gender and age cancelled out at test level (p=0.6 and p=0.8 
respectively). 
 
 Only item 20 (My sex life is affected) showed non-uniform DIF, but it was retained as 
it was identified as a very important and frequently occurring theme by family 
members during the interview stage. 
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 The summary statistics for the final version of the 16-item FROM indicate that it has a 
good fit to the Rasch model. The mean (S.D) fit residual values were -0.36 (1.07) for 
items and -0.22 (1.01) for persons (Total χ2 = 56.6, df = 48, p = 0.18). 
 
 Factor analysis was performed on the 16-item measure. 
 
 The principle component analysis for the 16-item FROM revealed three factors with 
Eigenvalues ≥1, which together explained 61% of the variance. 
 
 All items loaded above the minimum threshold value of 0.4. Items were assigned the 
factor to which they had the highest loading. 
 
 The items loaded onto the two factors in a logical way according to their theme or 
construct. 
 
 The first factor, “Emotional”, loaded five items: worried, angry, sad, frustrated, and 
difficult to talk to someone. The second factor, “Personal and Social Life” loaded 10 
items: hard to find time for self, travel, eating habits, family activities, holidays, sex 
life, work or study, relationships with other family members, family expenses and 
sleep. Item 9 loaded highly onto both factors but its concept matched better to the 
“Emotional” factor, which bought the factor total to six items. 
 
 The final version, the FROM-16 was then finalised and deemed ready for further 
validation. 
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CHAPTER 6 
 
Evaluation of the psychometric 
properties of the 16-item Family 
Reported Outcome Measure 
(FROM-16) 
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INTRODUCTION 
The previous chapters have proven that the FROM-16 shows high content validity. Before 
the measure can be used to collect data, it is important to ensure that it is measuring the 
concepts it is intended to measure and that it is accurate and reliable. As outlined in chapter 
2, the FROM-16 should score highly in terms of reliability, validity and sensitivity to change, 
and this chapter outlines the tests which the FROM-16 was put through in order to 
demonstrate this. The chapter also looks at the scoring distribution of the FROM-16 and 
whether the scores vary by factors such as age or gender. 
For the duration of this chapter, the term FROM refers to the 16-item final version of the 
instrument, FROM-16. 
METHODS 
Study population 
The study population for the validation of the FROM was made up of family members of 
patients across 25 medical and surgical specialties at the University Hospital of Wales, 
University Hospital Llandough, Velindre Hospital and General Practice in Cardiff. The earlier 
stages of the study were carried out with patients from 26 specialties, but recruitment 
problems in the mental health specialty meant that it had to be dropped from this stage of the 
study. During recruitment for this stage of the study, the investigator aimed to recruit equal 
numbers from each of the 25 specialties, and it was decided that a minimum of five family 
members from each specialty would be approached for recruitment.  
Recruitment of family members 
During this stage of the study, family members and patients were recruited from outpatient 
clinics and wards.  Patients were first approached by the consultant, and then the 
investigator to gain verbal consent to discussing the study. Patients and their family 
members were then taken to a private room and given the study information leaflet 
(Appendix O-R) to read. They were given the opportunity to ask any questions, and were 
then both asked to sign the consent form.  At this stage, family members were also asked to 
consent to email or postal follow up, although they were still eligible to take part in the study if 
they declined. Demographic details were then collected from the patients and their family 
members. The patients were then asked to leave the room so that they did not influence their 
family member’s responses to the questionnaires. The family member was asked to 
complete the FROM, which was timed. They were then asked to rate the patient’s health on 
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a scale of 0-10 (global health score) and complete written feedback about the FROM. They 
were also asked to complete the WHOQOL-BREF questionnaire. 
After 1-2 weeks, all 120 family members were contacted via post or email and asked to 
complete the FROM and the global health score again. They were provided with a freepost 
envelope, and a second follow up was sent a week later if no reply was given.  
After 2 months, 25 of the family members were contacted again via post or email and asked 
to complete the FROM and the global health score again. They were provided with a freepost 
envelope, and a second follow up was sent a week later if no reply was given.  
FROM scoring 
The final version of the FROM comprises of 16 items with three response options for each, 
ranging from Not At All (scoring 0), A little (scoring 1) and A Lot (scoring 2).  The lowest 
possible score of the FROM is 0 and the highest is 32. The higher the total score, the greater 
the effect on the family member’s quality of life. The items in the FROM are divided into two 
parts (domains): Emotional (comprising of 6 questions, maximum score of 12) and Personal 
and Social Life (comprising of 10 questions, maximum score of 20). For the purposes of 
validation, the FROM score for each family member was reported as both two separate 
domains, and as one complete score.  
RESULTS 
Demographic characteristics of the study participants 
131 family members were approached to take part in the study and nine declined to 
participate of whom seven did not have the time, and two for personal reasons. In addition, 
one family member decided to withdraw from the study before the questionnaires were 
complete, due to personal reasons and another subject was excluded due to incomplete 
answers on the questionnaires. The final validation was carried out using data from 120 
family members of patients, from 25 specialties (Table 6.1).  All 120 family members were 
asked to complete the FROM, the WHOQOL-BREF (a generic quality of life measure) and 
rate the patient’s health from 0-10 (0 meaning the poorest health possible and 10 meaning 
the best health possible). Most participants were female (n=79, 66%) Caucasian (n=125, 
94%), the spouse or partner of the patient (n=69, 52%), the parent (n=32, 24%) or the child 
(n=25, 19%) of the patient (Table 6.2). The remaining 5% were made up of a variety of other 
relatives. The mean age of family members was 54 years (range 17-85) and the mean age of 
patients was 52 years (range 1-90). The mean patient disease duration was 83 months (6 
years and 11 months) ranging from one month to 40 years. 
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Table 6.1: The 25 specialties included in the validation stage of the study. 
Cardiology Infectious Diseases 
Care of the Elderly Neurology 
Chronic Pain Oncology 
Colorectal Surgery Ophthalmology 
Dental Surgery Orthopaedics & Paediatric Orthopaedics 
Dermatology & Paediatric Dermatology Paediatric Endocrinology 
Ear, Nose and Throat Post-stroke 
Endocrinology Renal & Renal transplant 
Gastroenterology Respiratory 
General Practice Rheumatology 
Genetics Urology 
Gynaecology Wound Healing 
Haematology  
 
The FROM affirmation responses 
Scores of 1 (“a little”) and 2 (“a lot”) were considered as affirmation responses for each item 
(Table 6.3). This indicated that the family member found this item to be relevant and 
applicable to them, rather than selecting “not at all”. The most highly affirmed items were “I 
feel worried” and “I feel sad” and the lowest were “my eating habits are affected” and “my 
work or study is affected”. 
The FROM score 
Total scores for the FROM (0-32) ranged from 1 to 32, median = 11.50, mean = 12.28 and 
SD = 7.47. There was no floor effect (scoring 0), and only one subject scored 32 showing a 
minimal ceiling effect. The mean total domain scores were 5.6 (Emotional) and 6.7 (Personal 
and Social Life). Table 6.4 and Figures 6.1 and 6.2 show the distribution of FROM total 
scores. 
The majority of items (items 1,3,5,7,8,9,10,14,15 and 16) contained no missing data across 
the 120 family members who completed the measure. The remaining items contained only 
one or two cases of missing data, except for item 13 (work or study) where four family 
members had missing data. This still only represents 3% of missing data for this item, but 
suggests that the item may not be as acceptable to respondents as the other items. Looking 
at the content of the items and referring back to the qualitative work, this missing data may 
have arisen by family members not knowing how to answer the item if they are not currently 
working or study (for example if they are retired). This can be tested in future work when the 
FROM is further validated in individual disease areas, through cognitive debriefing interviews 
which assess the respondents understanding of the item wording and concepts. The low 
amount of missing data in the FROM overall, suggests that the measure is both acceptable 
to family members and that the scale used is feasible. 
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Table 6.2:  Demographics of the family members during the validation stage 
Total number of family members 
       Male 
       Female 
Family members age (years) 
       Mean 
       Median 
       Range 
120 
41 
79 
 
54 
53 
17-85 
Relationship to patient 
       Spouse/partner 
       Parent 
       Child 
       Othera 
 
52% 
24% 
19% 
5% 
Family member level of education 
       Less than secondary school/GCSEs/O Levels                   
       Completed secondary school/GCSEs/O Levels 
       A Levels/college course 
       University degree 
       Masters degree 
       Doctoral degree 
       Prefer not to say 
       Missing 
 
4% 
40% 
25% 
13% 
8% 
2% 
2% 
6% 
Family member household income per year 
       Less than £10,000 
       £10,000 - £20,000 
       £21,000 - £30,000 
       £31,000 - £40,000 
       £41,000 - £50,000 
       £51,000 - £60,000 
       £61,000 - £70,000 
       £71,000 - £80,000 
       Greater than £81,000 
       Prefer not to say 
       Missing 
 
11% 
26% 
15% 
13% 
7% 
3% 
4% 
1% 
4% 
10% 
6% 
Ethnic origin 
       Caucasian 
       Asian/Asian British 
       Afro-Caribbean 
 
94% 
3% 
2% 
Total number of patients 
       Male 
       Female 
120 
55 
65 
Patients’ age (years) 
       Mean 
       Median 
       Range 
Disease duration (months) 
       Mean 
       Median 
       Range 
 
52 
57 
1-90 
 
83 
48 
1-480 
a Other includes nephew, grandparent, sibling and grandchild.  
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Table 6.3: The affirmation percentage for each FROM item (n=120) 
FROM Items Number of family members affirming 
to item (%) 
Part 1 Worried 
      Angry 
      Sad 
      Frustrated 
      Talking about thoughts 
      Difficulty caring 
Part 2 Time for self 
     Travel 
     Eating habits 
     Family activities 
     Holiday 
     Sex life 
     Work or study 
     Family relationships 
     Family expenses 
     Sleep 
115 (95.1) 
48 (39.6) 
97 (80.2) 
95 (78.5) 
55 (45.5) 
72 (59.6) 
62 (51.3) 
52 (42.9) 
41 (33.9) 
87 (71.9) 
63 (52.1) 
51 (42.1) 
47 (38.8) 
55 (45.5) 
70 (57.9) 
77 (63.6) 
 
Table 6.4: Frequency of the total FROM scores (n=120) 
Score Frequency Percent 
Cumulative 
Percent 
0 0 0 0 
1 2 1.7 1.7 
2 8 6.7 8.3 
3 5 4.2 12.5 
4 2 1.7 14.2 
5 7 5.8 20.0 
6 3 2.5 22.5 
7 12 10.0 32.5 
8 4 3.3 35.8 
9 5 4.2 40.0 
10 10 8.3 48.3 
11 2 1.7 50.0 
12 9 7.5 57.5 
13 5 4.2 61.7 
14 5 4.2 65.8 
15 7 5.8 71.7 
16 3 2.5 74.2 
17 3 2.5 76.7 
18 3 2.5 79.2 
19 3 2.5 81.7 
20 3 2.5 84.2 
21 2 1.7 85.8 
22 1 .8 86.7 
23 4 3.3 90.0 
24 4 3.3 93.3 
26 4 3.3 96.7 
29 1 .8 97.5 
31 2 1.7 99.2 
32 1 .8 100.0 
Total 120 100.0  
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Figure 6.1: Histogram to illustrate total FROM score and frequency 
 
 
The scoring for each individual item was also looked at. The most highly scoring items based 
on their mean score (with a possible range of 0-2) were feeling worried (1.42), feeling sad 
(1.13), feeling frustrated (1.17), family activities being affected (0.93) and effect on sleep 
(0.90).  The mean scores for each of the 16 items are shown in Figure 6.3. 
Comparisons of the FROM scores for sociodemographic characteristics of family 
members and patients 
Family member gender  
Although the FROM mean total score varied slightly between males (11.83) and females 
(12.52), there was no significant difference between their scores (p=0.63). For individual 
items, there was no significant difference in the mean scores for males and females (p= 0.24- 
0.95), except for one item, “effect on sleep” (Table 6.5 and Figure 6.4). For this item, the 
mean individual item score for females was significantly higher than that of males (M= 0.63, 
F= 1.04, p<0.05). For the two domains (Part 1 and Part 2) of the FROM, there was no 
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significant difference in the scores for males and females in each domain (Part 1 p= 0.95, 
Part 2 p= 0.37) (Table 6.5).  
Figure 6.2: A box and whisker plot to illustrate distribution of the FROM total score 
(n=120) 
 
Patient gender 
Both the total FROM scores and the individual items scores were also compared for the 
gender of the related patients. The FROM mean total score of family members of male 
patients (12.73) was slightly higher than that of female patients (11.91), but this difference 
was not significant (p= 0.55) (Table 6.6). There was no significant difference in individual 
item scores for family members of male and female patients (p= 0.083-0.979) (Table 6.6). 
For the two domains (Part 1 and Part 2) of the FROM, there was no significant difference in 
the scores for family members of male and female patients in each domain (Part 1 p= 0.84, 
Part 2 p= 0.42) (Table 6.6).  
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Figure 6.3: The mean scores for individual items of the FROM (n=120) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Family member age  
The FROM mean score for family members’ age was calculated by dividing the family 
members up into six age groups. Group 1=16-30 years, group 2=31-40 years, group 3=41-50 
years, group 4=51-60 years, group 5=61-70 years, group 6≥ 71 years. The FROM mean total 
scores across the six groups were calculated (Table 6.7) and, as there were six groups, a 
one-way analysis of variance (ANOVA) was carried out to compare the mean scores. This 
was followed by a post-hoc test to identify which age groups, if any, differed most by their 
mean.  
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Table 6.5: Comparison of family members’ mean total and individual item scores for 
their own gender. 
FROM item Family 
member 
gender 
N (family 
members) 
Mean SD p value 
Worried Male 41 1.37 0.58 0.49 
Female 79 1.44 0.57 
Angry Male 41 0.56 0.71 0.61 
Female 77 0.49 0.68 
Sad Male 41 1.15 0.65 0.81 
Female 79 1.11 0.73 
Frustrated Male 41 1.07 0.72 0.95 
Female 77 1.06 0.66 
Talking about thoughts Male 41 0.59 0.71 0.57 
Female 79 0.67 0.81 
Difficulty caring Male 41 0.93 0.76 0.29 
Female 78 0.77 0.77 
Time for self Male 41 0.59 0.71 0.35 
Female 79 0.72 0.77 
Travel Male 41 0.61 0.80 0.64 
Female 79 0.54 0.69 
Eating habits Male 41 0.37 0.66 0.38 
Female 79 0.48 0.68 
Family activities  Male 41 0.90 0.66 0.27 
Female 79 0.95 0.71 
Holiday Male 40 0.85 0.83 0.58 
Female 79 0.76 0.85 
Sex life Male 40 0.68 0.86 0.67 
Female 79 0.61 0.78 
Work or study Male 40 0.43 0.59 0.34 
Female 76 0.58 0.77 
Family relationships  Male 41 0.51 0.64 0.54 
Female 79 0.59 0.73 
Family expenses Male 41 0.66 0.66 0.33 
Female 79 0.80 0.77 
Sleep Male 41 0.63 0.66 0.008 
Female 79 1.04 0.82 
FROM Score Male 41     11.83 6.96 0.63 
Female 79 12.52 7.76 
FROM Part 1 Score Male 41 5.66 2.99 0.84 
Female 79 5.54 3.01 
FROM Part 2 Score Male 41 6.17 4.85 0.42 
Female 79 6.97 5.37 
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Figure 6.4: Mean FROM score for individual items for male and female participants 
 
 
Figure 6.5 shows that the age group who experienced greatest impact on their life was 
Group 4 (51-60 years) with a mean FROM score of 14.93, and the group who experienced 
least impact was Group 2 (31-40 years) with a mean FROM score of 9.6. Results of the 
ANOVA test showed that there was no significant difference in the mean FROM total score 
across the six age groups (p=0.33) (Table 6.7).  
An ANOVA test was also carried out on the scores (0-2) for the individual items of the 
FROM, to investigate whether there was a significant difference in mean score for the 
individual items across the six age groups. There was a significant difference between family 
member age groups for three of the FROM items: Holidays (p=0.045), Sex life (p=0.045) and 
Work and Study (p=0.022). The Levene Test for Homogeneity of Variances was carried out 
to test the equality of the variances, as the ANOVA test assumes equal variance. The item 
“Holidays” (p=0.327) was found to have a non-significant Levene F statistic value, meaning 
that equality of variance can be assumed, and the ANOVA test value can be taken as 
correct.  The items “Sex Life” (p=0.005) and “Work and Study” (p<0.001) were found to have 
a significant Levene F statistic significance value (p<0.05), and the difference in mean item 
score between age groups was calculated using Welch’s t-test (assuming unequal variance). 
The Welch test showed that the item “Work and Study” showed significant differences in item 
score between the six age groups (p= 0.031), but the difference in score for age groups for 
the item “Sex Life” was not significant (p=0.053). The only other item to show evidence of 
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unequal variance (Levene F statistic value of p=0.018), was the item “Worried”, which went 
on to show no significant difference in the mean score across the six age groups as a result 
of the Welch test (p=0.178). 
Table 6.6: Family members’ mean total and individual item scores for patients’ gender. 
FROM item Patient 
gender 
N 
(patients) 
Mean SD p value 
Worried Male 55 1.42 0.60 0.98 
Female 65 1.42 0.56 
Angry Male 53 0.45 0.67 0.36 
Female 65 0.57 0.71 
Sad Male 55 1.04 0.69 0.21 
Female 65 1.20 0.71 
Frustrated Male 53 1.08 0.68 0.91 
Female 65 1.06 0.68 
Talking about 
thoughts 
Male 55 0.67 0.80 0.69 
Female 65 0.62 0.76 
Difficulty 
caring 
Male 54 0.83 0.75 0.90 
Female 65 0.82 0.79 
Time for self Male 55 0.80 0.78 0.10 
Female 65 0.57 0.71 
Travel Male 55 0.58 0.71 0.84 
Female 65 0.55 0.75 
Eating habits Male 55 0.49 0.69 0.46 
Female 65 0.40 0.66 
Family 
activities 
Male 55 1.02 0.68 0.22 
Female 65 0.86 0.70 
Holiday Male 55 0.75 0.82 0.60 
Female 64 0.83 0.87 
Sex life Male 54 0.72 0.81 0.26 
Female 65 0.55 0.79 
Work or 
study 
Male 53 0.62 0.77 0.18 
Female 63 0.44 0.67 
Family 
relationships 
Male 55 0.53 0.72 0.57 
Female 65 0.60 0.68 
Family 
expenses 
Male 55 0.78 0.76 0.67 
Female 65 0.72 0.72 
Sleep Male 55 1.04 0.82 0.08 
Female 65 0.78 .76 
FROM Score Male 55 12.73 7.61 0.55 
Female 65 11.91 7.39 
FROM Part 1 
Score 
Male 55 5.56 3.07 0.95 
Female 65 5.60 2.94 
FROM Part 2 
Score 
Male 55 7.16 5.35 0.37 
Female 65 6.31 5.06 
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Table 6.7: The FROM mean total scores for each category of family member’s age  
Family 
member 
age 
group 
Number 
of family 
members 
Mean 
FROM 
total 
score 
Std. 
Deviation 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
16-30 12 11.7 9.4 5.7 17.7 1 29 
31-40 10 9.6 4.4 6.5 12.7 2 15 
41-50 29 12.1 6.5 9.6 14.6 3 26 
51-60 29 14.9 8.4 11.7 18.1 2 31 
61-70 24 11.0 7.6 7.8 14.2 1 32 
Over 71 16 11.9 6.8 8.2 15.5 2 26 
Total 120 12.3 7.5 10.9 13.6 1 32 
 
Figure 6.5: The FROM mean scores for each age category of family members  
 
Therefore, the items “Holiday” and “Work and Study” which were identified to have significant 
differences in their mean scores by age underwent a Tukey post-hoc analysis. For the item 
“Holiday”, the main difference was between age groups 2 and 4, and for “Work and Study”, 
the main difference was between age groups 4 and 5. This latter observation may be 
explained by the fact that the majority of the subjects in group 6 (over the age of 71) were 
retired, and therefore the patient’s illness would have less of an effect on their work life.  
The mean score of the two domains of the FROM (“Emotional” and “Personal and Social 
Life”) were also analysed according to family member age using the ANOVA test. The 
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“Emotional” domain was found to have homogeneity of variances (p=0.80) and no significant 
difference in the mean score across the six age groups (p=0.89), however the “Personal and  
Social Life” domain was found to have unequal variances (p=0.03) and a statistically 
significant Welch test value (p=0.04). This suggests that the emotional effects on family 
members of patients are similar across all ages, but the effects on personal and social life 
differ by age, with the main differences between group 5 (51-60yrs) and all of the other 
groups. 
Spearman’s Rank Order Correlation coefficient showed that there was no significant 
correlation between the family members’ age and the total FROM score (r= 0.02, p= 0.80). 
This shows that family members of all ages are affected by illness, and that neither older or 
younger family members are likely to be affected more greatly. Figure 6.6 shows the 
relationship between family members’ age and total FROM score. 
Figure 6.6: The relationship between family members’ age and FROM total score 
 
Patient age  
The FROM mean score for patients’ age was also calculated by dividing the patients up into 
eight age groups. Group 1= 0-10 years, group 2= 11-20 years, group 3= 21-30 years, group 
4= 31-40 years, group 5= 41-50 years, group 6= 51-60 years, group 7= 61-70 group 8 ≥ 71 
years. The mean total FROM scores across the six groups were calculated (Table 6.8 and 
Figure 6.7). 
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Table 6.8: The mean total FROM scores for each patient age category 
Patient 
age 
group 
Number 
of 
patients 
Mean 
FROM 
total score 
Std. 
Deviation 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
0-10 8 10.6 10.4 2.0 19.3 1 29 
11-20 14 8.9 5.3 5.8 11.9 2 21 
21-30 5 21.8 7.9 12.1 31.6 13 32 
31-40 7 15.1 7.3 8.4 21.9 2 23 
41-50 15 11.2 6.8 7.4 15.0 3 26 
51-60 20 15.1 8.9 10.9 19.2 2 31 
61-70 18 11.2 5.5 8.5 14.0 2 24 
Over 
71 
33 11.5 6.5 9.2 13.8 2 26 
Total 120 12.3 7.5 11.0 13.6 1 32 
 
Figure 6.7 shows that the most affected family members were those with patients in Group 3 
(21-30 years) with a mean FROM score of 21.8, and the family members who experienced 
least impact were those with patients in group 2 (11-20 years) with a mean FROM score of 
8.86. Results of the ANOVA test showed that there was a significant difference in the FROM 
mean total score across the eight age groups (p=0.019). The post-hoc analysis showed that 
the main difference was found between group 2 and group 3 (p= 0.016). The mean score of 
individual items of the FROM were then compared according to patients’ age. Nine of the 16 
items showed equal variance, so the ANOVA test was performed. The other seven showed 
unequal variance, so were analysed using Welch’s t-test. Of the 16 items, four showed 
significant differences between the patient age groups. These items were “Worried” (p= 
0.008), “Talking about thoughts” (p= 0.006), “Eating habits” (p= 0.008) and “Family 
expenses” (p= 0.029).  
The mean score of the two domains of the FROM (“Emotional” and “Personal and Social 
Life”) were also analysed according to patient age using the ANOVA test. The “Emotional” 
domain was found to have homogeneity of variances (p=0.217) and a significant difference in 
the mean score across the eight age groups (p=0.004), however the “Personal and Social 
Life” domain was found to have unequal variances (p=0.018) and a non significant Welch 
test value (p=0.313). This suggests that the effects on family members’ personal and social 
lives are not likely to differ depending on the age of the patient, but that family members with 
certain patient age groups are more likely to suffer from emotional effects. Family members 
with patients in group 3 (21-30 yrs) were more likely to suffer emotional effects (mean 
“Emotional” domain score= 9.6 out of 12), than those with patients in groups 1 (age 0-10yrs, 
mean score= 4.38 out of 12) and 8 (age ≥ 71, mean score= 5.03 out of 12).  
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Figure 6.7: The FROM mean scores for each patient age category 
 
Spearman’s Rank Order Correlation coefficient showed that there was no significant 
correlation between the patients’ age and the total FROM score (r= 0.01, p= 0.88).  This 
shows that family members of patients of all ages are affected by illness, and that neither 
family members of older or younger patients are likely to be affected more. Figure 6.8 shows 
the relationship between patients’ age and total FROM score. 
Family member type 
In order to compare the mean total FROM scores between the different relatives of patients, 
family members were divided into five groups. Group 1= Partner (unmarried), Group 2= 
Spouse, Group 3= Child, Group 4= Parent, Group 5= Other (made up of more distant 
relatives including grandparents, grandchildren, nieces and nephews). The FROM mean total 
score was then calculated for each of the five groups. Table 6.9 shows that the highest mean 
total FROM scores were found in unmarried partners (13.45), closely followed by spouses 
(12.69) and parents (12.66). The lowest mean scores were found in the category “Other” 
which included more distant relatives. The results of an ANOVA test found that there was not 
a significant difference between the FROM mean total score with respect to the relationship 
between the patient and the family member (p=0.15). 
 
 
10.63 
8.86 
21.8 
15.14 
11.2 
15.05 
11.22 11.48 
0 
5 
10 
15 
20 
25 
Group 1 
(0-10yrs) 
Group 2 
(11-20yrs) 
Group 3 
(21-30yrs) 
Group 4 
(31-40yrs) 
Group 5 
(41-50yrs) 
Group 6 
(51-60yrs) 
Group 7 
(61-70yrs) 
Group 8 
(over 71 yrs) 
M
e
an
 t
o
ta
l F
R
O
M
 s
co
re
 (
0
-3
2
) 
Patient age group 
163 
 
y = 0.0014x + 12.211 
R² = 2E-05 
0 
5 
10 
15 
20 
25 
30 
35 
0 10 20 30 40 50 60 70 80 90 100 
M
e
an
 F
R
O
M
 s
co
re
 (
0
-3
2
) 
Patient age 
Figure 6.8: The relationship between patients’ age and total FROM score 
 
 
Table 6.9: The FROM mean total scores for each family member relationship category 
Relationship 
to patient 
N.o of 
family 
members 
Mean 
FROM 
total 
score 
S.D. 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Partner 11 13.5 6.3 9.2 17.7 4 23 
Spouse 52 12.7 8.1 10.4 15.0 2 31 
Child 24 12.0 5.8 9.5 14.4 2 24 
Parent 29 12.7 7.9 9.7 15.7 1 32 
Other 4 3.0 1.6 0.4 5.6 1 5 
Total 120 12.3 7.5 11.0 13.6 1 32 
 
Medical specialty 
Although the numbers of family members recruited from each medical specialty was small 
(around 5 from each), the mean total FROM scores were still calculated for each specialty. 
Although the numbers are too small to draw any firm conclusions, this test gives a 
preliminary idea of which family members are most greatly affected across the different 
disease areas. Only one family member was sampled from the genetics specialty at this 
stage of the study, and so this subject was excluded for this analysis (number of family 
members=119, number of specialties= 24) (Table 6.10). The highest mean scores were 
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found in family members of neurology patients (19.8), oncology patients (17.6), haematology 
patients (16.6) and chronic pain patients (16.6) (Figure 6.9). The lowest mean scores were 
found in family members of ophthalmology patients (4.25) and orthopaedics (5.80) (Figure 
6.9). As expected, the variances were found to be significantly unequal (Levene statistic 
p=0.028), and Welch’s t-test showed that there were significant differences in the mean 
values between specialties (p=0.01). This difference was expected, as illnesses from 
different specialties result in different symptoms, have different treatment courses and vary in 
severity, all of which can affect family members in different ways. 
The mean total FROM scores for family members of patients from each of the 24 specialties 
were also compared with the total scores for each of the two domains of the FROM 
(“Emotional” and “Personal and Social Life”). Table 6.11 shows the top five and bottom five 
specialties with regard to the mean total score (0-32), Part 1 (0-12) and Part 2 (0-20). This 
shows that family members of patients from neurology, chronic pain, oncology and 
haematology are likely to be affected both emotionally and socially as a result of the patient’s 
illness. Although family members of patients from urology score in the top five for Part 1 
“Emotional”, they do not appear in Part 2 “Personal and social life”, suggesting that they are 
more likely to be affected emotionally than socially. Although general practice scored close to 
the mid-point for total FROM score (15th out of 24), it scored lowly for Part 1, suggesting that 
family members are less affected emotionally, possibly because of the less urgent nature of 
long term conditions followed up in general practice. Family members of patients from both 
ophthalmology and orthopaedics scored lowly on both domains and the total FROM score, 
suggesting that family members are least affected by these conditions.  
Number of patient co-morbidities  
The number of co-morbidities the patient suffered from was correlated with the total FROM 
score. The aim of this test was to assess whether the number of different illnesses the 
patient has affects the quality of life of the family member. The correlation between number 
of co-morbidities and FROM score was 0.25 (p= 0.007), suggesting a weak positive 
correlation, and a weak association between the number of patient co-morbidities and the 
FROM score. This suggests that family members of patients with a large number of illnesses 
can be more greatly affected, but that this association only happens some of the time. 
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Table 6.10: The FROM mean total scores for family members of patients from each of 
the 24 specialties 
Specialty N.o of 
family 
members 
Mean 
FROM 
total 
score 
S.D. 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Haematology 5.0 16.6 8.9 5.6 27.6 6.0 24.0 
General practice 5.0 11.0 2.6 7.7 14.3 7.0 14.0 
Oncology 5.0 17.6 5.9 10.2 25.0 8.0 24.0 
Cardiology 5.0 9.8 4.8 3.8 15.8 5.0 15.0 
Neurology 5.0 19.8 3.4 15.6 24.1 15.0 23.0 
Colorectal 
surgery 
5.0 11.6 6.5 3.5 19.7 7.0 23.0 
Paediatric 
Endocrinology 
5.0 9.8 4.0 4.9 14.7 5.0 15.0 
Elderly 5.0 9.4 9.9 -2.9 21.7 2.0 26.0 
Orthopaedics 5.0 5.8 7.1 -3.0 14.6 1.0 18.0 
Rheumatology 5.0 11.4 11.6 -3.0 25.8 2.0 26.0 
Gastroenterology 5.0 14.4 7.2 5.4 23.4 7.0 26.0 
Renal 5.0 11.4 7.6 1.9 20.9 2.0 23.0 
Urology 5.0 14.0 3.8 9.3 18.7 9.0 19.0 
Chronic Pain 5.0 16.6 11.9 1.8 31.4 5.0 32.0 
ENT 5.0 13.6 10.2 1.0 26.2 5.0 31.0 
Respiratory 5.0 12.4 6.8 4.0 20.9 5.0 21.0 
Infectious 
Diseases 
5.0 10.0 6.2 2.3 17.8 2.0 17.0 
Dental surgery 5.0 10.4 6.3 2.5 18.3 3.0 20.0 
Dermatology 5.0 10.2 11.0 -3.4 23.8 2.0 29.0 
Post-stroke 5.0 11.8 6.7 3.5 20.1 3.0 19.0 
Wound healing 5.0 14.2 7.6 4.8 23.6 3.0 24.0 
Ophthalmology 4.0 4.3 2.6 0.1 8.4 2.0 7.0 
Diabetes 5.0 12.6 2.3 9.7 15.5 10.0 15.0 
Gynaecology 5.0 10.8 3.4 6.6 15.1 7.0 16.0 
Total 119.0 12.1 7.3 10.8 13.5 1.0 32.0 
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Table 6.11: The top five and bottom five specialties with regard to mean total FROM 
score and total score for each domain 
 Mean total FROM score 
(0-32) 
Mean total Part 1 
score (0-12) 
Mean total Part 2 score 
(0-20) 
Top 5 
specialties 
 
 
 
 
 
Neurology  
Oncology  
Haematology  
Chronic Pain  
Gastroenterology  
Wound Healing  
 
19.8 
17.6 
16.6 
16.6 
14.2
a 
14.2
a
 
Neurology  
Chronic Pain  
Haematology  
Wound Healing  
Urology  
Oncology  
8.0 
7.6 
7.0 
7.0 
6.8
b 
6.8
b
 
Neurology  
Oncology  
Haematology  
Chronic Pain  
Gastroenterology  
11.8 
10.8 
9.6 
9.0 
8.8 
Bottom 5 
specialties 
 
 
 
 
 
Ophthalmology  
Orthopaedics  
Elderly  
Paediatric 
endocrinology  
Cardiology  
4.3 
5.8 
9.4 
9.8 
9.8 
Ophthalmology  
Orthopaedics  
Paediatric 
endocrinology  
General Practice  
Diabetes  
3.0 
3.2 
 
4.2 
4.2 
4.4 
Ophthalmology  
Orthopaedics 
Infectious diseases  
Cardiology  
Gynaecology  
Elderly  
1.3 
2.6 
3.8 
4.6 
4.8
c 
4.8
c
 
a
 Both Paediatric endocrinology and Cardiology had the same mean total FROM score so 
are both listed in position 5 
b Both Urology and Oncology had the same mean score for Part 1 so are both listed in 
position 5 
c Both Gynaecology and Elderly had the same mean score for Part 1 so are both listed in 
position 5 
 
Socioeconomic status and FROM scores 
Socioeconomic data was collected from all subjects during this stage of the study. Tests 
were carried out on this data to investigate whether annual household income or level of 
education influenced the total FROM score. 
The family members’ level of education was divided into five groups. Group 1= Less than 
secondary school education, group 2= Secondary school education, group 3= A 
Levels/college course, group 4= University degree, group 5= Masters degree or above. 
Those family members who had chosen “Prefer not to say” or had missing values for 
education level were eliminated (n=110). Table 6.12 shows the mean total FROM score for 
each education level group. Although the family members in groups “A levels/college” and 
“Masters degree or above” had the highest mean total score (13.63 and 12.82 respectively), 
there was no trend towards higher scores depending on education level, and an ANOVA test 
showed that the difference in mean score between the groups was not significant (p=0.29).  
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Table 6.12: The mean total FROM score for family members according to level of 
education 
Family 
member 
education 
level 
Number 
of family 
members 
Mean 
FROM 
total 
score 
Std. 
Deviation 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Less than 
secondary 
education 
5.0 7.0 2.8 3.5 10.5 4.0 10.0 
Secondary 
school 
education 
48.0 12.3 7.5 10.1 14.5 1.0 29.0 
A 
levels/college 
30.0 13.6 8.2 10.6 16.7 2.0 32.0 
University 
degree 
16.0 10.1 7.2 6.2 13.9 1.0 24.0 
Masters 
degree or 
above 
11.0 12.8 5.4 9.2 16.4 7.0 23.0 
Total 110.0 12.1 7.4 10.7 13.5 1.0 32.0 
 
The family members’ total household income per year was divided into eight groups. Group 
1= Less than £10,000, group 2= £11,000-£20,000, group 3= £21,000-£30,000, group 
4=£31,000-£40,000, group 5=£41,000-£50,000, group 6=£51,000-£60,000, group 
7=£61,000-£70,000, group 8= over £71,000. Those family members who had chosen “Prefer 
not to say” or had missing values for household were eliminated (n=100). Table 6.13 shows 
the mean total FROM score for each household income level group. Although the family 
members in groups “£21,000-£30,000” and “£31,000-£40,000” had the highest mean total 
score (13.78 and 13.88 respectively), there was no trend towards higher scores depending 
on education level, and an ANOVA test showed that the difference in mean score between 
the groups was not significant (p=0.48). 
Patient disease duration and FROM scores 
The total FROM score was correlated with the patient’s disease duration to investigate 
whether the length of the patient’s illness has an effect on the quality of life of the family 
member. Spearman’s Rank Order Correlation coefficient showed that there was a poor, non 
significant correlation between the patient disease duration and the total FROM score (r= 
0.143, p= 0.131). This shows that the quality of life of family members is not associated with 
the duration of the patient’s illness (this may differ for individual, or groups of diseases), and 
that in this varied patient population, the impact on the family member does not increase as 
the disease duration progresses.  
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Table 6.13: The mean total FROM score for family members according to total 
household income per year 
Family 
member 
household 
income per 
year 
N.o. of 
family 
member
s 
Mean 
FROM 
total 
score 
S.D. 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Less than 
£10,000 
13.0 11.9 7.2 7.5 16.2 1.0 29.0 
£11,000 to 
£20,000 
31.0 12.4 7.6 9.6 15.2 2.0 26.0 
£21,000 to 
£30,000 
18.0 13.8 9.0 9.3 18.3 2.0 31.0 
£31,000-
£40,000 
16.0 13.9 7.1 10.1 17.7 2.0 32.0 
£41,000-
£50,000 
8.0 7.4 3.7 4.3 10.4 1.0 12.0 
£51,000-
£60,000 
4.0 12.0 6.1 2.4 21.6 6.0 19.0 
£61,000-
£70,000 
5.0 8.4 3.8 3.6 13.2 5.0 15.0 
£71,000 and 
over 
5.0 13.2 7.9 3.5 23.0 4.0 24.0 
Total 100.0 12.2 7.4 10.8 13.7 1.0 32.0 
 
The patient’s disease duration was then rescored into six groups. Group 1= 1-12 months, 
group 2= 13-24 months, group 3= 25-36 months, group 4= 37-72 months, group 5= 73-120 
months and group 6= over 121 months. The results of an ANOVA test showed that there was 
not a significant difference between the family member mean total FROM score across the 
six groups (p=0.54). Table 6.14 shows that the disease duration group with the highest mean 
total FROM score is group 4 (37-72 months) with a mean of 14.56. 
Table 6.14: The mean total FROM score for family members according to patient 
disease duration 
Patient 
disease 
duration 
(months) 
N.o. of 
family 
members 
Mean 
FROM 
total 
score 
S.D. 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
1-12 22.0 10.5 7.2 1.5 7.3 13.7 1.0 
13-24 15.0 11.3 7.9 2.1 6.9 15.7 2.0 
25-36 15.0 11.1 5.8 1.5 7.9 14.3 2.0 
37-72 16.0 14.6 8.5 2.1 10.1 19.1 5.0 
73-120 26.0 13.5 7.4 1.5 10.5 16.5 3.0 
over 121 26.0 12.5 7.8 1.5 9.4 15.7 1.0 
Total 120.0 12.3 7.5 0.7 10.9 13.6 1.0 
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Scores of the two FROM domains 
The FROM is made up of two domains (Part 1: six questions, scored 0-12 and Part 2: 10 
questions, scored 0-20). The total scores for each of the two domains were found to have a 
positive strong correlation (r= 0.62 p<0.001) using Spearman’s Rank Correlation Coefficient.  
This means that family members who score highly in one domain are also likely to score 
highly in the other, suggesting that the two domains, “Emotional” and “Personal and Social 
Life” are related.  
Reliability 
The reliability of the FROM was assessed in terms of internal consistency and test-retest 
reliability. 
Internal consistency 
The internal consistency of the FROM was measured to determine the extent to which all of 
the individual items measure the same attribute. Internal consistency of the FROM using 
Cronbach’s alpha coefficient was 0.91 suggesting high internal consistency (Table 6.15). 
This was not improved by deleting individual items (0.90-0.91) demonstrating that all of the 
items contribute to the total FROM score (Table 6.16). The two domains also showed high 
internal consistency (Emotional= 0.80, Personal and Social Life=0.89).The scale variance 
also remained within a relatively narrow range (49.4-54.4) when individual items were 
deleted, which is consistent with a high Cronbach’s alpha.  
 
Table 6.15: Internal consistency (Cronbach’s α) of the 16 items of the FROM 
 
Cronbach's 
alpha 
Cronbach's alpha 
based on standardized 
items N of Items 
0.911 0.910 16 
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Table 6.16: Item- total statistics of the FROM 
FROM item Scale mean 
if item 
deleted 
Scale 
variance if 
item 
deleted 
Corrected 
item-total 
correlation 
Cronbach's 
alpha if 
item 
deleted 
Worried 10.72 54.39 0.38 0.91 
Angry 11.62 52.44 0.51 0.91 
Sad 10.99 52.80 0.46 0.91 
Frustrated 11.09 52.41 0.52 0.91 
Talking about thoughts 11.5 50.20 0.66 0.90 
Difficulty caring 11.34 50.13 0.67 0.90 
Time for self 11.45 49.88 0.72 0.90 
Travel 11.56 51.11 0.60 0.91 
Eating habits 11.71 51.77 0.60 0.91 
Family activities  11.21 50.70 0.69 0.90 
Holiday 11.36 49.41 0.66 0.90 
Sex life 11.55 51.31 0.53 0.91 
Work or study 11.58 51.51 0.57 0.91 
Family relationships 11.59 51.13 0.65 0.90 
Family expenses 11.39 51.49 0.58 0.91 
Sleep 11.25 49.82 0.68 0.90 
 
Test-retest reliability 
The test-retest method was used to assess whether the FROM produces more or less the 
same results when it is administered to stable subjects on two different occasions separated 
by a period of time. All 121 family members were followed up via post or email and asked to 
complete a hard copy or an online version of the FROM a second time after a time period of 
7 to 14 days from when they were first recruited. Family members were also asked to 
complete a Global Health (GH) Score, which asked them to rate the patient’s health on a 
score of 0-10, both during initial recruitment and for the 7-14 day follow up. In accordance 
with the study design, those family members of patients whose GH score had changed by 
more than one point (suggesting that their health has changed, and they are therefore not 
stable) were eliminated from this stage of the study. One further subject was eliminated due 
to incomplete questionnaire responses.  
A total of 74 (61.2%) family members returned the second set of completed questionnaires 7-
14 days after first recruitment.  23 of these were eliminated due to a change in GH score of 
more than one point. The test-retest was based on data from 52 family members (43.0%) in 
whom the health status of the patient had not changed (as assessed by the family member). 
The ICC value for the total FROM score was 0.93 which suggests that the scale is able to 
show reproducible results in stable subjects.  
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For individual items, the ICC values ranged from 0.59 to 0.88 and the ICC values for the total 
scores for the two domains of the FROM were 0.86 and 0.93 (Table 6.17). These values 
indicate a strong agreement between scores at the two time intervals. Figure 6.10 shows the 
mean scores for each of the items at initial recruitment and follow up, demonstrating similar 
mean scores on the two occasions. Although the ICC is the recommended statistical method 
for the test-retest investigation (Streiner and Norman 2008) a paired sample t-test was also 
carried out to support the results of the ICC. The paired samples correlated strongly (r=0.87 
p<0.001) and there was no significant difference (p=0.51). Figure 6.11 shows the correlation 
between the initial and the follow up FROM scores. 
Table 6.17: Intraclass correlation coefficient values for individual items, total scores 
for domains and total FROM score. 
FROM item ICC 
95% CI p 
value Lower Upper 
Worry 0.65 0.88 0.96 <0.001 
Angry 0.76 0.58 0.86 <0.001 
Sad 0.72 0.51 0.84 <0.001 
Frustrated 0.75 0.56 0.86 <0.001 
Talking about thoughts 0.86 0.75 0.92 <0.001 
Difficulty caring 0.76 0.58 0.86 <0.001 
Time for self 0.82 0.69 0.9 <0.001 
Travel 0.78 0.63 0.88 <0.001 
Eating habits 0.89 0.81 0.94 <0.001 
Family activities 0.82 0.68 0.9 <0.001 
Holiday 0.85 0.74 0.92 <0.001 
Sex life 0.84 0.71 0.91 <0.001 
Work or study 0.91 0.84 0.95 <0.001 
Family relationships 0.59 0.28 0.76 0.001 
Family expenses 0.76 0.59 0.86 <0.001 
Sleep 0.85 0.74 0.91 <0.001 
Part 1 0.86 0.77 0.92 <0.001 
Part 2 0.93 0.88 0.96 <0.001 
Total 0.93 0.88 0.96 <0.001 
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Figure 6.10: The relationship between the initial FROM score and the follow up FROM 
score 7-14 days later for family members of stable patients 
 
 
Figure 6.11: Mean scores for the individual items of the FROM at initial recruitment 
and follow up after 7-14 days 
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Face validity and practicality 
Although content validity was carried out during the item reduction stage of development, a 
test of face validity was carried out during the validation stage, to ensure that the changes 
made to the FROM during item reduction did not compromise the validity of the instrument. 
During initial recruitment, all 120 family members were asked to complete four questions 
about the face validity and practicality of the FROM using “yes” or “no” tick boxes. For the 
final question, family members were also asked to explain their answer if they ticked “no”.  
Question 1: Is the questionnaire easy to complete? 
120 (99.2%) family members answered “yes” and 1 family member (0.8%) answered 
“no”. 
Question 2: Are the response options for the questions straight-forward? 
120 (100%) family members answered “yes”. 
Question 3: Are the instructions and statements clear? 
118 (99.2%) family members answered “yes” and 1 family member (0.8%) answered 
“no”. (n=119 as one missing value was eliminated) 
Question 4: Do the questions cover all the areas of your life which have been affected by 
your family member’s illness? 
104 (87.4%) family members answered “yes” and 15 (12.6%) family members 
answered “no”. (n=119 as one missing value was eliminated). 
Those family members who had answered “no” for questions 4 (12.6%), were asked to 
comment below the questions about what they thought was missing from the questionnaire. 
Seven family members made comments, and their answers are shown in Table 6.18 
alongside the investigators comments for each. No new areas of life were suggested which 
were not covered by the FROM, so therefore no changes were made as a result of the family 
members comments, as justified in Table 6.18. 
The high levels of agreement for the four questions suggest that the FROM has high face 
validity, is practical and easy to use. 
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Table 6.18: Comments from family members regarding the face validity and 
practicality of the FROM and corresponding comments from the study investigator. 
Family member comments Comments/justification from investigator 
More detail The items are designed to be simple and widely 
applicable so adding more detail to them would 
potentially affect the validity 
Although it mentions added expense it 
fails to mention the added stress of 
being the sole provider and caring for 
someone with a disability as well as 
raising children and maintaining the 
home 
These aspects are covered by a number of items in 
the FROM (several of the “Emotional” items, fam ily 
activities, work and family expenses) and would not 
be applicable to the majority of family members (as 
reflected during the qualitative interviews) so would 
not justify an additional item. 
Because we have children living at home 
and they have been affected by 
[patient’s name] illness I think they would 
benefit from counseling 
This comment does not relate directly to the 
questionnaire content 
My son is very forgetful which is a worry 
as he no longer lives around the corner 
from me 
This aspect comes under Item 1 “I feel worried”, 
and is an example of this theme 
Other aspects affecting other things not 
addressed i.e. other family illness/caring 
responsibilities and own illness 
The questionnaire is designed to assess the QoL of 
one family member as a result of one patient’s 
illness and not the family as a whole. Caring is 
covered by item 6 “Caring for my family member is 
difficult” 
How it affects work This is covered in item 13 “My work or study is 
affected” 
My wife also has health problems The questionnaire is designed to assess the QoL of 
one family member as a result of one patient’s 
illness and not the family as a whole 
As a further test of practicality, the family members were timed as they completed the FROM. 
The mean completion time (n=108) of the FROM was 115 seconds (1 minute and 55 
seconds) with a range of between 55 seconds and 272 seconds (4 minutes 32 seconds). The 
standard deviation was 54.1 seconds. A positive correlation between the FROM timing and 
the family member’s age was also found using Pearson’s Coefficient (r=0.44, p<0.001) 
Readability and item length 
The FROM was designed to be easy to read and be able to be completed by any adult family 
member.  This was tested by looking at the length of items, and the instrument Flesch 
readability score. The Flesch readability score for the FROM was 64.7. Documents with a 
Flesch readability score of between 60 and 70 are given a “standard” reading ease (Flesch 
1948) which can be understood by most people. The mean length of the 16 items was 5.6 
words (range= 3-12 words), demonstrating that the items are concise and easy to read.  
Sensitivity to change 
Family members from five of the core specialties were included in the sensitivity to  change 
study. The sensitivity to change study was designed to assess whether the FROM scores 
change with a change in the patient’s health. This part of the study was designed to assess 
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whether the FROM scores can detect change. Participants included five family members 
from colorectal surgery, respiratory, renal, dermatology and rheumatology. The 25 family 
members were sent a copy of the FROM along with a global health score (scored 0-10) after 
a period of 2-3 months after initial recruitment.  The family members were followed up using 
their initial method of choice, either by post or email. In accordance with the study design, 
those family members of patients whose GH score had changed by more than one point 
(suggesting that their health has changed) were included in this stage of the study. A second 
reminder was sent out to those who had not returned the questionnaires after 14 days. 
A total of 14 (56%) family members returned the second set of completed questionnaires 2-3 
months after recruitment. Only two out of the 14 responses showed a change of more than 
two points on the GH score and were therefore eligible for the analysis. The other 12 
participants showed no change (4 out of 14) or a change of less than two GH score points (8 
out of 14) and so were excluded from the analysis.  
The number of valid responses from this test was too low to carry out any statistical analysis 
or draw any conclusions regarding the sensitivity to change of the FROM. This is discussed 
further in the Discussion chapter of this thesis. However, as the majority of participants 
showed a stable health state after 2-3 months (a change of less than 2 points on the GH 
score), an additional test-retest reliability study was carried out on this data. 
Additional test-retest study 
The additional test-retest was based on data from 12 family members in whom the health 
status of the patient had not changed after 2-3 months (as assessed by the family member). 
The ICC value for the total FROM score was 0.94 which suggests that the scale is able  to 
show reproducible results in stable subjects, even after 2-3 months with no change in health 
state.  
Construct validity 
The construct validity of the FROM was assessed by testing two a priori hypotheses about 
the construct of the scale.  
Hypothesis 1: The impact of illness on family member’s QoL is correlated to the family 
member’s overall QoL. 
To test the first hypothesis, the scores of the FROM were compared with the scores of a 
generic quality of life measure, the WHOQOL-BREF, which was also administered to family 
members during initial recruitment. The attributes of the two measures are compared in 
Table 6.19. 
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Table 6.19: The attributes of the FROM and the WHOQOL-BREF 
 The FROM The WHOQOL-BREF 
(Skevington et al. 2004; World 
Health Organisation 1996) 
Concept measured The impact of a patient’s 
illness on their family member 
A subject’s subjective quality of 
life 
Target population Family members (age ≥ 16) of 
patients (of any age) 
Adults 
Number of items 16 26 
Possible total score 
range 
0-32 1-130a 
Number of domains 2 (“Emotional” and “Personal 
and Social Life”) 
4 (“Physical health”, 
“Psychological”, “Social 
relationships” and 
“Environment”) 
Scoring format Scores are added to form total 
scoreb 
Scores are added to form total 
score 
Scoring direction Higher score= lower QoL Higher score= higher QoL 
a The WHOQOL-BREF has several different scoring systems allowing the raw score to be 
converted to a transferred score and compared to the WHOQOL-100. For the purposes of 
this test, the raw score (1-130) is used.  
b The two domain scores for the FROM are usually reported separately (as they form two 
factors), however for simplicity in this study (as there are no direct clinical implications), the 
scores of the two domains are added to form a total score. 
 
 
Data from family members were analysed for correlation. One subject was removed due to 
incomplete WHOQOL-BREF score (n=119). Table 6.20 shows the descriptive statistics for 
each of the questionnaires. 
 
Table 6.20: Descriptive statistics of the FROM and the WHOQOL-BREF 
 FROM score WHOQOL-BREF score 
N 119 119 
Mean 12.28 96.87 
Std. error of mean 0.69 1.61 
95% confidence interval 
for mean 
Lower bound = 10.92 
Upper bound =13.64 
Lower bound= 93.68 
Upper bound= 100.06 
Standard deviation 7.50 17.57 
Minimum 1 53 
Maximum 32 127 
Range 31 74 
Median 11.0 99.0 
Interquartile range 10 28 
Skewness 0.62 -0.48 
Std. error of skewness 0.22 0.22 
Using Spearman’s rank correlation coefficient, a correlation was found between the FROM 
scores and the WHOQOL-BREF scores (r= -0.55, p<0.001).  The correlation is negative due 
to the different scoring directions of the two questionnaires. This shows that a family member 
with a high FROM score is likely to have a low WHOQOL-BREF score, indicating that the 
impact of illness on family members of patients is correlated to their overall QoL. This 
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correlation is shown in Figure 6.12, showing a large range (1-32) of FROM scores, but that 
most of the WHOQOL-BREF scores were in the top half of the scale (above 65). This data 
confirms the first construct validity hypothesis. 
Figure 6.12: The relationship between the FROM and the WHOQOL-BREF scores 
Correlations were also assessed for the two domains of the FROM and the four domains of 
the WHOQOL (Table 6.21). The strongest correlation (r= -0.57) was found between the 
FROM domain “Personal and Social Life” and the WHOQOL-BREF domain “Social 
relationships”. 
Table 6.21: The correlations between the domains of the FROM and the WHOQOL-
BREF 
                                  FROM 
WHOQOL- 
BREF 
Domain 1  
“Emotional” 
 
Domain 2 
“Personal and Social Life”  
Domain 1 
“Physical health” 
-0.36 -0.44 
Domain 2 
“Psychological” 
-0.43 -0.50 
Domain 3 
“Social relationships” 
-0.44 -0.57 
Domain 4 
“Environment” 
-0.38 -0.48 
 
Hypothesis 2: The impact of illness on family member’s QoL is correlated to the health 
of the patient 
The second hypothesis was tested by comparing the FROM score with the global health 
(GH) score. At the time of initial recruitment, family members were asked to rate the patient’s 
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health on a scale of 0-10. The GH score representing the family member’s assessment of the 
patient’s health ranged from 0-10 with a mean of 5.1 (SD=2.5). The GH score was found to 
correlate negatively with the total FROM score using Spearman’s rank correlation coefficient 
(r= -0.51, p<0.001). The two domains also showed a moderate correlation with the GHS 
(Emotional r= -0.48, p<0.001;Personal and Social Life r=-0.45, p<0.001). This shows that the 
lower a patient’s health (as perceived by the family member) the greater the impact on the 
family member’s quality of life (Figure 6.13). The large degree of scatter on either side of the 
trendline shows the variability of correlation at the individual level.  
Figure 6.13: The relationship between the total FROM score and the Global health 
score (family members’ assessment of patients’ health) 
 
The scores of each of the 16 FROM items were also compared to the GH score (Table 6.22). 
The correlation was significant for all of the items (r= -0.21-0.46). The items showing the 
strongest correlation with the GH score were those concerning holiday (r=-0.46), difficulty 
caring (r=-0.45), and time for self (r=-0.44). This suggests that as the patient’s health 
deteriorates, the family member experiences more problems with going on holiday, finds 
caring for the patient more difficult and has less time for themselves. The two items showing 
the weakest correlation were those concerning sex life (r=-0.21), and family expenses (r=-
0.26), suggesting that these two aspects are less affected by the health of the patient.  
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Table 6.22: Correlations between the individual items of the FROM and the global 
health score 
FROM item r p 
Worried -0.35 <0.001 
Angry -0.28 0.002 
Sad -0.30 0.001 
Frustrated -0.30 0.001 
Talking about thoughts -0.28 0.002 
Difficulty caring -0.45 <0.001 
Time for self -0.44 <0.001 
Travel -0.37 <0.001 
Eating habits -0.30 0.001 
Family activities  -0.42 <0.001 
Holiday -0.46 <0.001 
Sex Life -0.21 0.02 
Work or study -0.39 <0.001 
Family relationships -0.28 0.02 
Family expenses -0.26 0.04 
Sleep -0.29 0.02 
 
Multiple regression analysis 
A multiple regression analysis was carried out to explore some of the factors influencing the 
family members’ QoL. Health of the patient (assessed by the family member) has already 
been identified as one of these influencing factors during the testing of the second 
hypothesis, therefore a hierarchical regression analysis was chosen. The total FROM score 
was set as the dependent variable, and independent variables were health of the patient (GH 
score), family member age, family member gender, patient age, patient gender, relationship 
between family member and patient, patient’s disease duration, family member’s education 
level and family member’s total annual household income. These nine variables were 
entered into the analysis in the order given, and the summary results are shown in Table 
6.23(a,b). Table 6.23(a) shows that the correlation between the set of independent variables 
and the dependent variable (FROM score) was moderate (R=0.54 for model 9). The results 
of the regression analysis showed that the GH score was the main predictor, explaining 25% 
of the variance. It was the only variable to cause a significant change in the R2 value 
(change= 0.25, p<0.001). The second highest change in R2 can be seen when patient age is 
added (change=0.03, p=0.06).  Family member age, family member gender, patient age, 
patient gender, relationship between family member and patient, patient’s disease duration, 
family member’s education level and family member’s total annual household income only 
added 4% to the variance. From Table 6.23(b), it can be seen that the GH score was the 
variable with the most significant association with the total FROM score (β= -1.65, p<0.001) 
and therefore the main predictor. This reflects the results found in testing the second 
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hypothesis. The only other significant predictor in this model was patient’s age, although the 
β value was small (β=-0.07, p=0.04). 
 
Table 6.23(a and b): Results of the hierarchical multiple regression analysis for the 
total FROM scores 
(a) 
Model 
R R
2
 
Adjusted 
R
2
 
Std. 
error of 
the 
estimate 
Change Statistics 
 R
2 
change 
F 
change df1 df2 
Sig. F 
change 
1 (a) .502 .252 .245 6.446 .252 35.650 1 106 .000 
2 (b) .502 .252 .237 6.476 .000 .008 1 105 .931 
3 (c) .505 .255 .234 6.492 .004 .492 1 104 .485 
4 (d) .530 .281 .253 6.411 .026 3.658 1 103 .059 
5 (e) .535 .287 .252 6.415 .006 .846 1 102 .360 
6 (f) .540 .292 .250 6.423 .005 .768 1 101 .383 
7 (g) .540 .292 .243 6.455 .000 .001 1 100 .971 
8 (h) .541 .293 .236 6.482 .001 .153 1 99 .697 
9 (i) .542 .294 .229 6.511 .001 .113 1 98 .737 
 
a. Predictors: (Constant), Global Health Score 
b. Predictors: (Constant), Global Health Score, Family Member Age 
c. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender  
d. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age 
e. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age, Patient Gender 
f. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age, Patient Gender, Relationship 
g. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age, Patient Gender, Relationship, Disease Duration 
h. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age, Patient Gender, Relationship, Disease Duration, Family Member education level  
i. Predictors: (Constant), Global Health Score, Family Member Age, Family Member Gender, 
Patient Age, Patient Gender, Relationship, Disease Duration, Family Member education 
level, Family Member household income 
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(b) 
Variables (predictors) Unstandardised 
coefficients 
Standardised 
coefficients 
t Sig.  B 
Std. 
Error Beta 
(Constant) 24.062 5.573  4.318 .000 
Global health score -1.650 .271 -.541 -6.101 .000 
Family member age .052 .052 .105 .995 .322 
Family member gender .459 1.572 .029 .292 .771 
Patient age -.070 .033 -.228 -2.088 .039 
Patient gender -1.133 1.443 -.077 -.785 .434 
Relationship -.389 .446 -.085 -.873 .385 
Disease duration .000 .007 .000 -.001 .999 
Family member education level -.279 .586 -.044 -.476 .635 
Family member household 
income 
.100 .297 .031 .336 .737 
 
DISCUSSION 
This study indicates that the FROM-16 is reliable and valid in family members of patients 
from a variety of specialties and diseases. Although the numbers of family members 
recruited from each specialty was small, the mean total FROM scores were still calculated for 
each specialty. This gives a preliminary idea of in which specialties family members are most 
affected, though disease specific data will be needed before any clear conclusions can be 
drawn. 
The reliability of the FROM was demonstrated by a high Cronbach’s alpha (0.91) and high 
ICC (0.93) for test-retest reliability. The validity of the FROM was successfully proven using 
two a priori hypothesis. The use of the global health score proved successful in the FROM 
validation and previous studies have found that family members are able to accurately 
assess patient disease severity (Housman et al. 2002) further increasing the reliability of this 
result. The high correlation seen between the FROM and the WHOQOL-BREF suggests that 
the impact on a family member’s quality of life as a result of the patient’s illness contributes 
greatly to their general QoL, even with other potential external influences. 
SUMMARY 
 The study population for the validation of the FROM was made up of 120 family 
members of patients across 25 medical and surgical specialties. 
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 The family member was asked to complete the FROM, which was timed. They 
were then asked to rate the patient’s health on a scale of 0-10 (global health 
score) and complete written feedback about the FROM. They were also asked to 
complete the WHOQOL-BREF questionnaire. 
 
 After 1-2 weeks, all family members were asked to complete the FROM and the 
global health score again. 
 
 After 2 months, 25 of the family members were contacted again and asked to 
complete the FROM and the global health score again.  
 
 Total scores for the FROM (0-32) ranged from 1 to 32, median = 11.50, mean = 
12.28 and SD = 7.47. There was no floor effect (scoring 0), and only one subject 
scored 32 showing a minimal ceiling effect. 
 
 Although the FROM mean total score varied slightly between males (11.83) and 
females (12.52), there was no significant difference between their scores 
(p=0.63). 
 
 Spearman’s Rank Order Correlation coefficient showed that there was no 
significant correlation between the family members’ age and the total FROM 
score (r= 0.02, p= 0.80). 
 
 Spearman’s Rank Order Correlation coefficient showed that there was a poor, 
non significant correlation between the patient disease duration and the total 
FROM score (r= 0.143, p= 0.131). 
 
 Internal consistency of the FROM using Cronbach’s alpha coefficient was 0.91 
suggesting high internal consistency. 
 
 The test-retest ICC value for the total FROM score was 0.93 which suggests that 
the scale is able to show reproducible results in stable subjects.  
 
 The mean completion time (n=108) of the FROM was 115 seconds (1 minute and 
55 seconds) with a range of between 55 seconds and 272 seconds (4 minutes 32 
seconds). 
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 The number of valid responses for the sensitivity to change was too low to carry 
out any statistical analysis or draw any conclusions regarding the sensitivity to 
change of the FROM. 
 
 Using Spearman’s rank correlation coefficient, a correlation was found between 
the FROM scores and the WHOQOL-BREF scores (r= -0.55, p<0.001).   
 
 The GH score was found to correlate negatively with the total FROM score using 
Spearman’s rank correlation coefficient (r= -0.51, p<0.001). 
 
 The results of the regression analysis showed that the GH score was the main 
predictor, explaining 25% of the variance. 
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CHAPTER 7 
 
General Discussion 
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Family quality of life and the impact of illness on family members of patients are subjects 
which have been explored and studied in several areas of medicine, but little information is 
available in the literature about the impact of illness on families across medicine as a whole. 
One of the key objectives of this study was to explore the existing research available in the 
area of family quality of life, and identify gaps which need addressing. Therefore, the 
structured literature review, which was first carried out at the beginning of the study and then 
updated over the following two years formed an important part of this study (Golics et al. 
2013). Health, psychological and social databases were used to identify papers to review 
during the literature search, and the study team, including the investigator and supervisors 
identified the key search terms used during the search. Ideally, a full systematic review of the 
literature would have been carried out, but given the time constraints of the study this was 
not possible as effective systematic reviews rely on adequate time and resources (Jones 
2004). In the case of this study, the structured review identified a gap in the literature, but 
published procedures required for systematic reviews were not followed. Instead, every effort 
was made by the investigator to make the review both reproducible and accountable. This 
included reporting the number of articles identified, screened and reviewed from each of the 
searches and reporting the date of each search and the key terms used. This information 
was then used to update the review on a six-monthly basis.  
The literature review highlighted the lack of information about the impact of illness on families 
across the whole of medicine. Although the numbers of articles found were reasonably high 
for most of the search terms used, after review the majority of articles were found to be 
unrelated to family quality of life. Many disease-specific studies looking at family impact were 
identified from the review, and several disease-specific measures were also found. Very little 
information was found about the generic impact of illness on family members, and no 
instrument currently exists to measure this impact. Instruments containing the term “family” 
were identified and at first glance these appeared to measure the generic impact on family 
members, but although they had been given very generic-sounding names, all of these 
measures were designed for specific populations, usually family members of paediatric 
patients. The results of the literature review confirmed that the impact of illness on family 
members is often underestimated and has not been fully explored in most medical 
specialties. In those areas where the impact had been explored, it was found to be severe 
and widespread. It was therefore felt that a generic family quality of life study would produce 
interesting and valuable information to compare to, and expand the current available 
literature. There was not enough information found in the current literature to suggest 
whether the areas of impact on family members of patients are the same across all areas of 
medicine. It is important to note that during the two years after the literature review was first 
carried out, the only new information identified was disease-specific and that no generic, 
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multi-speciality study was found. The information found in the literature review was compared 
to the qualitative results of this study, as explained later in this chapter. 
Qualitative work and study design 
The semi-structured interviews with family members of patients resulted in detailed and 
extensive information about the family impact of illness. Although many of the family 
members interviewed became emotional during the interviews and found it difficult to talk 
about their experiences, the rapport built between the family member and the interviewer 
helped family members to open up and share information that many claimed not have shared 
with anyone else before, and was therefore uncovered for the first time in this study. The 
willingness of the family members to open up and share information when questioned on 
their own in a private room also suggests that the FROM-16 measure may be best 
completed individually by family members, without patients or professionals directly 
observing or being able to influence answers. The use of a semi-structured interview guide 
helped to direct family members towards relevant areas and topics without introducing bias 
or asking leading questions. The questioning style used during the interviews was to begin 
with open questions and follow them up with closed questions to encourage the participants 
to provide examples. The use of the general open question at the start and end of each 
interview proved successful, as many family members were prompted to talk about subjects 
they had forgotten or had been overlooked by the interviewer. In hindsight, the choice of one-
to-one interviews over focus groups was considered to be the correct choice, as the detail of 
information provided by the family members was more sensitive than originally predicted and 
family members may not have felt comfortable enough to discuss these impacts in front of 
others, especially when they are not used to discussing them themselves.  
One of the strengths of the qualitative work in this study was the large number of interviews 
carried out with family members of patients suffering from a variety of illnesses. The inclusion 
of family members of patients with co-morbidities provided more realistic and diverse 
information. On reflection, excluding family members of patients with more than one illness 
would have produced a measure with a much narrower use potential, as patients commonly 
suffer from more than one medical condition (Gabriel and Michaud 2009; Guh et al. 2009). 
Since it was important to gather information from a wide range of diseases during the 
qualitative phase, the interviewer directed the family member to talk about the primary 
condition, as identified by the clinic they were attending. This also proved successful and 
added to the richness of the data.  
The determination of saturation of information from the interviews in this study was different 
from other qualitative studies. Usually, interviews are completed in batches, analysed and 
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assessed for saturation (the point after which no new information arises). The saturation 
point therefore determines the total interview number required (Guest et al. 2006). However, 
in this study it was important to interview a cross-section of family members and interview 
equal numbers from each speciality. Since there were 26 specialties involved in the study, 
due to the practical time constraints it was impossible to interview one from each speciality in 
turn, then a second, third etc. Therefore, it was decided that a minimum of five family 
members from each specialty would be interviewed regardless of whether saturation was 
reached. This ensured a cross-section of family members and a variety of medical conditions 
from each specialty. Therefore, although the continuation of interviews from number 40 
(saturation point) to number 133 seems excessive, it ensured that the views of family 
members from all 26 specialties were considered. 
The use of a pilot study of five family members helped the interviewer to practice using the 
interview guide and questioning style. Since informed consent was taken from the patient 
and family member, there was a significant amount of paperwork to be completed before the 
interview, so the pilot study helped to ensure that this procedure went smoothly during the 
study interviews. The qualitative themes resulting from the study were similar to those 
identified across previous studies during the literature review. However, the extent of the 
impact and the emotional examples given by family members were beyond what was initially 
anticipated by the study team. These themes are discussed below. It is often not considered 
appropriate to report the percentages of participants mentioning each theme in qualitative 
research (Kitzinger 1995). This is especially true where a non-structured interview technique 
is used, and participants are asked different questions in each interview. However, it is felt 
that in this study, reporting the percentages of family members affected by each theme adds 
to the depth and interest of the data, especially as this is a new population which has not 
been investigated in this way before, and as there were a large number of interviews. As the 
interview guide used was semi-structured, and reviewed after the pilot interviews, all family 
members were given the chance to report on the key themes. It is important to note that the 
percentages attached to the qualitative report were not used to place a greater emphasis on 
certain themes in the final questionnaire, and all were considered in this context equally. The 
percentages reported came in useful when deciding which items to include in the FROM (a 
5% cut off point was used), but all items mentioned by over 5% of the family members were 
considered as equally important for inclusion. The 5% cut off level allowed the large volumes 
of data from 133 interviews to be managed and controlled so that the most relevant and 
common themes were included in the instrument.  
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Family quality of life themes 
The emotional impact of illness on the family was one of the main findings from the 
qualitative part of this study. Many other disease specific studies also found a large 
emotional impact, including family members of patients with multiple sclerosis (Aymerich et 
al. 2009; Bowen et al. 2011), where high levels of anxiety and frustration were reported. 
Emotional impact was the most highly reported theme in both this study (92% of family 
members affected), and in a study with family members of dermatology patients (98%), 
where similar emotions including worry, frustration and stress were reported (Basra and 
Finlay 2007). In this study, 20% of family members felt they had no one to talk to about the 
way they were feeling, which was also noted by Davis et al (Davis et al. 2009) who found that 
family members were unable to share their true feelings with others. The great emotional 
impact felt by family members in this study is consistent with that of a study of spouses of 
patients with prostate cancer (Kornblith et al. 1994), who were found to experience a greater 
emotional impact than patients themselves. 
Problems with daily activities were reported by family members of patients in this study. 
Other studies have also identified this aspect, including going shopping and hobbies such as 
walking (Eghlileb et al. 2007). Daily activities of family members were shown by Goldbeck 
(2006) to be affected immediately after the diagnosis, as well as in chronic conditions, 
reflecting the results of this study where patient disease durations ranged between one 
month and 60 years. Siblings of patients with a disability have also reported a decrease in 
family activities (Opperman and Alant 2003), as seen in the family members in this study, 
often preferring to spend time on their own. Changing their daily activities and routine as a 
result of the patient’s condition meant that some family members had to completely alter the 
way they lived their lives, and this also impacted on others around them such as other 
members of the family, friends or work colleagues. Often, family members reported spending 
less time on things they enjoy (e.g. hobbies and family activities) and more time on activities 
relating to the patient (e.g. caring and attending medical appointments). A large number of 
family members reported spending more time caring for the patient, for example helping with 
washing, bathing and dressing. Most of these family members were not registered carers, 
but many were caring for the patients on a full time basis. These family members represent 
hidden carers; those who are caring for patients but not receiving any financial support, and 
often do not realise they may be classed as “carers” (Olsen et al. 2005). These results 
support the fact that this study is looking at “family members”, as opposed to “family 
caregivers” or “carers”. Most of the family members experiencing an impact on their lives 
would not have been eligible for the study if they were required to be carers, and many of the 
important issues surrounding the lives of the family members would have been overlooked. 
When designing studies involving family members it is important to consider whether it is the 
190 
 
impact on the family or family member, or the impact on the caregiver which is to be 
measured, and how the “carer” status will be assessed. 
Several of the partners and spouses of patients interviewed in this study reported marital and 
relationship problems as a result of the patient’s illness. Parents of unwell children have also 
been shown to report low marital satisfaction and depressive symptoms directly related to the 
severity of the child’s condition (Berge et al. 2006; Golics et al. 2013). Many family members 
found it difficult to accept their changing role in the relationship with the patient; children 
having to look after their parents, and spouses having to act as carers. This was also 
reflected in a study by Boeije and Van Doorne-Huiskes (2003) who explored the difficulties in 
the changing relationships between spouses and patients with multiple sclerosis, and in a 
study of family members of advanced heart failure patients (Aldred et al. 2005). The negative 
impact of patient’s illness on family member’s sex life was an important theme in this study, 
and one which was also identified in a study of family members of patients with overactive 
bladder (Coyne et al. 2010) and prostate cancer (Kornblith et al. 1994). A lack of family 
cohesion was also found to be a predictor of depression in families of patients with HIV 
(Demi et al. 1997), reflecting the relationship identified in this study between the themes 
family relationships and emotional impact. 
Another finding of this study was the impact of illness on the sleep and health of the family 
member, particularly the effects of stress and worry at night. The physical effects of having to 
get up in the night to help the patient were also reported. Sleep was also shown to be a 
major problem in family members of patients with bladder disorders (Coyne et al. 2010) and 
parents of children with cerebral palsy (Davis et al. 2009). The extent of the impact of illness 
on the family members’ health was evident in this study, with family members reporting 
diagnoses of depression and existing illnesses worsening. This study identifies family 
members as a hidden “patient” group, with an apparent “ripple effect” of illness; one patient 
being unwell has the potential to create several more “patients” in the family (Lieberman and 
Fisher 1995). This can then magnify problems with finances and family relationships, in a 
vicious cycle. This hidden burden has a potentially large financial impact on the health care 
system that could potentially be reduced with appropriate family support. This also suggests 
that clinicians should consider not just the health of the patient during consultations, but also 
the potential health problems of the family members as a result. This would be particularly 
applicable in primary care settings where general practitioners often provide care to more 
than one member of a family. Additionally, clinicians should consider the health status of 
relatives and the support available to the family as possible causes or trigger factors when 
making a diagnosis of depression. 
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Many of the problems faced by family members of patients in this study were similar to those 
reported by family members of patients with psoriasis (Eghlileb et al. 2007), including 
stopping going on holiday abroad, restricted activity on holiday, or feeling worried or 
uncomfortable whilst away on holiday. The frequency of dialysis appointments for patients 
with chronic renal failure also causes problems for families trying to organise holidays 
(Reynolds et al. 1988). Typically, people use holidays as a method of relaxation, and from 
this study it was evident that many families of patients were either unable to go on holiday or 
experienced problems when they did go away. This meant that they were not getting the 
relaxation or escapism they needed, which could potentially increase the levels of stress they 
feel on a daily basis. Not only were their levels of stress increasing and their lives being 
affected on a daily basis, they were not able to experience the break from every day routine 
which most people take for granted. Many of the family members also found that the services 
available to them when they were on holiday, for example mobility services, were inadequate 
and difficult to acquire. These are services which need reviewing or improving if family 
members are to have any chance of enjoying holidays.  
Many of the family members in this study felt uncomfortable asking for the support they 
required, something which is reflected in a study by Brown et al. (2003) who found that many 
families of paediatric patients with intellectual disability were dissatisfied with the amount of 
support they received from others. This study also found that families did not have time to 
seek out social support services, linking to the “Time planning” theme found with the family 
members interviewed. Caregivers of cancer patients also reported problems with medical 
care, similar to those found in this study including difficulty getting help from professional 
organisations and problems co-ordinating different healthcare professionals (Osse et al. 
2006). “Disability-related support” was identified as an important factor in the family quality of 
life of children with disabilities (Summers et al. 2005). With such difficulty in accessing 
funding and support available to them, many family members claim carer benefits, especially 
if they are unable to work. If appropriate social support was provided, many of the family 
members may have been able to continue working, reducing the burden on government 
financial resources.  
This study found that many family members had problems with their work or study as a result 
of the patient’s condition, with a minority (9%) having to give up work altogether. This was 
similar to findings in other studies. For example, caregivers (5%) of breast cancer patients 
had to give up work completely (Grunfeld et al. 2004) and many also used up their holidays 
to care for the patient. For family members of patients with multiple sclerosis, it was not just 
the strain of loss of work they felt, but also the problems with adjusting to the loss of income 
as a result, and even just the threat of lost income caused financial stress (De Judicibus and 
McCabe 2007).  
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Family members in this study described the financial impact of having to travel to hospital 
appointments, or to visit the patient in hospital. This particular financial aspect was also 
identified in families of children with thalassaemia major (Clarke et al. 2009) and children with 
chronic illnesses in general (Gannoni and Shute 2010).  Many of the other financial issues 
mentioned specifically by family members across all specialties in this study were also 
identified in family members of children with chronic diseases (Gannoni and Shute 2010), 
including the cost of food items and employment.  
The impact of illness on the social life of family members was an issue for family members in 
this study, particularly when they felt restricted to looking after the patient. Social well-being 
was identified as an important issue for family quality of life in family members of children 
with disabilities (Poston et al. 2003), who reported impact on their own friendships. As a 
result of a restricted social life, and having to cancel planned activities, family members of 
patients with advanced heart failure feel isolated (Aldred et al. 2005) and stop seeing their 
friends and family. The Impact on Family Scale (Williams et al. 2006), to assess the impact of 
paediatric chronic illness on the family, also contains several items relating to social impact, 
including seeing friends and family less, changing plans at the last minute and having little 
desire to socialise. These are also all examples given by family members in this study. 
Time planning was a significant problem for family members in this study as a result of 
having an unwell relative. This was also reflected in a study by Basra and Finlay (Basra and 
Finlay 2007) who found that family members of dermatology patients also had trouble 
planning their time around caring for the patient. In turn, families of patients with chronic pain 
have been shown to cope better with the situation if family rituals and routines are 
unchanged (Bush and Pargament 1997) something which family members in this study found 
very difficult to do. 
Although several positive themes were also found during the interviews (for example, the 
illness bringing the family closer together), these were not included as items in the FROM-16, 
as the intention of the instrument was to measure the negative impact. Equally, themes 
relating to areas of life which cannot be changed were not selected as individual items, as the 
measure has been designed to be used to assess change in family quality of life as a result 
of specific interventions. For example, during the development process, the item “I have had 
to give up work/retire early” was incorporated into a general item about work, as retiring is 
something which, although not impossible, could often not be easily changed as a result of 
an intervention.  
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Quantitative work and study design 
The quantitative stage of the study was carried out in 25 of the 26 specialities originally 
involved in the study during the qualitative phase. The speciality which was excluded from 
the quantitative analysis was mental health, as the outpatient community clinics proved very 
difficult to recruit from in the time available. The community-based clinics only saw a handful 
of patients a day and often family members did not attend with patients or did not want to 
take part in research studies. A second consultant clinician was drafted in to help with 
recruitment efforts but recruitment was unsuccessful. Although this means that the FROM-16 
did not involve family members of patients from mental health in its initial validation, several 
of the patients with other conditions had mental health co-morbidities including depression 
and anxiety. Further speciality-specific validation of FROM will be required in the future.  
The development of the final version of the FROM-16 was carried out using a combination of 
content validity panel feedback, Rasch and factor analysis. This three-way approach 
combined the traditional classical test theory approach, which has been heavily criticised 
(Prieto et al. 2003), with the modern approach of Rasch analysis which is becoming more 
commonly used for item reduction, and the qualitative voice of the family members and 
experts on the content validity panel. Although the use of Rasch analysis for item reduction is 
not routinely used alone, the use of a pure statistical method to remove items from a 
measure was recently criticised at the 2012 International Society for Quality of Life Research 
conference during the Industry Advisory Committee symposium (2012), where it was felt that 
the “patient voice” would be lost. This had already been taken into consideration during the 
design of this study, where a combination of methods was used for item reduction. As 
expected when three methods were used, there was some tension between the results 
produced by each method. The first tension arose between members of both content validity 
panels (expert and family members), where different members of the two panels had 
opposing views about some items. This highlighted the importance of the focus group 
discussion for the cognitive debriefing of the FROM, which allowed these issues to be 
debated between the members of each panel until a consensus was reached. Generally, 
when the family member panel disagreed with the expert panel, the view of the family 
member panel was taken, as the instrument was designed for their use. The qualitative and 
quantitative feedback was drawn from a large number of judges from mixed backgrounds, 
increasing confidence that changes made to the items were representative of the general 
population of family members, and were clinically relevant across a range of specialties. The 
second tension arose between the results of the Rasch analysis and the content validity 
panel results. Great care was taken during the Rasch analysis to refer back to the concept 
elicitation interviews and to ensure that the views of the family members were represented in 
the measure. This included taking into account the endorsement rate of each item and 
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considering the reasons why the item could be performing badly according to the Rasch 
model before removal or re-wording.  
The most challenging decision made as a result of the Rasch analysis was the collapsing of 
the five response categories down to three and deciding upon uniform scaling across all 
items. This goes against the most common practice of collapsing response categories in 
different ways for different items (Lamoureux et al. 2008). However, the aim of the FROM 
was to be an easy to use and easy to score instrument, and it was strongly felt that having a 
complex non-uniform scoring system would jeopardise the usability of the FROM. It was also 
thought that non-uniform scoring would put an unwanted emphasis on certain items. This 
decision was made with the views of the family members in mind and was an example of 
where the statistical methods and reality of the proposed use did not mirror each other. In the 
process of factor analysis, another example of tension between the methods was seen, 
where wording of the qualitative interviews was consulted when deciding upon on which 
factor to place a highly cross-loading item.  It was therefore felt that the item reduction of the 
FROM was executed in the most robust way possible, considering both the statistical and 
scientific methods alongside the human voice of the content validity panels. This careful 
balance and step by step approach to item reduction was considered one of the strong points 
of the FROM-16 development and was reflected by the successful validation of the measure. 
The naming of the measure and the two domains was an important part in the development 
of the FROM-16. The name “Family Reported Outcome Measure” and the acronym “FROM” 
are instantly recognisable and self-explanatory. They also differ from the existing family 
measure names, and fit well alongside the area of patient reported outcomes (PROMs), 
suggesting that the measure is defining a new concept, which is different from PROMs, but is 
of similar importance and significance. The memorable and innovative name “FROM” will aid 
in its promotion and publication. The two FROM domains were named “emotional” and 
“personal and social life”. These names were chosen to reflect the content of the items 
contained within them, but following discussions regarding naming, an interesting 
observation was made. When describing patients’ health-related quality of life, three domains 
are often considered: physical, psychological and social (Phillips 2008). The FROM-16 
contains the psychological and social domains, but lacks a physical domain. This observation 
makes sense when assessing family quality of life, as the FROM-16 is not designed to 
measure the physical problems of the family members themselves; the physical domain 
would be relevant to the unwell patient, but less relevant (or irrelevant) to the healthy family 
member. The FROM-16 should be scored as two individual domain scores, as the results of 
the Rasch and factor analysis proved that a total score was inappropriate and the measure 
was made up of two different constructs. As with this study, in future work the total score of 
the FROM-16 could be used for comparison with other measures, but the individual domains 
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should also be assessed separately. For clinical purposes, and when assessing family 
members on an individual basis, the two domains should be scored separately.  
Although the numbers of family members recruited from each specialty was small, the mean 
total FROM scores were still calculated for each specialty. This gives a preliminary idea of in 
which specialties family members are most affected, though disease-specific data will be 
needed before any clear conclusions can be drawn. The disease areas where family 
members scored most highly on the FROM were oncology, neurology, haematology and 
chronic pain, where the diseases tend to be very disabling, with few cures and long-term 
treatments, often with severe side-effects. On the other hand, ophthalmology, where 
conditions tend to have a gradual onset, and orthopaedics, where many illnesses are cured 
operatively produced the lowest FROM scores.  
The reliability of the FROM was demonstrated by a high Cronbach’s alpha (0.91) and high 
ICC (0.93) for test-retest reliability. The minimum acceptable value for α varies between 
authors (Clark and Watson 1995; Heppner et al. 1992), and it has been suggested that for a 
measure to be used clinically, the α should be above 0.9 (Ponterotto and Ruckdeschel 2007), 
a criterion met by the FROM. As the items came directly from the family members 
interviewed and used language taken from the interview transcripts, it was expected that the 
reliability would be high, as the family members would be able to relate to the items and have 
no trouble understanding them or relating them to their own experiences. The choice of time 
interval for follow up in a test-retest analysis was an important consideration (Pallant and 
Tennant 2007). A retest interval of between two and 14 days is usually considered 
acceptable (Streiner and Norman 2008), so an interval of 7-14 days was considered 
appropriate for this study. The use of postal and email follow-up, freepost return envelopes 
and a second round of follow up for non-responders proved successful, and produced a 
moderately high response rate.  
Positive results were seen from both construct validity tests. Ideally, an existing measure 
measuring the same, or similar concept would have been used to assess the construct 
validity. However, as already identified, no such measure exists. One option would have 
been to make alterations to an existing measure in order to use it as a comparator for  
content validity, but as it was unclear whether the results of this study would be similar to 
previous studies of family members of paediatric patients, or carers, this approach was 
considered inappropriate. Instead, two a priori hypotheses were tested in relation to the 
concept of the FROM-16. For the first hypothesis, the scores of the FROM were compared 
with the scores of a generic quality of life measure, the WHOQOL-BREF. The WHOQOL-
BREF was chosen as it is widely used and has strong psychometric properties (Skevington 
et al. 2004), so it would be robust enough to rely on to measure the intended concept. The 
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correlation between the two measure scores was -0.55 (p<0.001). This correlation is within 
the range expected by the study team, as the relationship between family and patient quality 
of life has been already demonstrated with similar correlations in disease-specific studies 
(Basra et al. 2007; Kornblith et al. 1994; Weitzenkamp et al. 1997). It was also unknown how 
strongly the concepts of family quality of life and patient quality of life would be correlated in 
most of the disease areas before the study, so the study team did not expect a very high 
correlation. Considering this proven link between patient quality of life and family member 
quality of life, it would be interesting to see whether providing support for the family member 
and improving their quality of life would improve the quality of life, and even the health of the 
patient (Rees et al. 2001). 
During the construct validity testing, many of the family members commented about how 
much easier the FROM-16 was to complete, in comparison with the WHOQOL-BREF. Family 
members struggled with the wording and meaning of some of the items of the WHOQOL-
BREF, for example questioning what was meant by the item “How healthy is my physical 
environment?”. This often meant that the family member spent longer than anticipated with 
the investigator during this stage of the study, and often assistance was required from the 
investigator to complete the WHOQOL-BREF. Although the completion of the instrument was 
not timed in this study, it has been suggested that the WHOQOL-BREF can be completed by 
healthy individuals in under five minutes (Skevington et al. 2004). However, this was not 
consistent with the family members in this study, who often took longer than five minutes, 
and in some cases up to 15 minutes to complete the WHOQOL-BREF. Whilst not officially 
timed, an estimate of time taken to complete the measure was made by the investigator, in  
relation to the total time the family member spent with the investigator. It is possible that the 
family member population in this study and in the WHO study (Skevington et al. 2004) varied 
in terms of demographics, explaining the difference in completion time. However, using a 
different, more simple and easy to use generic measure may have increased the speed of 
data collection and put less burden on the family members completing the measures.  
The second hypothesis assessing whether the impact of illness on family member’s QoL is 
correlated to the health of the patient, using the global health score, resulted in a correlation 
of -0.51 (p<0.001). This is a relationship which has been widely demonstrated in previous 
disease-specific studies (Balkrishnan et al. 2003; Reiter-Purtill et al. 2008; Zashikhina and 
Hagglof 2009), and so the correlation was expected to be stronger in this study. This 
moderate correlation either suggests that family members are unable to accurately predict 
the health of the patient across all specialties, in contradiction to previous evidence 
(Housman et al. 2002), or that the family member’s life is not impacted more greatly when 
the patient’s health is low. This finding may suggest that family members are affected by a 
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patient’s illness regardless of the severity of that illness, and that their quality of life is not 
reduced further when the patient’s illness is more severe.  
The lack of sensitivity to change data produced from the study is considered to be a limitation 
and is also discussed later in this chapter. Sensitivity to change is an ongoing process, often 
completed over a course of several months or years, and involving intervention studies, 
where a change in patient disease state is likely, or expected. The time limitations of this 
study meant that only a preliminary sensitivity to change study was designed, with 25 family 
members of patients recruited. The patients were not subjected to an intervention, and the 
results from the sensitivity to change study found that only two of the family members had 
reported a change in the patient’s health state and were therefore eligible for the analysis. 
This meant that the numbers were too small to analyse, so no sensitivity to  change data 
resulted. This could have been avoided by tying the sensitivity to change study in with a 
clinical intervention, or change in treatment. This is planned as a future study.  
Evaluation of the FROM-16 
The newly developed FROM-16 instrument is designed for “real life” use. Throughout the 
development of the measure, great emphasis was put upon the usability and simplicity of the 
FROM-16. With a growing number of quality of life instruments being developed and several 
disease-speciality family measures already in existence, the FROM-16 must be able to show 
advantages over existing measures, and be attractive to researchers and clinicians to use on 
a regular basis and not purely as a research tool.  The title, instructions, items, response 
options and scoring of the measure are all contained on one A4 page. This reduces the 
chance of sections of the FROM-16 being lost during photocopying or pages being 
separated, and means that the completed FROM-16 can be filed alongside other A4 clinical 
notes. The single-page measure is also more appealing to family members, as the measure 
looks short and concise, and lack of completion from not noticing a second page is 
eliminated. The number of items in the FROM-16 is an additional factor in assisting its 
usability, as only 16 items are needed to capture the extent of the family impact of illness. 
During the design of the FROM-16 it was decided that the language used would be simple 
and the items should be readable by family members of all backgrounds and reading 
abilities. One of the ways this was implemented during the design process was by choosing 
not to include examples or lengthy explanations in the FROM-16 items. High readability was 
proven by the mean item length (5.6 words) and the Flesch readability score of 64.7. These 
factors lead to a short mean completion time of two minutes for the FROM (n=108). This 
short completion times gives the FROM-16 an advantage over other longer quality of life 
measures and will place less burden on the questionnaire administrator as the FROM-16 can 
be completed and scored easily and quickly.  The quantitative content validity statistics can 
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be used to further evaluate whether the FROM-16 is successful in its design aim to be simple 
and easy to complete yet inclusive. All family members thought that the FROM was easy to 
complete, the response options were straightforward and the instructions were clear. The 
feasibility and acceptability of the measure were reinforced by the low volume of missing 
data in the cohort completing the final version of the measure. Furthermore a great majority 
thought that the FROM-16 items covered all areas of their life which had been affected. This 
demonstrates that family members see the FROM as user friendly and have few problems 
with completion. 
As well as that of being user friendly, there are additional advantages to producing a concise 
and simple measure. In the future, the measure may be required to be translated into 
different languages. The simplicity and shortness of the items will allow for ease of accuracy 
of translation and the simple response option labels will help to reduce ambiguity during 
translation. This increases the international use potential of the FROM-16. Although the 
FROM-16 has proven high readability and simplicity, it also has the potential to be made 
even more user-friendly. For example, pictures or cartoons could be added next to each item 
to aid visualisation of each item for those with low literacy skills, and to help focus the mind 
for each item.   
When evaluating the properties of the FROM-16, it is important to compare it to existing 
measures available to identify its strengths and weaknesses. The FROM-16 is shorter than 
the existing family measures, including the Impact-on-Family Scale (Stein and Riessman 
1980), the Beach Center Family Quality of Life Scale (Hoffman et al. 2006), the Family 
Quality of Life Survey (Issacs et al. 2007) and the Family Strain Questionnaire (Ferrario et al. 
2004), and has a shorter completion time. Of the four measures mentioned, the Impact-on-
Family Scale (IOF) has the shortest completion time of 10 minutes compared to the time of 2 
minutes for the FROM-16. The IOF also has the shortest number of items; 24 compared to 
the 16 items of the FROM-16. The Family Strain Questionnaire Short Form, developed in 
2010, contains 30 items and can be completed in five minutes (Vidotto et al. 2010). The 
FROM-16 also has the advantage over existing measures that it was developed from 
interviews with family members of patients rather than from existing literature, so contains 
items derived directly from the words of family members themselves. This is an advantage 
over existing measures developed from literature and expert opinion (Ferrario et al. 2004; 
Issacs et al. 2007). The main advantage of the FROM-16 over other “family” measures is that 
it contains items designed for any family member of any patient with any disease. This is 
unique to the FROM-16 as the other measures identified all specify disease populations. For 
example, the existing measures have been designed for use in family members of paediatric 
patients (Hoffman et al. 2006; Stein and Riessman 1980) or caregivers of patients (Ferrario 
et al. 2004; Issacs et al. 2007). Although the measures have been designed for different 
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populations, similar domains and item themes to the FROM-16 can be seen. Both the 
FROM-16 and the other four measures identified contain domains and items relating to an 
emotional impact. Other overlapping themes include family relationships (Ferrario et al. 2004; 
Hoffman et al. 2006; Issacs et al. 2007)  and financial impact (Issacs et al. 2007; Stein and 
Riessman 1980). Interestingly, the majority of the domains covered in the previous family 
measures are also covered in the FROM items. For example, the Family Strain 
Questionnaire contains a domain specifically called “thoughts about death”(Ferrario et al. 
2004). Although this is not covered directly as an item in the FROM-16, there are several 
items relating to emotional impact which could be used to express this feeling, for example 
items about feeling worried or sad. One potential disadvantage of the FROM-16 over other 
measures is that it is restricted to self-administration use only. The Impact-on-Family Scale 
has the option to be interviewer administered if the family member has poor literacy skills 
(Stein and Riessman 1980). The FROM-16 has not been validated for interviewer 
administration and although self-administration would be the preferred methods of 
administration, there may be some benefit in carrying out a separate validation study in those 
with low literacy skills. A gap analysis study involving the FROM-16 and the four existing 
family measures would also be an interesting and beneficial future study, to understand the 
novel, specific themes which have been uncovered during the development of the FROM-16. 
Although it is difficult to make direct comparisons between the FROM-16 and disease-
specific family measures, many similarities were seen between themes and items in the 
disease-specific family measures. The Overactive Bladder Family Impact Measure (Coyne et 
al. 2010) contains items about difficulties with travel, social activities, caring for the patient, 
frustration and sleep, which are also contained in the FROM-16. In turn, the Family 
Dermatology Life Quality Index (Basra et al. 2007) contains items about emotional impact, 
relationships, social life, burden of care and work which are also contained in the FROM-16. 
The majority of items contained in disease-specific measures are covered by the 
comprehensive, generic items of the FROM-16. For example, the Quality of Life in Life 
Threatening Illness - Family Carer Version (Cohen et al. 2006) uses the term “distressed” for 
one of its emotional items. It is likely that this would be covered by the FROM-16 items of 
feeling sad, worried or frustrated. As “distressed” is such an extreme and emotive word, it 
would be expected that a family member would select the “A lot” response option to convey 
their experiences using the FROM-16. When making comparisons between the disease 
specific measures and the FROM-16, it is also important to bear in mind the target 
population. The Quality of Life in Life Threatening Illness - Family Carer Version (Cohen et 
al. 2006) is designed for carers of cancer patients and so contains items such as “Over the 
past two days (48 hours) I wondered if the place [the patient] was staying (home, hospital, 
other) was the right place to be”. Items like this may be specifically carer-related and 
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therefore not always applicable to the family members in this study, as many of them did not 
see themselves as caring for the patient, but were still affected by their illness. This all-
inclusive aspect of the FROM-16, designed for family members who are not necessarily 
carers allows much broader use across family members compared to other measures. 
In order to further assess whether the FROM-16 is likely to be appropriate for use in family 
members of patients with a wide range of illnesses, includes relevant themes and has the 
potential to be used as an alternative to existing measures, the content of the FROM-16 was 
compared with two of the identified disease-specific family measures. On reviewing the 10 
items in the Family Dermatology Life Quality Index (Basra et al. 2007), 90% were covered by 
items in the FROM-16. The only item not included related to an increase in housework. In 
some situations, this may be covered by the FROM-16 item “Caring for my family member is 
difficult”. On reviewing the 19 items in the Overactive Bladder- Family Impact Measure 
(Coyne et al. 2010), 95% were covered by items in the FROM-16. The only item not covered 
specified a feeling of guilt. Other items were approximated by the FROM-16, for example 
feeling annoyed (FROM-16 item containing the term “angry”), or impatient (FROM-16 item 
containing the term “frustrated”). This gives assurance that it is likely that FROM may be 
used appropriately in families with a sufferer of these diseases, though this of course will 
eventually have to be specifically tested in a prospective study. Concerning those items not 
covered by the FROM-16, these are all themes which were identified during the qualitative 
analysis in this study, and were developed as items in the developmental version of the 
FROM-16. It may be that different versions of the FROM are required for different specialties, 
but this is unknown without further testing.  
In previous work looking at the impact of illness on family members, and on those closest to 
the patient, this impact has been referred to as a “secondary impact”. In one dermatology 
study, the close social group around the patient affected by the impact of the patients’ illness 
was described as the “Greater Patient concept” (Basra and Finlay 2007), an analogy to a city 
with a nucleus and surrounding suburbs. The authors of this study suggested that  this term 
could be applied to specialties other than their own. Throughout the course of this study, 
these terms to describe the impact of illness on family members were considered in relation 
to the themes and experiences described by the participants.  It was felt that the term 
“secondary impact” was generally unsuitable when describing the impact of illness on family 
members. Although the impact is “secondary” to the patient and their illness (it affects 
someone other than the patient themselves), the impact is a “primary” impact, as it is being 
described by the family members and relates directly to the way that they feel and the ways 
their lives are affected. The impact can be seen as “secondary” to the patient, but it is 
important to consider it is “primary” to the family member as it being reported directly by 
themselves. This terminology should be considered when designing and reporting studies 
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using the FROM, and whether the focus of the study is primarily on family members, or is a 
secondary outcome of a patient-related study. As the term “secondary impact” was felt not to 
always be appropriate to the impact of illness on family members, the term “family impact” 
was felt to be more focused and offer more clarity. 
At all stages of the study the family members gave feedback about the importance of the 
study, the study design and the end product, the FROM-16. The comments made by family 
members were positive and encouraging. One of the most common comments made by 
family members was regarding the high importance and relevance of the study, and about 
how they had not had the chance to talk about the impact on themselves before. Family 
members talked about how infrequently they were asked about their own feelings, both by 
their own family and friends and also by healthcare professionals. This meant that their 
feelings often stayed bottled up inside and as a result built up rather than being resolved. 
During the interviews, many family members had to be reminded, or re-directed to talk about 
the impact on themselves, and not the patient, as they were so used to talking about the 
patient and how they were affected. Many found it difficult to talk about their feelings, as this 
was the first time they had been asked about the impact on themselves, and a surprisingly 
high number of participants became visibly emotional, especially during the qualitative 
interviews. Although all were given the option to withdraw from the interview when they 
became upset, all participants insisted on continuing, suggesting that they understood the 
importance of the study and were both willing and keen to participate. The past experience 
and training undertaken by the interviewer helped to ensure that participants felt comfortable 
during the interview, and this was proven by the rich, in-depth personal information obtained. 
Family members also recognised that other members of their own family were affected and 
could benefit from this study, and many expressed how they wished that all of their family 
could be interviewed individually. During the validation stage of the study, many family 
members commented informally about the items in the FROM-16, particularly how relevant 
they were to them, and how all of the important areas of their life had been included in the 
measure. One particularly memorable quote from a participant was: 
“This questionnaire is spot on. How did you come up with the questions? It’s covered 
everything, it’s like you have jumped into my head. My wife and I had an honest discussion 
the other day about how her illness has affected me and these were just the kind of things 
we talked about”. 
As well as the informal feedback from family members, there was informal feedback and 
involvement from patients.  Many of the patients involved in the study encouraged their 
family members to take part and felt that it was important that their views were heard. Many 
said that they recognised the impact that their illness was having on their family member(s) 
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and the lack of interest in the area, and they thought the family member should be offered 
more support. This was echoed by the collaborating consultants in the study, who strongly 
recognised the importance of being able to measure the impact of illness on family members 
of patients. As this area of research is not widely recognised and has been largely 
overlooked in the past, it was expected that the consultants may have had reservations 
about the study or not recognise its potential relevance to their clinical practice. Involving the 
consultants so closely in the recruitment of participants and designing of the FROM-16 gave 
the investigator a real-life insight into their opinions and reactions to the study. From the 
initial invitation meeting with each consultant, through to the dissemination of the study 
results, many expressed their personal interest in the study and suggested ways they would 
like to use the FROM-16 in the future. At each stage of the study, the clinicians were 
interested in the results obtained and offered their input and suggestions with regard to the 
development of the FROM-16. The overwhelming positive and enthusiastic feedback from 
both family members and clinicians was unexpected, but reflected and strengthened the 
views of the study team regarding the importance of the study. The interest in the study from 
healthcare professionals is also encouraging for the future use of the FROM-16 and the 
development of the research area. 
Potential scope and usage 
Access and future use of the FROM 
As the first generic family quality of life measure, the FROM has the potential to be used in a 
wide variety of situations. These range from being used clinically to identify areas of family 
members’ lives which are affected, to being used as a secondary endpoint in a clinical trial of 
a new drug. When choosing to use the FROM, it is important for the investigator to identify 
their goals for using the measure, to familiarise themselves with the scoring of the measure 
and to plan how the results will be used to meet their goals. It is planned that permission will 
usually be given to any researcher who wishes to use the FROM, and that it will be easily 
accessible to researchers through a dedicated website. Clinicians or patients who wish to 
use the FROM for routine clinical use will be able to do so directly, without seeking 
permission, by downloading the FROM from the website. Members of the FROM study team 
will be available to guide researchers on the use of the FROM, and a manual will be 
available detailing the patient and family member populations used in the development of the 
FROM, the use and scoring of the FROM and information regarding the validation of the 
measure. Researchers will be encouraged to use the FROM both as a single tool, and 
alongside other measures as part of larger projects. 
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Clinical trials 
Due to the robust development of the FROM and its extensive validation, the measure has 
the potential to be used in clinical trials of pharmaceuticals sponsored by the industry, for 
example as a secondary endpoint. As well as demonstrating that a new drug treatment or 
device benefits a patient in terms of symptom control or quality of life improvement, 
pharmaceutical companies will now be able to show that a drug treatment has an impact on 
the lives of family members of patients.  Although no specific guidance is offered by 
regulatory agencies with regard to the measurement of impact of illness on family members, 
the FDA have issued guidance relating to the use of patient reported outcome measures in 
trials (FDA 2009). This guidance advises that such measures should have demonstrated 
validation including the implementation of several of the psychometric tests carried out during 
the validation of the FROM, including test re-test and construct validity. In order to be used in 
a clinical trial, the FROM will need to have demonstrated responsiveness to change, 
something which has not been tested during this study, but will need to be addressed in 
future work. The FDA also recommends that patient reported outcome measures are re-
validated in the intended population within the trial. In particular, re-validation of content 
validity is important, through the process of cognitive debriefing, as there remains a 
possibility that new concepts that are not covered by the FROM could emerge for specific 
diseases, though the extensive and excessive interviewing beyond saturation in the 
qualitative study make this unlikely.  Although the reporting of family quality of life is a new 
concept within clinical trials, FROM could have a potential role in assessing treatments which 
through their effect have a potential impact on the family. It is as yet unknown whether 
regulatory agencies such as the FDA or EMA might in the future accept label claims relating 
to the impact of a treatment on families of patients as well as on patients themselves, 
however the simplicity of the FROM allows for the possibility of the measure to be 
incorporated into a trial as an additional measure with minimal cost or time burden. The FDA 
already recognises the influence of the family in the field of patient reported outcomes, as 
their 2009 guidance states that PRO instrument items can be developed from “literature 
reviews, transcripts from focus groups, or interviews with patients, clinicians, family 
members, researchers, or other sources”(FDA 2009). Interest in, and use of, the FROM in 
the commercial and industrial world has the potential to influence regulatory agencies to 
issue specific guidance on the use of family measures in trials.  
Service provision 
The FROM also has the potential to be used in service provision and treatment regulation. 
Health Technology Assessment (HTA) authorities such as the National Institute for Health 
and Clinical Excellence (NICE) in the UK have shown an increasing interest in using patient 
reported outcome measures in development of treatment algorithms and guidelines (Doward 
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et al. 2010). The FROM has the potential to be used alongside patient measures in service 
provision, particularly when a new treatment has a possible benefit to families. One example 
of the potential use of the FROM in service provision could be, say, in the context of an 
expensive treatment with a once weekly hospital-based administration, when a current thrice-
weekly treatment has shown to have an impact on both the patient and the family members’ 
lives. The inclusion of a family-based measure, particularly in diseases where families are 
highly impacted or involved in care and treatment, would encourage assessing clinicians to 
take a more family-centred approach to treatment and service provision.  
The development of the FROM-16 also provides the opportunity for the exploration of utility 
data relating to family members of patients. Patient health states relating to different FROM-
16 scores could be developed and the utility values for family members of patients with 
different diseases could be calculated using the standard gamble or time trade-off (TTO) 
methods. The attributes for each health state could be developed for family members using 
the items of the FROM-16 and the qualitative data from this study. Utilities for family 
members could be calculated and attached to the FROM-16. The FROM-16 utility data could 
be then used as an additional tool in service provision, for example in the evaluation of 
pharmaceuticals by NICE, alongside patient utilities (Brazier 2008).  
Disease education and support services 
Due to the comprehensive nature of the FROM and the items being derived from the 
experiences of family members themselves, the measure has the potential to be used in 
disease education programmes. Although disease education programmes exist for patients, 
few support programmes are available specifically for families. In this study, we have 
identified the great need for support for families of patients with chronic illness, and both the 
qualitative results and themes and the FROM itself could be used as the basis for setting up 
a generic national family support group. A few support groups exist in the UK for families of 
patients with specific diseases, for example Rethink who provide support to family members 
and patients with mental illness (http://www.rethink.org/index.html). Many other disease-
specific support and education websites focus on “carers” and so may be unsuitable for, or 
seem inaccessible to, family members. There are extensive online resources available for 
patients, including websites with directories of patient agencies, but no such website exists 
for family members of patients. The qualitative themes identified in this study could be used 
as a basis for planning the areas of support provided by a generic family support service, and 
the FROM has the potential to be used as a screening tool to identify areas of concern for 
family members participating in such a support group. As many of the family members 
interviewed in this study expressed relief at being able to open up and talk about the impact 
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on their lives, and expressed feeling “alone”, access to a support group and being able to 
meet others in similar positions may also have a positive impact on family members’ lives.   
In addition to being used as a guide to establishing family support services, the FROM also 
has the potential to be included in existing services to improve understanding of the family 
impact of disease. For example, the FROM could be used in existing patient education 
programmes, to indicate that the service providers are interested in taking into account the 
views of the patient’s family, and to tailor some of their course material towards  the 
secondary impact of disease. The FROM could be given to family members of patients in 
advance of the course and the results used to inform the course leaders of the family themes 
deemed important to cover during the programme. Support could then be offered in relation 
to these themes in particular. This use of the FROM has the potential to improve 
communication between patients and members of their family, and to encourage them to talk 
about and address issues which are affecting both family members and patients. One of the 
major themes identified in this study was “Family Relationships”, and using the FROM in 
educational programmes with family members and patients could help to address some of 
the components of this theme, including communication between the patient and family 
member and arguments and tensions within the family. The items in the FROM provide 
family members and patients with starting points for discussions and common terminology to 
use when talking about the impact of disease. 
Support and care for family members could also be provided through established community-
based patient programmes such as the Expert Patients Programme 
(http://www.expertpatients.co.uk/). This programme already has elements of family-related 
support, such as a specific parent programme and the use of software designed to help 
patients and family members communicate about their experiences of living with a disease. 
The use of a generic family measure like the FROM could help to assess the impact of the 
illness on families and identify specific areas where they require support. The short 
completion time and ease of scoring mean that the FROM could easily be incorporated into 
existing programmes. The FROM could be used to identify any change in family quality of life 
before, after or during the programme and could be used as a tool to evaluate the 
effectiveness of such programmes on families as well as patients.  The standardised scoring 
of the FROM and the lack of weighted items means that it could also be used to compare the 
effectiveness of two or more different support or education programmes, and be used in 
advertising claims for such groups. 
Research 
Being the first measure of its kind, the FROM has many uses and roles within research. The 
existence of a generic family measure now allows for the field of secondary impact of 
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disease and family impact to be explored more widely. Comparisons can be made between 
the family impact of different diseases, different treatments for the same diseases and the 
impact on different family members within one family. Findings from disease-specific family 
studies can be compared to findings in the same population using the FROM. The 
relationship between patient and family quality of life will be able to be further explored using 
the FROM as a key tool in this research area. As well as individual research studies, larger 
population and social studies looking at the impact of illness on family members will now be 
possible to be carried out using the FROM as the primary research tool. For example, the 
impact of illness on family members of patients could be compared between geographical 
areas, NHS trusts, or GP practices, looking at both the extent of the impact (total FROM 
domain scores) and the areas of most concern (endorsement percentages of individual 
items). The development of the FROM opens up a whole new field of healthcare research, 
one which has previously been largely untouched and unable to be measured. The potential 
impact on medical and social research is considerable, with the FROM being able to play a 
key role in many types of studies.  
Clinical use 
The FROM has the potential to be used widely in clinical environments. The use of the 
FROM in clinical practice could have many of the same previously reported advantages of 
using patient reported outcomes in clinical practice (Greenhalgh et al. 2005). The use of the 
FROM before or during consultations with the patient and family member(s) could encourage 
a more family-centred approach to care. In clinical practice, the FROM could be used as a 
tool in multi-disciplinary team meetings to improve communication between healthcare 
professionals, encouraging them to discuss and act on decisions regarding patient care and 
treatment which have an impact on family members, and consider this potential impact when 
starting new treatments. As well as improving communication between healthcare 
professionals, use of the FROM empowers the patient to raise family issues during 
consultations and to make the clinician aware of the impact of their disease on their family. In 
the same way that previous research has suggested that partners attend medical 
consultations with patients to be given the chance to discuss issues relating to the family 
(Rees et al. 2001), it may also be of benefit for other family members to be invited to attend 
consultations with the patient, with the FROM being used as a tool to identify issues for 
discussion. 
Currently, if a clinician wanted to measure the impact of illness on a patient’s family, they 
would have to use a disease-specific measure, if an appropriate one existed. There is a lack 
of evidence of the routine use of disease-specific measures in clinical practice, and many 
authors of these measures are very vague about their potential for future use, for example 
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suggesting use in “research and clinical settings”(Coyne et al. 2010). Furthermore, there is 
no evidence that these existing measures are comparable in their scoring, so the clinician 
would be limited to measuring the impact of one disease. From this study, it has been 
hypothesised that the FROM could be used across all disease areas, as a generic measure. 
It can be used to compare the impact of illness on the family across the whole of medicine, 
for example when measuring the impact of a patient with more than one illness. This is 
particularly useful in general practice, where a general practitioner may wish to evaluate the 
impact of several illnesses on family members of patients. The FROM is therefore more 
flexible in its scope of use than existing disease-specific family measures and may replace 
the use of them in many clinical areas. 
The FROM can be used to address a number of goals in clinical practice, many of which 
complement the goals and uses of patient reported outcomes in clinical practice (Greenhalgh 
et al. 2005; Snyder et al. 2011).  The FROM could be used as a secondary measure when 
assessing the improvement or worsening of a disease, or when comparing or assessing 
treatments. It gives the clinician extra useful and relevant information to work with alongside 
the patient’s clinical and QoL data when making decisions regarding patient care. As well as 
being used as an assistive monitoring tool, the FROM could also be used as a screening tool 
in clinical practice to detect potential patient problems. Used routinely, the FROM could 
identify problems with the patient’s management or treatment which are not necessarily 
having a large impact on the patient, but have an impact on the family. With its short 
completion time, using the FROM routinely would cause minimal burden to the clinician or 
family member.  
Challenges 
In general, clinicians feel it is appropriate to discuss quality of life issues with patients and 
see quality of life information as important (Greenhalgh et al. 2005). However, these findings 
are only in relation to patient data, and not data concerning the impact of illness on family 
members. The use of patient reported outcome measures in clinical practice is a relatively 
new area, and one which is still in early stages of exploration and use in many disease 
areas. Will the introduction of the concept of measuring family quality of life in clinical 
practice be too ambitious given the lack of routine collection of patient data in clinical 
practice? The area of family impact of disease is one which will be new to the majority of 
clinicians as until a concept can be measured, it has a minimal profile or “existence” with 
more importance in the scientific world. The results of this study and the publication of the 
FROM could subtly alter the mindset of the medical profession in terms of placing the patient 
in a more family-centred context. As well as altering the mindset of the medical profession, 
this study is also likely to produce data which is a big challenge to the profession, as the 
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impact of illness on families has been shown to be great but largely overlooked. At the 
moment, the impact of illness on family members is generally ignored, and this study 
challenges the medical profession to respond to this significant issue and identify ways to 
support family members of patients.  
As well as changing the mindset of the medical profession in general, there may be a need 
for individual healthcare professionals to alter their practice and their way of thinking, and to 
accept the fact that the family burden of disease is so great. Whilst this poses a hypothetical 
challenge to individuals, the positive and enthusiastic response to the study by healthcare 
professionals involved is encouraging. The majority of healthcare professionals recognised 
the importance of the study results and the need for a generic family outcome measure, 
particularly in specialties where family measures do not already exist.  
From the experiences of the study team, it is apparent that healthcare professionals are 
already routinely thinking about how illness affects families, with many clinicians providing 
examples specific to their speciality during the focus group discussions. In particular, the 
nurses involved recognised the great impact of illness on family members through working 
closely with patients in their home environment. The challenge posed by the results of this 
study is how to bridge the gap between the knowledge and ideas of the healthcare 
professionals and using this information, along with the FROM, to inform and improve clinical 
practice.  
Study implications 
 The literature review presented in this thesis identified that no previous study or 
measure exists to assess the impact of illness on family members of patients over a 
wide range of conditions. The literature review will help future researchers understand 
the gaps in the area and an overview of the previous related work.  
 
 The qualitative interviews with family members of patients from 26 specialties 
identified 10 key family quality of life themes. These themes may be used in the 
future development of this area of research, and direct researchers towards the areas 
of importance for family members. In addition, this could inform development of an 
organised generic family support group. 
 
 This study highlights the importance of using an appropriate definition of “family” 
when carrying out research in the area, and the impact that disease has on family 
members of patients who are not necessarily carers. 
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 This study highlights the extent of the impact on family members, which has been 
previously immeasurable in most specialties. It identifies a hidden area of healthcare 
which needs to be explored and studied further. 
 
 This study provides a comprehensive and robust way of measuring the impact of 
illness on family members of patients.  
 
 The results of this study demonstrate a relationship between patient quality of life and 
family member quality of life. This relationship has not been shown in a generic 
context before. 
 
 The results of this study demonstrate a relationship between the health of the patient 
and the family member quality of life, as seen before in individual disease areas, but 
never in a generic context. 
 
 Preliminary information about which specialties are most affected has been provided, 
and this can be investigated further by future research.  
 
 This study has shown how both Rasch and factor analysis can successfully 
complement each other in the development of an outcome measure. This is an 
approach which can be explored further in future studies. 
 
 This study provides information which challenges the mindset of the medical 
profession to develop strategies to address the unmet need identified.  
 
 The measure produced in this study (the FROM) has implications for use in clinical 
practice, research, disease education and support, clinical trials and service 
provision.  
Limitations 
Although the study was designed to the highest possible standards, there were still a number 
of limitations: 
 Although the literature search carried out during the study was structured it was not 
strictly systematic (according to PRISMA guidelines), meaning that some papers 
could have been missed during the search. It is difficult to assess the likelihood of this 
happening, and if there were no time constraints associated with the study a 
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systematic review would have been carried out. This would have ensured that no 
existing publications were missed during the literature search.  
 The majority of participants were White British. It is possible that culture and ethnicity 
could influence the way family members are affected by illness, and some themes 
could be of greater importance to specific cultural groups. This could be determined 
by further sampling of family members of patients from different ethnic backgrounds. 
It is also important to be aware of potential cross-cultural issues with the FROM-16, 
as translation has been suggested as potential future work. The assessment of 
quality of life in different cultures depends upon a variety of factors including cultural 
based illnesses, perception and response to illness and religious and social 
behaviours (Bullinger 1997). It is likely that there will be specific cultures where the 
items of the FROM-16 are not applicable to family members, particularly those which 
are very different to the western society in terms of views on illness and ways of life. 
As well as the aspects of life the FROM-16 covers, it is important to consider the 
concept and definition of “family” when assessing the cross-cultural suitability of the 
FROM-16. For example, in traditional Indian cultures where women are often 
considered subordinate to men, and elderly family members often remain with their 
families (Mullatti 1995), many of the items of the FROM-16 may be irrelevant. For 
example, the female family members may not go out to work, or have knowledge of 
the household financial situation. In turn, when an elderly member of the family is 
unwell, the other family members may feel that it is their duty to care for them, and 
many of the emotional questions in the “Emotional” domain of the FROM-16 may be 
irrelevant, or even offensive to individuals of this culture. Further testing and content 
validity studies using the FROM-16 in different cultures are required, to measure the 
extent of its cross- cultural relevance.  
 
 The median age of family members during the qualitative and quantitative stages of 
the study were 56 years and 53 years respectively.  Although the age range of family 
members was wide, ranging from 18 years old to participants in their 90s, the median 
age was high, suggesting that the sample was not representative of the full age 
range. However the number of patients interviewed who were aged 18 – 40 was 24. 
This could result in some of the items in the FROM being less relevant to younger 
family members. This could be determined by carrying out a large scale study with 
equal numbers of family members across all age categories. 
 
 Several of the items in the FROM contain the word “impact”, but do not specify 
whether this impact is positive or negative. As discussed in chapter 3, the aim of the 
FROM was to measure only the negative impact of illness on family members of 
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patients, as the positive effects were so rarely seen during the interviews. Using the 
word “impact” suggests that the items can be answered positively or negatively, but 
the scaling chosen does not permit positive responses to be recorded; only negative 
and neutral. This is a limitation of the measure, as it may be seen as confusing for 
some family members and affect the way that they respond to items. This may have 
been avoided by wording all of the items in a clearly negative way, or allowing for 
positive scoring. As the positive effects were so rarely seen during the interviews, the 
most suitable option would have been to word the items negatively. This may have 
improved the clarity of the measure.  
 
 Another limitation is that not all medical conditions from each specialty were 
represented fully, both in the qualitative and quantitative phases of the study due to 
time restrictions of the study. Physicians were asked to select patients with different 
conditions best representing their specialty. This expert knowledge and the large total 
number of interviews carried out beyond the saturation point helped to ensure a 
representative sample. However, there is still a chance that selection bias may have 
occurred during the identification and recruitment of participants as purposive 
sampling was used (Tongco 2007). This method of sampling was chosen by the 
investigators as it provides a cross section of rich, detailed data and in the case of 
this study, it ensured that a wide variety of patient medical conditions were sampled. 
Although we presume that the FROM is generalisable with respect to family members 
of patients with all diseases, this should be demonstrated definitely for individual 
diseases or disease areas. 
 
 The small numbers of patients and family members collected from each speciality 
could also be considered a limitation of this study. However, the qualitative interviews 
proved that there were a limited number of ways family members lives are affected, 
and commonality was seen across the specialties. Furthermore, during the face 
validity testing, 87.4% of family members felt that the FROM covered all areas of their 
life which had been affected, and the majority of the feedback comments provided to 
explain this were concerned with individuals’ examples of items, which were covered 
more broadly (e.g. “There is no item to cover the fact that I am worried whenever my 
son leaves the house”). This is also reflected in the fact that although the interview 
saturation point was number 40, interviews were continued to 133.  
 
 The majority of family members in the study were sampled from patients in secondary 
care settings including hospital wards and outpatient clinics. Only one of the 26 
specialties in the study was based in general practice. It is possible that additional 
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themes specific to family members of patients in primary care settings would have 
been revealed if a larger sample was taken from primary care. This limitation can be 
addressed in the future by carrying out a detailed content validation study in family 
members of primary care patients.  
 
 Due to the small sample size and the lack of intervention or change in patient disease 
state, no reliable sensitivity to change data emerged from this study. This is the only 
psychometric data lacking for the FROM, and the lack of evidence of responsiveness 
to change limits the potential use of the FROM as it is currently presented. It is 
possible that reducing the number of response categories from five to three during 
the Rasch analysis decreased the responsiveness and sensitivity (and therefore 
power) of the measure as this produced a smaller range of possible total scores and 
differences between family member quality of life scores are less prominent and 
subtle differences in scoring may be unable to identify In order to be used in many of 
the ways proposed by the study team, the FROM must undergo further sensitivity to 
change studies to ensure its reliability for use in interventional research. This is 
proposed as a future study. 
 
 Although the FROM has been designed to be used in any family member of a patient, 
a high proportion of the family members sampled in this study were partners. 
Although parents, siblings and children were also represented, this could have had an 
impact on the themes identified, and they could be considered to be more orientated 
towards partners of patients. A future large-scale study involving a sample of many 
different family members would determine the extent of the potential partner bias in 
the study. 
 
 During the psychometric testing, a web-based version of the FROM was used. This 
web-based tool was not tested for its equivalence to the paper version of the FROM. 
This could have potentially introduced bias into the study for those family members 
who used the web-based tool. This is a limitation which can be corrected in future 
work, though there is no reason to think that the paper and web versions will not be 
equivalent. 
 
 The FROM and the WHOQOL-BREF were used as comparators in the construct 
validity stage of the study. However, these two measures have different recall periods 
(immediate and last two weeks), which may have affected the answers given by 
participants. The influence of this on the construct validity is unknown but expected to 
be minimal. 
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 One possible limitation of the FROM-16 is that the closeness of the relationship of the 
family member to the patient could distort their perception of the disease impact. This 
could result in exaggeration or underestimation of certain areas of impact and skew 
the resultant measure score. However, as the impact on the family member is 
subjective, this bias could prove negligible. The extent or certainty of this impact has 
not previously been demonstrated, but the availability of the FROM-16 now allows the 
possibility of specific studies to address this. 
Future work 
 A large-scale multi-specialty study using the FROM is planned. A larger number of 
family members of patients from each specialty or disease area will be sampled, and 
further information regarding the scoring distribution and properties of the FROM will 
be collected. During this study, a greater number of patient conditions will be 
sampled, and the larger sample size will enable further testing of the psychometric 
properties of the FROM. The summary data from such a study could be used as a 
baseline or comparator for further studies, or when validating the measure in specific 
diseases. A large-scale study will provide information as to which items on the FROM 
are most highly endorsed by family members, and the areas where family members 
need more support. Further comparisons will be made with family members of 
patients between different specialties, and specialties where family members are 
most greatly affected will be identified.  
 
 The original 31 items of the developmental version of the FROM could be re-visited, 
alongside the qualitative data to produce several different versions of the FROM. 
These could vary by length and intended purpose of use; for example, a short version 
could be produced with one or two summary items from each of the two FROM 
domains. Computer adaptive testing (CAT) could be used to produce a dynamic 
version of the FROM with items varying depending upon relevance to the patient’s 
disease. New versions of the FROM will need to be psychometrically re-validated to 
the same robust standards as the original FROM-16 measure. Producing a number of 
different versions of the FROM will increase its use potential and practicality, but 
could result in confusion for potential users. 
 
 In this study, only one family member from each patient was sampled. Future studies 
could include using the FROM as a tool to compare the effects of a patient’s illness 
on different members of the family, and identify those members of the family who are 
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most affected. Separate content validation could be carried out for the FROM within 
different relationship groups, for example parents, children or siblings. Items of the 
FROM which are most relevant for each relationship group could be identified and 
provide information as to the areas of support needed for each family member of a 
patient.  
 
 Although only small numbers of secondary relatives were included in this study, the 
effects of illness on more distant relatives (for example cousins and grandparents) 
could be studied. This could be compared to the results for closer family members, to 
determine the distance that the family impact of disease travels as family members 
less close to the patient are introduced. Other comparison groups within families 
could include those who live with the patient and those who do not (although this 
study suggests that there will be little difference). Families where more than one 
member is unwell could also be compared to families where there is only one patient, 
to assess the effect on the well family members.  
 
 The FROM could be compared with other existing family measures. A high correlation 
would be expected to be seen between the scores of the FROM and the scores of 
other family quality of life measures, due to the similar effects seen on family 
members from different specialties in this study. One interesting piece of future work 
would be to carry out a gap analysis between the FROM and other existing family 
measures, to identify those concepts where the FROM differs from other measures, 
and to further demonstrate the need for a generic family measure. 
 
 As an additional output to the FROM, a conceptual framework and model of family 
quality of life could be designed to represent the themes identified during the 
qualitative work and their relationship to one another. The themes covered by the 
FROM and existing family quality of life instruments could also be included in the 
model.  
 
 The difference between the impact of illness on family members and carers could be 
assessed using the FROM and one of the existing measures for carers of patients. 
This would determine whether there is as much of a difference between the impact on 
family members and carers as was hypothesised in this study. 
 
 A study involving a control group should be carried out with the FROM. The control 
group could be made up of family members of healthy individuals, or patients who 
have been cured of a disease. The inclusion of a control group would help to prove 
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that the impact on family members is a result of the patient’s illness with minimal 
influence from other external factors, therefore strengthening the reliability of the 
FROM. 
 
 During further development and studies involving the FROM, it is important to 
establish population normative values (“norms”)  or the measure. This could include 
norm values for family members of a healthy population, or norm values for different 
disease areas or family members. These norm values can then be used as 
benchmarks for FROM scores and for comparison between different disease areas. 
 
 This study has identified areas of daily activity where family members are affected 
and require support. In future work, any existing family support groups could be 
identified and the areas of support they provide to families could be compared to the 
themes included in the FROM. Additional areas where support for families is needed 
could be identified and included in these support groups. The information gathered 
through the development and validation of the FROM could be used as a basis of 
content for a new family support group or internet network.  
 
 At the moment, the only information provided by the total FROM score for each 
domain is that a higher score is equivalent to a lower quality of life. Banding of scores 
in a future study would aid with score interpretation and the impact that different total 
scores have on family members’ lives. These score bands could be used to identify 
improvement or decline in family member’s quality of life, or could be compared to the 
score banding for generic patient measures. 
 
 The results of the sensitivity to change study were inadequate to provide evidence as 
to the responsiveness of the FROM. Therefore a future large-scale interventional 
study will be required to collect sensitivity to change data. The possibility of using the 
FROM in a treatment intervention study will also be explored. 
 
 In order for the FROM to be accessible and easy to use, an electronic version of the 
measure should be developed and validated. This would enable the FROM to be 
used on electronic devices such as computers, tablets or smart phones. The web-
based measure used in the psychometric testing study should also be tested for its 
equivalence to the FROM to increase the reliability of the test-retest data. 
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 A large-scale study using the FROM in a primary care setting should be carried out to 
identify any differences between the impact of illness on family members in primary 
and secondary care which were not identified during the present study.  
 
 The FROM should be validated in individual disease areas and specialties for future 
disease-specific studies. The psychometric validation procedures outlined in this 
thesis provide guidance on how future disease-specific validation studies should be 
completed. Of particular importance is the content validation and cognitive debriefing 
of the FROM in individual disease areas. 
 
 This study showed a correlation between family quality of life and patient quality of life 
using the FROM and the generic patient measure, the WHOQOL-BREF. Future 
studies could include correlating the FROM with disease-specific patient measures, to 
further improve the construct validity of the FROM.  
 
 One of the many proposed uses of the FROM is in clinical settings. It is important to 
consider how the measure will be integrated into the clinical practice setting and how 
results will be used to influence practice (Snyder et al. 2011). Therefore, it would be 
useful to carry out a feasibility study with clinicians and use the results of this study to 
influence the future recommendations for clinical use of the FROM. 
 
 Although the FROM is designed mainly for use with family members of patients with 
chronic diseases, future studies could be carried out to identify the areas of a 
patient’s specific disease progression where family members are most likely to be 
affected, and therefore require support. For example, the FROM could be 
administered when the patient first experiences symptoms, immediately after 
diagnosis, during different types of treatment, or before and after surgery.  
 
 Several of the specialties included in this study were paediatric specialties. Although 
similar family quality of life themes were seen across all areas of medicine, an 
interesting future study could be to carry out a paediatric-specific study with different 
family members of child patients, and compare the impact of child and adult patients 
on family members. 
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Conclusion 
This study provides new and detailed information into the ways that family members lives are 
affected by patients’ illness. Many of the specialties and disease areas included in this study 
have been previously overlooked in terms of family impact, and the results from this study 
have helped to understand both the individual areas of family members lives which are 
impacted, and also the extent of the impact. The qualitative results have proven that the 
impact of illness on family members is widespread and profound across all disease areas, 
particularly the emotional impact felt by those closest to the patient. This study has also 
shown that family members do not receive enough support to cope with the issues that they 
face, and that these issues are very rarely addressed by healthcare professionals.  
Previously, the term “secondary impact” has been used when describing the impact of illness 
on family members, but this study has shown that this impact is far greater than a secondary 
impact, and that the term “family impact” is more comprehensive and offers more clarity. The 
most important outcome of this study is the Family Reported Outcome Measure (FROM), as 
the concept of family quality of life is now possible to be measured, quantified and brought to 
the attention of healthcare professionals and researchers. This unique instrument is simple, 
easy to complete and score, and this study has shown evidence of its reliability and validity. 
The FROM has the potential to be used in many different settings, including clinical settings, 
clinical trials, research and disease education. The results from this study, and the 
development of the FROM provide a platform for further research into family quality of life.  
Although the numbers sampled from each of the 26 specialties in this study were small, a 
preliminary comparison between specialties was made, and the data showed that family 
members of patients from certain specialties were affected more than others. The study also 
provides further evidence that the patient’s quality of life correlates with that of the family 
member, and that the patient’s health state correlates with the family member’s quality of life. 
These findings should be considered by clinicians when making decisions regarding patient 
care and treatment, and how the family are affected by decisions made. It is hoped that the 
results from this study will help the medical profession to focus towards a key area of 
healthcare which is often overlooked, and give the family members a stronger role in patient 
care, encouraging shared decision-making. The views and needs of family members should 
be taken into account during medical consultations, and new strategies should be put in 
place to provide support to family members as well as patients.  
This thesis described in detail a new, exciting and highly relevant area of medicine. It 
challenges the way that healthcare professionals view patients and families, and provides a 
more detailed and comprehensive picture of the areas of family members ’ lives which are 
affected, and the similarities between medical specialties. It challenges healthcare 
218 
 
professionals to think beyond the patient, and whilst healthcare is often described as “patient 
centred”, this study proves that the impact on the family is a significant issue which needs to 
be considered and addressed by all healthcare professionals.  
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Abdominal wound Duplex kidney system Neuropathic pain 
Acne Dysphagia Non-hodgkin's lymphoma 
Addisons disease Eczema Obesity 
Adenomyeloneuropathy Epilepsy Ostearthritis 
ADHD Fibromyalgia Osteonecrosis of the gums 
Agenesis of corpus couosum Folliculitis of the vulva Osteoporosis 
Alzheimers Gallstones Pancreatic transplant 
Anaemia Glaucoma Pancreatitis 
Angina Global Development Delay Paralysis of vocal chords 
Aortic dilatation GORD Pituitary adenoma 
Aortic Stenosis Gout Pneumonia 
Asthma Haemophilia Polymyalgia rheumatica 
Atherosclerosis Haemophilic arthropathy Primary biliary cirrhosis 
Atopic dermatitis Hayfever Prostate cancer 
Atrial fibrillation Hearing loss Pseudophakia 
Auto-immune hepatitis Heart bypass Psoriasis 
Benign tremor Heart failure Pulmonary embolism 
Bi-polar disorder Hepatitis C Raynaud's 
Bladder cancer Hernia Renal cancer 
Bowel cancer HIV Retinal detachment 
Brain tumour Hypercholesterolemia Rheumatoid arthritis 
Breast cancer Hypertension Rosacea 
Broken jaw Hyperthyroidism Sarcoidosis 
Bronchiectasis Hypothyroidism Schizo-affective disorder 
Bronchopulmonary aspergillosis Idiopathic pulmonary fibrosis Schizophrenia 
Cancer of pharynx Incontinence Sciatica 
Cardiomegaly Irritable bowel syndrome Sleep apnea 
Cataracts Ischaemic heart disease Small bowel cancer 
Cerebral palsy Ischaemic nephropathy Spinal surgery 
Charcot-marie-tooth syndrome Knee replacement Splenic lymphoma 
Chondromalacia patellae Large granular lymphocyte 
leukaemia 
Stomach ulcer 
Chronic back pain Learning difficulties Stroke 
Chronic hyperventilation Leber optic atrophy Talipes 
Chronic kidney diease  Left ventricular failure Talonavicular arthritis 
Chronic pain Leg ulcer Thyroidtoxicosis 
Chronic UTI Leukaemia Total 
Coeliac disease Lichen planus Trigeminal nerve damage 
Colitis Lichen sclerosis Turners syndrome 
Conjunctivitis Lupus Upper GI bleed 
COPD Lymphodema Urinary retention 
Crohns disease Lymphoma Uterine cancer 
Curvature of the spine Macular degeneration Vascular disease 
Dementia Microcephaly Vertigo 
Depression Missing Visual inattention 
Diabetes Motor neurone disease Vulval intra-epithelial 
neoplasia 
Diabetes type 1 Multiple sclerosis Vulvodynia 
Diabetes type 2 Muscular dystrophy Wart on gum 
Diabetic retionopathy Myeloma Wolff–Parkinson–White 
syndrome 
Digeorge syndrome Neuromyelitis optica  
Patient medical conditions, as reported by patients and confirmed by the content of their 
medical notes for the qualitative stage of the study. 
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Stage 2 Family Member 
 
Information Leaflet 
Version 3- 17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Your relative has already agreed to take part in the study, and has given permission for you 
to be approached too. 
Please take time to read the information carefully, and decide if you want to take part.  
Please ask if you have any questions about the study, or if there is anything you find unclear.  
 
What is the purpose of the study? 
 
It is well known that any illness and medical condition can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative.  
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have a relative who has been diagnosed with a medical condition.  
This means you can take part. There will be about 600 other people taking part in the study 
too. 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason.  
A decision to take part or not to take part or to withdraw will not affect the standard of care 
your relative will receive. 
 
What will happen to me if I decide to take part? 
 
The study will involve an informal interview/discussion- you will be invited to talk about the 
ways you think your life has been affected by your relative’s medical condition.  
 
You may decide to take part in the interview now. You can also choose to have the interview 
at your home, or come back to the hospital at a more convenient time. If you decide to come 
back to the hospital, your travel expenses will be reimbursed. 
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This interview will be audio-recorded, but only the study team will have access to these 
tapes. 
There are no tests .You will not need to take any medication.  
 
How long will it take? 
 
It will take on average 30 minutes to complete the interview.  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from this study may 
help improve the treatment of people, and support the families of people with the same 
condition that your relative has. 
 
What are the possible risks of taking part? 
 
We may ask you to talk about effects of your relatives condition which could make you feel 
emotional. If this does happen, you have the option to stop the interview at any point, without 
having to give a reason. We can also support you if this happens, by discussing the problem 
with your relative’s care team if you both agree to this, or by directing you to support services 
or information. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this 
publication if you are interested. 
 
What if there is a problem? 
If there is a problem during the interview, you can ask for the interview to be stopped at any 
time. You will be asked whether you would like the information you have given us to be 
destroyed. 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet.  
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. Your personal data will be kept for up to a year 
after the study has ended, The results of the study will not reveal your name or address. 
 
Examples of how the information you give will be described in publications include:  
 
“A 30 year old female whose husband has been suffering from psoriasis for 10 years 
described feeling frustrated by his condition”.  
 
“One male felt he could not continue with his job as a builder as a result of his father’s 
heart failure” 
 
Sometimes we may use direct quotes, for example: 
 
A 56 year old female described the effect of her sister’s depression on her own social 
life: “ I never go out any more, I worry about her too much”. 
 
 
Who has reviewed the project? 
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All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
Procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
If you have any complaint regarding any aspect, you can contact any of the following:  
 
1. Prof S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
3. Cardiff University (sponsor) Tel: 029 20879130 
 
Contact for further information 
 
If you have further questions, please feel free to contact one of the study team:  
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Stage 2,4,5. Family member 
 
Consent form  
 
Version 2- 08/03/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
  
Code No:                                                                     
                                                                         
                                                                                                                                
 Please initial 
I confirm that I have read the information sheet (Version 3) and 
understand the intent of the study. I also have 
had the opportunity to ask questions, and had these answered 
satisfactorily. 
 
 
 
I understand that my participation is voluntary and that I am                          
free to withdraw at any time without giving any reason and without 
my relatives medical care being affected. 
 
 
 
I hereby, give written consent to participate in the study that                                      
involves me taking part in an interview/ completing a questionnaire 
about the effects of my relative’s medical condition on my life quality. 
I understand that interviews will be audio-recorded. 
 
 
 
I agree to take part in the above study 
 
 
 
 
 
 
  
Name of participant 
 
....................................................................................... 
Date 
 
.......................................................................................  
Signature 
 
........................................................................................  
 
 
Name of investigator 
 
.......................................................................................  
Date 
 
.......................................................................................  
Signature 
 
........................................................................................ 
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Stage 2 Patient 
 
Information Leaflet 
Version 3 – 17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the information carefully, and decide if you want to take part.  
Please ask if you have any questions about the study, or if there is anything you find unclear.  
 
What is the purpose of the study? 
 
It is well known that any illness and medical conditions can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative. 
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have been diagnosed with a medical condition, and are attending a clinic with a member 
of your family, or a member of your family is visiting you in hospital.  
This means you can take part.  
There will be about 600 other people taking part in the study too.  
 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason.  
A decision not to take part or not to take part or to withdraw will not affect the standard of 
care you will receive. 
 
What will happen to me if I decide to take part? 
 
The study will involve an informal interview/discussion with your relative - they will be invited 
to talk about the ways their life has been affected by your medical condition.  
Appendix H 
 255 
 
 
This interview will be audio-recorded, but only the study team will have access to these 
tapes. 
 
You will not need to take part in the interview. 
 
There are no tests (e.g. blood tests, x-rays). You will not need to take any extra medication. 
 
How long will it take? 
 
It will take on average 30 minutes to complete the interview with your relative.  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from the study may 
help improve the treatment of people, and support the families of people with the same 
condition that you have. 
 
What are the possible risks of taking part? 
 
We may ask your relative to talk about effects of your condition which could make them feel 
emotional.  If this does happen, they have the option to stop the interview at any point, 
without having to give a reason. We can also support them if this happens, by discussing the 
problem with your care team if you both agree to this, or by directing them to support 
services or information. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this 
publication if you are interested. 
 
 
What if there is a problem? 
If there is a problem during the interview, your relative can ask for the interview to be stopped 
at any time. You will be asked whether you would like the information they have given us to 
be destroyed. 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet.  
 
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. Your personal data will be kept for up to a year 
after the study has ended, The results of the study will not reveal your name or address. 
 
Examples of how the information your relatives give will be described in publications include: 
 
“A 30 year old female whose husband has been suffering from psoriasis for 10 years 
described feeling frustrated by his condition”.  
 
“One male felt he could not continue with his job as a builder as a result of his father’s 
heart failure” 
 
Sometimes we may use direct quotes, for example: 
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A 56 year old female described the effect of her sister’s depression on her own social 
life: “ I never go out any more, I worry about her too much”. 
 
Who has reviewed the project? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
 
If you have any complaint regarding any aspect, you can contact any of the following: 
 
1. Prof. S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
3. Cardiff University (sponsor) Tel: 029 20879130 
 
Contact for further information 
 
If you have further questions, please feel free to contact one of the study team: 
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Stage 2,4,5. Patient 
 
Consent form  
 
Version 2 – 08/03/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
Code No:                                                                                                                                              
 
 
 Please initial 
I confirm that I have read the information sheet (Version 3)) and 
understand the intent of the study. I also have 
had the opportunity to ask questions, and had these answered 
satisfactorily. 
 
 
 
I hereby give written consent that I have no objection  
if any of my family members wants to participate in the  
study. This involves the participant taking part in an interview or 
completing a questionnaire on the effects that my medical condition 
has on the life quality of my family member. 
 
 
 
I understand that sections of my medical notes may be looked                            
at by study investigators where it is relevant to my family taking part 
in the research. I give permission for these individuals to have 
access to my medical records. 
 
 
 
I agree to take part in the above study 
 
 
 
 
 
 
Name of patient 
 
....................................................................................... 
Date 
 
.......................................................................................  
Signature 
 
........................................................................................  
 
 
Name of investigator 
 
.......................................................................................  
Date 
 
.......................................................................................  
Signature 
 
........................................................................................ 
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Family member & Patient Demographic Data Sheet 
Version 1- 26/08/09 
 
Study Title: The conceptualisation, development, validation and practical 
application of a Generic Family Quality of Life measure. 
 
 
Family member Information 
 
Code number  
 
Initials  
 
 
 
Age 
 
 
 
Gender 
 
 
 
Ethnic Origin 
 
White / Mixed / Asian or Asian British / Black or Black 
British / Chinese / Other ………………………….. 
Relation to patient 
 
 
 
Current Occupation  
 
Patient information 
 
Name/ initials and code number 
 
 
 
Hospital number 
 
 
 
Age 
 
 
 
Gender 
 
 
 
Ethnic Origin 
 
White / Mixed / Asian or Asian British / Black or Black 
British / Chinese / Other……………………..………….. 
Diagnosis 
 
 
 
Other diagnoses  
 
Disease duration 
 
 
Current Occupation  
Socioeconomic Code  
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01/12/11 
 
 
Dear ............................................................................ 
 
Thank you for your interest in being a part of our questionnaire feedback panel.  
 
The information from the interview which I carried out with you last year, and the other 132 
interviews I also carried out, has been used to design a questionnaire for family members of 
patients. The questionnaire will be used to assess the impact of illness on families of 
patients. 
 
We are interested in getting feedback about the questionnaire. I would therefore like to invite 
you to be a part of a feedback panel which will involve an hour long informal discussion with 
myself, my project team and some other family members of patients.  
 
Your attendance at this meeting will be greatly valued. It may not benefit you directly, but it is 
likely that it will help other family members in the future. 
 
The details for the meeting are as follows: 
 
Wednesday 14th December 2011 
2pm-3pm 
Library, 3rd floor, Glamorgan House, Heath Park, University Hospital of Wales, Cardiff, 
CF14 4XW. 
 
Please let me know if you are able to attend by telephoning me on 07791 727553 or email 
golicscj@cardiff.ac.uk as soon as possible. 
 
In the mean time, I enclose a copy of the questionnaire and a feedback form for you to 
complete and bring to the meeting. 
 
If you have any problems or questions please do not hesitate to contact me. 
 
Regards, 
 
Catherine Golics 
PhD Student, Cardiff University 
 
Project supervisors: Professor Andrew Finlay, Professor Sam Salek and Dr Mohammad 
Basra 
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Family Quality of Life research meeting. Wed 14th Dec,12.30, Glamorgan House, UHW. 
  
 
Dear Dr...................................................................... 
 
I am emailing in relation to my PhD project, The Family Quality of Life Study.  
 
You kindly allowed me to attend your clinics/visit patients on your ward/visit your patient’s 
homes last year to carry out interviews with family members of patients.  
 
The content from these interviews has now been used to form a questionnaire to measure 
the impact of disease on family members of patients.  
 
A critical part of validation of the questionnaire is gaining your views on the content and I am 
emailing to invite you to attend a lunchtime discussion group to assess the content validity of 
the questionnaire. 
 
The details for the discussion group are as follows: 
 
Wednesday 14th December 2011 
Dermatology Board Room, 3rd Floor, Glamorgan House (next to Medicentre), UHW. 
12.30pm-1.30pm 
Lunch will be provided 
 
I am also keen to invite specialist nurses in order to gain their views. I would be grateful if 
you could provide me with the contact details for a nurse in your team who may be 
interested. 
 
On your reply to this email I will email you a copy of the questionnaire and a brief pre-
meeting feedback form to complete. I will also post a copy of these documents to you next 
week. Please bring these to the meeting. 
 
If you are unable to attend the meeting it is still critical for this part of the study that we 
receive your feedback. Please complete the feedback form and send it back to me via email 
or internal mail (Room 2.51A, Redwood Building, Cathays Park) before Tuesday 13th 
December. 
 
The meeting will only last one hour, lunch is provided and your attendance will be greatly 
valued. 
 
Regards, 
 
Miss Catherine Golics 
Dr Mohammad Basra 
Professor Andrew Finlay 
Professor Sam Salek 
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Questionnaire feedback form- content validity 
 
Name............................................................................        
 
 
Thank you for agreeing to take part in the questionnaire feedback as part of the content validity.  
Each item on the questionnaire needs to be assessed for language clarity, completeness, relevance 
and scaling. The following definitions are provided to ensure standardisation and so that each person 
has the same understanding of these criteria. 
Please rate each of the questionnaire items on the following: 
 
A. Language clarity: the sentences and wording should be clear, understandable, 
straightforward and simple. Phrases and wording should be unambiguous and jargon free 
and should be understood by someone with a reading ability of 12 years. 
 
B. Completeness:  the sentences should be complete, not broken and should end appropriately. 
 
C. Relevance: each item should be relevant to the subject area and target population. 
 
D. Scaling: the scoring system is a 5 point adjectival scale. Panel members should rate the 
scaling system as to whether the response options fit the question, or not. 
 
PLEASE NOTE- YOU DO NOT NEED TO COMPLETE THE QUESTIONNAIRE YOURSELF. 
 
Item  1: I feel worried 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
  
 
Item  2: I feel angry 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  3: I feel guilty 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  4: I feel sad 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  5: I feel frustrated 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  6: I feel tired 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  7: My behaviour or personality is affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  8: I feel I have no one to talk to about my thoughts 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  9: I feel a burden of caring for my family member 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  10: My housework has increased 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  11: My eating habits are changed 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  12: My family activities are affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  13: My leisure activities are affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  14: My hobbies are affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  15: It is hard to find time for myself 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  16: I need to stay at home 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  17: My every day travel is difficult 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  18: My time is taken up visiting my family member in hospital or attending medical appointments 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  19: My sex life is affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  20: I argue with my family member 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  21: My family expenses have increased 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  22: I experience problems with holidays 
 Strongly agree Agree Disagree Strongly disagree Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  23: I find it hard to plan my time and activities 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  24: My own health or well-being is affected because of my family member’s condition 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  25: My sleep is affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  26: My social life is affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Item  27: I worry about strangers’ reactions to my family member’s condition 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  28: I find it difficult to talk about my family member’s condition 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  29: My work or study is affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
 
Item  30: My relationships with other family members are affected 
 Strongly 
agree 
Agree Disagree Strongly 
disagree 
Any comments: 
Language clarity              
              
Completeness              
              
Relevance              
              
Scaling              
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
General 
comments on 
layout 
The questionnaire layout 
is very simple to use 
The questionnaire is 
too busy for elderly 
people. Could space 
out the questions more 
to reduce chance or 
error. 
Language clarity 
was very good 
The use of grey 
shading in the 
questionnaire 
I wonder if the coloured 
lines for every other 
question would make 
the individual feel that 
these questions are of 
some significance. 
Whether it would be 
better kept plain? 
Grey shading is useful 
as it directs you to the 
line. 
Would prefer to 
not have grey 
shading 
It doesn’t make some 
items appear more 
important than others  
Grey shading is 
good as splits up 
the questions 
Does it look better 
shaded or with dotted 
lines? Could shade 
every line as it’s then 
easy to follow. I agree 
that we need to do 
something to guide 
people to the right 
response. 
I think that having 
dotted lines 
wouldn’t 
encourage people 
to write on them- 
would be a good 
idea 
Could you shade the 
items which are most 
important? That would 
get people to mark the 
items most important. 
There could be 
potential problem with 
grey colouring when 
photocopying/printing. 
The font type and 
size 
 Font size is fine Font size is fine 
General 
comments about 
items 
Generally the question 
wording is relevant and 
straight forward 
You could use 
examples in the items 
Use of examples? 
I think it would be 
useful to remind 
you of things like 
insurance and 
things you don’t 
think of. 
Don’t use “is affected”, 
say if its negative or 
positive 
Examples-I don’t 
think it limits you 
as it’s just 
examples 
Item 1 Should be changed to “I 
am worried” 
I am worried that the 
respondent will tick the 
same response option 
for all of the emotion 
questions  
Clear and relevant 
Item 2 Angry at what?   
Should change to “I am” 
Item 3 Guilty about what?   
Guilty about what? Is 
this disease specific? 
Appendix N 
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
Item 4 No comments   
Item 5 Change to “I am”- it’s 
clearer 
  
Item 6 In what way? Does it matter if 
emotionally or 
physically tired?  
 
Emotionally or 
physically? Or does it 
not matter? 
 
Tired= exhaustion or 
tired= emotional/fed up? 
Does it matter? 
Change to “I am” 
Item 7 Maybe ask two 
questions? 
 What if both are 
affected? They are 
two different things 
Behaviour and 
personality are possibly 
two different things? 
“extremely” does not 
seem to apply. 
Two different 
things- personality 
would be the way I 
am thinking about 
things and 
behaviour would 
be the way I am 
behaving with 
other people. 
These are two 
statements. Personality 
is very abstract- stick to 
behaviour. 
I think one is the 
way you think and 
one is the way I 
communicate with 
others- they are 
different 
Could be changed to 
“has been changed”  
Should be split into 
two questions 
Affected negatively or 
positively? Often out of 
adversity emerges 
positive behaviour 
Item 8 Delete “I feel” Not sure about 
response options, 
especially “extremely” 
Is clear 
Scaling perhaps needs 
to be related to 
timings/frequency? 
Response categories 
aren’t appropriate for 
question 
The response 
scale doesn’t quite 
sound right - would 
be hard to work 
out which word 
fits. 
It’s more of a yes 
or no question, not 
something you can 
quantify 
There are different 
people you can 
talk to about 
different things 
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
Item 9 Needs to be rephrased, 
doesn’t read right 
Burden is a bad word I don’t like burden 
– it’s too emotive. 
You could use the 
word 
“responsibility” 
Not terribly elegantly 
stated! 
Not clear if the burden 
is the patient or family 
mental? 
Burden makes you 
feel like you’re 
blaming the 
patient. I don’t 
regard it as a 
burden, I don’t like 
the word 
? Grammar?  This is a good 
question 
Burden could be 
relevant to some 
people 
Do not like the use of 
the word “burden” 
Will people know what 
this means? Who is 
the burden? 
Responsibility and 
commitment are 
suggestions of 
alternative words 
to use 
The term “burden” is a 
problem 
Could say “it is a 
burden caring for my 
family member” 
How about saying 
it’s time 
consuming? 
I don’t understand this 
statement. Does the 
patient’s relative feel 
that they are a burden or 
that they are burdened 
by the patient? 
Or “I feel burdened” 
Say “caring for my 
family member is a 
burden to me” 
Or “I feel caring for my 
family member is a 
burden” 
Could the question be 
worded “I feel caring for 
my family member is a 
burden” 
I understood what you 
were trying to get from 
that but I didn't like the 
way it was worded. 
Re scaling: “extremely” 
doesn’t fit. Is 
“tremendously” or 
“immensely” more 
appropriate or too 
emotive? 
I think if the patient 
read this, they would 
feel from looking at the 
questions that they are 
a burden. I think they 
already feel a burden 
and seeing these 
questions in the 
extreme then it would 
feel a burden and 
that's what worries me 
about this. I don’t want 
the patient to feel like 
this.  
This question is a true 
representation of how 
people feel and its 
good that someone is 
thinking about them. 
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
Patients are very 
aware of this issue 
and they know about 
the burden they place 
on the carer. 
Item 10 May not be relevant to 
all  
 It’s straight forward 
“Extremely” doesn’t fit 
Item 11 Less time or no 
appetite? 
Should be eating 
habits have changed. 
Yes, relevant 
Either “are” or “have” 
changed? 
Is this negative or 
positive? 
?”diets” 
Eating habits HAVE 
changed. 
Again, “extremely” 
doesn’t fit 
Item 12 Positive or negative? Is this negative or 
positive? 
The term “family 
activities” is clear. 
Activities with my family 
are affected 
How about “my family 
activities are adversely 
affected”? 
Family activities is 
good as affects 
other children too 
Wording unclear. Need 
to define better 
Does my family 
activities mean the 
same as my activities 
with my family? 
I think it means 
you can’t do things 
as a family, maybe 
because the one 
member is ill so 
cant join you. 
? the activities of the 
family as a whole or the 
relative’s activity within 
the family? 
Language clarity is 
poor (explained the 
origins of question), 
wording needs 
changing 
I think it means 
you can’t get 
involved in family 
activities 
Not sure of the 
differences/similarities 
between questions 12, 
13 and 14 
Needs the word 
“shared” i.e. “shared 
family activities”. 
I think it could 
mean if you’re 
tired then you can’t 
do things for as 
long a period of 
time as you’d like 
I think it’s clear and 
can’t see any other 
way it could be 
interpreted. 
I think it’s similar to 
social activities 
Needs clarity 
Item 13 Positive or negative?  I think 12 and 13 
could be linked 
maybe 
What is the difference 
between leisure and 
hobby? 
Item 14 Positive or negative? Big overlap of 13 and 
14. 
13 and 14 could 
be linked but 
leisure activities 
could be more 
social and hobbies 
are by yourself 
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
Items 13 and 14 overlap 
a bit, I’m not sure how 
relevant 14 is? 
Depends on 
interpretation of 
hobbies and leisure 
activities 
I think of leisure 
activities as 
something outside 
the house 
Overlap with 13 13 and 14 are 
repetitive 
Is watching TV a 
leisure activity? 
Yes, I think it is  
13 and 14 very similar- 
drop one 
Leisure and 
hobbies should be 
as 2 separate 
questions 
Do we need this as well 
as 13? Combine 13 and 
14. 
What is the difference 
between leisure and 
hobby? 
Item 15 It is relevant but it’s 
difficult to quantify 
Overlaps with 13 and 
14 a bit 
Clear and fits with 
response 
categories 
Item 16 Why? Need to care? Could say “I am forced 
to stay at home” 
It’s relevant but 
depends on 
people’s situation 
and the illness 
The word “extremely” 
does not really fit 
Or “I feel the need to 
stay at home” 
I don’t think 
“extremely” fits 
well here. “Very 
much” would be 
better. 
I am forced to stay at 
home?  
Couldn’t quite 
understand this item 
Could change to “I feel 
the need to...”. Not sure 
this question is relevant 
at all, what are you 
trying to answer with this 
question? 
Can you say “I can’t 
go out”? 
How about “I can’t go 
out” 
Some people feel they 
can’t leave and other 
people literally can’t 
leave so I think to me 
there are 2 different 
issues.  
Include a “duration” 
reference. Maybe “I 
need to stay at home 
more” or “I need to 
spend more time at 
home” 
I feel the need to and I 
have to are two 
different questions 
 
Would “I feel the need to 
stay at home” be more 
appropriate? 
Item 17 Why? If they can go out and 
do something then 
their travel is probably 
not affected. Do you 
mean if you take the 
patient.....?   
More relevant to 
parents of children 
I think. 
I struggle to understand Could put examples in Every day travel 
 274 
 
Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
what you are getting at 
here? Mode of transport, 
duration, freedom to 
travel or destinations? 
there to make clearer means going out 
somewhere. 
Not sure what you are 
trying to say with this 
question? Is it relevant? 
Not too relevant to 
some specialties 
I think this will be 
more relevant 
depending on the 
age of the relative 
and patient 
This question may not 
obtain the info needed. 
I.e. if the person 
completing the 
questionnaire is still 
going to work they might 
do this without any 
impact. However, if this 
question is “my usual 
travel with my family 
member is difficult” a 
different, more relevant 
answer might be 
obtained 
Is this with or without 
the relative? 
Item 18 This could be two 
questions 
 Fits response 
categories 
These are two different 
points and if the first is 
true then this will 
provide a different 
impact  
Could be two 
questions 
Item 19 Positive or negative? Should not be phrased 
as “intimate 
relationships” as “sex 
life” is clearer and they 
actually mean different 
things - is it physical? 
Yes. 
Wording is obvious 
but shouldn’t use 
more subtle term 
A very important but 
often avoided subject 
“intimate 
relationships” is 
different to sex life. 
Wouldn’t be 
offended by this  
Item 20 Argue more? Does this mean the 
patient? Should this be 
clarified or does it 
mean they argue with 
everyone all the time 
as they are so worried 
about what is going on 
around them? 
How about “I 
argue with family 
members” 
because if you're 
under stress you 
take it out on 
whoever is nearest 
Might be worth clarifying 
the “affected” and not 
other family members 
Whole family or 
patient? The way it is 
worded implies one 
person  
I think it depends 
on whether you're 
trying to find out 
the reaction to the 
person who’s ill 
which is different 
from the general 
family 
Do you need to clarify if 
it’s the ill family 
member? 
Is this in comparison 
with before? Have 
they always argued 
I think there should 
be a question to 
cover the fact that 
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Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
with their family 
member? 
you also argue 
with other family 
members, maybe 
they don’t 
appreciate it. This 
could overlap with 
question 30. 
With the disabled family 
member? Or all? 
As a result of....? 
Is this the family 
member with the 
illness? 
Perhaps “more than 
usual” should be added 
to Q. Many family 
members argue anyway! 
Item 21 Not relevant to me 
What are family 
expenses? 
It sounds good I don’t count things 
up like that 
I wouldn’t think to 
include things like 
hospital parking 
when answering 
this question 
I think insurance 
would come under 
this question too 
Item 22 Why? Is this physically going 
on holiday, school 
holidays, Christmas? 
With the affected 
person?  
Yes, very relevant 
You almost want a 
“because of” at the end 
of the sentence 
It’s not a complete 
question for me. At the 
end there should be a 
because.... 
I think of travel and 
things whilst on 
holiday 
I have problems 
planning a holiday 
You might find that 
people will put “not 
relevant” when they 
mean they can’t go 
anymore, but in a 
sense that is 
“extremely”. We find 
that people do tick “not 
relevant”. It comes 
down to individual 
interpretation. 
I think of insurance 
as well 
Vague? Financial 
implications/lack of 
disabled 
facilities/carrying extra 
luggage/meds/insurance 
costs/decreased mobility 
of patient etc etc. 
That’s down to how 
you introduce the 
questionnaire. You 
need to know if they 
can remember when 
their family member 
was well. Maybe they 
didn't know that family 
member when they 
were well. 
Potential problem 
with people ticking 
not at all/not 
relevant if they 
can’t go at all 
(when they should 
be ticking 
extremely) 
With or without 
relative? 
How about 
“problems with 
going on holiday” 
as holiday could 
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just mean once 
you’re there 
Item 23 Too similar to other 
questions 
 I think it’s relevant 
?repetitive 
Say “it is hard to....” 
Item 24   I think it’s relevant 
Item 25  Is this negatively? Links to item 24 
Item 26 Too similar to other 
questions 
Is this negatively? Straight forward 
 ?repetitive Maybe use 
“deteriorated” rather 
than “affected” 
 
Item 27 Is it different from 
question 1? (I feel 
worried). It’s a negative 
reaction? 
Is the issue worry or 
the reaction? 
(reaction). Not clear if 
it’s a negative 
reaction. 
Relevant.  
Don’t like word 
“strangers”. How about 
“I worry about how 
others will react to my 
family member’s 
condition” 
This is really 
applicable to a lot of 
specialties 
Item 28 Do you mean isolated?  Links to not having 
anyone to talk to 
Relevant 
Item 29 Positive or negative?  Straightforward 
Item 30 Any in particular? Needs clarity Related to 
question 20 
The 
questionnaire 
instructions 
Change opening 
statement to “The 
following statements 
relate to how your life is 
being affected at the 
moment by your 
relative’s condition”. At 
the moment it is 
confusing as has two 
separate tenses. 
You’re asking “has 
been affected” and 
then “at the moment”, 
should it be “is 
affected”? We’re 
talking about the 
present tense. Or “is 
being affected” 
 
The opening statement 
could read .......relate to 
how your life is being 
affected by your family 
member’s condition. (Do 
you need anything more 
i.e. at the moment?) 
Could you put the 
name of the patient in 
the instructions e.g. 
“caring for X”. 
Use the word “mark” 
instead of “tick” 
“At the moment” can 
be different from the 
last 2 or 3 weeks so is 
a time frame better 
than at the moment? If 
it’s for a chronic 
condition then a time 
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frame gives you more 
scope for capture but 
acute intervention 
might carry different 
meaning. Sometimes 
patients can 
misinterpret at the 
moment e.g. in pain 
clinics (before or after 
taking meds).  
People’s interpretation 
of any time frame will 
be different anyway so 
it doesn’t matter which 
one you use. “At the 
moment” will probably 
give you the result you 
want. 
Maybe you could put a 
time frame in brackets 
after “at the moment” 
Putting a time frame 
e.g. a week would 
have a problem for 
some questions e.g. 
holidays, whereas 
present would be ok. 
Use the word “mark” 
instead of “tick”, as 
“tick” may be alien to 
some people. Could 
use “mark clearly”. 
 
Do you want people to 
reflect or answer 
straight away? Might 
need to give them 
some guidance about 
this. 
 
Use of the term 
“family member” 
or “relative”? 
Participants may be put 
off by the use of the cold 
term “family member”, 
who might be their much 
loved child, hence 
suggestion to change to 
“your relative’s 
condition”. 
You say caring for 
your relative but I'm 
worried that in some 
cases they will have 
more than one.  
Family member is 
best as not much 
difference 
Is it worth adding to 
the front page “is there 
more than one family 
member you are 
looking after” or 
another way of putting 
it. 
I think family 
member is 
someone who is 
close to you now. 
Relative could be 
distant 
Could you put how 
many people they look 
after? E.g. a box for a 
Could use close 
family member 
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number? 
Either exclude people 
looking after more 
than one family 
member or include a 
space for them to 
specify how many 
people they look after. 
Use of the term 
“condition”, 
“illness” or 
“disease” 
 Use condition Not disease, 
condition is best Could have a problem 
with “condition” as 
there are 
interventions, 
operations etc.  
The language 
used in the items 
and potential 
translation 
problems 
The language appears 
to be pitched at the right 
level 
Should the questions 
all be negative? (yes) 
The language 
appears to be 
pitched at the right 
level 
“I am” is easier to 
understand than “I 
feel” for translational 
purposes. Especially 
for the emotional 
questions. Possible 
idea. 
Some cultures would 
think you are not 
entitled to these 
emotions as it’s your 
duty. 
Might be translational 
problems with “very 
much”, “extremely” 
etc. In Indian only one 
word for these. Might 
be better with yes/no. 
The use of 
reminders 
throughout the 
questionnaire 
 I think reminders 
should go in 
Just at the top of 
the page 
I think if you space out 
the questions and it 
goes onto the next 
page, so at the top of 
each page would be a 
reminder, not after 
each question as that 
might be confusing. 
Don’t need 
reminders on 
every question 
The response 
categories 
Extremely replaced by 
All the time 
Restrictive. Maybe use 
only 3 categories - 
very much, 
moderately, not at all.  
“Extremely” does 
not fit well. “Very 
much” would be 
better. 
Or, a lot, a little and 
not at all. 
Order of response 
options is OK 
Could leave unlabelled 
boxes between the 3 
response categories 
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At the start of the 
questionnaire you 
should have a number 
scale, or show people 
the number (e.g. 1/10) 
that is equivalent to 
each response 
category. This will 
standardise it and 
have equal intervals. 
Or different scales for 
different items. 
Or just give them the 
scale, numbers not 
any category labels, 
but reliability very low  
Possible translation 
problems with 
response categories. 
Extremely should be 
replaced 
Time scale should be 
used 
Would very much be 
better than extremely? 
Yes it would. 
Order of categories- 
should be the other 
way around. Start 
negatively.  
Makes sense to start 
with negatively- risk of 
getting it wrong 
Generally don’t like 
wording of scale 
throughout 
The use of the 
response 
category “not 
relevant” 
Not sure that not 
relevant option is 
necessary as have not 
at all option. 
Is there a difference 
between not relevant 
and not at all? 
The use of not 
relevant is 
important to some 
questions 
I am not sure I or others 
will understand the 
difference between the 
categories of “not at all” 
and “not relevant”. 
Is “not relevant” a 
relevant category for 
the emotion 
questions? It could be 
given as a response 
option for some 
questions only. 
“not relevant” should 
be removed 
completely (half the 
people agreed) 
Could move not 
relevant to the end so 
it separates them. 
 280 
 
Discussion topic Written feedback Expert panel 
discussion 
Family member 
panel discussion 
Or put on separate 
line? 
The words 
“hobbies” and 
“leisure 
activities” 
Items 13 and 14 overlap 
a bit, I’m not sure how 
relevant 14 is? 
 Items 13 and 14 
overlap a bit, I’m 
not sure how 
relevant 14 is? 
13 overlaps with 14 13 overlaps with 
14 
13 and 14 very similar- 
drop one 
13 and 14 very 
similar - drop one 
Do we need this as well 
as 13? Combine 13 and 
14. 
Do we need this 
as well as 13? 
Combine 13 and 
14. 
The 
demographics 
and utility 
questions 
Should the patient’s age 
be included for ease of 
analysis i.e. to 
specifically break down 
data regarding family 
members of 
paediatrics/elderly 
patients etc? 
I’m wondering why the 
two utility questions 
are separate on the 
front? (I explained it 
was just for 
demographic 
purposes).  
Cant quantify “how 
many hours”- very 
difficult 
Regarding  How many 
hours ….. doing 
housework. 
Some patients’ carers 
might be extremely 
house proud and might 
not be able to do as 
much house work as 
they did previously 
because their relative is 
ill.  Similarly, if a patient 
used to do the house-
work and now their carer 
has taken over, (s)he  
will see an increase in 
the number of hours 
spent. Therefore is this 
information relevant.  
What is it telling 
you???? 
Is the patient’s age 
relevant? It’s different 
for different 
generations. Do you 
have the details of the 
patient anyway? 
Should it be included? 
(decided possibly no). 
“How many hours” 
depends on the 
condition. Would 
be better to put “on 
average”.  The 
examples are not 
necessary, its a bit 
restrictive 
 
Housework is an 
important issue in 
some specialties, but 
is it relevant to all? 
The examples on 
the “how many 
hours” is 
confusing. Think it 
suggests you 
should cross off 
the ones you don’t 
do 
Losing sleep through 
worry and through 
getting up are two 
different things. Worry 
does not necessarily 
impact on life, 
whereas moving 
someone several 
times a night is totally 
different impact on 
your life than worry so 
I think it should be 2 
questions, also “I feel 
worried” is also a 
question. 
Impossible to 
answer.  
General Whilst I understand this We are so focused on  
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comments about 
the project 
is extremely valuable 
work, I am concerned 
that many patients 
already feel 
burdensome and this 
questionnaire might add 
to this feeling. 
As a patient, I would be 
interested to know what 
my carer is being asked 
to complete and how 
(s)he is responding.  
Relationships involving 
patients with chronic 
conditions, as you are 
no doubt aware, are 
under extreme stress.  
Secrecy surrounding the 
questionnaire would add 
to this.  Openness on 
the other hand might 
exacerbate patients’ 
feelings of guilt, 
worthlessness etc.  
Openness might also 
influence carers’ 
responses if they are 
attempting to protect 
their family member’s 
feelings.  It’s so very 
difficult to untangle 
caring   ---- GOOD 
LUCK! 
the patient and totally 
forget about the family 
members. 
It’s not us being 
judgemental - these 
topics have all arisen 
from developmental 
work so they are very 
legitimate 
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Stage 5 Family Member 
 
Information Leaflet 
Version 3-17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Your relative has already agreed to take part in the study, and has given permission for you 
to be approached too. 
Please take time to read the information carefully, and decide if you want to take part.  
Please ask if you have any questions about the study, or if there is anything you find unclear.  
 
What is the purpose of the study? 
 
It is well known that any illness and medical conditions can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative.  
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have a relative who has been diagnosed with a medical condition.  
This means you can take part. There will be about 600 other people taking part in the study 
too. 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason.  
A decision to take part or not to take part or to withdraw will not affect the standard of care 
your relative will receive. 
 
What does it involve? 
 
You will be asked to fill out a questionnaire about the ways your life has been affected by 
your relative’s medical condition. 
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There are no tests. You will not need to take any medication.  
 
How long will it take? 
 
It will take on average 10 minutes to complete the questionnaire.  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from the study may 
help improve the treatment of people, and support the families of people with the same 
condition that your relative has. 
 
What are the possible risks of taking part? 
 
This study involves questionnaires so there are no risks associated with it. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this  
publication if you are interested. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet.  
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. The results of the study will not reveal your name 
or address. 
 
Who has reviewed the project? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
Procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
 
If you have any complaint regarding any aspect, you can contact any of the following:  
 
1. Prof. S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
3. Cardiff University (sponsor) Tel: 029 20876017 
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Contact for further information 
 
If you have further questions, please feel free to contact one of the study team:  
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Stage 5 Patient 
 
Information Leaflet 
Version 3-17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the information carefully, and decide if you want to take part. 
Please ask if you have any questions about the study, or if there is anything you find unclear.  
 
What is the purpose of the study? 
 
It is well known that any illness and medical conditions can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative. 
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have been diagnosed with a medical condition, and are attending a clinic with a member 
of your family, or a member of your family is visiting you in hospital.  
This means you can take part. There will be about 600 other people taking part in the study 
too. 
 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason.  
A decision to take part or not to take part or to withdraw will not affect the standard of care 
you will receive. 
 
What does it involve? 
 
In this study, your relative will be asked to fill out a questionnaire about the ways their life has 
been affected by your medical condition. 
 
You will not need to fill out a questionnaire. 
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There are no tests (e.g. blood tests, x-rays). You will not need to take any extra medication. 
 
How long will it take? 
 
It will take on average 10 minutes for your relative to complete the questionnaire.  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from the study may 
help improve the treatment of people, and support the families of people with the same 
condition that you have. 
 
What are the possible risks of taking part? 
 
This study involves questionnaires so there are no risks associated with it. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this 
publication if you are interested. 
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet. 
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. The results of the study will not reveal your name 
or address. 
 
Who has reviewed the project? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
Procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
 
If you have any complaint regarding any aspect, you can contact any of the following:  
 
1. Prof. S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
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3. Cardiff University (sponsor) Tel: 029 20879130 
 
Contact for further information 
 
If you have further questions, please feel free to contact one of the study team: 
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Stage 6 Family Member 
 
Information Leaflet 
Version 3-17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Your relative has already agreed to take part in the study, and has given permission for you 
to be approached too. 
Please take time to read the information carefully, and decide if you want to take part.  
Please ask if you have any questions about the study, or if  there is anything you find unclear. 
 
What is the purpose of the study? 
 
It is well known that any illness and medical conditions can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative.  
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have a relative who has been diagnosed with a medical condition.  
This means you can take part. There will be about 600 other people taking part in the study 
too. 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason. 
A decision to take part or not to take part or to withdraw will not affect the standard of care 
your relative will receive. 
 
What does it involve? 
 
In this study, you will be asked to fill out a questionnaire about the ways your life has been 
affected by your relative’s medical condition.  
Appendix Q 
 289 
 
 
Your relative will be asked to fill out a questionnaire about how their life has been affected by 
their medical condition. They will also be asked to rate their health on a scale. 
 
We will ask if we can contact you and your relative by post, to send you a questionnaire after 
the study. This is optional. You can still take part in this part of the study if you do not want to 
be contacted by post. 
 
There are no tests. You will not need to take any medication. 
 
How long will it take? 
 
It will take on average 10 minutes to complete the questionnaire.  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from the study may 
help improve the treatment of people, and support the families of people with the same 
condition that your relative has. 
 
What are the possible risks of taking part? 
 
This study involves questionnaires so there are no risks associated with it. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this 
publication if you are interested. 
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet.  
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. The results of the study will not reveal your name 
or address. 
 
Who has reviewed the project? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
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Procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
 
If you have any complaint regarding any aspect, you can contact any of the following:  
 
1. Prof. S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
3. Cardiff University (sponsor) Tel: 029 20879130 
 
Contact for further information 
 
If you have further questions, please feel free to contact one of the study team:  
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Stage 6 Patient 
 
Information Leaflet 
Version 3 – 17/05/10 
 
Study Title: The conceptualisation, development and validation of a generic Family 
Quality of Life measure. 
 
We are investigating the impact of illness on the quality of life of the patient’s family. 
 
Invitation 
 
You are being invited to take part in this study. Before you decide whether to take part, it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the information carefully, and decide if you want to take part.  
Please ask if you have any questions about the study, or if there is anything you find unclear.  
 
What is the purpose of the study? 
 
It is well known that any illness and medical conditions can have a big impact on a patients’ 
quality of life, in terms of physical discomfort, psychological distress and social problems.  
Several studies have also looked at the effect of particular conditions on the patient’s family 
members, and how their lives have changed as a result of living with an ill relative.  
We intend to gather information on the quality of life of the family members of patients with a 
wide range of illnesses. 
This information will then be used to develop a questionnaire to measure family quality of life.  
Eventually, it is hoped that this information will lead to increased patient care, with the views 
and needs of the patient’s family being further understood and taken into account when 
making treatment decisions. 
 
Why have I been chosen? 
 
You have been diagnosed with a medical condition, and are attending a clinic with a member 
of your family, or a member of your family is visiting you in hospital.  
This means you can take part. There will be about 600 other people taking part in the study 
too. 
 
 
Do I have to take part? 
 
No, it is up to you whether you take part.  
If you do decide to take part you will be asked to sign a consent form after reading this 
leaflet. 
If you to decide to take part you can still withdraw at any time without giving a reason.  
A decision to take part or not to take part or to withdraw will not affect the standard of care 
you will receive. 
 
What does it involve? 
 
You will be asked to fill out a questionnaire about how your life has been affected by your 
medical condition. You will also be asked to rate your health on a scale. 
 
In this study, your relative will be asked to fill out a questionnaire about the ways their life has 
been affected by your medical condition. 
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We will ask if we can contact you and your relative by post, to send you a questionnaire after 
the study. This is optional. You can still take part in this part of the study if you do not want to 
be contacted by post. 
 
There are no tests (e.g. blood tests, x-rays). You will not need to take any extra medication. 
 
How long will it take? 
 
It will take on average 10 minutes to complete the questionnaire  
 
What are the benefits of taking part? 
 
We cannot promise the study will help you but the information we get from the study may 
help improve the treatment of people, and support the families of people with the same 
condition that you have. 
 
What are the possible risks of taking part? 
 
This study involves questionnaires so there are no risks associated with it. 
 
What happens when the research stops? 
 
The results will be used as part of a PhD thesis and will be published in a scientific journal.  
You will not be identified in any report or publication. You will be provided with a copy of this 
publication if you are interested. 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the will be addressed. Contact 
numbers for the study team are given at the end of this leaflet.  
 
Will my taking part be kept confidential? 
 
All the information which is collected from you will be kept strictly confidential. Each person 
involved is given a code number for confidentiality. Only the investigators will have access to 
your details that link with the code number. The results of the study will not reveal your name 
or address. 
 
Who has reviewed the project? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by South East Wales Research Ethics Committee. 
 
Who is funding the project? 
 
The project is being funded by Cardiff University. 
 
What should I do if I have any complaints about the conduct? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions [029 20876017]. If you remain 
unhappy and wish to complain formally, you can do this using the NHS Complaints 
Procedure. Details can be obtained from Cardiff and Vale University Health Board website 
[http://www.wales.nhs.uk/sitesplus/864/page/40894].  
 
 
If you have any complaint regarding any aspect, you can contact any of the following:  
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1. Prof. S. Salek Tel: 029 20876017 
2. Cardiff and Vale University Health Board Tel: 029 20743742 
3. Cardiff University (sponsor) Tel: 029 20879130 
 
Contact for further information 
 
If you have further questions, please feel free to contact one of the study team:  
 
1. Prof. A.Y Finlay  Tel: 029 20744721 
2. Catherine Golics (investigator) Tel: 029 20 8760 17 
 
3. Dr M.K.A Basra Tel: 029 2074 5874 
  
4. Prof. S. Salek Tel: 029 20 8760 17 
  
Thank you for taking time to read this and for your help. 
 
Project Protocol Version 10- 17/05/10 
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Family Reported Outcome Measure (FROM)© Feedback  
 
 
 
Please answer the following questions about the FROM: 
 
 
 
1. Is the questionnaire easy to complete?  
 
Yes    No 
 
 
2. Are the response options for the questions straight forward? 
 
Yes    No 
 
 
3. Are the instructions and statements clear? 
 
Yes    No 
 
 
4. Do the questions cover all the areas of your life which have been 
affected by your family member’s illness? 
 
Yes    No 
 
 
If no, what has been missed? 
............................................................................................................................. ...
................................................................................................................................
............................................................................................................................. 
 
Thank you 
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Date: 
 
Dear Sir/Madam, 
 
You were recently approached to take part in a Family Quality of Life research project. At the 
time you completed a questionnaire looking at the impact of your family member’s condition 
on your life. 
 
As part of the project we are sending participants another copy of our questionnaire to 
complete 1-2 months later. We would be grateful if you could complete the enclosed 
questionnaire and the global health score and return them to us in the stamp addressed 
envelope provided as soon as possible. 
 
We cannot promise that the study will help you but the information that we get from this study 
may help improve the treatment of people, and support the families of, people with the same 
condition your relative has. In order for the study to be successful, it is important that we 
have a high number of questionnaires returned. 
 
If you would prefer to complete the questionnaire online, please visit 
https://www.surveys.cardiff.ac.uk/family ,  or you have any questions, please contact 
Catherine on 02920 876017 or GolicsCJ@Cardiff.ac.uk. 
 
Yours faithfully, 
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Family member interview guide 
 
Introduction 
 Remind participant that the information they give is confidential. 
 Remind participant that the interview will be tape recorded. 
 Remind participant that they can terminate the interview at any time. 
 Tell the participant that the purpose of the interview is to find out how their lives have 
been affected by having a relative with a disease, and encourage them to answer 
questions as honestly as they can, giving examples when possible.  
 
Opening question 
 Can you tell me about any ways your life has been affected by your family member’s 
condition? 
 
Main interview questions (overview) 
 Can you tell me how living with someone with your relative’s condition makes you 
feel? 
 Can you tell me what things in particular make you feel like this? Can you give 
examples? 
 Do your activities change as a result of feeling like this? If so, how? 
 How do you cope with feeling like this? 
 Who do you talk to about feeling like this? 
 Do you use any support services eg websites/counseling to help you with your 
feelings? If so, what do you use and why? 
 How does your relative’s condition affect your social life? 
 Can you think of any social activities that you used to do which you can’t now as a 
result of your relative’s condition? 
 What effect does your relative’s condition have on your day to day activities?  
 Does your relative’s condition have any effect on your housework? If so, how?  
 What effect does your relative’s condition have on your friendships with others, both 
friends and strangers? 
 Has your relative’s condition affected any relationships in your family? If so, how? 
 Do you feel that any of the family member’s roles or responsibilities have changed as 
a result of your relatives condition? Can you explain how? 
 Do you buy anything special of different as a result of your relative’s condition? Can 
you explain what and why? 
 Do you have any financial problems associated with your relative’s condition? What 
are the cause of these? 
 Does your relative’s condition affect your job at all? If so, how?  
 Has your relative’s condition affected going on holiday at all? If so, how?  
 Does your relative’s condition affect your sleep? If so, why?  
 Has your relative’s condition affected your health at all? If so, how?  
 Have you changed what you eat at all? If so, how? 
 Do you have any support from people or groups? Can you tell me more? 
 Has your sex life been affected at all? (partners only) If so, how? 
 
Closure 
 Is there anything else you can think of that you haven’t told me? 
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 Is there anything else you would like to discuss? 
 Thank you for your time.
  
 
 
